[{"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1490910304, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/62h1vw/durable_responses_with_singleagent_ibrutinib_in/", "gilded": 0, "id": "62h1vw", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/62h1vw/durable_responses_with_singleagent_ibrutinib_in/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "BpxpiTJ-MqysIS4R-KBMVmaic5OAtPqUseLMASE7R58", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/AulphgsPKEny0ti5VBeIG96r6EgSI2UJhEf93iIsva0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=93285471951a1b398cac31e330ee4fce", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/AulphgsPKEny0ti5VBeIG96r6EgSI2UJhEf93iIsva0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=523e170278f740c5500919963b3cc8e8", "width": 216}, {"height": 214, "url": "https://i.redditmedia.com/AulphgsPKEny0ti5VBeIG96r6EgSI2UJhEf93iIsva0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=29516d0cb15e1a78c5ee20d4f2a54368", "width": 320}, {"height": 428, "url": "https://i.redditmedia.com/AulphgsPKEny0ti5VBeIG96r6EgSI2UJhEf93iIsva0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=7fd3dae81713de3a8ad723a16f47d821", "width": 640}], "source": {"height": 485, "url": "https://i.redditmedia.com/AulphgsPKEny0ti5VBeIG96r6EgSI2UJhEf93iIsva0.jpg?s=6c08ab655ef9e8f6994fde522624d35e", "width": 724}, "variants": {}}]}, "retrieved_on": 1492471591, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/_XYtQBhb2TQxWmpSvQ0B3wlqB9n5TvZXXsZR6FXm6qM.jpg", "title": "Durable Responses With Single-agent Ibrutinib in CLL/SLL", "url": "http://www.cancertherapyadvisor.com/hopa-2017/ibrutinib-chronic-leukemia-cll-durable-response/article/647264/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1490546450, "domain": "iflscience.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/61mh2o/not_cll_specific_major_breakthrough_could_enable/", "gilded": 0, "id": "61mh2o", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 1, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/61mh2o/not_cll_specific_major_breakthrough_could_enable/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "rzRAVBdTMzWK53vB-ge9j_-lU6TBJg1w_RB0poxxLfA", "resolutions": [{"height": 60, "url": "https://i.redditmedia.com/AW4lOPR-hYCnR9AyKqPwG0deGCgemHGSog6s2ujMW2I.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=bb603b7d6b4ba3b53a94a39a98971cde", "width": 108}, {"height": 121, "url": "https://i.redditmedia.com/AW4lOPR-hYCnR9AyKqPwG0deGCgemHGSog6s2ujMW2I.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=3f77e3c27321237cc684296d81a92b50", "width": 216}, {"height": 180, "url": "https://i.redditmedia.com/AW4lOPR-hYCnR9AyKqPwG0deGCgemHGSog6s2ujMW2I.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=9ee1bd2d3ceb9d133eee1ac1285b1525", "width": 320}, {"height": 360, "url": "https://i.redditmedia.com/AW4lOPR-hYCnR9AyKqPwG0deGCgemHGSog6s2ujMW2I.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=7c208a40cdbcc96351673eddd1543f47", "width": 640}], "source": {"height": 405, "url": "https://i.redditmedia.com/AW4lOPR-hYCnR9AyKqPwG0deGCgemHGSog6s2ujMW2I.jpg?s=b4625e9eee423e3c0396d6878887d6cd", "width": 720}, "variants": {}}]}, "retrieved_on": 1492452258, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/Vjqu9m0_j7_Vq4gGIOAJwi_XOLF6Sbf1Cn3IuEWujvQ.jpg", "title": "NOT CLL SPECIFIC: Major Breakthrough Could Enable Mass Produced Artificial Blood", "url": "http://www.iflscience.com/health-and-medicine/major-breakthrough-could-enable-mass-produced-artificial-blood/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1490369359, "domain": "clinicaloncology.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/619kv3/immunotherapies_for_cll_complement_targeted_agents/", "gilded": 0, "id": "619kv3", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/619kv3/immunotherapies_for_cll_complement_targeted_agents/", "retrieved_on": 1492445005, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Immunotherapies for CLL Complement Targeted Agents", "url": "http://www.clinicaloncology.com/Hematologic-Malignancies/Article/03-17/Immunotherapies-for-CLL-Complement-Targeted-Agents/40748"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1490369325, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/619kq2/dr_rai_on_handicaps_of_chemotherapy_in_cll/", "gilded": 0, "id": "619kq2", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/619kq2/dr_rai_on_handicaps_of_chemotherapy_in_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "ReKF9U1yYFJ1gEXVq-Q82FORTMBfZJzZcBSPSxkhBoQ", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/l1bzFFifiHTsPRq2L-se52qbbvxg_w_k8OIF3yGbjvU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=ac4777e6775b42a1e745268725ca4cfd", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/l1bzFFifiHTsPRq2L-se52qbbvxg_w_k8OIF3yGbjvU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=b27586854a4a1a3a2c2a0819934a5751", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/l1bzFFifiHTsPRq2L-se52qbbvxg_w_k8OIF3yGbjvU.jpg?s=9ffa77bb3b0da61d0aa30add8fb6ec93", "width": 250}, "variants": {}}]}, "retrieved_on": 1492445003, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/6FSxCuFyaF-Q9kMDnU4Eb5v2JeLmHDtkCkPlkk8tYY4.jpg", "title": "Dr. Rai on Handicaps of Chemotherapy in CLL", "url": "http://www.onclive.com/onclive-tv/dr-rai-on-handicaps-of-chemotherapy-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1490131105, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/60qedj/new_standards_are_emerging_for_follicular/", "gilded": 0, "id": "60qedj", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/60qedj/new_standards_are_emerging_for_follicular/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "wKeACROFoGyiofQaquoNoFxSmi99KhH43j3-5YSZ1Zc", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/v907sUKEE1cAMjFUQHcVUQynEbk0QZwQAaQ8NgY3IYY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=f853911a787ea636e28f8c86a832db8d", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/v907sUKEE1cAMjFUQHcVUQynEbk0QZwQAaQ8NgY3IYY.jpg?s=e3a240ab5fe606c8c357595b8dc8ba52", "width": 200}, "variants": {}}]}, "retrieved_on": 1492434719, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/RAcgT6GlnARrTZLjgzR7ADefHXjl5EehJCyU6D-ySOI.jpg", "title": "New Standards Are Emerging for Follicular Lymphoma and CLL", "url": "http://www.onclive.com/publications/oncology-live/2017/vol-18-no-16/new-standards-are-emerging-for-follicular-lymphoma-and-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1490039631, "domain": "pharmacychoice.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/60isnl/new_chronic_lymphocytic_leukemia_study_findings/", "gilded": 0, "id": "60isnl", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/60isnl/new_chronic_lymphocytic_leukemia_study_findings/", "retrieved_on": 1492430925, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "New Chronic Lymphocytic Leukemia Study Findings Reported from M.D. Anderson Cancer Center", "url": "http://www.pharmacychoice.com/news/article.cfm?Article_ID=1711083"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1489813716, "domain": "bloodjournal.org", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/602kf5/ibrutinibresistant_cll_unwanted_and_unwonted/", "gilded": 0, "id": "602kf5", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/602kf5/ibrutinibresistant_cll_unwanted_and_unwonted/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "89LKZXxl4HhOqdYGzOD6jlT9bg6JE1Dgjjyitz2IIOU", "resolutions": [{"height": 139, "url": "https://i.redditmedia.com/Fq8VSKKpiu0a1LVdyNECDATFQAvrfVfXWTmWuH7S1Lc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=ccd4237f1b132f95cc8b586cdf4a60d0", "width": 108}, {"height": 279, "url": "https://i.redditmedia.com/Fq8VSKKpiu0a1LVdyNECDATFQAvrfVfXWTmWuH7S1Lc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=21baf861efb1934341aaed11c15e783c", "width": 216}, {"height": 414, "url": "https://i.redditmedia.com/Fq8VSKKpiu0a1LVdyNECDATFQAvrfVfXWTmWuH7S1Lc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=2014c7d001bec408612f4457becfccba", "width": 320}, {"height": 828, "url": "https://i.redditmedia.com/Fq8VSKKpiu0a1LVdyNECDATFQAvrfVfXWTmWuH7S1Lc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=7b97799a34f1981e3d624c203b207558", "width": 640}, {"height": 1242, "url": "https://i.redditmedia.com/Fq8VSKKpiu0a1LVdyNECDATFQAvrfVfXWTmWuH7S1Lc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=03973161e56f16cfffbe6d59d8db9a84", "width": 960}, {"height": 1397, "url": "https://i.redditmedia.com/Fq8VSKKpiu0a1LVdyNECDATFQAvrfVfXWTmWuH7S1Lc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=18e3b11a2ade9283d996fa9d24a5e533", "width": 1080}], "source": {"height": 2376, "url": "https://i.redditmedia.com/Fq8VSKKpiu0a1LVdyNECDATFQAvrfVfXWTmWuH7S1Lc.jpg?s=71efdc981a9a79170c0635a747b5968c", "width": 1836}, "variants": {}}]}, "retrieved_on": 1492422842, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/lodfOiTHa9jQwgWAPVrB2p5QaUCJEgA1DW4w-uhx-Nk.jpg", "title": "Ibrutinib-resistant CLL: unwanted and unwonted!", "url": "http://www.bloodjournal.org/content/129/11/1407?sso-checked=true"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1489644482, "domain": "seekingalpha.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5zoy67/standalone_imbruvica_may_not_stand_up_to_cll/", "gilded": 0, "id": "5zoy67", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5zoy67/standalone_imbruvica_may_not_stand_up_to_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "Cb0I2kk1ox1oZfSWPN5IWnpbmUjHZcGSp04Bv2ZgB4M", "resolutions": [{"height": 79, "url": "https://i.redditmedia.com/-tnJYZ_073aGDQeU8s5nnEFUcdGU9jBucWXUJyKNLOc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=8c4627a011541674455d80e90a3f944c", "width": 108}, {"height": 158, "url": "https://i.redditmedia.com/-tnJYZ_073aGDQeU8s5nnEFUcdGU9jBucWXUJyKNLOc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=b49af808194264b4cb56a8f1548f58ac", "width": 216}, {"height": 234, "url": "https://i.redditmedia.com/-tnJYZ_073aGDQeU8s5nnEFUcdGU9jBucWXUJyKNLOc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=05cb61baaf9e52b5410f5cdeae740aeb", "width": 320}, {"height": 468, "url": "https://i.redditmedia.com/-tnJYZ_073aGDQeU8s5nnEFUcdGU9jBucWXUJyKNLOc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=28dc2c09dfcd36b5cad2e841523b8e5f", "width": 640}, {"height": 702, "url": "https://i.redditmedia.com/-tnJYZ_073aGDQeU8s5nnEFUcdGU9jBucWXUJyKNLOc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=db3d28ea22a7a7d67a9d49039f23f2d0", "width": 960}], "source": {"height": 732, "url": "https://i.redditmedia.com/-tnJYZ_073aGDQeU8s5nnEFUcdGU9jBucWXUJyKNLOc.jpg?s=a9ddbed87e989277c7a32045b7cf2e59", "width": 1000}, "variants": {}}]}, "retrieved_on": 1492415714, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/RyDe21Hw8KQIRHTDG2o6X4psGeClgAdLo6SQ5QCX0yg.jpg", "title": "Standalone Imbruvica May Not Stand Up To CLL; Combo Needed", "url": "http://seekingalpha.com/article/4054636-abbvie-standalone-imbruvica-may-stand-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1489526658, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5zf1nu/ibrutinib_for_the_relief_of_gvhdrelated_symptoms/", "gilded": 0, "id": "5zf1nu", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5zf1nu/ibrutinib_for_the_relief_of_gvhdrelated_symptoms/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "-bnnKbjfpIUy33Ot_UV1gwjnpWJyO31Ps_T7Jw2Kwfc", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/vrS6PsQbNsrqY5ktPxRMJ2AEmSZcnShRJXO1JiIQpz4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=cefb3adce875edc98d02b8620e203921", "width": 108}, {"height": 143, "url": "https://i.redditmedia.com/vrS6PsQbNsrqY5ktPxRMJ2AEmSZcnShRJXO1JiIQpz4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=a465a72ff0544523221b2b6aa42e5808", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/vrS6PsQbNsrqY5ktPxRMJ2AEmSZcnShRJXO1JiIQpz4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=2cbe17c587107bc8d3baa341f679df87", "width": 320}], "source": {"height": 339, "url": "https://i.redditmedia.com/vrS6PsQbNsrqY5ktPxRMJ2AEmSZcnShRJXO1JiIQpz4.jpg?s=75c6be38ad046654e6cb5859482ba5a2", "width": 509}, "variants": {}}]}, "retrieved_on": 1492410712, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/dzVmQDShL3CS77s4YZLhXvNPd4sAl86I8EZfWFr8TVw.jpg", "title": "Ibrutinib for the Relief of GVHD-related Symptoms", "url": "http://www.cancertherapyadvisor.com/hematologic-cancers/ibrutinib-graft-versus-host-gvhd-symptoms-treatment/article/643617/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1489338051, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5yzmkc/expert_discusses_emerging_agents_in_cll/", "gilded": 0, "id": "5yzmkc", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5yzmkc/expert_discusses_emerging_agents_in_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "_n2dJJl0sSpxTQHbR0CqHUxhPjGmiByIO5cGWn3LzoE", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/_xdEUhTVwtJIkUw2NagnKjexTZ4qXt06loC0MHjMfE8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=5fb50fbdb78bc85bf522abab905212fb", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/_xdEUhTVwtJIkUw2NagnKjexTZ4qXt06loC0MHjMfE8.jpg?s=31fa2caf4f931482d325db4c4c6913e4", "width": 200}, "variants": {}}]}, "retrieved_on": 1492402762, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/sqx18PbDsoylvMJ487sqzczdlJtwIe1nUwo7LwP-AVc.jpg", "title": "Expert Discusses Emerging Agents in CLL", "url": "http://www.onclive.com/web-exclusives/expert-discusses-emerging-agents-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1489294448, "domain": "targetedonc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5yx3m0/ublituximabibrutinib_combo_significantly_improves/", "gilded": 0, "id": "5yx3m0", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 1, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5yx3m0/ublituximabibrutinib_combo_significantly_improves/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "XM_RjMlUF9pfEX0raaO0HDgrS9PwTWm5q9RS-r8Crq8", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=8b8bdfe16d31a7b36f7f6995991b63ca", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?s=c1fa7073f91a3a13437fb6762069e070", "width": 200}, "variants": {}}]}, "retrieved_on": 1492401483, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/X0YEO57HWjbvVUp5PE35XIzrODTxvGM_KGc3NOmp3Ko.jpg", "title": "Ublituximab/Ibrutinib Combo Significantly Improves ORR in Phase III CLL Study", "url": "http://www.targetedonc.com/news/ublituximabibrutinib-combo-significantly-improves-orr-in-phase-iii-cll-study"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1488397983, "domain": "thespec.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5wy9v1/doctors_tackle_nutrition_myths_in_cancer_treatment/", "gilded": 0, "id": "5wy9v1", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 2, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5wy9v1/doctors_tackle_nutrition_myths_in_cancer_treatment/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "V-ikFNTfvdzqVG5m8VpXGT7pGWEsv6WAtppNjewTSBo", "resolutions": [{"height": 78, "url": "https://i.redditmedia.com/MRs7dCd5WGbBzGtLc1MnPFcneTptF2Km38Fm5MofVgs.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=45be8e2db4b57e0701e2e18bf8575d57", "width": 108}, {"height": 157, "url": "https://i.redditmedia.com/MRs7dCd5WGbBzGtLc1MnPFcneTptF2Km38Fm5MofVgs.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=8f9a7fe396b3b75c677735ddfeff2f9c", "width": 216}, {"height": 233, "url": "https://i.redditmedia.com/MRs7dCd5WGbBzGtLc1MnPFcneTptF2Km38Fm5MofVgs.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=26cb1c76edeece79fc451185fbb4a5b3", "width": 320}], "source": {"height": 359, "url": "https://i.redditmedia.com/MRs7dCd5WGbBzGtLc1MnPFcneTptF2Km38Fm5MofVgs.jpg?s=74d0b0ce03d2ba45f33741b4545d2ab6", "width": 493}, "variants": {}}]}, "retrieved_on": 1492365410, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/2pux2jOhtckYQRgnlrSMqz6_uRGeqZPEJeEsH-Gt-a4.jpg", "title": "Doctors tackle nutrition myths in cancer treatment", "url": "http://www.thespec.com/community-story/7163926-doctors-tackle-nutrition-myths-in-cancer-treatment/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1488348671, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5wto6g/dr_rai_on_novel_approaches_in_cll/", "gilded": 0, "id": "5wto6g", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5wto6g/dr_rai_on_novel_approaches_in_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "xwJanLdDACzYcAzLvAeNSZTHOpH1r_anRTplBn5TG_s", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/__BG6xS6IInLNB6XvBGnqmffb2ZmDWw7uvcA1eJXwx8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=fa7060e2691277a4911c3a4ce63299ef", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/__BG6xS6IInLNB6XvBGnqmffb2ZmDWw7uvcA1eJXwx8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=cc71dfd55bc11ad57a2a59aa66abcd55", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/__BG6xS6IInLNB6XvBGnqmffb2ZmDWw7uvcA1eJXwx8.jpg?s=461083bea73662e1ad1ac3cde180a505", "width": 250}, "variants": {}}]}, "retrieved_on": 1489599579, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/4eJPjdgn60XrLk4AEiljQe0Enr04ZA9e5vm-7CWCsNI.jpg", "title": "Dr. Rai on Novel Approaches in CLL", "url": "http://www.onclive.com/onclive-tv/dr-rai-on-novel-approaches-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1488348636, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5wto30/dr_brown_discusses_acalabrutinib_in_cll/", "gilded": 0, "id": "5wto30", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5wto30/dr_brown_discusses_acalabrutinib_in_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "VuSplyCzqtOvvmJOSkxGb7XMNOWqdNccLWbX9q7n_ic", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/DQkOWuTeQLfIEIRmAOrTMRRts4nT6Qork9rMP-922lo.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=3343449638f074522cd6de7e4657e1d3", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/DQkOWuTeQLfIEIRmAOrTMRRts4nT6Qork9rMP-922lo.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=4644397719e09f25e0a25b1a02e9fb86", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/DQkOWuTeQLfIEIRmAOrTMRRts4nT6Qork9rMP-922lo.jpg?s=49fdde946de0f11d6beed80761631984", "width": 250}, "variants": {}}]}, "retrieved_on": 1489599578, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/HjXTQyZTXvMj9KVDVjsuMaAPqRt9LS0iyJJM1yvdnfU.jpg", "title": "Dr. Brown Discusses Acalabrutinib in CLL", "url": "http://www.onclive.com/onclive-tv/dr-brown-discusses-acalabrutinib-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1488309696, "domain": "telegraph.co.uk", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5wpwn6/terminal_cancer_patients_in_complete_remission/", "gilded": 0, "id": "5wpwn6", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5wpwn6/terminal_cancer_patients_in_complete_remission/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "rLAeN__1LW3fLZLej2UTQjAgi3hgMd1TBL3Tee1-zfU", "resolutions": [{"height": 67, "url": "https://i.redditmedia.com/qulzIhsNjZZkE1_j3igsXikZm8gsADNGkUisC4PNBqk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=01d92b9f1bb32c29502e5c9d852360df", "width": 108}, {"height": 135, "url": "https://i.redditmedia.com/qulzIhsNjZZkE1_j3igsXikZm8gsADNGkUisC4PNBqk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=21bc56c9eb93644ebfb559e374862d75", "width": 216}, {"height": 200, "url": "https://i.redditmedia.com/qulzIhsNjZZkE1_j3igsXikZm8gsADNGkUisC4PNBqk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=8f3c616e6fe2618ae6b2a5a3915b71b9", "width": 320}, {"height": 400, "url": "https://i.redditmedia.com/qulzIhsNjZZkE1_j3igsXikZm8gsADNGkUisC4PNBqk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=8a94ad48a64cc9bfeee6ad0b6a35275f", "width": 640}, {"height": 600, "url": "https://i.redditmedia.com/qulzIhsNjZZkE1_j3igsXikZm8gsADNGkUisC4PNBqk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=5434b9ee3d0c1ef6edff417c886eb5ea", "width": 960}, {"height": 675, "url": "https://i.redditmedia.com/qulzIhsNjZZkE1_j3igsXikZm8gsADNGkUisC4PNBqk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=dfcaa86fbea2f348bbd465d0c93cff21", "width": 1080}], "source": {"height": 775, "url": "https://i.redditmedia.com/qulzIhsNjZZkE1_j3igsXikZm8gsADNGkUisC4PNBqk.jpg?s=44435e645f52f41f51ba5dcf33bcb4d4", "width": 1240}, "variants": {}}]}, "retrieved_on": 1489597724, "score": 3, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/UW7qpG9aAWNfkRx09MChwUrEf_hnkAMWX2dTBFdVPU0.jpg", "title": "Terminal cancer patients in complete remission after one gene therapy treatment", "url": "http://www.telegraph.co.uk/science/2017/02/28/terminal-cancer-patients-complete-remission-one-gene-therapy/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1488132902, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5wbg4v/researchers_examine_acquired_mutations_linked_to/", "gilded": 0, "id": "5wbg4v", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5wbg4v/researchers_examine_acquired_mutations_linked_to/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "at2ZyMRBbagJf4lXkaLR_jmSjqzy1ERbY4pOku7RTCU", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/X-6tZPjbpzTp20YM2gLrUVLp232U-gD1UKlDDqBaeNg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=9f7b0655b6ee20c9c77f7a73dc978199", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/X-6tZPjbpzTp20YM2gLrUVLp232U-gD1UKlDDqBaeNg.jpg?s=de3c13a01cbf3fc4ed06a83428b82055", "width": 200}, "variants": {}}]}, "retrieved_on": 1489590574, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/ZMEg0Cg1MphbGMwADVexiAmzd4aISBGBVUUgSp75GIg.jpg", "title": "Researchers Examine Acquired Mutations Linked to Ibrutinib Resistance in CLL", "url": "http://www.onclive.com/web-exclusives/researchers-examine-acquired-mutations-linked-to-ibrutinib-resistance-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1488132880, "domain": "cancernetwork.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5wbg27/frontline_cll_therapy_changes_in_paradigm/", "gilded": 0, "id": "5wbg27", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5wbg27/frontline_cll_therapy_changes_in_paradigm/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "tI-rjWFiPHvgJe-JbB5o29ghdp1LlyXO__AuR5QS4XE", "resolutions": [{"height": 142, "url": "https://i.redditmedia.com/HQ7ONRHwYwMJCM1lZdd1VehhRWJqnjQwUvLdGkX3zJ4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=71b895d3115e65195ea31b9f5bb6ecf6", "width": 108}], "source": {"height": 198, "url": "https://i.redditmedia.com/HQ7ONRHwYwMJCM1lZdd1VehhRWJqnjQwUvLdGkX3zJ4.jpg?s=a3285fb5208435491708a1cf6ebcf31e", "width": 150}, "variants": {}}]}, "retrieved_on": 1489590573, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/6a8xYCadJpzBjePN-bMG-d5rR4xfn8jgL1B-UifJ4qs.jpg", "title": "Frontline CLL Therapy: Changes in Paradigm", "url": "http://www.cancernetwork.com/ichm-2017/frontline-cll-therapy-changes-paradigm"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1488124779, "domain": "healio.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5waps8/ruxolitinib_controls_diseaserelated_symptoms_in/", "gilded": 0, "id": "5waps8", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5waps8/ruxolitinib_controls_diseaserelated_symptoms_in/", "retrieved_on": 1489590212, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Ruxolitinib controls disease-related symptoms in CLL", "url": "http://www.healio.com/hematology-oncology/leukemia/news/in-the-journals/%7Bcdd8e2fc-996c-4d16-9df1-baa84719725b%7D/ruxolitinib-controls-disease-related-symptoms-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1488124745, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5wapnz/dr_jones_on_studying_venetoclax_in_rr_cll/", "gilded": 0, "id": "5wapnz", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5wapnz/dr_jones_on_studying_venetoclax_in_rr_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "SatoLhfgQtxnym0Jd3ayXaKAEupKDa3ikkxhA9YxSZ8", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/8Zb00c2_y9c9Xq4cdaX8D5Q6EB53ypz_LDOFXkunsY4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=8e977e17fcea4f54d113fa354ceaf378", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/8Zb00c2_y9c9Xq4cdaX8D5Q6EB53ypz_LDOFXkunsY4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=f7b182cb0bbab1ec9b908892d897d064", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/8Zb00c2_y9c9Xq4cdaX8D5Q6EB53ypz_LDOFXkunsY4.jpg?s=8501a18b22701cab62c76c0070d20176", "width": 250}, "variants": {}}]}, "retrieved_on": 1489590211, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/o10qep6X2kHLjUjWyMKXcdnK5vzEJ1zFTo-7zPYcjqw.jpg", "title": "Dr. Jones on Studying Venetoclax in R/R CLL", "url": "http://www.onclive.com/onclive-tv/dr-jones-on-studying-venetoclax-in-rr-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1488124730, "domain": "satprnews.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5wapmo/evaluating_a_novel_chemofree_combination_therapy/", "gilded": 0, "id": "5wapmo", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5wapmo/evaluating_a_novel_chemofree_combination_therapy/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "k3w237XCWJIxbL0ZcyVDrrAFONLZCNxnUlDK0yCl7bE", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/waalGbHbW9KprrShvfZASkncy3IgDCiOIdbANfcBqh0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=b0be09ce6c497403baf11615dfcdf03e", "width": 108}, {"height": 143, "url": "https://i.redditmedia.com/waalGbHbW9KprrShvfZASkncy3IgDCiOIdbANfcBqh0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=41deeb912f5ed459d645f4ed5c8d2c55", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/waalGbHbW9KprrShvfZASkncy3IgDCiOIdbANfcBqh0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=b165feecc40f2e767563989452e53802", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/waalGbHbW9KprrShvfZASkncy3IgDCiOIdbANfcBqh0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=08be25ee71a113414f6927e5d422a00d", "width": 640}, {"height": 639, "url": "https://i.redditmedia.com/waalGbHbW9KprrShvfZASkncy3IgDCiOIdbANfcBqh0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=d7dfda3f648c8bca50695767f0f0e931", "width": 960}, {"height": 719, "url": "https://i.redditmedia.com/waalGbHbW9KprrShvfZASkncy3IgDCiOIdbANfcBqh0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=03629172aa53793a23a87abeff2e7465", "width": 1080}], "source": {"height": 1333, "url": "https://i.redditmedia.com/waalGbHbW9KprrShvfZASkncy3IgDCiOIdbANfcBqh0.jpg?s=cda34bc5778a869f31f10aff344305d4", "width": 2000}, "variants": {}}]}, "retrieved_on": 1489590210, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/U3jMLqWJs_S9HjpehJTuzqPr5lXf55zrVSUoWIejjes.jpg", "title": "Evaluating A Novel Chemo-free Combination Therapy for Lymphocytic Leukemia", "url": "http://www.satprnews.com/2017/02/24/evaluating-a-novel-chemo-free-combination-therapy-for-lymphocytic-leukemia/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1488124714, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5wapl3/cart_cell_therapies_in_cll/", "gilded": 0, "id": "5wapl3", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 2, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5wapl3/cart_cell_therapies_in_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "zZUmrxGglm7yZhf-af-moQEp8Zr6BhXs8pdZaWYNNiI", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/n_Opl3G6lmA-SgpLoVbPPUXAhaaykkn9XXe02b4xi_I.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=e527137cdceeca6f3abf9184fc816468", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/n_Opl3G6lmA-SgpLoVbPPUXAhaaykkn9XXe02b4xi_I.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=8283afd1d6dad15cc20a934bec1aa802", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/n_Opl3G6lmA-SgpLoVbPPUXAhaaykkn9XXe02b4xi_I.jpg?s=97ab2e16745e8c2ed139e3fbbb27a058", "width": 250}, "variants": {}}]}, "retrieved_on": 1489590210, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/QxBT6JgLs4VFlc2nrY98aXDaNIlaXt9a-0Ggr388IpQ.jpg", "title": "CAR-T Cell Therapies in CLL", "url": "http://www.onclive.com/peer-exchange/nhl-treatment-paradigms/cart-cell-therapies-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1487808423, "domain": "globenewswire.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5vmjm0/tg_therapeutics_inc_clinical_data_from_the_phase/", "gilded": 0, "id": "5vmjm0", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5vmjm0/tg_therapeutics_inc_clinical_data_from_the_phase/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "jHRjX6VCjQcOpJgBDSINddQLt4EcWKs0Hr3lSsgE2AA", "resolutions": [{"height": 31, "url": "https://i.redditmedia.com/Cb2ONJHgXhsoT2k5JOvQA5kq4x3qRhs7xtHnWIj5J80.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=394d0f6814424d7a0ebabc571764b656", "width": 108}], "source": {"height": 44, "url": "https://i.redditmedia.com/Cb2ONJHgXhsoT2k5JOvQA5kq4x3qRhs7xtHnWIj5J80.jpg?s=71b181174a6ef6c878e5dd0d636737ae", "width": 150}, "variants": {}}]}, "retrieved_on": 1489578299, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/L5cCypxXSNQtsEkVRGz6GFnOARjRMVYqxlb8hqtyC_w.jpg", "title": "TG Therapeutics, Inc. - Clinical Data from the Phase 1/2 Trial of TG-1101 (ublituximab) Monotherapy", "url": "https://globenewswire.com/news-release/2017/02/21/925803/0/en/TG-Therapeutics-Inc-Announces-Publication-of-Clinical-Data-from-the-Phase-1-2-Trial-of-TG-1101-ublituximab-Monotherapy-in-the-British-Journal-of-Haematology.html"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1487808272, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5vmj2h/ibrutinib_for_cll_with_deletion_17p/", "gilded": 0, "id": "5vmj2h", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5vmj2h/ibrutinib_for_cll_with_deletion_17p/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "q5qhDDyyOlHJtb_V3235Rjiu3FZG__V5YyNJ025PSEM", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/JWUlvhKeu0XIe0edCP3_SwgHhx0t1d7qR1gDzyBYQGY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=800abb51f67d39665009adf39c8f95d3", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/JWUlvhKeu0XIe0edCP3_SwgHhx0t1d7qR1gDzyBYQGY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=7a5917a9c7783e110b8e23275239e394", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/JWUlvhKeu0XIe0edCP3_SwgHhx0t1d7qR1gDzyBYQGY.jpg?s=10cc206b60917be666c767ac290b55e7", "width": 250}, "variants": {}}]}, "retrieved_on": 1489578292, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/_gUIZVtN8gcODPPo7nV7BWtwMJuMT3rDXIuazmVhFyg.jpg", "title": "Ibrutinib for CLL with Deletion 17p", "url": "http://www.onclive.com/peer-exchange/nhl-treatment-paradigms/ibrutinib-for-cll-with-deletion-17p"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1487806538, "domain": "ascopubs.org", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5vmcfg/mediated_resistance_to_ibrutinib_in_chronic/", "gilded": 0, "id": "5vmcfg", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5vmcfg/mediated_resistance_to_ibrutinib_in_chronic/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "VpKSCaMvavca4AmqJELkIjrL1BLj2Gqxqxi-iD07ugw", "resolutions": [{"height": 55, "url": "https://i.redditmedia.com/ii-FGqmf_Ra1qhUF7YX7Sdp3QjYXqYourXI1ZbBw-wk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=022150987e9d8201d6bf5c2d85b43788", "width": 108}], "source": {"height": 90, "url": "https://i.redditmedia.com/ii-FGqmf_Ra1qhUF7YX7Sdp3QjYXqYourXI1ZbBw-wk.jpg?s=ca0d6669f2b28c8f23b6d7eca4fc3828", "width": 175}, "variants": {}}]}, "retrieved_on": 1489578200, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/SWvE7hywvuhwUEnhKO_Cc5quFGpCQ5jPdaUhKeAwTCg.jpg", "title": "Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia: Journal of Clinical Oncology: Vol 0, No 0", "url": "http://ascopubs.org/doi/abs/10.1200/JCO.2016.70.2282"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1487296419, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5uji9f/managing_ibrutinib_toxicity_in_cll/", "gilded": 0, "id": "5uji9f", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5uji9f/managing_ibrutinib_toxicity_in_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "dOf-bBNVtFF_7FuC56O6tr2OJGCx5JQQsH6jw0mlg8U", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/vkVi6tuNlK2GPQ_8zlj1kQrpjK1lPLpSTxSsj6g6WUE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=01865ae6d3de51a359cf94ac0f92c8a6", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/vkVi6tuNlK2GPQ_8zlj1kQrpjK1lPLpSTxSsj6g6WUE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=6408f44260a45908a643823e86e5e443", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/vkVi6tuNlK2GPQ_8zlj1kQrpjK1lPLpSTxSsj6g6WUE.jpg?s=0899e2fc30badeb8679d70115fd88b69", "width": 250}, "variants": {}}]}, "retrieved_on": 1489555426, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/5YhJT5kixlbqkzwGbp2bEo8P-lbmye3eIdPMRHN_-n8.jpg", "title": "Managing Ibrutinib Toxicity in CLL", "url": "http://www.onclive.com/peer-exchange/nhl-treatment-paradigms/managing-ibrutinib-toxicity-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1487210692, "domain": "clinicaloncology.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5ubz4p/ash_report_lenalidomide_maintenance_may_extend/", "gilded": 0, "id": "5ubz4p", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5ubz4p/ash_report_lenalidomide_maintenance_may_extend/", "retrieved_on": 1489549461, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "ASH Report: Lenalidomide Maintenance May Extend PFS in CLL", "url": "http://www.clinicaloncology.com/Hematologic-Malignancies/Article/02-17/ASH-Report-Lenalidomide-Maintenance-May-Extend-PFS-in-CLL/40356"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1487210656, "domain": "oncologynurseadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5ubz0n/idelalisib_increases_progressionfree_survival_in/", "gilded": 0, "id": "5ubz0n", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5ubz0n/idelalisib_increases_progressionfree_survival_in/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "bvH-3X8ZHIymO4sOG8hcCUfsX7oVkdlGO2pb6GhA9N8", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/Tt8a8T3rjM47LvWGlDU4QSBxV9F2f7CSJ7WSLRrsqfA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=fefadadae837fe7686aa0185bce0b408", "width": 108}], "source": {"height": 133, "url": "https://i.redditmedia.com/Tt8a8T3rjM47LvWGlDU4QSBxV9F2f7CSJ7WSLRrsqfA.jpg?s=fcc8133aa1342ad075b21055b0b3cbb9", "width": 200}, "variants": {}}]}, "retrieved_on": 1489549461, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/-xExNJ4qdSfVvArXXwFI-nUnYiSllU-iBuuV2igqv40.jpg", "title": "Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia", "url": "http://www.oncologynurseadvisor.com/leukemia/idelalisib-to-bendamustine-plus-rituximab-increase-pfs-in-patients-with-rr-chronic-lymphocytic-leukemia/article/638153/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1487210620, "domain": "cancernetwork.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5ubyx0/novel_and_expanded_oncology_drug_approvals_of/", "gilded": 0, "id": "5ubyx0", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5ubyx0/novel_and_expanded_oncology_drug_approvals_of/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "tI-rjWFiPHvgJe-JbB5o29ghdp1LlyXO__AuR5QS4XE", "resolutions": [{"height": 142, "url": "https://i.redditmedia.com/HQ7ONRHwYwMJCM1lZdd1VehhRWJqnjQwUvLdGkX3zJ4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=71b895d3115e65195ea31b9f5bb6ecf6", "width": 108}], "source": {"height": 198, "url": "https://i.redditmedia.com/HQ7ONRHwYwMJCM1lZdd1VehhRWJqnjQwUvLdGkX3zJ4.jpg?s=a3285fb5208435491708a1cf6ebcf31e", "width": 150}, "variants": {}}]}, "retrieved_on": 1489549459, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/_n3crI8jxZoGkQNgxmANsbICSzi8jQkPs0IsGPW00mE.jpg", "title": "Novel and Expanded Oncology Drug Approvals of 2016\u2014PART 2", "url": "http://www.cancernetwork.com/oncology-journal/novel-and-expanded-oncology-drug-approvals-2016-part-2"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1487207379, "domain": "fiercepharma.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5ubor1/nice_shoots_down_abbvies_wannabe_leukemia/", "gilded": 0, "id": "5ubor1", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5ubor1/nice_shoots_down_abbvies_wannabe_leukemia/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "wV1M1luS4FF4R7b5i7620p1HyNzqYAbT33WsUHalbIc", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/BJ34KBD8-nYo3Kj_18ubEazhMLEd2Sb0VlFnw4ieM1o.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=aea03bf8680279951036bd182c5da16f", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/BJ34KBD8-nYo3Kj_18ubEazhMLEd2Sb0VlFnw4ieM1o.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=b8775a57078d6e055ba4686c44256f26", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/BJ34KBD8-nYo3Kj_18ubEazhMLEd2Sb0VlFnw4ieM1o.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=4ce17a039f816251db8ebde0daefecd8", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/BJ34KBD8-nYo3Kj_18ubEazhMLEd2Sb0VlFnw4ieM1o.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=ea3c6c822fecccac5d966bd902915083", "width": 640}, {"height": 640, "url": "https://i.redditmedia.com/BJ34KBD8-nYo3Kj_18ubEazhMLEd2Sb0VlFnw4ieM1o.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=61121de6334056a6a9ead2e97a2fdb6e", "width": 960}, {"height": 720, "url": "https://i.redditmedia.com/BJ34KBD8-nYo3Kj_18ubEazhMLEd2Sb0VlFnw4ieM1o.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=5e19b0afdc23247e768d31ede3d5ce0a", "width": 1080}], "source": {"height": 867, "url": "https://i.redditmedia.com/BJ34KBD8-nYo3Kj_18ubEazhMLEd2Sb0VlFnw4ieM1o.jpg?s=44670dc9b5b4f057a301f9e6bbc0899d", "width": 1300}, "variants": {}}]}, "retrieved_on": 1489549303, "score": 3, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/6EeKFnGqiUJhRJsMOJOji0phf59o3ksFcNgebAivmTA.jpg", "title": "NICE shoots down AbbVie's wannabe leukemia blockbuster Venclexta", "url": "http://www.fiercepharma.com/pharma/england-s-cost-watchdogs-shoot-down-abbvie-s-wannabe-leukemia-blockbuster-venclexta"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1487107188, "domain": "clincancerres.aacrjournals.org", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5u33dv/extended_treatment_with_singleagent_ibrutinib_at/", "gilded": 0, "id": "5u33dv", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5u33dv/extended_treatment_with_singleagent_ibrutinib_at/", "retrieved_on": 1489545072, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Extended Treatment with Single-Agent Ibrutinib at the 420 mg Dose Leads to Durable Responses in CLL", "url": "http://clincancerres.aacrjournals.org/content/early/2017/02/13/1078-0432.CCR-16-1431.full-text.pdf"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1487107119, "domain": "mdedge.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5u334o/in_cll_specific_mutation_is_key_to_ibrutinib/", "gilded": 0, "id": "5u334o", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5u334o/in_cll_specific_mutation_is_key_to_ibrutinib/", "retrieved_on": 1489545067, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "In CLL, specific mutation is key to ibrutinib resistance", "url": "http://www.mdedge.com/hematologynews/article/131427/cll/cll-specific-mutation-key-ibrutinib-resistance"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1487033734, "domain": "ascopubs.org", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5twy09/longform_clinical_implications_of_novel_genomic/", "gilded": 0, "id": "5twy09", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5twy09/longform_clinical_implications_of_novel_genomic/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "VpKSCaMvavca4AmqJELkIjrL1BLj2Gqxqxi-iD07ugw", "resolutions": [{"height": 55, "url": "https://i.redditmedia.com/ii-FGqmf_Ra1qhUF7YX7Sdp3QjYXqYourXI1ZbBw-wk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=022150987e9d8201d6bf5c2d85b43788", "width": 108}], "source": {"height": 90, "url": "https://i.redditmedia.com/ii-FGqmf_Ra1qhUF7YX7Sdp3QjYXqYourXI1ZbBw-wk.jpg?s=ca0d6669f2b28c8f23b6d7eca4fc3828", "width": 175}, "variants": {}}]}, "retrieved_on": 1489542038, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/580GxxOTdK-WzQwxkgCmhDL2rY10_BomagYzz4LedOg.jpg", "title": "LONGFORM: Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia: Journal of Clinical Oncology: Vol 0, No 0", "url": "http://ascopubs.org/doi/full/10.1200/JCO.2016.71.0822"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1487033687, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5twxu4/acquired_btk_and_plcg2_mutations_linked_to_future/", "gilded": 0, "id": "5twxu4", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5twxu4/acquired_btk_and_plcg2_mutations_linked_to_future/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "oTDxcoD_bGakTi6N5GRGawLfVUKha3_n8ibWkBxc-5s", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/nz7qp13JzneKnJ1apd6Hgg3ho8BeYUSvYP16K4Eb5Vc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=70e5a65c550dadaf6d72b444bf0e2fe3", "width": 108}], "source": {"height": 133, "url": "https://i.redditmedia.com/nz7qp13JzneKnJ1apd6Hgg3ho8BeYUSvYP16K4Eb5Vc.jpg?s=b512c380035d7cb5de0fc88a78522852", "width": 200}, "variants": {}}]}, "retrieved_on": 1489542036, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/F71u2vgffj0_VrF2OQy_0olL38x-3g5W4gelsL9yr5E.jpg", "title": "Acquired BTK and PLCG2 Mutations Linked to Future CLL Relapse", "url": "http://www.cancertherapyadvisor.com/chronic-lymphocytic-leukemia/btk-plcg2-mutation-chronic-leukemia-cll-relapse-mutation-treatment/article/637662/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1486941963, "domain": "medscape.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5tp95g/in_the_era_of_novel_therapies_new_prognostic/", "gilded": 0, "id": "5tp95g", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5tp95g/in_the_era_of_novel_therapies_new_prognostic/", "retrieved_on": 1489537922, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "In the Era of Novel Therapies, New Prognostic Markers for Chronic Lymphocytic Leukemia Required", "url": "http://www.medscape.com/viewarticle/875428"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1486941933, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5tp90x/study_identifies_potential_biomarkers_for_car/", "gilded": 0, "id": "5tp90x", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5tp90x/study_identifies_potential_biomarkers_for_car/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "FUH0Po_4onPMFLc_ebmQZO1OY5AIdnwlKmXBEGO54K0", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/VhTACDaBhMoDr710BBbIkqzoSHhL3UNNqmu9ltaUfHI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=d83d0bc4b841225d3640178092e9a0ad", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/VhTACDaBhMoDr710BBbIkqzoSHhL3UNNqmu9ltaUfHI.jpg?s=a38fa031088e0c48c801e473b53ae7e1", "width": 200}, "variants": {}}]}, "retrieved_on": 1489537921, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/lXk0xJ1YZY5pprwc6xN81gv1i5gMNu2dYEeCsAasNNo.jpg", "title": "Study Identifies Potential Biomarkers for CAR T-Cell Therapy Response in CLL", "url": "http://www.onclive.com/web-exclusives/study-identifies-potential-biomarkers-for-car-tcell-therapy-response-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1486941913, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5tp8xm/ibrutinib_could_enhance_car_tcell_treatment/", "gilded": 0, "id": "5tp8xm", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5tp8xm/ibrutinib_could_enhance_car_tcell_treatment/", "retrieved_on": 1489537920, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Ibrutinib Could Enhance CAR T-Cell Treatment Impact in CLL", "url": "http://www.onclive.com/web-exclusives/ibrutinib-could-enhance-car-tcell-treatment-impact-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1486669098, "domain": "curetoday.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5t29ul/exploring_car_tcell_therapy_in_blood_cancers/", "gilded": 0, "id": "5t29ul", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5t29ul/exploring_car_tcell_therapy_in_blood_cancers/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "4fXsOshAArW-wuUMGmhUhnzgSwkzDIXWi_2_E6UNvj0", "resolutions": [{"height": 59, "url": "https://i.redditmedia.com/LQPQSskzJuUaN8JCIlzrTvnTjJAi7DT6fJQMnBb7GdQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=38c2fd650ba056f2921d5b36ac803b66", "width": 108}, {"height": 118, "url": "https://i.redditmedia.com/LQPQSskzJuUaN8JCIlzrTvnTjJAi7DT6fJQMnBb7GdQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=c557c6d53d6c1f4189285c2d08cccad5", "width": 216}, {"height": 175, "url": "https://i.redditmedia.com/LQPQSskzJuUaN8JCIlzrTvnTjJAi7DT6fJQMnBb7GdQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=fd467a0bc221dec303f43bf7e7807f37", "width": 320}], "source": {"height": 282, "url": "https://i.redditmedia.com/LQPQSskzJuUaN8JCIlzrTvnTjJAi7DT6fJQMnBb7GdQ.jpg?s=c2ffaa7c613ac81c3d5bc9c9d8cb2b19", "width": 514}, "variants": {}}]}, "retrieved_on": 1489526373, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/WS53KGRJy8Y4jc50adOVf9bRrY92G2pc3ZAAI0ddqqM.jpg", "title": "Exploring CAR T-Cell Therapy in Blood Cancers", "url": "http://www.curetoday.com/articles/exploring-car-tcell-therapy-in-blood-cancers"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1486668932, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5t298y/cll_longterm_outcomes_after_ibrutinib/", "gilded": 0, "id": "5t298y", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5t298y/cll_longterm_outcomes_after_ibrutinib/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "0qY7T4FeFK4ZsfpjDgWrXGpeqHsi2uZFF-EIs5IF7SA", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/wH0TJyr4gVzinkM9khlV4QPGNhJaByHTlB8PC-g6REs.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=ae5d542cb163d82a51d1a0488e71ca8c", "width": 108}], "source": {"height": 133, "url": "https://i.redditmedia.com/wH0TJyr4gVzinkM9khlV4QPGNhJaByHTlB8PC-g6REs.jpg?s=c85d35b57147224c9131ff2d112196ee", "width": 200}, "variants": {}}]}, "retrieved_on": 1489526364, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/IjhSyC8XhNcO904wTO28lDF1sEfbdBvAcKbFDJzxXsI.jpg", "title": "CLL: Long-term Outcomes After Ibrutinib Discontinuation", "url": "http://www.cancertherapyadvisor.com/chronic-lymphocytic-leukemia/chronic-leukemia-cll-ibrutinib-discontinue-long-term-outcomes/article/636995/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1486668857, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5t28yo/dr_woyach_on_preliminary_efficacy_results_of/", "gilded": 0, "id": "5t28yo", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5t28yo/dr_woyach_on_preliminary_efficacy_results_of/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "35vqDS6zhF8Fkntid02MQF-BEixJHM5cr6BTaANK1wk", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/jDsOeRnnOFyfDCri78Dl-G1I8OEAqV9NUUpXAfjG6Ew.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=69901d07bfb9d3e11834c76c2dc723a9", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/jDsOeRnnOFyfDCri78Dl-G1I8OEAqV9NUUpXAfjG6Ew.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=ff7364f1dd7a30f47fd0a62271f0510c", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/jDsOeRnnOFyfDCri78Dl-G1I8OEAqV9NUUpXAfjG6Ew.jpg?s=021bf9e6309193a829e7a145e1b1347e", "width": 250}, "variants": {}}]}, "retrieved_on": 1489526360, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/hToxhwVMNepP4KBbNQ1yT7Mje80KhuNJPQ-isF8oB60.jpg", "title": "Dr. Woyach on Preliminary Efficacy Results of MOR208 Trial in CLL", "url": "http://www.onclive.com/onclive-tv/dr-woyach-on-preliminary-efficacy-results-of-mor208-trial-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1486668797, "domain": "cancernetwork.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5t28rj/chemotherapy_vs_ibrutinib_for_frontline_treatment/", "gilded": 0, "id": "5t28rj", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5t28rj/chemotherapy_vs_ibrutinib_for_frontline_treatment/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "13CHNs4kFf-DuotWIl6EMsBhwjcgR3i6hvIPuKucDLs", "resolutions": [{"height": 142, "url": "https://i.redditmedia.com/6U7ulCeuPpCaMMHKQg7S2HDu0qGqWJCk8qGq5YdqzUo.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=ea743b19fa4e88fe4cf9a74aebf124c8", "width": 108}], "source": {"height": 198, "url": "https://i.redditmedia.com/6U7ulCeuPpCaMMHKQg7S2HDu0qGqWJCk8qGq5YdqzUo.jpg?s=8dad18a83b360ce98a463ee4c8446b5c", "width": 150}, "variants": {}}]}, "retrieved_on": 1489526358, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/ljjm1hezvuN1Pf_kVqylUwyBfQdExzshRXsdUK_VakY.jpg", "title": "Chemotherapy vs Ibrutinib for Frontline Treatment of Chronic Lymphocytic Leukemia", "url": "http://www.cancernetwork.com/videos-hematologic-malignancies/chemotherapy-vs-ibrutinib-frontline-treatment-chronic-lymphocytic-leukemia"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1486668592, "domain": "dovepress.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5t27x9/study_attached_profile_of_venetoclax_and_its/", "gilded": 0, "id": "5t27x9", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5t27x9/study_attached_profile_of_venetoclax_and_its/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "hq73X5EeZXU-WtHb7zuSeNvlCcrW5zRA5BI-eJ2M_ws", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/d7w_BjQwsuvNHR0snNCJImgYByetlzhJgVPXWu7BXYQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=a7b34cc0f7a982de0513dcbc60da7612", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/d7w_BjQwsuvNHR0snNCJImgYByetlzhJgVPXWu7BXYQ.jpg?s=54fdd9e7fef2fda23afcc8d655a4a5e0", "width": 200}, "variants": {}}]}, "retrieved_on": 1489526346, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/5po8mwOUYcDXuXo7BewoTiPzHS3BKLtuuSyDbKZFWo0.jpg", "title": "STUDY ATTACHED: Profile of venetoclax and its potential in the context of treatment of CLL", "url": "https://www.dovepress.com/profile-of-venetoclax-and-its-potential-in-the-context-of-treatment-of-peer-reviewed-article-OTT"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1486401998, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5sfjil/expert_discusses_value_of_venetoclax_after_bcr/", "gilded": 0, "id": "5sfjil", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5sfjil/expert_discusses_value_of_venetoclax_after_bcr/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "btkwNmeIkzah1C3IprqpZ9RjMgY-_P--ikZG_Ff0zVs", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/tHqu-7MPTfWCTbFyloiMUcj5u45z_kBxgudJVP1fQb0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=3f596ab244a6544835bf696664fccc8e", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/tHqu-7MPTfWCTbFyloiMUcj5u45z_kBxgudJVP1fQb0.jpg?s=df067a775982dc574b16e944be269299", "width": 200}, "variants": {}}]}, "retrieved_on": 1489514802, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/HXHR7Dn_pW5nv8-wBb_AgO8ix6WCyv4jWjiFyi3jeAI.jpg", "title": "Expert Discusses Value of Venetoclax After BCR Inhibition in CLL", "url": "http://www.onclive.com/web-exclusives/expert-discusses-value-of-venetoclax-after-bcr-inhibition-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1486401733, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5sfika/upfront_ibrutinib_continues_to_impress_in_cll/", "gilded": 0, "id": "5sfika", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5sfika/upfront_ibrutinib_continues_to_impress_in_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "OTGb9mcyJ8duoxusiPtplDbt7RR3NAQK394M15NMnrE", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/IUi4xcFqQf_Ghqv9q0QsKf0XxRFb_00Of4qy8rXNd7o.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=a88b00a6d031d5e9b94a687d08f30d6b", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/IUi4xcFqQf_Ghqv9q0QsKf0XxRFb_00Of4qy8rXNd7o.jpg?s=1f8f06057ea8f8bbbc9e296002ce3477", "width": 200}, "variants": {}}]}, "retrieved_on": 1489514790, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/JmgQBuuqBkGSzW5WY_AcwOveD6HLGhNe1Ctqq2fhsqw.jpg", "title": "Upfront Ibrutinib Continues to Impress in CLL", "url": "http://www.onclive.com/web-exclusives/upfront-ibrutinib-continues-to-impress-in-cll"}, {"author": "irenehsieh12", "author_created_utc": 1427209605, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_mgjn9", "brand_safe": false, "contest_mode": false, "created_utc": 1485960310, "domain": "self.CLL_Leukemia", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5rfua5/anyone_interested_to_participate_in_a_patient/", "gilded": 0, "id": "5rfua5", "is_self": true, "locked": false, "media_embed": {}, "num_comments": 2, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5rfua5/anyone_interested_to_participate_in_a_patient/", "retrieved_on": 1489497141, "score": 2, "secure_media_embed": {}, "selftext": "We are currently conducting a study with a goal to understand impact of CLL to patients/caregivers- and how can they improved their overall experience. As the population is harder to reach, I thought maybe Reddit will be able to help me out :) \n\nIf you are interested, please let me know. \n\nthanks!  ", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "self", "title": "Anyone interested to participate in a patient experience study?", "url": "https://www.reddit.com/r/CLL_Leukemia/comments/5rfua5/anyone_interested_to_participate_in_a_patient/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1485824490, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5r4y50/adding_idelalisib_to_bendamustine_and_rituximab/", "gilded": 0, "id": "5r4y50", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5r4y50/adding_idelalisib_to_bendamustine_and_rituximab/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "cL8O6HiAvixeMBNRXG2EgwYBvqWNujzeUtQyVfnanIo", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/83iC4JW5Fi1AtqdG8hz_g_N25l3YT4evDuPElD18jaQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=fffe43fa91f15398d900228a532c906a", "width": 108}], "source": {"height": 133, "url": "https://i.redditmedia.com/83iC4JW5Fi1AtqdG8hz_g_N25l3YT4evDuPElD18jaQ.jpg?s=ad158cdd5cc5992c2ae1f48cce655f84", "width": 200}, "variants": {}}]}, "retrieved_on": 1489491757, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/2hBgv9MWJ4CV8mo8OCMiUhZccERhmOEo2bTZMPDWsnE.jpg", "title": "Adding Idelalisib to Bendamustine and Rituximab Improves PFS in CLL", "url": "http://www.cancertherapyadvisor.com/chronic-lymphocytic-leukemia/chronic-leukemia-cll-idelalisib-bendamustine-rituximab-treatment-survival/article/634557/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1485818982, "domain": "pmlive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5r4f6i/abbvie_weak_on_new_drug_sales_shareholders_want/", "gilded": 0, "id": "5r4f6i", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5r4f6i/abbvie_weak_on_new_drug_sales_shareholders_want/", "retrieved_on": 1489491499, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "AbbVie weak on new drug sales, Shareholders want newer drugs such as Imbruvica (ibrutinib) and Venclexta (venetoclax) to build momentum", "url": "https://www.pmlive.com/pharma_news/abbvie_weak_on_new_drug_sales,_but_humira_stays_strong_1185427"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1485737216, "domain": "dovepress.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5qxg8p/full_text_obinutuzumab_in_chronic_lymphocytic/", "gilded": 0, "id": "5qxg8p", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5qxg8p/full_text_obinutuzumab_in_chronic_lymphocytic/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "hq73X5EeZXU-WtHb7zuSeNvlCcrW5zRA5BI-eJ2M_ws", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/d7w_BjQwsuvNHR0snNCJImgYByetlzhJgVPXWu7BXYQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=a7b34cc0f7a982de0513dcbc60da7612", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/d7w_BjQwsuvNHR0snNCJImgYByetlzhJgVPXWu7BXYQ.jpg?s=54fdd9e7fef2fda23afcc8d655a4a5e0", "width": 200}, "variants": {}}]}, "retrieved_on": 1489488062, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/AdanBNK2vKpL9iHITVC79R_DeL8uIXlY_bBN2JkH--k.jpg", "title": "[Full text] Obinutuzumab in chronic lymphocytic leukemia: design, development and | DDDT", "url": "https://www.dovepress.com/obinutuzumab-in-chronic-lymphocytic-leukemia-design-development-and-pl-peer-reviewed-fulltext-article-DDDT"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1485736221, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5qxcrm/mor208_combo_regimens_show_early_promise_in_cll/", "gilded": 0, "id": "5qxcrm", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5qxcrm/mor208_combo_regimens_show_early_promise_in_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "at2ZyMRBbagJf4lXkaLR_jmSjqzy1ERbY4pOku7RTCU", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/X-6tZPjbpzTp20YM2gLrUVLp232U-gD1UKlDDqBaeNg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=9f7b0655b6ee20c9c77f7a73dc978199", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/X-6tZPjbpzTp20YM2gLrUVLp232U-gD1UKlDDqBaeNg.jpg?s=de3c13a01cbf3fc4ed06a83428b82055", "width": 200}, "variants": {}}]}, "retrieved_on": 1489488014, "score": 3, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/hQRNcr095UoCMBqzmtpb3R-BvffIOQqoBrxor18_1U8.jpg", "title": "MOR208 Combo Regimens Show Early Promise in CLL", "url": "http://www.onclive.com/web-exclusives/mor208-combo-regimens-show-early-promise-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1485452076, "domain": "knowridge.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5qbiu8/for_adults_with_common_form_of_leukemia_new_drug/", "gilded": 0, "id": "5qbiu8", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5qbiu8/for_adults_with_common_form_of_leukemia_new_drug/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "8AePCVdRrlceKbNm2E7sKKqsjhi-qqumIlTCOOLp-qY", "resolutions": [{"height": 44, "url": "https://i.redditmedia.com/w15ITKmK6ANwen61rdzfELaaEQkI7GN71bWCejwXEVc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=d6a5ec0346a0569c9528e643fe6798ac", "width": 108}, {"height": 88, "url": "https://i.redditmedia.com/w15ITKmK6ANwen61rdzfELaaEQkI7GN71bWCejwXEVc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=7d312bbd4021b142dd44b7f5bf3beff0", "width": 216}, {"height": 130, "url": "https://i.redditmedia.com/w15ITKmK6ANwen61rdzfELaaEQkI7GN71bWCejwXEVc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=521d725b7c3115c1458f33b862cd15bb", "width": 320}, {"height": 261, "url": "https://i.redditmedia.com/w15ITKmK6ANwen61rdzfELaaEQkI7GN71bWCejwXEVc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=40ec08776f9f8291dc91a6e9e0807d4e", "width": 640}], "source": {"height": 261, "url": "https://i.redditmedia.com/w15ITKmK6ANwen61rdzfELaaEQkI7GN71bWCejwXEVc.jpg?s=dec0c43a185819de5414682ae34e9919", "width": 640}, "variants": {}}]}, "retrieved_on": 1489476723, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/Y_Un5TWFEfA5ZTWDfFJiTKchfkOqVENa5Q3bNpG-qbw.jpg", "title": "For adults with common form of leukemia, new drug promises fewer side effects | Knowridge Science Report", "url": "https://knowridge.com/2017/01/for-adults-with-common-form-of-leukemia-new-drug-promises-fewer-side-effects/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1485451809, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5qbhsn/dr_leis_on_promising_combo_regimens_being/", "gilded": 0, "id": "5qbhsn", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5qbhsn/dr_leis_on_promising_combo_regimens_being/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "gWHq_zAdhJtfjclH2cZEgCVlpW_JgZ3H9u0Knj959jM", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/-Hoccd5M7IL3qecyM8cXWZbWW21iYVC1xCpgWNOXBLM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=04ea6776117f3dff40f9ba4b3a536138", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/-Hoccd5M7IL3qecyM8cXWZbWW21iYVC1xCpgWNOXBLM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=8f254562a2616881290d20a04e334331", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/-Hoccd5M7IL3qecyM8cXWZbWW21iYVC1xCpgWNOXBLM.jpg?s=817fecebd9d3b9c5697d9650ccf05bf1", "width": 250}, "variants": {}}]}, "retrieved_on": 1489476708, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/il_ImZkw7tmhJu8zFsjd1o7DzbUkq2d_Uzy2ceYtIVs.jpg", "title": "Dr. Leis on Promising Combo Regimens Being Explored in CLL", "url": "http://www.onclive.com/onclive-tv/dr-leis-on-promising-combo-regimens-being-explored-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1485310289, "domain": "medscape.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5q0ivv/exciting_venetoclax_plus_rituximab_unprecedented/", "gilded": 0, "id": "5q0ivv", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5q0ivv/exciting_venetoclax_plus_rituximab_unprecedented/", "retrieved_on": 1489471310, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "EXCITING: Venetoclax Plus Rituximab: 'Unprecedented' Efficacy in CLL", "url": "http://www.medscape.com/viewarticle/874861"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1485303636, "domain": "healio.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5pzxwn/ibrutinib_salvage_therapy_effective_for_relapsed/", "gilded": 0, "id": "5pzxwn", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5pzxwn/ibrutinib_salvage_therapy_effective_for_relapsed/", "retrieved_on": 1489471021, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Ibrutinib salvage therapy effective for relapsed CLL following transplantation", "url": "http://www.healio.com/hematology-oncology/leukemia/news/in-the-journals/%7Ba553ec55-db32-4b45-824e-1f2d6d0d9bc6%7D/ibrutinib-salvage-therapy-effective-for-relapsed-cll-following-transplantation"}, {"author": "KongFuPanda", "author_created_utc": 1344977704, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_8o4e3", "brand_safe": false, "contest_mode": false, "created_utc": 1485075594, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5pg3bs/dr_tam_on_btk_inhibitor_bgb3111_in_cll/", "gilded": 0, "id": "5pg3bs", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5pg3bs/dr_tam_on_btk_inhibitor_bgb3111_in_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "iWFiFMx29hWoo6GaswDJafDzOWKMEJDyTCOniBnIbiM", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/SwAliYmUAG6Fgl6zvFWPYjHUIomYKl2GqDhbW0O5d7c.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=26543c0084ce24d6d9b5a1a15907012a", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/SwAliYmUAG6Fgl6zvFWPYjHUIomYKl2GqDhbW0O5d7c.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=b3ff623d3a8bd5285795b64caaf9e8da", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/SwAliYmUAG6Fgl6zvFWPYjHUIomYKl2GqDhbW0O5d7c.jpg?s=435f8be99a5e71046d9af164f89b2441", "width": 250}, "variants": {}}]}, "retrieved_on": 1489461208, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/ZQ9hvvr8BhdqrIRofV419FDoe7jjIRvnUKcT6ueLswc.jpg", "title": "Dr. Tam on BTK Inhibitor BGB-3111 in CLL", "url": "http://www.onclive.com/onclive-tv/dr-tam-on-btk-inhibitor-bgb3111-in-cll"}, {"author": "KongFuPanda", "author_created_utc": 1344977704, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_8o4e3", "brand_safe": false, "contest_mode": false, "created_utc": 1485074969, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5pg29i/dr_woyach_on_ibrutinib_resistance_in_cll/", "gilded": 0, "id": "5pg29i", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5pg29i/dr_woyach_on_ibrutinib_resistance_in_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "N_Nxjfq4xYrF5gdU_TiiZykPC08Vhm8KY16fMUsTx5g", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/qDyDHXimptx64ZlOpY31pFsA2E2CSqv_pMDjkHWsjTk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=4003ed6b1ee2cb8d2f10b8271b6e86f5", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/qDyDHXimptx64ZlOpY31pFsA2E2CSqv_pMDjkHWsjTk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=075241fffbc0f088a775794e76bc0b67", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/qDyDHXimptx64ZlOpY31pFsA2E2CSqv_pMDjkHWsjTk.jpg?s=2971ed114f96c40c384d2c89c82e634c", "width": 250}, "variants": {}}]}, "retrieved_on": 1489461193, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/a-OHgHMmikNJpM3zh5UgcKBZc7Yc9CoJdy39d2ACtyY.jpg", "title": "Dr. Woyach on Ibrutinib Resistance in CLL", "url": "http://www.onclive.com/onclive-tv/dr-woyach-on-ibrutinib-resistance-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484965234, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5p891a/novel_targeted_agents_for_firstline_cll_treatment/", "gilded": 0, "id": "5p891a", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5p891a/novel_targeted_agents_for_firstline_cll_treatment/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "MH-nd8rye9tcKlGGJBgKTORFkNlPwI0nhwgZEkeOk28", "resolutions": [{"height": 77, "url": "https://i.redditmedia.com/xUiUH8zAtc2STySBCHBAiGIRqIKfsi0NL4YgifOZRms.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=98c44f0936d82a0b08909082ff797ae2", "width": 108}], "source": {"height": 143, "url": "https://i.redditmedia.com/xUiUH8zAtc2STySBCHBAiGIRqIKfsi0NL4YgifOZRms.jpg?s=7c34eae14850580fe852c62727045881", "width": 200}, "variants": {}}]}, "retrieved_on": 1489457349, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/JI6XJuR8bnTwj-fdZ2JvTOMCw3p8zrW5BfyxPNqcZbQ.jpg", "title": "Novel Targeted Agents For First-line CLL Treatment", "url": "http://www.cancertherapyadvisor.com/chronic-lymphocytic-leukemia/chronic-leukemia-cll-novel-target-agents-treatment/article/632794/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484950761, "domain": "ajmc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5p710e/prior_ibrutinib_treatment_improves_car_tcell/", "gilded": 0, "id": "5p710e", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5p710e/prior_ibrutinib_treatment_improves_car_tcell/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "X_SeRej_cExFu0OGRBhMPNVuOWL-fFj95Tm7Lq6Nl0w", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=29432581c1ea537453069c8c2faae36e", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=79bbc4cbb8a632ab71abfac7d9970d0a", "width": 216}], "source": {"height": 270, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?s=f6ead69e3a1a9ce00422387615828049", "width": 270}, "variants": {}}]}, "retrieved_on": 1489456745, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/3PkWtKkOCUyGwTw6bitgYyH06ThO410M8Umt42Wr53c.jpg", "title": "Prior Ibrutinib Treatment Improves CAR T-Cell Expansion, Could Impact Response in CLL", "url": "http://www.ajmc.com/journals/evidence-based-oncology/2017/january-2017/prior-ibrutinib-treatment-improves-car-t-cell-expansion-could-impact-response-in-cll-"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484780843, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5osuwd/dr_james_on_update_of_ibrutinib_for_chronic/", "gilded": 0, "id": "5osuwd", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5osuwd/dr_james_on_update_of_ibrutinib_for_chronic/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "NC-KFyoqWeeRsznXSqhNm11vWHP3r5IKg9oqwVuD_YY", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/OMNjrbROREv2lpIT0EoPNLytpHJEc8ZWp4BUZ38o4UI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=acd07fc59368ab3c1152e9b69238272b", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/OMNjrbROREv2lpIT0EoPNLytpHJEc8ZWp4BUZ38o4UI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=5c9825fa8ab56a3e6abc799c778806e8", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/OMNjrbROREv2lpIT0EoPNLytpHJEc8ZWp4BUZ38o4UI.jpg?s=ffbccc7042d450ef4958f9c21e1331f3", "width": 250}, "variants": {}}]}, "retrieved_on": 1489449759, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/8YmCCuGt2_C33catf4bpm7DByfzHmFnMMNaZU28B6qU.jpg", "title": "Dr. James on Update of Ibrutinib for Chronic Lymphocytic Leukemia", "url": "http://www.onclive.com/onclive-tv/dr-james-on-update-of-ibrutinib-for-chronic-lymphocytic-leukemia"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484760832, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5oqqi2/frontline_ibrutinib_benefit_sustained_in_pivotal/", "gilded": 0, "id": "5oqqi2", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5oqqi2/frontline_ibrutinib_benefit_sustained_in_pivotal/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "-d8fKd-8LriRoJ73obz9rrHNmkR-FSuoa6zZv7tMQA0", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/AbrzdQ9ztLknCxB7NGWYUquxvWnTxtr8zvetTWTQoDA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=5de7979d9ef8fc03b1a571573bcd1ffe", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/AbrzdQ9ztLknCxB7NGWYUquxvWnTxtr8zvetTWTQoDA.jpg?s=85fe46d5ee339ca02a020879543ae63d", "width": 200}, "variants": {}}]}, "retrieved_on": 1489448711, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/4Q5lpVZdnsxlmUx_MpwbvIRv6fViMaVcSPZ4Hclk3xQ.jpg", "title": "Frontline Ibrutinib Benefit Sustained in Pivotal Trial Update", "url": "http://www.onclive.com/web-exclusives/frontline-ibrutinib-benefit-sustained-in-pivotal-trial-update"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484760765, "domain": "ajmc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5oqq84/cart_cells_of_defined_composition_effective_in/", "gilded": 0, "id": "5oqq84", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5oqq84/cart_cells_of_defined_composition_effective_in/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "X_SeRej_cExFu0OGRBhMPNVuOWL-fFj95Tm7Lq6Nl0w", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=29432581c1ea537453069c8c2faae36e", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=79bbc4cbb8a632ab71abfac7d9970d0a", "width": 216}], "source": {"height": 270, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?s=f6ead69e3a1a9ce00422387615828049", "width": 270}, "variants": {}}]}, "retrieved_on": 1489448707, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/GicDhTrvXF7zrBWn0F9nA26DT6H47QyXxCrEFCDSKbo.jpg", "title": "CAR-T Cells of Defined Composition Effective in Ibrutinib-Refractory CLL", "url": "http://www.ajmc.com/journals/evidence-based-oncology/2017/january-2017/car-t-cells-of-defined-composition-effective-in-ibrutinib-refractory-cll-"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484760750, "domain": "ajmc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5oqq5o/early_results_show_palbociclib_helps_sustain/", "gilded": 0, "id": "5oqq5o", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5oqq5o/early_results_show_palbociclib_helps_sustain/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "X_SeRej_cExFu0OGRBhMPNVuOWL-fFj95Tm7Lq6Nl0w", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=29432581c1ea537453069c8c2faae36e", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=79bbc4cbb8a632ab71abfac7d9970d0a", "width": 216}], "source": {"height": 270, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?s=f6ead69e3a1a9ce00422387615828049", "width": 270}, "variants": {}}]}, "retrieved_on": 1489448707, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/CXjtJolU3fJgVbU9SMuPSopxtzV6PLAR_bifkSUG6dc.jpg", "title": "Early Results Show Palbociclib Helps Sustain Patient Response to Ibrutinib in MCL", "url": "http://www.ajmc.com/journals/evidence-based-oncology/2017/january-2017/early-results-show-palbociclib-helps-sustain-patient-response-to-ibrutinib-in-mcl-"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484760733, "domain": "medwirenews.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5oqq2w/venetoclax_plus_rituximab_attractive_potential/", "gilded": 0, "id": "5oqq2w", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5oqq2w/venetoclax_plus_rituximab_attractive_potential/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "LiruQ3iALmwQFj-xOM8OGCkoMfg6mbva8DV3PhbIKaA", "resolutions": [{"height": 142, "url": "https://i.redditmedia.com/BcL5j2dahzJ1v9xCkz1OJZuCcoDO8NiVBtpuuyJki2Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=1ee7bdc66e674b098e006af5a0958126", "width": 108}, {"height": 285, "url": "https://i.redditmedia.com/BcL5j2dahzJ1v9xCkz1OJZuCcoDO8NiVBtpuuyJki2Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=7b3daccdb57ba02ea0657f68d8a14da0", "width": 216}], "source": {"height": 404, "url": "https://i.redditmedia.com/BcL5j2dahzJ1v9xCkz1OJZuCcoDO8NiVBtpuuyJki2Y.jpg?s=4e66b15cc90c16321f84d32f5685a423", "width": 306}, "variants": {}}]}, "retrieved_on": 1489448706, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/MX85dlHE5SMya8Isv_PDAjHaZkLyL3U0S-CGuWM6pwM.jpg", "title": "Venetoclax plus rituximab \u2018attractive potential option\u2019 for relapsed, refractory CLL", "url": "https://www.medwirenews.com/leukaemia/oncology/venetoclax-plus-rituximab-attractive-potential-option-for-relaps/12002444"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484760716, "domain": "curetoday.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5oqq06/pivotal_trial_finds_that_imbruvica_shows_benefit/", "gilded": 0, "id": "5oqq06", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5oqq06/pivotal_trial_finds_that_imbruvica_shows_benefit/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "j4f6Qf0tUHn4GlK9hjVUNWroTYZ14W2myQ5aqwrduCk", "resolutions": [{"height": 59, "url": "https://i.redditmedia.com/s8OptjGZJJfx_LG5YiqK0Ueve3AP6GIzuNfA12SfEkg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=54ef4ea68be375571cf1112827d3635b", "width": 108}, {"height": 118, "url": "https://i.redditmedia.com/s8OptjGZJJfx_LG5YiqK0Ueve3AP6GIzuNfA12SfEkg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=304a4317657d45382c47f17944089bed", "width": 216}, {"height": 175, "url": "https://i.redditmedia.com/s8OptjGZJJfx_LG5YiqK0Ueve3AP6GIzuNfA12SfEkg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=e73d53a4daec66d74005df1d15fe2726", "width": 320}], "source": {"height": 282, "url": "https://i.redditmedia.com/s8OptjGZJJfx_LG5YiqK0Ueve3AP6GIzuNfA12SfEkg.jpg?s=639a69b7a4799edffecfa6dda19b3afe", "width": 514}, "variants": {}}]}, "retrieved_on": 1489448705, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/suMvEVpBSE5qfokSThcLQv5wzcNlN5bpXBsbq2U3E1I.jpg", "title": "Pivotal Trial Finds That Imbruvica Shows Benefit in CLL and SLL", "url": "http://www.curetoday.com/articles/pivotal-trial-finds-imbruvica-shows-benefit-in-cll-and-sll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484760700, "domain": "ajmc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5oqpxr/cytokine_biomarkers_can_predict_response_to_car/", "gilded": 0, "id": "5oqpxr", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5oqpxr/cytokine_biomarkers_can_predict_response_to_car/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "X_SeRej_cExFu0OGRBhMPNVuOWL-fFj95Tm7Lq6Nl0w", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=29432581c1ea537453069c8c2faae36e", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=79bbc4cbb8a632ab71abfac7d9970d0a", "width": 216}], "source": {"height": 270, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?s=f6ead69e3a1a9ce00422387615828049", "width": 270}, "variants": {}}]}, "retrieved_on": 1489448704, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/u8Oowcpv35e33SIA0xo9K1BrfS9-eJdIzz7T-VkPyoI.jpg", "title": "Cytokine Biomarkers Can Predict Response to CAR T-Cell Treatment in CLL", "url": "http://www.ajmc.com/journals/evidence-based-oncology/2017/january-2017/cytokine-biomarkers-can-predict--response-to-car-t-cell-treatment--in-cll-"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484760686, "domain": "lymphomanewstoday.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5oqpw2/chronic_lymphocytic_leukemia_combo_in_phase_3/", "gilded": 0, "id": "5oqpw2", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5oqpw2/chronic_lymphocytic_leukemia_combo_in_phase_3/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "-sDLsCXzsSZvUiFQPKIWzui6ZEEj8vtdoNeJzfHla2c", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/TFbqFnNcKIFm9d56Qw9s7zp68PuyHsRBsW_-_Sb3gRs.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=149b2d81fce8f879ec2c2081b34e270e", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/TFbqFnNcKIFm9d56Qw9s7zp68PuyHsRBsW_-_Sb3gRs.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=1dd262323859d07bcca29c2431f296da", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/TFbqFnNcKIFm9d56Qw9s7zp68PuyHsRBsW_-_Sb3gRs.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=0eea2b62679a47b8efc5e337559a4eaa", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/TFbqFnNcKIFm9d56Qw9s7zp68PuyHsRBsW_-_Sb3gRs.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=97dd65b982ede4291d53d006db569868", "width": 640}, {"height": 640, "url": "https://i.redditmedia.com/TFbqFnNcKIFm9d56Qw9s7zp68PuyHsRBsW_-_Sb3gRs.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=5bab34fb851c37dab896e26317c38f01", "width": 960}], "source": {"height": 667, "url": "https://i.redditmedia.com/TFbqFnNcKIFm9d56Qw9s7zp68PuyHsRBsW_-_Sb3gRs.jpg?s=9a404f2ba015f9d658c3ae0a1ec90600", "width": 1000}, "variants": {}}]}, "retrieved_on": 1489448703, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/-mtTs0Vtzm2GO0Ak8fxtusXPOsvBVvkHzIcEHfROGrQ.jpg", "title": "Chronic Lymphocytic Leukemia Combo in Phase 3 Study Named Orphan Drug by fDA", "url": "https://lymphomanewstoday.com/2017/01/17/tg-therapeutics-combination-tg-1101-tgr-1202-for-chronic-lymphocytic-leukemia-named-orphan-drug/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484452101, "domain": "oncologynurseadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5o1ul2/ruxolitinib_may_improve_symptom_control_in/", "gilded": 0, "id": "5o1ul2", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5o1ul2/ruxolitinib_may_improve_symptom_control_in/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "bvH-3X8ZHIymO4sOG8hcCUfsX7oVkdlGO2pb6GhA9N8", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/Tt8a8T3rjM47LvWGlDU4QSBxV9F2f7CSJ7WSLRrsqfA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=fefadadae837fe7686aa0185bce0b408", "width": 108}], "source": {"height": 133, "url": "https://i.redditmedia.com/Tt8a8T3rjM47LvWGlDU4QSBxV9F2f7CSJ7WSLRrsqfA.jpg?s=fcc8133aa1342ad075b21055b0b3cbb9", "width": 200}, "variants": {}}]}, "retrieved_on": 1489436412, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/4O-4ZWUbWgSOr_XyO9qlgQGKJh8bKCVbIGhMrri1fLg.jpg", "title": "Ruxolitinib May Improve Symptom Control in Patients With CLL", "url": "http://www.oncologynurseadvisor.com/leukemia/ruxolitinib-may-improve-qol-for-patients-with-chronic-lymphocytic-leukemia/article/631441/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484452083, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5o1ujl/venetoclax_plus_rituximab_promising_for/", "gilded": 0, "id": "5o1ujl", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5o1ujl/venetoclax_plus_rituximab_promising_for/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "9UGN6DMfhu-wNutGzxWz3SgkKYXgriai_ZyN3-iFrQQ", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/05fRvZ7t7U6grpOL6tpiv-H8m8m4IJ_WaazDhsRVEEo.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=0744ccaa89edc3aedfa276c888b71607", "width": 108}], "source": {"height": 133, "url": "https://i.redditmedia.com/05fRvZ7t7U6grpOL6tpiv-H8m8m4IJ_WaazDhsRVEEo.jpg?s=dcede4dd8d8a1d1ececa742678633a0b", "width": 200}, "variants": {}}]}, "retrieved_on": 1489436411, "score": 3, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/rl6y6jUz2DF7YiQ7QvMIAHA0ULSPPu4BXgH0xsGRkvI.jpg", "title": "Venetoclax Plus Rituximab Promising for Relapsed/Refractory CLL", "url": "http://www.cancertherapyadvisor.com/chronic-lymphocytic-leukemia/chronic-leukemia-cll-venetoclax-rituximab-promising-treatment/article/631455/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484452060, "domain": "thelancet.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5o1uhg/venetoclax_plus_rituximab_in_relapsed_or/", "gilded": 0, "id": "5o1uhg", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5o1uhg/venetoclax_plus_rituximab_in_relapsed_or/", "retrieved_on": 1489436411, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study", "url": "http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(17)30012-8/fulltext?rss=yes"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484451972, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5o1u95/dr_von_tresckow_on_sequential_triplet_trial_in_cll/", "gilded": 0, "id": "5o1u95", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5o1u95/dr_von_tresckow_on_sequential_triplet_trial_in_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "UlqvY3ixvX_vMTg1ClAAeKCpjn9tqL5wJyK4qAE1oBA", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/0WDGkL5g9QMNZHlEk3SwuaJoPztkf5IpJbPvgCf4BcQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=11f0e0648c1cbaf89f6e9785f8201c6e", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/0WDGkL5g9QMNZHlEk3SwuaJoPztkf5IpJbPvgCf4BcQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=f6a42a62af0c7df57dc53bc201c087d7", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/0WDGkL5g9QMNZHlEk3SwuaJoPztkf5IpJbPvgCf4BcQ.jpg?s=ba751da44398ce112000ea51d573f324", "width": 250}, "variants": {}}]}, "retrieved_on": 1489436408, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/HZoUlmezdWSRgq1QLmHemB46JFgRJR_szEdxGPr71KA.jpg", "title": "Dr. von Tresckow on \"Sequential Triple-T\" Trial in CLL", "url": "http://www.onclive.com/onclive-tv/dr-von-tresckow-on-sequential-triplet-trial-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484267639, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5nn95e/singleagent_ibrutinib_therapy_provides_durable/", "gilded": 0, "id": "5nn95e", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5nn95e/singleagent_ibrutinib_therapy_provides_durable/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "ub-yXdH4BWz5rrYMZCvREXzfRn2OMDDQtOunwCF5mtA", "resolutions": [{"height": 74, "url": "https://i.redditmedia.com/2OowPNDoTXvH_WobWn81geikp47NjAITZYU4Dl4JUxg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=e786b12ca3ea8f73ce06d48bebadf0c0", "width": 108}], "source": {"height": 138, "url": "https://i.redditmedia.com/2OowPNDoTXvH_WobWn81geikp47NjAITZYU4Dl4JUxg.jpg?s=f5b51b55b2ae17b77eb3ea1c72fc66d1", "width": 200}, "variants": {}}]}, "retrieved_on": 1489429181, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/JuJHTbVYDXorm_ilDF_UqQhTq304K0oYvxblh43MMrc.jpg", "title": "Single-agent Ibrutinib Therapy Provides Durable Response in CLL/SLL", "url": "http://www.cancertherapyadvisor.com/chronic-lymphocytic-leukemia/chronic-leukemia-cll-single-agent-ibrutinib-therapy-durable-response/article/631312/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484186096, "domain": "health.economictimes.indiatimes.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5nghx4/drug_that_melts_cancer_cells_now_available_for/", "gilded": 0, "id": "5nghx4", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 1, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5nghx4/drug_that_melts_cancer_cells_now_available_for/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "RGwZ9eRawfF0NFTEtVZGfp1wvYJmch3D0MQXOGzQviI", "resolutions": [{"height": 69, "url": "https://i.redditmedia.com/TbJu3aUfLkCgGdlZILAs_0ItsPZXtISEZ4XPWJYia24.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=8091c7f668f41c9fa8268765f79540c2", "width": 108}, {"height": 138, "url": "https://i.redditmedia.com/TbJu3aUfLkCgGdlZILAs_0ItsPZXtISEZ4XPWJYia24.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=a35feeb03c5d02721daa4afbabccc91b", "width": 216}, {"height": 205, "url": "https://i.redditmedia.com/TbJu3aUfLkCgGdlZILAs_0ItsPZXtISEZ4XPWJYia24.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=8726f7d3c76a3611e623be5654b109bb", "width": 320}, {"height": 410, "url": "https://i.redditmedia.com/TbJu3aUfLkCgGdlZILAs_0ItsPZXtISEZ4XPWJYia24.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=4f63af45b838e47c427c748a0635f713", "width": 640}], "source": {"height": 449, "url": "https://i.redditmedia.com/TbJu3aUfLkCgGdlZILAs_0ItsPZXtISEZ4XPWJYia24.jpg?s=257354ef716817c2c0be7ad1b9f4be26", "width": 700}, "variants": {}}]}, "retrieved_on": 1489425853, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/v4Wwte0QeLpnbvE6r72NItez-rWfwMQqX46mUR91VEc.jpg", "title": "Drug that 'melts' cancer cells now available for human use - ET HealthWorld", "url": "http://health.economictimes.indiatimes.com/news/diagnostics/drug-that-melts-cancer-cells-now-available-for-human-use/56442676"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484109543, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5na4mf/mrd_eradication_with_alemtuzumarb_consolidation/", "gilded": 0, "id": "5na4mf", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5na4mf/mrd_eradication_with_alemtuzumarb_consolidation/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "D8qGrjiso1RiwIPtcU0vEOHLbnTVXGaUb2dRwf0eUNI", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/XoItvtRhMlGbsZmOk4zVaeMYUx1O4ffCcyNJVFOO0MI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=9f905f2292c81befbcd11f8ad49a4b45", "width": 108}], "source": {"height": 133, "url": "https://i.redditmedia.com/XoItvtRhMlGbsZmOk4zVaeMYUx1O4ffCcyNJVFOO0MI.jpg?s=f19ab49731e5def10e80eca1c91379d2", "width": 200}, "variants": {}}]}, "retrieved_on": 1489422636, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/6e8uKwERPjDzuHh8KoR8mPK8TQxgwwXTnIbPott9sFA.jpg", "title": "MRD Eradication With Alemtuzumarb Consolidation Improves OS, PFS in CLL", "url": "http://www.cancertherapyadvisor.com/chronic-lymphocytic-leukemia/chronic-leukemia-cll-minimal-disease-mrd-alemtuzumab-better-survival/article/630490/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1484108886, "domain": "ibtimes.com.au", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5na2q8/venetoclax_australian_leukaemia_sufferers_to/", "gilded": 0, "id": "5na2q8", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5na2q8/venetoclax_australian_leukaemia_sufferers_to/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "3oW5oe--H31kdIySCBPVLPIOVHLQrYNbNv0Ym-iASAI", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/IBkgwmBhRVtJM_6cKF3iTYTrdn7tofLfGIfn_dv1KW8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=cd45f01118081bfe25b94f5f2b9f0bb7", "width": 108}, {"height": 143, "url": "https://i.redditmedia.com/IBkgwmBhRVtJM_6cKF3iTYTrdn7tofLfGIfn_dv1KW8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=953c92247da4edc6f0c39c3561ee4d10", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/IBkgwmBhRVtJM_6cKF3iTYTrdn7tofLfGIfn_dv1KW8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=d9f68fe073207b3cea2728e447bd3e19", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/IBkgwmBhRVtJM_6cKF3iTYTrdn7tofLfGIfn_dv1KW8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=ebdf961b4a8df228240a6d1de04bd0a5", "width": 640}, {"height": 639, "url": "https://i.redditmedia.com/IBkgwmBhRVtJM_6cKF3iTYTrdn7tofLfGIfn_dv1KW8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=0f194795c84724b249a57e0ca2542937", "width": 960}, {"height": 719, "url": "https://i.redditmedia.com/IBkgwmBhRVtJM_6cKF3iTYTrdn7tofLfGIfn_dv1KW8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=d8eedaceca850f684b0bd6e2b66953dd", "width": 1080}], "source": {"height": 1466, "url": "https://i.redditmedia.com/IBkgwmBhRVtJM_6cKF3iTYTrdn7tofLfGIfn_dv1KW8.jpg?s=f4f186dc302a1a7b0f3d018955265315", "width": 2200}, "variants": {}}]}, "retrieved_on": 1489422610, "score": 5, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/G33NGDnvs5DPpEsiX702Smp9XqIHnZyOWrbpXXEyHlw.jpg", "title": "Venetoclax: Australian Leukaemia sufferers to benefit immensely from drug; Venclexta forces cancer cells to commit cell suicide", "url": "http://www.ibtimes.com.au/blood-cancer-drug-venetoclax-australian-leukaemia-sufferers-benefit-immensely-drug-venclexta-forces"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1483813374, "domain": "satprnews.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5mlvda/report_available_global_leukemia_therapeutic/", "gilded": 0, "id": "5mlvda", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5mlvda/report_available_global_leukemia_therapeutic/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "k3w237XCWJIxbL0ZcyVDrrAFONLZCNxnUlDK0yCl7bE", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/waalGbHbW9KprrShvfZASkncy3IgDCiOIdbANfcBqh0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=b0be09ce6c497403baf11615dfcdf03e", "width": 108}, {"height": 143, "url": "https://i.redditmedia.com/waalGbHbW9KprrShvfZASkncy3IgDCiOIdbANfcBqh0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=41deeb912f5ed459d645f4ed5c8d2c55", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/waalGbHbW9KprrShvfZASkncy3IgDCiOIdbANfcBqh0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=b165feecc40f2e767563989452e53802", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/waalGbHbW9KprrShvfZASkncy3IgDCiOIdbANfcBqh0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=08be25ee71a113414f6927e5d422a00d", "width": 640}, {"height": 639, "url": "https://i.redditmedia.com/waalGbHbW9KprrShvfZASkncy3IgDCiOIdbANfcBqh0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=d7dfda3f648c8bca50695767f0f0e931", "width": 960}, {"height": 719, "url": "https://i.redditmedia.com/waalGbHbW9KprrShvfZASkncy3IgDCiOIdbANfcBqh0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=03629172aa53793a23a87abeff2e7465", "width": 1080}], "source": {"height": 1333, "url": "https://i.redditmedia.com/waalGbHbW9KprrShvfZASkncy3IgDCiOIdbANfcBqh0.jpg?s=cda34bc5778a869f31f10aff344305d4", "width": 2000}, "variants": {}}]}, "retrieved_on": 1489410674, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/UNhwAn9n8iac1ylHhWmuWMgwwdkoiRqkZlJn4-9eGV4.jpg", "title": "Report Available: Global Leukemia Therapeutic Market Estimated to Grow Strongly by 2021", "url": "http://satprnews.com/2017/01/06/leukemia-therapeutic-market/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1483805019, "domain": "business-standard.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5ml4g0/natco_may_launch_leukemia_drug_in_us_mkt_on_or/", "gilded": 0, "id": "5ml4g0", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5ml4g0/natco_may_launch_leukemia_drug_in_us_mkt_on_or/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "dgYKoOivY5Ve4WeTRsgEMI23Am7_IzT43YhrA9-EUfI", "resolutions": [{"height": 80, "url": "https://i.redditmedia.com/5ku4AaYzOAmJzqKI2aT9q3O44mE1owFvpzyIv9Cl9CU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=39ea3f7d1586b3d0f6c86777e50f81de", "width": 108}, {"height": 161, "url": "https://i.redditmedia.com/5ku4AaYzOAmJzqKI2aT9q3O44mE1owFvpzyIv9Cl9CU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=232b6ea14c5119736d6d7b7f719fe1ec", "width": 216}, {"height": 239, "url": "https://i.redditmedia.com/5ku4AaYzOAmJzqKI2aT9q3O44mE1owFvpzyIv9Cl9CU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=13f06bf9ad45b11ffc0b773159742244", "width": 320}], "source": {"height": 464, "url": "https://i.redditmedia.com/5ku4AaYzOAmJzqKI2aT9q3O44mE1owFvpzyIv9Cl9CU.jpg?s=e92a2bcf926f2081f2c681d43bf5231c", "width": 620}, "variants": {}}]}, "retrieved_on": 1489410304, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/FN8crIw-xCWTFpol-SS17nqoHi_BTi5k_A1NSpoOs88.jpg", "title": "Natco may launch leukemia drug in US mkt on or before Nov 2019", "url": "http://www.business-standard.com/article/pti-stories/natco-may-launch-leukemia-drug-in-us-mkt-on-or-before-nov-2019-117010600459_1.html"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1483727161, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5mf78w/evolution_anticipated_in_firstline_treatment_for/", "gilded": 0, "id": "5mf78w", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5mf78w/evolution_anticipated_in_firstline_treatment_for/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "OGhT4ZOI_vorLHuTGtbLO-ugjeGZKkHaWHe8zb0M5z8", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/0xkplaMHFZo5NJ-JX1M8TTyesvY2N1q0a_NXW8HQYFA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=fa4df82c53dfbbb941ead1c482bd00c4", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/0xkplaMHFZo5NJ-JX1M8TTyesvY2N1q0a_NXW8HQYFA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=2cf59345704f5bd7b9b14b2f5c52b6ef", "width": 216}], "source": {"height": 223, "url": "https://i.redditmedia.com/0xkplaMHFZo5NJ-JX1M8TTyesvY2N1q0a_NXW8HQYFA.jpg?s=dd2771da96c2134cec4240f3041f7dba", "width": 223}, "variants": {}}]}, "retrieved_on": 1489407385, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/zoSASVH3kVA7NVLL6NC7cW79Gz4gT4mS463xpqN372o.jpg", "title": "Evolution Anticipated in First-Line Treatment for CLL, Indolent Lymphomas", "url": "http://www.onclive.com/web-exclusives/evolution-anticipated-in-firstline-treatment-for-cll-indolent-lymphomas?p=1"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1483726820, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5mf60f/dr_zelenetz_on_treatment_for_patients_with_cll/", "gilded": 0, "id": "5mf60f", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5mf60f/dr_zelenetz_on_treatment_for_patients_with_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "kHfBvT1ykrtGmhFuXzKjB12W41PF9IrZ1e_IKU36HYI", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/-l0u3WjaxbPcq9co_mJA9jgT3cmAlVNzgaodz6L-yuU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=cba066ab72f15069240dc0e467cf349f", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/-l0u3WjaxbPcq9co_mJA9jgT3cmAlVNzgaodz6L-yuU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=128e8abed6d61baacf2f221d4e46e7e2", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/-l0u3WjaxbPcq9co_mJA9jgT3cmAlVNzgaodz6L-yuU.jpg?s=a2e4368f5fc12ba51530bd66846bff07", "width": 250}, "variants": {}}]}, "retrieved_on": 1489407369, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/oQUJAW37e7mEszv2Y11pSxkDKCAbajZeF399qjw-yVQ.jpg", "title": "Dr. Zelenetz on Treatment for Patients With CLL Who Fail on Ibrutinib or Idelalisib", "url": "http://www.onclive.com/onclive-tv/dr-zelenetz-on-treatment-for-patients-with-cll-who-fail-on-ibrutinib-or-idelalisib"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1483662633, "domain": "bloodjournal.org", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5maaea/systematic_identification_of_personal/", "gilded": 0, "id": "5maaea", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5maaea/systematic_identification_of_personal/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "jye5Bqgs3vceAqYmAKKiw3Oj8xKefushfqeAKVhRN9o", "resolutions": [{"height": 142, "url": "https://i.redditmedia.com/4O0pjp9hVK2pzxuGoy4XZXsIhBAxYpLzPC4bEdOeNss.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=472bd5e04ae8158cbea2bc24508f27e8", "width": 108}, {"height": 285, "url": "https://i.redditmedia.com/4O0pjp9hVK2pzxuGoy4XZXsIhBAxYpLzPC4bEdOeNss.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=a6fc927f107a4d6d52b773170fc3a627", "width": 216}, {"height": 422, "url": "https://i.redditmedia.com/4O0pjp9hVK2pzxuGoy4XZXsIhBAxYpLzPC4bEdOeNss.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=669af6d4e6b80664b9161179feee9123", "width": 320}, {"height": 845, "url": "https://i.redditmedia.com/4O0pjp9hVK2pzxuGoy4XZXsIhBAxYpLzPC4bEdOeNss.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=69101f293ac6443400baad688b6360b9", "width": 640}], "source": {"height": 1088, "url": "https://i.redditmedia.com/4O0pjp9hVK2pzxuGoy4XZXsIhBAxYpLzPC4bEdOeNss.jpg?s=fff3e786d12a72aadb465f34fda9680d", "width": 824}, "variants": {}}]}, "retrieved_on": 1489404961, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/zl1n3QfUmUzKEFQJYa35bIwqKxmLQDOTX87Lgy8401U.jpg", "title": "Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia", "url": "http://www.bloodjournal.org/content/124/3/453?sso-checked=true"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1483662393, "domain": "ajmc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5ma9mg/combining_cart_cells_with_other_immunotherapies/", "gilded": 0, "id": "5ma9mg", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5ma9mg/combining_cart_cells_with_other_immunotherapies/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "X_SeRej_cExFu0OGRBhMPNVuOWL-fFj95Tm7Lq6Nl0w", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=29432581c1ea537453069c8c2faae36e", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=79bbc4cbb8a632ab71abfac7d9970d0a", "width": 216}], "source": {"height": 270, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?s=f6ead69e3a1a9ce00422387615828049", "width": 270}, "variants": {}}]}, "retrieved_on": 1489404950, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/Ydxt_kUOPdqjJ1mTJwmd2F_0U0H2aGala61VSKcjnJw.jpg", "title": "Combining CAR-T Cells With Other Immunotherapies the Next Logical Step", "url": "http://www.ajmc.com/interviews/dr-david-l-porter-says-car-t-cells-will-be-combined-with-other-immunotherapies"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1483574888, "domain": "bloodjournal.org", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5m2w47/clonal_evolution_leading_to_ibrutinib_resistance/", "gilded": 0, "id": "5m2w47", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5m2w47/clonal_evolution_leading_to_ibrutinib_resistance/", "retrieved_on": 1489401316, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia", "url": "http://www.bloodjournal.org/content/early/2017/01/03/blood-2016-06-719294?sso-checked=true"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1483574829, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5m2vy1/expert_discusses_sequential_triplet_trials_in_cll/", "gilded": 0, "id": "5m2vy1", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5m2vy1/expert_discusses_sequential_triplet_trials_in_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "UiiJ40YVW1Uy6iV0Ygi2edHeh8iUESpLhzcy9oSSbww", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/b_TXD_gEERtPWuFWztxPhJwyjqqndl9ZFwSlO0P1oTY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=4d593604fd2d9bf9c47a4ba6d2a54419", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/b_TXD_gEERtPWuFWztxPhJwyjqqndl9ZFwSlO0P1oTY.jpg?s=9a58b83d0d03667d8ae583230a0e6fa7", "width": 200}, "variants": {}}]}, "retrieved_on": 1489401314, "score": 3, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/eu7ySPLf_1vg7laITlP0aFkVfI9HTvqJb_OTR6ZpQsw.jpg", "title": "Expert Discusses \"Sequential Triple-T\" Trials in CLL", "url": "http://www.onclive.com/web-exclusives/expert-discusses-sequential-triplet-trials-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "contest_mode": false, "created_utc": 1482451729, "domain": "bloodjournal.org", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5ju0d1/highlevel_ror1_associates_with_accelerated/", "gilded": 0, "id": "5ju0d1", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5ju0d1/highlevel_ror1_associates_with_accelerated/", "post_hint": "link", "preview": {"images": [{"id": "keBJjjKNerjRMWvnEc7tP80QzE1Pcuj1kwncKGU-kus", "resolutions": [{"height": 139, "url": "https://i.redditmedia.com/Iwr7rRtV6hPCS5Rs93YsFC48IjmukAjLmXtBNWaX3Vo.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=5ded28dc279b7eb50e0109880c5fe5f4", "width": 108}, {"height": 279, "url": "https://i.redditmedia.com/Iwr7rRtV6hPCS5Rs93YsFC48IjmukAjLmXtBNWaX3Vo.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=0a4ac309832003ccdbbdc8637d270ad7", "width": 216}, {"height": 414, "url": "https://i.redditmedia.com/Iwr7rRtV6hPCS5Rs93YsFC48IjmukAjLmXtBNWaX3Vo.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=6fea9ce7e0d99ae108b6e052a9ca3845", "width": 320}, {"height": 828, "url": "https://i.redditmedia.com/Iwr7rRtV6hPCS5Rs93YsFC48IjmukAjLmXtBNWaX3Vo.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=6ab78e1a5a2e0166c318416e2b23c546", "width": 640}, {"height": 1242, "url": "https://i.redditmedia.com/Iwr7rRtV6hPCS5Rs93YsFC48IjmukAjLmXtBNWaX3Vo.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=6ad98e1fddd56b8ade15d2faf253a0b4", "width": 960}, {"height": 1397, "url": "https://i.redditmedia.com/Iwr7rRtV6hPCS5Rs93YsFC48IjmukAjLmXtBNWaX3Vo.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=59edac7cefa2305e35eb36ff47b4a68f", "width": 1080}], "source": {"height": 2376, "url": "https://i.redditmedia.com/Iwr7rRtV6hPCS5Rs93YsFC48IjmukAjLmXtBNWaX3Vo.jpg?s=5e59c4f5b6523a5bac3141ffcff9e441", "width": 1836}, "variants": {}}]}, "retrieved_on": 1484432176, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "thumbnail": "http://a.thumbs.redditmedia.com/LIE4qnxIYMuhLR8xFi2RgY187rt2HHop4G_L4nKnho0.jpg", "title": "High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia", "url": "http://www.bloodjournal.org/content/128/25/2931?sso-checked=true"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "contest_mode": false, "created_utc": 1482451688, "domain": "digitaljournal.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5ju07d/the_increasing_number_of_chronic_disease_amongst/", "gilded": 0, "id": "5ju07d", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5ju07d/the_increasing_number_of_chronic_disease_amongst/", "retrieved_on": 1484432173, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "thumbnail": "default", "title": "The increasing number of chronic disease amongst aging population is expected to boost the demand of chronic lymphocytic leukemia therapeutics market in near future.", "url": "http://www.digitaljournal.com/pr/3184368"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "contest_mode": false, "created_utc": 1482446231, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5jtjwy/dr_jones_on_the_efficacy_of_venetoclax_in/", "gilded": 0, "id": "5jtjwy", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5jtjwy/dr_jones_on_the_efficacy_of_venetoclax_in/", "post_hint": "link", "preview": {"images": [{"id": "eW62BtQCmEuazg2F40yhN-RDomp_G_cdupVikFCzx40", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/INOzItKCcgfZc2UOhmjLpjwXs7HuGFQMpk4hux4CzHU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=bc994b48f48d9810d1067f8fef475f42", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/INOzItKCcgfZc2UOhmjLpjwXs7HuGFQMpk4hux4CzHU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=e48a2ff40d84731259deb9ac6602a288", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/INOzItKCcgfZc2UOhmjLpjwXs7HuGFQMpk4hux4CzHU.jpg?s=575aabc5363047f07dbed79db1e222b9", "width": 250}, "variants": {}}]}, "retrieved_on": 1484431928, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "thumbnail": "http://b.thumbs.redditmedia.com/qozYQxKFjrbYrVmHnsInBwYrtmk1-YO-lWp8mZWEOdM.jpg", "title": "Dr. Jones on the Efficacy of Venetoclax in Relapsed/Refractory CLL", "url": "http://www.onclive.com/onclive-tv/dr-jones-on-the-efficacy-of-venetoclax-in-relapsedrefractory-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "contest_mode": false, "created_utc": 1482286002, "domain": "cancerres.aacrjournals.org", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5jhcws/nicotinamide_blocks_proliferation_and_induces/", "gilded": 0, "id": "5jhcws", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5jhcws/nicotinamide_blocks_proliferation_and_induces/", "post_hint": "link", "preview": {"images": [{"id": "tcQ5bQtNiu0wexspPZUGvG_y8_Fm0rgdCRXnVZYzmKA", "resolutions": [{"height": 138, "url": "https://i.redditmedia.com/hkdKqND1X1JkmbGI8xSb2leZJan2er83h4MJoAnwAaM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=ddc5944c1a0bdedae60b03bc0b5b2010", "width": 108}], "source": {"height": 150, "url": "https://i.redditmedia.com/hkdKqND1X1JkmbGI8xSb2leZJan2er83h4MJoAnwAaM.jpg?s=3e7b44d2cc6def08ca28e6e5908bb16d", "width": 117}, "variants": {}}]}, "retrieved_on": 1484425070, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "thumbnail": "http://b.thumbs.redditmedia.com/nBqK3cR5OXh5wzSYyBsdOB0JGeNGqSjs4YIy9UP4k_I.jpg", "title": "Nicotinamide Blocks Proliferation and Induces Apoptosis of Chronic Lymphocytic Leukemia Cells", "url": "http://cancerres.aacrjournals.org/content/71/13/4473"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "contest_mode": false, "created_utc": 1481839981, "domain": "medscape.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5ikhn1/meaningful_responses_with_ibrutinib_in_chronic/", "gilded": 0, "id": "5ikhn1", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5ikhn1/meaningful_responses_with_ibrutinib_in_chronic/", "retrieved_on": 1484406914, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "thumbnail": "default", "title": "'Meaningful' Responses With Ibrutinib in Chronic GVHD", "url": "http://www.medscape.com/viewarticle/873327"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "contest_mode": false, "created_utc": 1481762884, "domain": "targetedonc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5iefi4/acalabrutinib_shows_promise_in/", "gilded": 0, "id": "5iefi4", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5iefi4/acalabrutinib_shows_promise_in/", "post_hint": "link", "preview": {"images": [{"id": "XM_RjMlUF9pfEX0raaO0HDgrS9PwTWm5q9RS-r8Crq8", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=8b8bdfe16d31a7b36f7f6995991b63ca", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?s=c1fa7073f91a3a13437fb6762069e070", "width": 200}, "variants": {}}]}, "retrieved_on": 1484403612, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "thumbnail": "http://b.thumbs.redditmedia.com/Q3m0WXF8tPd6kU4LrtWjyABNqOG-foz-m_e3NRrSdWo.jpg", "title": "Acalabrutinib Shows Promise in Ibrutinib-Intolerant CLL/SLL", "url": "http://www.targetedonc.com/news/acalabrutinib-shows-promise-in-ibrutinibintolerant-cllsll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "contest_mode": false, "created_utc": 1481762790, "domain": "clinicalleader.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5ief3m/kinda_boring_and_specific_but_progress_nonetheless/", "gilded": 0, "id": "5ief3m", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5ief3m/kinda_boring_and_specific_but_progress_nonetheless/", "retrieved_on": 1484403605, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "thumbnail": "default", "title": "Kinda Boring and Specific, but Progress Nonetheless", "url": "http://www.clinicalleader.com/doc/morphosys-starts-trial-mor-idelalisib-patient-relapsed-refractory-cll-or-sll-btk-inhibitor-0001"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "contest_mode": false, "created_utc": 1481762564, "domain": "healio.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5ieea3/lenalidomide_may_be_practice_changing_for/", "gilded": 0, "id": "5ieea3", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5ieea3/lenalidomide_may_be_practice_changing_for/", "retrieved_on": 1484403592, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "thumbnail": "default", "title": "Lenalidomide may be \u2018practice changing\u2019 for physicians treating leukemia", "url": "http://www.healio.com/hematology-oncology/leukemia/news/online/%7Be63ad40e-2999-4ca5-8c4d-dd22443f8fea%7D/video-lenalidomide-may-be-practice-changing-for-physicians-treating-leukemia"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "contest_mode": false, "created_utc": 1481762273, "domain": "pipelinereview.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5ied6h/european_commission_grants_marketing/", "gilded": 0, "id": "5ied6h", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5ied6h/european_commission_grants_marketing/", "retrieved_on": 1484403575, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "thumbnail": "default", "title": "European Commission Grants Marketing Authorization for Arzerra\u00ae (ofatumumab) in combination with Fludarabine and Cyclophosphamide in Relapsed CLL", "url": "http://pipelinereview.com/index.php/2016121463336/Antibodies/European-Commission-Grants-Marketing-Authorization-for-Arzerra-ofatumumab-in-combination-with-Fludarabine-and-Cyclophosphamide-in-Relapsed-CLL.html"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "contest_mode": false, "created_utc": 1481704477, "domain": "thepharmaletter.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5i9iyf/conditional_european_marketing_approval_for/", "gilded": 0, "id": "5i9iyf", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5i9iyf/conditional_european_marketing_approval_for/", "post_hint": "link", "preview": {"images": [{"id": "dM8ivh0a3YA5VBkwiISiLfrLesYM_KIJa9MnLGgFpcA", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/KrrYajyFb1MdSFfxXBSc7wZNMjpjLptWOpn6G8sjcAk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=15564292ae0ced16866c31cf73bfa0dd", "width": 108}, {"height": 143, "url": "https://i.redditmedia.com/KrrYajyFb1MdSFfxXBSc7wZNMjpjLptWOpn6G8sjcAk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=cec929875c28db17d55450c81259d93c", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/KrrYajyFb1MdSFfxXBSc7wZNMjpjLptWOpn6G8sjcAk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=3500c7daf2e0c27bf0bd4e220584e64a", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/KrrYajyFb1MdSFfxXBSc7wZNMjpjLptWOpn6G8sjcAk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=3b8ee4fd31623d60708971c3d8b545ad", "width": 640}], "source": {"height": 466, "url": "https://i.redditmedia.com/KrrYajyFb1MdSFfxXBSc7wZNMjpjLptWOpn6G8sjcAk.jpg?s=d3af7aad49a4baf904ce78280a2c61a8", "width": 700}, "variants": {}}]}, "retrieved_on": 1484400816, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "thumbnail": "http://a.thumbs.redditmedia.com/zYy4GXapbuLaP2vjdTYBNCjMSR-hGW6MIHaUIhFqBI4.jpg", "title": "Conditional European marketing approval for Venclyxto in CLL", "url": "http://www.thepharmaletter.com/article/conditional-european-marketing-approval-for-venclyxto-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "contest_mode": false, "created_utc": 1481704435, "domain": "targetedonc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5i9ivk/high_response_rate_with_venetoclax_in/", "gilded": 0, "id": "5i9ivk", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5i9ivk/high_response_rate_with_venetoclax_in/", "post_hint": "link", "preview": {"images": [{"id": "ebnIVR2C7NNSbbk1Y_boNi0F4k9iC5SRyzafwaY1yQ4", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/QXqaeuGDS7yCew8sPAuf-nL_ijPECq9RdHYbDH0n05w.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=44c18c6da60b765e70d86bbd8cf3b458", "width": 108}], "source": {"height": 135, "url": "https://i.redditmedia.com/QXqaeuGDS7yCew8sPAuf-nL_ijPECq9RdHYbDH0n05w.jpg?s=5c13247297441db75a15e7199a165a05", "width": 135}, "variants": {}}]}, "retrieved_on": 1484400815, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "thumbnail": "http://b.thumbs.redditmedia.com/MWBQYW9WN1ClzrVYlE2uvmv90tnUqwXcsUJTkYX8dUg.jpg", "title": "High Response Rate With Venetoclax in Relapsed/Refractory CLL", "url": "http://www.targetedonc.com/conference/ash-cll-spotlight/high-response-rate-with-venetoclax-in-relapsedrefractory-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "contest_mode": false, "created_utc": 1481704407, "domain": "ajmc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5i9iu4/car_tcells_of_defined_composition_effective_in/", "gilded": 0, "id": "5i9iu4", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5i9iu4/car_tcells_of_defined_composition_effective_in/", "post_hint": "link", "preview": {"images": [{"id": "X_SeRej_cExFu0OGRBhMPNVuOWL-fFj95Tm7Lq6Nl0w", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=29432581c1ea537453069c8c2faae36e", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=79bbc4cbb8a632ab71abfac7d9970d0a", "width": 216}], "source": {"height": 270, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?s=f6ead69e3a1a9ce00422387615828049", "width": 270}, "variants": {}}]}, "retrieved_on": 1484400815, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "thumbnail": "http://b.thumbs.redditmedia.com/9Teb_xeZ4QNvlRrl82QfGcnFbcMUu2j3gbi423TpTio.jpg", "title": "CAR T-Cells of Defined Composition Effective in Ibrutinib-Refractory CLL", "url": "http://www.ajmc.com/newsroom/car-t-cells-of-defined-composition-effective-in-ibrutinib-refractory-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "contest_mode": false, "created_utc": 1481704386, "domain": "lifesciencedaily.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5i9is8/earlyphase_car_tcell_therapy_produces_promising/", "gilded": 0, "id": "5i9is8", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5i9is8/earlyphase_car_tcell_therapy_produces_promising/", "post_hint": "link", "preview": {"images": [{"id": "VPK1fjHI49Bl4nsBKzUjd7OnAOgmprJR0FTj_7odS_s", "resolutions": [{"height": 43, "url": "https://i.redditmedia.com/yvfPAJHXRuepPPLscXSX087SgD80GAdX831IusLZ9_E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=0db3c701c7f14514a621b5ce4f5ffcc1", "width": 108}, {"height": 87, "url": "https://i.redditmedia.com/yvfPAJHXRuepPPLscXSX087SgD80GAdX831IusLZ9_E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=44755876a535923c272714f10b6652be", "width": 216}, {"height": 128, "url": "https://i.redditmedia.com/yvfPAJHXRuepPPLscXSX087SgD80GAdX831IusLZ9_E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=0316332092feebadbe7ad4dbda02106e", "width": 320}, {"height": 257, "url": "https://i.redditmedia.com/yvfPAJHXRuepPPLscXSX087SgD80GAdX831IusLZ9_E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=a04834d66137612b3757dfaf8c79ad19", "width": 640}], "source": {"height": 282, "url": "https://i.redditmedia.com/yvfPAJHXRuepPPLscXSX087SgD80GAdX831IusLZ9_E.jpg?s=9f28ccbe5ef5a1e08b448a0cfd3628ba", "width": 700}, "variants": {}}]}, "retrieved_on": 1484400814, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "thumbnail": "http://b.thumbs.redditmedia.com/EFk1Vh6yFIHGzJGAVpw_Cw23ribuDR-0b4JwSlcIF_E.jpg", "title": "Early-phase CAR T-cell therapy produces promising results in CLL patients", "url": "https://lifesciencedaily.com/stories/19456-early-phase-car-t-cell-therapy-produces-promising-results-cll-patients/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "contest_mode": false, "created_utc": 1481704313, "domain": "scienceworldreport.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5i9ine/chronic_lymphocytic_leukemia_can_be_treated_with/", "gilded": 0, "id": "5i9ine", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5i9ine/chronic_lymphocytic_leukemia_can_be_treated_with/", "post_hint": "link", "preview": {"images": [{"id": "dg33QYl7RWkTVMaPI1qKnLh6V-aGVwK4sFHk1w4xadQ", "resolutions": [{"height": 47, "url": "https://i.redditmedia.com/CXXhdEoToBmIvaO8O_9tyLZdoAjAhQJBWReJaWCWFHU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=f8d1d849e517cfc56d8d360baa3871ef", "width": 108}, {"height": 94, "url": "https://i.redditmedia.com/CXXhdEoToBmIvaO8O_9tyLZdoAjAhQJBWReJaWCWFHU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=1578a4fcb5350ba65290716e01c16dce", "width": 216}, {"height": 140, "url": "https://i.redditmedia.com/CXXhdEoToBmIvaO8O_9tyLZdoAjAhQJBWReJaWCWFHU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=b8437e89a631d6d916f964ba53f3ff95", "width": 320}], "source": {"height": 211, "url": "https://i.redditmedia.com/CXXhdEoToBmIvaO8O_9tyLZdoAjAhQJBWReJaWCWFHU.jpg?s=55e059e5c8c67f1b4c380dcc73a81b2e", "width": 480}, "variants": {}}]}, "retrieved_on": 1484400811, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "thumbnail": "http://b.thumbs.redditmedia.com/E-Oe_9wMW9m6a7jF1WMNNRXWBDEFEsm_MwPT0JVTUdw.jpg", "title": "Chronic Lymphocytic Leukemia Can Be Treated With Chimeric Antigen Receptor T-Cell Immunotherapy, CAR-T", "url": "http://www.scienceworldreport.com/articles/53868/20161207/chronic-lymphocytic-leukemia-chimeric-antigen-t-cell-immunotherapy.htm"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "contest_mode": false, "created_utc": 1481704185, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5i9ies/high_response_rate_with_venetoclax_in/", "gilded": 0, "id": "5i9ies", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5i9ies/high_response_rate_with_venetoclax_in/", "post_hint": "link", "preview": {"images": [{"id": "btkwNmeIkzah1C3IprqpZ9RjMgY-_P--ikZG_Ff0zVs", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/tHqu-7MPTfWCTbFyloiMUcj5u45z_kBxgudJVP1fQb0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=3f596ab244a6544835bf696664fccc8e", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/tHqu-7MPTfWCTbFyloiMUcj5u45z_kBxgudJVP1fQb0.jpg?s=df067a775982dc574b16e944be269299", "width": 200}, "variants": {}}]}, "retrieved_on": 1484400808, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "thumbnail": "http://a.thumbs.redditmedia.com/VISAt14lNCRJH0LdIGYUn9PQPWIBizjjz03pFVXoNv0.jpg", "title": "High Response Rate With Venetoclax in Relapsed/Refractory CLL", "url": "http://www.onclive.com/web-exclusives/high-response-rate-with-venetoclax-in-relapsedrefractory-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "contest_mode": false, "created_utc": 1481704157, "domain": "nasdaq.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5i9icr/rocheabbvies_leukemia_drug_venclyxto_gains_eu/", "gilded": 0, "id": "5i9icr", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5i9icr/rocheabbvies_leukemia_drug_venclyxto_gains_eu/", "post_hint": "link", "preview": {"images": [{"id": "dPgRp3fR1h_Kc_Ant1B2IiqIsd5973FZT1fw6TmXqhw", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/1-laLbtdpMtCGlBGedBwhb2NDGeLgdrw0VaZMwvd6no.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=d4d6c594f710134d660904bd81501866", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/1-laLbtdpMtCGlBGedBwhb2NDGeLgdrw0VaZMwvd6no.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=25496ff7dadef0f0069babe605ca9964", "width": 216}], "source": {"height": 300, "url": "https://i.redditmedia.com/1-laLbtdpMtCGlBGedBwhb2NDGeLgdrw0VaZMwvd6no.jpg?s=b801406435161bdbd0cb8847e23eeeaa", "width": 300}, "variants": {}}]}, "retrieved_on": 1484400807, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "thumbnail": "http://b.thumbs.redditmedia.com/drnfm5GzZ3zrpbXqZkqNv92VFlZ7eeSEKB57bwHm6fA.jpg", "title": "Roche/AbbVie's Leukemia Drug Venclyxto Gains EU Approval", "url": "http://www.nasdaq.com/article/rocheabbvies-leukemia-drug-venclyxto-gains-eu-approval-cm720126"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "contest_mode": false, "created_utc": 1481704118, "domain": "gurufocus.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/5i9ia8/roches_leukemia_drug_approved_for_next_step_in/", "gilded": 0, "id": "5i9ia8", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/5i9ia8/roches_leukemia_drug_approved_for_next_step_in/", "post_hint": "link", "preview": {"images": [{"id": "XkldVMjzWEDl2FUQVVZy2pIx9WoXAD7kYZrA6J9Iap8", "resolutions": [{"height": 185, "url": "https://i.redditmedia.com/uwRQgbcitZRDUJJLKa7BWrQ4tB0thsRV-wgxtSgHBxw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=7531eebf9b10df783134a45e15f02a2c", "width": 108}, {"height": 370, "url": "https://i.redditmedia.com/uwRQgbcitZRDUJJLKa7BWrQ4tB0thsRV-wgxtSgHBxw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=d744dfb67e99b73cd878044dbd6e6084", "width": 216}, {"height": 548, "url": "https://i.redditmedia.com/uwRQgbcitZRDUJJLKa7BWrQ4tB0thsRV-wgxtSgHBxw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=783c293957c2da214dc526b12f72118b", "width": 320}], "source": {"height": 641, "url": "https://i.redditmedia.com/uwRQgbcitZRDUJJLKa7BWrQ4tB0thsRV-wgxtSgHBxw.jpg?s=bc4a93bb139ceffcc068634e4f0f5c34", "width": 374}, "variants": {}}]}, "retrieved_on": 1484400805, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "thumbnail": "http://b.thumbs.redditmedia.com/F7KszrMTbjkeeXctQQkXMepaTze8lKvbcGzTk4rp4pM.jpg", "title": "Roche's Leukemia Drug Approved for Next Step in Europe", "url": "http://www.gurufocus.com/news/463698/roches-leukemia-drug-approved-for-next-step-in-europe-"}, {"all_awardings": [], "allow_live_comments": false, "author": "BirthControlMethods", "author_flair_css_class": null, "author_flair_richtext": [], "author_flair_text": null, "author_flair_type": "text", "author_fullname": "t2_1cuotapq", "author_patreon_flair": false, "author_premium": false, "awarders": [], "can_mod_post": false, "contest_mode": false, "created_utc": 1592937163, "domain": "medicalfightagainst-cancer.info", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/hek540/who_usually_gets_cll/", "gildings": {}, "id": "hek540", "is_crosspostable": true, "is_meta": false, "is_original_content": false, "is_reddit_media_domain": false, "is_robot_indexable": true, "is_self": false, "is_video": false, "link_flair_background_color": "", "link_flair_richtext": [], "link_flair_text_color": "dark", "link_flair_type": "text", "locked": false, "media_only": false, "no_follow": true, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/hek540/who_usually_gets_cll/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "UA64Iwx-d8hFYc9A-O9yYajKFFp16iaCIJEGUeb1tzY", "resolutions": [{"height": 56, "url": "https://external-preview.redd.it/8YES7wVJKdTQqY-JViuwSW_Wo7S28uFSptqub8soDkg.jpg?width=108&amp;crop=smart&amp;auto=webp&amp;s=33efc4674491175611ce617c3c6d1a5245e75b3b", "width": 108}, {"height": 113, "url": "https://external-preview.redd.it/8YES7wVJKdTQqY-JViuwSW_Wo7S28uFSptqub8soDkg.jpg?width=216&amp;crop=smart&amp;auto=webp&amp;s=14e513dff7e45d9534a9f6edb394fd81149ea40c", "width": 216}, {"height": 167, "url": "https://external-preview.redd.it/8YES7wVJKdTQqY-JViuwSW_Wo7S28uFSptqub8soDkg.jpg?width=320&amp;crop=smart&amp;auto=webp&amp;s=c0cea88edf14ac77d27a2fdb65f3631fc2ca41f2", "width": 320}], "source": {"height": 313, "url": "https://external-preview.redd.it/8YES7wVJKdTQqY-JViuwSW_Wo7S28uFSptqub8soDkg.jpg?auto=webp&amp;s=fde04eecf4a274dace4ca5c6e3f7ca46937f8b3f", "width": 598}, "variants": {}}]}, "retrieved_on": 1592940059, "score": 1, "selftext": "", "send_replies": true, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "subreddit_subscribers": 93, "subreddit_type": "public", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/vXMU8AQVYnuUYHihJz65VghUhxJvLVi8i8HaEAOMpuw.jpg", "thumbnail_height": 73, "thumbnail_width": 140, "title": "Who usually gets CLL?", "total_awards_received": 0, "treatment_tags": [], "upvote_ratio": 1.0, "url": "https://www.medicalfightagainst-cancer.info/2020/06/who-usually-gets-cll.html", "url_overridden_by_dest": "https://www.medicalfightagainst-cancer.info/2020/06/who-usually-gets-cll.html"}, {"all_awardings": [], "allow_live_comments": false, "author": "abraca10", "author_flair_css_class": null, "author_flair_richtext": [], "author_flair_text": null, "author_flair_type": "text", "author_fullname": "t2_5vznm52p", "author_patreon_flair": false, "author_premium": false, "awarders": [], "can_mod_post": false, "contest_mode": false, "created_utc": 1584649088, "domain": "self.CLL_Leukemia", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/flgyxl/understanding_imbruvica_survey/", "gildings": {}, "id": "flgyxl", "is_crosspostable": true, "is_meta": false, "is_original_content": false, "is_reddit_media_domain": false, "is_robot_indexable": true, "is_self": true, "is_video": false, "link_flair_background_color": "", "link_flair_richtext": [], "link_flair_text_color": "dark", "link_flair_type": "text", "locked": false, "media_only": false, "no_follow": true, "num_comments": 1, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/flgyxl/understanding_imbruvica_survey/", "pinned": false, "post_hint": "self", "preview": {"enabled": false, "images": [{"id": "YWyxkh3HUIWlstcubnWexyuDDRokfymGsIRd8K0ihMU", "resolutions": [{"height": 36, "url": "https://external-preview.redd.it/38IVDTjzZiJrsByhR3snxfF8Cn_6cyFU4i6LE8lItLg.jpg?width=108&amp;crop=smart&amp;auto=webp&amp;s=de9ef4f286ca3a43945de02a221e9df6e8dfe8f5", "width": 108}], "source": {"height": 64, "url": "https://external-preview.redd.it/38IVDTjzZiJrsByhR3snxfF8Cn_6cyFU4i6LE8lItLg.jpg?auto=webp&amp;s=7628cff671f5c8388f0fbcaad30d5004bae8cbf1", "width": 189}, "variants": {}}]}, "retrieved_on": 1584649393, "score": 1, "selftext": "SURVEY LINK: [https://ibrutinib.typeform.com/to/UHcKX5](https://ibrutinib.typeform.com/to/UHcKX5)\n\nI am a graduate student working on a research project to evaluate the real-world perceptions of Imbruvica(ibrutinib). I am hoping to identify barriers to treatment, or unmet needs in people with the indicated conditions, in order to improve access to innovative therapeutic products. Any and all data collected is anonymous and we request you do not include any self-identifying information. I would really appreciate your input if you could take 5 minutes to fill out this survey. Thank you in advance!", "send_replies": true, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "subreddit_subscribers": 84, "subreddit_type": "public", "suggested_sort": "confidence", "thumbnail": "self", "title": "Understanding Imbruvica - SURVEY", "total_awards_received": 0, "url": "https://www.reddit.com/r/CLL_Leukemia/comments/flgyxl/understanding_imbruvica_survey/"}, {"all_awardings": [], "allow_live_comments": false, "author": "cpclos", "author_flair_css_class": null, "author_flair_richtext": [], "author_flair_text": null, "author_flair_type": "text", "author_fullname": "t2_a1pkg", "author_patreon_flair": false, "author_premium": false, "awarders": [], "can_mod_post": false, "contest_mode": false, "created_utc": 1577133584, "domain": "youtu.be", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/eeq7ie/dr_brian_koffman_but_the_most_impressive_thing_is/", "gildings": {}, "id": "eeq7ie", "is_crosspostable": true, "is_meta": false, "is_original_content": false, "is_reddit_media_domain": false, "is_robot_indexable": true, "is_self": false, "is_video": false, "link_flair_background_color": "", "link_flair_richtext": [], "link_flair_text_color": "dark", "link_flair_type": "text", "locked": false, "media": {"oembed": {"author_name": "Hidden Forces", "author_url": "https://www.youtube.com/channel/UC8URhgYos5fjHqFSO4RSIEg", "height": 338, "html": "&lt;iframe width=\"600\" height=\"338\" src=\"https://www.youtube.com/embed/1cD-UVIdqfc?feature=oembed&amp;enablejsapi=1\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen&gt;&lt;/iframe&gt;", "provider_name": "YouTube", "provider_url": "https://www.youtube.com/", "thumbnail_height": 360, "thumbnail_url": "https://i.ytimg.com/vi/1cD-UVIdqfc/hqdefault.jpg", "thumbnail_width": 480, "title": "Cutting Edge Therapy: Cancer Cured After Eleven Years of Battling CLL | Brian Koffman", "type": "video", "version": "1.0", "width": 600}, "type": "youtube.com"}, "media_embed": {"content": "&lt;iframe width=\"600\" height=\"338\" src=\"https://www.youtube.com/embed/1cD-UVIdqfc?feature=oembed&amp;enablejsapi=1\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen&gt;&lt;/iframe&gt;", "height": 338, "scrolling": false, "width": 600}, "media_only": false, "no_follow": true, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/eeq7ie/dr_brian_koffman_but_the_most_impressive_thing_is/", "pinned": false, "post_hint": "rich:video", "preview": {"enabled": false, "images": [{"id": "zuEEZJ-mb-YEcvpxppajTgADk_f8TsLSqz0_xo5N_s4", "resolutions": [{"height": 81, "url": "https://external-preview.redd.it/RPWZMxJIYhnOJWf3Ir7vPT2gG1Pg96spcpg8zG3PKWk.jpg?width=108&amp;crop=smart&amp;auto=webp&amp;s=e95d480a18ab8745e28443dcdde093403e883a4e", "width": 108}, {"height": 162, "url": "https://external-preview.redd.it/RPWZMxJIYhnOJWf3Ir7vPT2gG1Pg96spcpg8zG3PKWk.jpg?width=216&amp;crop=smart&amp;auto=webp&amp;s=0f14609baab21a9b7703f28397694dfb0f41c75d", "width": 216}, {"height": 240, "url": "https://external-preview.redd.it/RPWZMxJIYhnOJWf3Ir7vPT2gG1Pg96spcpg8zG3PKWk.jpg?width=320&amp;crop=smart&amp;auto=webp&amp;s=63582a0107c8de457a8d872530709ca70013842d", "width": 320}], "source": {"height": 360, "url": "https://external-preview.redd.it/RPWZMxJIYhnOJWf3Ir7vPT2gG1Pg96spcpg8zG3PKWk.jpg?auto=webp&amp;s=1977f93e7fcf6679068d00319f5e0a744176fff6", "width": 480}, "variants": {}}]}, "retrieved_on": 1577133585, "score": 1, "secure_media": {"oembed": {"author_name": "Hidden Forces", "author_url": "https://www.youtube.com/channel/UC8URhgYos5fjHqFSO4RSIEg", "height": 338, "html": "&lt;iframe width=\"600\" height=\"338\" src=\"https://www.youtube.com/embed/1cD-UVIdqfc?feature=oembed&amp;enablejsapi=1\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen&gt;&lt;/iframe&gt;", "provider_name": "YouTube", "provider_url": "https://www.youtube.com/", "thumbnail_height": 360, "thumbnail_url": "https://i.ytimg.com/vi/1cD-UVIdqfc/hqdefault.jpg", "thumbnail_width": 480, "title": "Cutting Edge Therapy: Cancer Cured After Eleven Years of Battling CLL | Brian Koffman", "type": "video", "version": "1.0", "width": 600}, "type": "youtube.com"}, "secure_media_embed": {"content": "&lt;iframe width=\"600\" height=\"338\" src=\"https://www.youtube.com/embed/1cD-UVIdqfc?feature=oembed&amp;enablejsapi=1\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen&gt;&lt;/iframe&gt;", "height": 338, "media_domain_url": "https://www.redditmedia.com/mediaembed/eeq7ie", "scrolling": false, "width": 600}, "selftext": "", "send_replies": true, "spoiler": false, "steward_reports": [], "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "subreddit_subscribers": 76, "subreddit_type": "public", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/XIOMb94bktxtVRX3L_WDv8xWeWwUnoZ6YK4vn5DKJmE.jpg", "thumbnail_height": 105, "thumbnail_width": 140, "title": "Dr. Brian Koffman: \u201cBut the most impressive thing is they looked in my bone marrow, which had been heavily involved with CLL and they could find no trace of CLL down a one in 100,000 or one in a million cells.\u201d", "total_awards_received": 0, "url": "https://youtu.be/1cD-UVIdqfc"}, {"all_awardings": [], "allow_live_comments": false, "author": "No-Criticism5002", "author_flair_css_class": null, "author_flair_richtext": [], "author_flair_text": null, "author_flair_type": "text", "author_fullname": "t2_9lpec3uf", "author_is_blocked": false, "author_patreon_flair": false, "author_premium": false, "awarders": [], "can_mod_post": false, "contest_mode": false, "created_utc": 1640634100, "domain": "m.facebook.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/rpvgzk/log_into_facebook/", "gildings": {}, "id": "rpvgzk", "is_created_from_ads_ui": false, "is_crosspostable": true, "is_meta": false, "is_original_content": false, "is_reddit_media_domain": false, "is_robot_indexable": true, "is_self": false, "is_video": false, "link_flair_background_color": "", "link_flair_richtext": [], "link_flair_text_color": "dark", "link_flair_type": "text", "locked": false, "media_only": false, "no_follow": true, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/rpvgzk/log_into_facebook/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "trgr9WRWJnlvR2jWUoPw041sqDOhwTh-7zaoxFgvsHc", "resolutions": [{"height": 108, "url": "https://external-preview.redd.it/ZZM9ydeQiRH3OYX__vyFArEBCdtkQ6cSELc55K-Mp08.jpg?width=108&amp;crop=smart&amp;auto=webp&amp;s=669133c8fdeedbef5eb3d65f08e86331b56e25b0", "width": 108}, {"height": 216, "url": "https://external-preview.redd.it/ZZM9ydeQiRH3OYX__vyFArEBCdtkQ6cSELc55K-Mp08.jpg?width=216&amp;crop=smart&amp;auto=webp&amp;s=ed720fb4fae962c0162028566053bc3c8c36daa8", "width": 216}, {"height": 320, "url": "https://external-preview.redd.it/ZZM9ydeQiRH3OYX__vyFArEBCdtkQ6cSELc55K-Mp08.jpg?width=320&amp;crop=smart&amp;auto=webp&amp;s=246f67bbf6b88aab2b30d8a03bddc4fe02f3eb9e", "width": 320}], "source": {"height": 325, "url": "https://external-preview.redd.it/ZZM9ydeQiRH3OYX__vyFArEBCdtkQ6cSELc55K-Mp08.jpg?auto=webp&amp;s=7ec64b8ea8710ceb959986ad3a54eba19643c5d8", "width": 325}, "variants": {}}]}, "retrieved_on": 1640634110, "score": 1, "selftext": "", "send_replies": true, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "subreddit_subscribers": 138, "subreddit_type": "public", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/cuzmv45CW9uB06n7nPC7w4VFCwVgZfks3NB874Q74Zc.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Log into Facebook", "total_awards_received": 0, "treatment_tags": [], "upvote_ratio": 1.0, "url": "https://m.facebook.com/story.php?story_fbid=10224497155350993&amp;id=1070797170&amp;sfnsn=mo", "url_overridden_by_dest": "https://m.facebook.com/story.php?story_fbid=10224497155350993&amp;id=1070797170&amp;sfnsn=mo"}, {"all_awardings": [], "allow_live_comments": false, "author": "Aggravating-Term-355", "author_flair_css_class": null, "author_flair_richtext": [], "author_flair_text": null, "author_flair_type": "text", "author_fullname": "t2_bx5lhz3j", "author_is_blocked": false, "author_patreon_flair": false, "author_premium": false, "awarders": [], "can_mod_post": false, "contest_mode": false, "created_utc": 1636926994, "domain": "self.CLL_Leukemia", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/qu0ixb/medications/", "gildings": {}, "id": "qu0ixb", "is_created_from_ads_ui": false, "is_crosspostable": true, "is_meta": false, "is_original_content": false, "is_reddit_media_domain": false, "is_robot_indexable": true, "is_self": true, "is_video": false, "link_flair_background_color": "", "link_flair_richtext": [], "link_flair_text_color": "dark", "link_flair_type": "text", "locked": false, "media_only": false, "no_follow": true, "num_comments": 1, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/qu0ixb/medications/", "pinned": false, "retrieved_on": 1636927005, "score": 1, "selftext": "Any body pay high prices for sprycel", "send_replies": true, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "subreddit_subscribers": 134, "subreddit_type": "public", "suggested_sort": "confidence", "thumbnail": "self", "title": "Medications", "total_awards_received": 0, "treatment_tags": [], "upvote_ratio": 1.0, "url": "https://www.reddit.com/r/CLL_Leukemia/comments/qu0ixb/medications/"}, {"all_awardings": [], "allow_live_comments": false, "author": "Caroline_Griffin", "author_flair_css_class": null, "author_flair_richtext": [], "author_flair_text": null, "author_flair_type": "text", "author_fullname": "t2_a0p4fhxt", "author_patreon_flair": false, "author_premium": false, "awarders": [], "can_mod_post": false, "contest_mode": false, "created_utc": 1623242667, "domain": "self.CLL_Leukemia", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/nvv1hg/psychological_wellbeing_of_cancer_survivors/", "gildings": {}, "id": "nvv1hg", "is_created_from_ads_ui": false, "is_crosspostable": true, "is_meta": false, "is_original_content": false, "is_reddit_media_domain": false, "is_robot_indexable": true, "is_self": true, "is_video": false, "link_flair_background_color": "", "link_flair_richtext": [], "link_flair_text_color": "dark", "link_flair_type": "text", "locked": false, "media_only": false, "no_follow": true, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/nvv1hg/psychological_wellbeing_of_cancer_survivors/", "pinned": false, "post_hint": "self", "preview": {"enabled": false, "images": [{"id": "GK7rSp3R0thMgzt4NCmu4LI7e6qGa2Nr1220tOqGeak", "resolutions": [{"height": 108, "url": "https://external-preview.redd.it/uDiKXtVSlkPNkYxfDIvgr7yH7BWPfC8LeNNCRqPlM3E.jpg?width=108&amp;crop=smart&amp;auto=webp&amp;s=8374a68de12fc48283fc2e257e3ed9714832ea9a", "width": 108}, {"height": 216, "url": "https://external-preview.redd.it/uDiKXtVSlkPNkYxfDIvgr7yH7BWPfC8LeNNCRqPlM3E.jpg?width=216&amp;crop=smart&amp;auto=webp&amp;s=916d5d1a4d4b69d8c35648b9a353185fc2e928ed", "width": 216}, {"height": 320, "url": "https://external-preview.redd.it/uDiKXtVSlkPNkYxfDIvgr7yH7BWPfC8LeNNCRqPlM3E.jpg?width=320&amp;crop=smart&amp;auto=webp&amp;s=4a8855abb91dd866bb18c117bddae18cc53388d8", "width": 320}], "source": {"height": 400, "url": "https://external-preview.redd.it/uDiKXtVSlkPNkYxfDIvgr7yH7BWPfC8LeNNCRqPlM3E.jpg?auto=webp&amp;s=4a960d143b86287f5c7ee3aec614f1749807a3e5", "width": 400}, "variants": {}}]}, "retrieved_on": 1623242771, "score": 1, "selftext": "The research team at the University of Chester are currently investigating factors which predict who copes better following cancer diagnosis, and what we can do to maximise psychological wellbeing. Given the focus of this Reddit forum on chronic lymphocytic leukemia, we thought some people here might be interested in participating. If you are over 16 years of age and were diagnosed with cancer between 1 and 3 years ago, you might be eligible to do so. Participants will be asked to complete an online questionnaire which takes around half an hour to complete. You can find out more here: [https://chester.onlinesurveys.ac.uk/psychological-wellbeing-of-cancer-survivors](https://chester.onlinesurveys.ac.uk/psychological-wellbeing-of-cancer-survivors) \n\nIf you have any queries about this project, do not hesitate to get in touch with us.\n\nBest wishes, Caroline and Nicole.", "send_replies": true, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "subreddit_subscribers": 124, "subreddit_type": "public", "suggested_sort": "confidence", "thumbnail": "self", "title": "Psychological Wellbeing of Cancer Survivors research study", "total_awards_received": 0, "treatment_tags": [], "upvote_ratio": 1.0, "url": "https://www.reddit.com/r/CLL_Leukemia/comments/nvv1hg/psychological_wellbeing_of_cancer_survivors/"}, {"all_awardings": [], "allow_live_comments": false, "author": "Sensitive_Sherbert23", "author_flair_css_class": null, "author_flair_richtext": [], "author_flair_text": null, "author_flair_type": "text", "author_fullname": "t2_cffg8yu1", "author_patreon_flair": false, "author_premium": false, "awarders": [], "can_mod_post": false, "contest_mode": false, "created_utc": 1622402622, "domain": "self.CLL_Leukemia", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/noifi9/in_need_of_adviceknowledge/", "gildings": {}, "id": "noifi9", "is_crosspostable": true, "is_meta": false, "is_original_content": false, "is_reddit_media_domain": false, "is_robot_indexable": true, "is_self": true, "is_video": false, "link_flair_background_color": "", "link_flair_richtext": [], "link_flair_text_color": "dark", "link_flair_type": "text", "locked": false, "media_only": false, "no_follow": true, "num_comments": 1, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/noifi9/in_need_of_adviceknowledge/", "pinned": false, "retrieved_on": 1622402633, "score": 1, "selftext": "My mom just got a leukemia diagnosis, good news is that it was caught \u201cearly\u201d / hasn\u2019t caused any other major issues (doctors missed it for 8-10 years but I\u2019m not touching that can of worms right now \ud83d\ude43) so it\u2019s still manageable!\n\nHowever I do know this will come with many changes over time, and was hoping I could get some advice or reputable links about it; also any advice for how to give the best care and support would be appreciated. I\u2019m kinda lost and have never dealt with major grief/loss, and I can\u2019t help but be terrified for my mom\u2019s future.\n\nPlease, please don\u2019t throw the \u201cthoughts and prayers\u201d phrase at me, it\u2019s simply not a fitting sentiment for what I\u2019m in need of despite the compassion that no doubt comes with it.", "send_replies": true, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "subreddit_subscribers": 120, "subreddit_type": "public", "suggested_sort": "confidence", "thumbnail": "self", "title": "In need of advice/knowledge", "total_awards_received": 0, "treatment_tags": [], "upvote_ratio": 1.0, "url": "https://www.reddit.com/r/CLL_Leukemia/comments/noifi9/in_need_of_adviceknowledge/"}, {"all_awardings": [], "allow_live_comments": false, "author": "therealrobinnuss", "author_flair_css_class": null, "author_flair_richtext": [], "author_flair_text": null, "author_flair_type": "text", "author_fullname": "t2_49l0gk8", "author_patreon_flair": false, "author_premium": false, "awarders": [], "can_mod_post": false, "contest_mode": false, "created_utc": 1618443290, "domain": "self.CLL_Leukemia", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/mr2vcn/low_platelet_count_vaccine_reaction/", "gildings": {}, "id": "mr2vcn", "is_crosspostable": true, "is_meta": false, "is_original_content": false, "is_reddit_media_domain": false, "is_robot_indexable": true, "is_self": true, "is_video": false, "link_flair_background_color": "", "link_flair_richtext": [], "link_flair_text_color": "dark", "link_flair_type": "text", "locked": false, "media_only": false, "no_follow": true, "num_comments": 2, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/mr2vcn/low_platelet_count_vaccine_reaction/", "pinned": false, "retrieved_on": 1618443303, "score": 1, "selftext": "My 80+yo dad's CLL has been completely stable for several years. He has routine blood work every 3 months. He completed the Moderna vaccines a month ago. After reviewing the blood work results form the other day, we were surprised to see that his platelet count dropped significantly. Has anyone heard of/experienced a Moderna vaccine reaction of platelet counts dropping?", "send_replies": true, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "subreddit_subscribers": 118, "subreddit_type": "public", "suggested_sort": "confidence", "thumbnail": "self", "title": "Low platelet count vaccine reaction?", "total_awards_received": 0, "treatment_tags": [], "upvote_ratio": 1.0, "url": "https://www.reddit.com/r/CLL_Leukemia/comments/mr2vcn/low_platelet_count_vaccine_reaction/"}, {"all_awardings": [], "allow_live_comments": false, "author": "jsnigdha75", "author_flair_css_class": null, "author_flair_richtext": [], "author_flair_text": null, "author_flair_type": "text", "author_fullname": "t2_4q4gj84e", "author_patreon_flair": false, "author_premium": false, "awarders": [], "can_mod_post": false, "contest_mode": false, "created_utc": 1617092035, "domain": "self.CLL_Leukemia", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/mgb1gc/study_on_cancer_treatment_in_singapore/", "gildings": {}, "id": "mgb1gc", "is_crosspostable": true, "is_meta": false, "is_original_content": false, "is_reddit_media_domain": false, "is_robot_indexable": true, "is_self": true, "is_video": false, "link_flair_background_color": "", "link_flair_richtext": [], "link_flair_text_color": "dark", "link_flair_type": "text", "locked": false, "media_only": false, "no_follow": true, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/mgb1gc/study_on_cancer_treatment_in_singapore/", "pinned": false, "retrieved_on": 1617092046, "score": 1, "selftext": "Hey,\n\nI am looking to have a discussion with any cancer survivors or their care givers who have traveled to Singapore for Leukemia or Lymphoma treatment.\nIt will be a paid discussion (100 USD) as it is for a research study.\nIf anyone is interested please do contact me on apelohealthcareconsulting@gmail.com", "send_replies": true, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "subreddit_subscribers": 114, "subreddit_type": "public", "suggested_sort": "confidence", "thumbnail": "self", "title": "STUDY ON CANCER TREATMENT IN SINGAPORE", "total_awards_received": 0, "treatment_tags": [], "upvote_ratio": 1.0, "url": "https://www.reddit.com/r/CLL_Leukemia/comments/mgb1gc/study_on_cancer_treatment_in_singapore/"}, {"all_awardings": [], "allow_live_comments": false, "author": "steminist77", "author_flair_css_class": null, "author_flair_richtext": [], "author_flair_text": null, "author_flair_type": "text", "author_fullname": "t2_9avc6sae", "author_patreon_flair": false, "author_premium": false, "awarders": [], "can_mod_post": false, "contest_mode": false, "created_utc": 1615855705, "domain": "self.CLL_Leukemia", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/m5wvhs/tell_me_about_your_experience_with_imrbuvica/", "gildings": {}, "id": "m5wvhs", "is_crosspostable": true, "is_meta": false, "is_original_content": false, "is_reddit_media_domain": false, "is_robot_indexable": true, "is_self": true, "is_video": false, "link_flair_background_color": "", "link_flair_richtext": [], "link_flair_text_color": "dark", "link_flair_type": "text", "locked": false, "media_only": false, "no_follow": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/m5wvhs/tell_me_about_your_experience_with_imrbuvica/", "pinned": false, "retrieved_on": 1615855953, "score": 1, "selftext": "Hi! I'm a grad student writing up some research on Imbruvica. We recently posted a survey but I also though this might be a good place to get real world insights. If you're comfortable, please leave a note on what your experience is like. Some things we want to know:\n\n1. what is your general experience as a CLL patient?\n2. what is your general experience with Imbruvica?\n3. were you offered any other options as an alternative?\n4. would you consider switching to a drug that you only had to take temporarily?\n5. what are some common side effects you experience?\n6. anything else you think we should know?", "send_replies": true, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "subreddit_subscribers": 114, "subreddit_type": "public", "suggested_sort": "confidence", "thumbnail": "self", "title": "Tell me about your experience with Imrbuvica (ibrutinib)", "total_awards_received": 0, "treatment_tags": [], "upvote_ratio": 1.0, "url": "https://www.reddit.com/r/CLL_Leukemia/comments/m5wvhs/tell_me_about_your_experience_with_imrbuvica/"}, {"all_awardings": [], "allow_live_comments": false, "author": "the_cat_scientist", "author_flair_css_class": null, "author_flair_richtext": [], "author_flair_text": null, "author_flair_type": "text", "author_fullname": "t2_avf8yl3c", "author_patreon_flair": false, "author_premium": false, "awarders": [], "can_mod_post": false, "contest_mode": false, "created_utc": 1615829161, "domain": "self.CLL_Leukemia", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/m5pw7t/experiences_with_imbruvica/", "gildings": {}, "id": "m5pw7t", "is_crosspostable": true, "is_meta": false, "is_original_content": false, "is_reddit_media_domain": false, "is_robot_indexable": true, "is_self": true, "is_video": false, "link_flair_background_color": "", "link_flair_richtext": [], "link_flair_text_color": "dark", "link_flair_type": "text", "locked": false, "media_only": false, "no_follow": true, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/m5pw7t/experiences_with_imbruvica/", "pinned": false, "post_hint": "self", "preview": {"enabled": false, "images": [{"id": "p3M1N-E_RmCnoUkPGpH7NkRMEv7u5mXPNK6q-lOfMZQ", "resolutions": [{"height": 56, "url": "https://external-preview.redd.it/j-iMI_cQHo0dhdYcNHQuIwrsvUsg-OKb_dW5htBeYWY.jpg?width=108&amp;crop=smart&amp;auto=webp&amp;s=09d5a031f1a4184738e191675420d5faf68f6173", "width": 108}, {"height": 113, "url": "https://external-preview.redd.it/j-iMI_cQHo0dhdYcNHQuIwrsvUsg-OKb_dW5htBeYWY.jpg?width=216&amp;crop=smart&amp;auto=webp&amp;s=d3f8a321bfe692ed6e38e03a6c4e9f937480419c", "width": 216}, {"height": 168, "url": "https://external-preview.redd.it/j-iMI_cQHo0dhdYcNHQuIwrsvUsg-OKb_dW5htBeYWY.jpg?width=320&amp;crop=smart&amp;auto=webp&amp;s=c66f6af54a3f73a4671d4843a32420a206a08b63", "width": 320}, {"height": 336, "url": "https://external-preview.redd.it/j-iMI_cQHo0dhdYcNHQuIwrsvUsg-OKb_dW5htBeYWY.jpg?width=640&amp;crop=smart&amp;auto=webp&amp;s=6d09a4632668609dd4bd4c5931d3758fabd480b9", "width": 640}, {"height": 504, "url": "https://external-preview.redd.it/j-iMI_cQHo0dhdYcNHQuIwrsvUsg-OKb_dW5htBeYWY.jpg?width=960&amp;crop=smart&amp;auto=webp&amp;s=6e5fda6777df94acebe8b37aa31b77e6f8449484", "width": 960}, {"height": 567, "url": "https://external-preview.redd.it/j-iMI_cQHo0dhdYcNHQuIwrsvUsg-OKb_dW5htBeYWY.jpg?width=1080&amp;crop=smart&amp;auto=webp&amp;s=ee7553231dcc5df701d898c3e630d599fada3857", "width": 1080}], "source": {"height": 630, "url": "https://external-preview.redd.it/j-iMI_cQHo0dhdYcNHQuIwrsvUsg-OKb_dW5htBeYWY.jpg?auto=webp&amp;s=34588574165b53e83a915cffd4942b7db065046e", "width": 1200}, "variants": {}}]}, "retrieved_on": 1615829172, "score": 1, "selftext": "My team and I are graduate students doing a project on your experience and perceptions of Imbruvica (ibrutinib). We are hoping to gain some insight on your experience using Impruvica and other treatments for chronic lymphocytic leukaemia (CLL).\n\nWe would really appreciate if you could take 5 minutes to fill out the following survey. The information collected in the survey will be entirely anonymous. Please do not disclose any self-identifying information when completing the survey. Thank you in advance! \n\nLink to survey: [https://forms.gle/GF3nsc6bAgRnJ31r7](https://forms.gle/GF3nsc6bAgRnJ31r7)", "send_replies": true, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "subreddit_subscribers": 114, "subreddit_type": "public", "suggested_sort": "confidence", "thumbnail": "self", "title": "Experiences with Imbruvica", "total_awards_received": 0, "treatment_tags": [], "upvote_ratio": 1.0, "url": "https://www.reddit.com/r/CLL_Leukemia/comments/m5pw7t/experiences_with_imbruvica/"}, {"author": "charlesfang1992", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1513319425, "domain": "self.CLL_Leukemia", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/7jxzyt/jinxing_capsule_content_introduction/", "id": "7jxzyt", "is_crosspostable": false, "is_reddit_media_domain": false, "is_self": true, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/7jxzyt/jinxing_capsule_content_introduction/", "pinned": false, "retrieved_on": 1513381115, "score": 1, "selftext": "[removed]", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "subreddit_type": "public", "suggested_sort": "confidence", "thumbnail": "default", "title": "JINXING capsule content introduction", "url": "https://www.reddit.com/r/CLL_Leukemia/comments/7jxzyt/jinxing_capsule_content_introduction/"}, {"author": "charlesfang1992", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1512959687, "domain": "self.CLL_Leukemia", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/7iz1i7/ginsenoside_rh2_actual_content_of_jinxing_capsule/", "id": "7iz1i7", "is_crosspostable": false, "is_reddit_media_domain": false, "is_self": true, "is_video": false, "locked": false, "num_comments": 1, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/7iz1i7/ginsenoside_rh2_actual_content_of_jinxing_capsule/", "pinned": false, "retrieved_on": 1513020839, "score": 1, "selftext": "[removed]", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "subreddit_type": "public", "suggested_sort": "confidence", "thumbnail": "default", "title": "Ginsenoside Rh2 actual content of JINXING capsule", "url": "https://www.reddit.com/r/CLL_Leukemia/comments/7iz1i7/ginsenoside_rh2_actual_content_of_jinxing_capsule/"}, {"author": "charlesfang1992", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1512110284, "domain": "self.CLL_Leukemia", "edited": 1512110486, "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/7gta1b/break_the_mysterious_ingredients_of_jinxing/", "id": "7gta1b", "is_crosspostable": true, "is_reddit_media_domain": false, "is_self": true, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/7gta1b/break_the_mysterious_ingredients_of_jinxing/", "pinned": false, "retrieved_on": 1512191030, "score": 1, "selftext": "What is JINXING capsule, Why so many people are taking it? What is JINXING capsule, is it anti-aging and relieve fatigue? Today, we are bearking the mysterious ingredients of JINXING capsule.\n\n&amp;nbsp;\n\nJINXING capsule ingredients\n\n&amp;nbsp;\n\nFirstly, I think JINXING capsule must has special ingredients and complex composition. After reading the product introduction, which is a low-key and simple ingredient. \n\n&amp;nbsp;\n\nJINXING capsule ingredient is ginsenoside Rh2 and starch, one capsule is 125mg, ginsenoside rh2 content is 20.25mg per capsule, content percent is 16.2% or more. It is in the line with best absorption content of ginsenoside Rh2.\n\n&amp;nbsp;\n\nDoing a research of ginsenoside Rh2 in Chinese market, JINXING capsule is a Unilateral product only, others are compound products. Except ginsenoside Rh2, compound products contains other ingredients or other ginsenosides. Whatever of unilateral products and compound products, they have its own merits.\n\n&amp;nbsp;\n\nRegardless of the dosage form(injections, capsules, powders and others), JINXING capsule is A single measurable ingredients, function is determined and full play the effect of ginsenoside Rh2. There is no intestinal load which caused by ingredients during absorption, thereby affecting absorption effect.\n\n&amp;nbsp;\nGinsenoside Rh2 compound product contains other ingredient except ginsenoside Rh2, which is no rigorously verified, Absorption and utilization rate will be low, the effect of adjuvant therapy remains to be seen.\n\n&amp;nbsp;\n\nWhat is function of ginsenoside Rh2\n\n&amp;nbsp;\n\nJINXING capsule mysterious ingredients is ginsenoside Rh2, which efficacy is reflect by ginsenoside Rh2. What is function of ginsenoside Rh2? \n\n&amp;nbsp;\n\n1.Enhance immunity\nMany people know the side effect of low immunity. Ginsenoside Rh2 can enhance immunity is by enhancing immune cell activity, such as the killing activity of Lymphocytes, T cells, macrophages and others, enhance the monitoring of the immune system to prevent the invasion of harmful substances and bacteria. \n\n&amp;nbsp;\n\n2.Relieve fatigue\nFatigue is due to the accumulation of human lactic acid and other metabolites, which leads to muscle tension and exercise durability decreased. At the same time, due to the accumulation of carbon dioxide and stimulate the nerve center, which leads to sleepy, yawning, sluggish and other performance. Ginsenoside Rh2 has relieve fatigue function is by increasing the body's glycogen reserves, reducing the consumption of glycogen, reducing serum urea levels after exercise and inhibitting the increase in blood lactate levels after exercise. \n\n&amp;nbsp;\n\n3.Anti-tumor\nThe reason of ginsenoside Rh2 caused by scholars attention is anti-tumor effect. Many literature and experiments have prove it. But now, there is no ginsenoside Rh2 products for medicine use.  \n\n&amp;nbsp;\n\n4.Other effects\nGinsenoside Rh2 also has health care functions, such as antibacterial, improve cardiovascular and cerebrovascular insufficiency, regulate the central nervous system, enhance memory, anti-aging and so on. \n\n&amp;nbsp;\n\n\nJINXING capsule mysterious ingredient is ginsenoside Rh2. Just look at it, ginsenoside Rh2 is indeed a good thing and a modern Chinese medicine molecular medicine, which is a small molecule structure and should be able to play the above effects. At the same time hope that the friends who take this JINXING capsule can have good effect and longevity. \n\n\n                                                    \u7834\u89e3\u4eca\u5e78\u80f6\u56ca\u7684\u795e\u79d8\u6210\u5206\n\n&amp;nbsp;\n\n\u4eca\u5e78\u80f6\u56ca\u662f\u4f55\u65b9\u795e\u7269\uff0c\u5982\u4eca\u8fd9\u4e48\u591a\u4eba\u5728\u5403\uff0c\u4eca\u5e78\u80f6\u56ca\u662f\u4f55\u79cd\u795e\u5668\uff0c\u80fd\u5ef6\u7f13\u8870\u8001\uff0c\u7f13\u89e3\u75b2\u52b3\uff1f\u8ba9\u6211\u4eec\u6765\u7834\u89e3\u4eca\u5e78\u80f6\u56ca\u7684\u795e\u79d8\u6210\u5206\u3002\n\n&amp;nbsp;\n\n\u4eca\u5e78\u80f6\u56ca\u7684\u6210\u5206 \n\n&amp;nbsp;\n\n\u8d77\u521d\u6211\u4e5f\u4e00\u76f4\u4ee5\u4e3a\uff0c\u8fd9\u4e48\u5389\u5bb3\u7684\u4eca\u5e78\u80f6\u56ca\uff0c\u4e00\u5b9a\u662f\u6709\u7279\u522b\u7684\u6210\u5206\uff0c\u590d\u6742\u7684\u6210\u5206\u7ec4\u6210\uff0c\u8c01\u66fe\u60f3\uff0c\u770b\u8fc7\u4e86\u8be5\u4ea7\u54c1\u7684\u4ecb\u7ecd\u4ee5\u540e\uff0c\u7adf\u7136\u662f\u5982\u6b64\u4f4e\u8c03\uff0c\u5355\u4e00\u7684\u6210\u5206\u3002\n\n&amp;nbsp;\n\n\u4eca\u5e78\u80f6\u56ca\u7684\u6210\u5206\u662f\u4eba\u53c2\u7682\u82f7Rh2\u548c\u6dc0\u7c89\uff0c\u6bcf\u7c92\u80f6\u56ca125mg\uff0c\u5176\u4e2d\u4eba\u53c2\u7682\u82f7Rh2\u542b\u91cf\u4e3a20.25mg\uff0c\u542b\u91cf\u6bd4\u4f8b\u4e3a16.2%\uff0c\u751a\u81f3\u4ee5\u4e0a\uff0c\u7b26\u5408\u4eba\u4f53\u5bf9\u4e8e\u4eba\u53c2\u7682\u82f7Rh2\u7684\u6700\u4f73\u5438\u6536\u542b\u91cf\u3002\n\n&amp;nbsp;\n\n\u7b14\u8005\u5bf9\u56fd\u5185\u5e02\u573a\u4e0a\uff0c\u7f51\u7edc\u4e0a\u7684\u8bf8\u591a\u4eba\u53c2\u7682\u82f7Rh2\u4ea7\u54c1\u8fdb\u884c\u4e86\u4e00\u4e2a\u5c0f\u5c0f\u7684\u8c03\u67e5\u548c\u5bf9\u6bd4\uff0c\u4eca\u5e78\u80f6\u56ca\u662f\u56fd\u5185\u552f\u4e00\u7684\u4e00\u6b3e\u4eba\u53c2\u7682\u82f7Rh2\u5355\u65b9\u4ea7\u54c1\uff0c\u5176\u4ed6\u7684\u4ea7\u54c1\u90fd\u662f\u590d\u65b9\u578b\uff0c\u9664\u4e86\u542b\u6709\u4eba\u53c2\u7682\u82f7Rh2\u4ee5\u5916\uff0c\u8fd8\u542b\u6709\u4e00\u4e2a\u5176\u4ed6\u7684\u6210\u5206\uff0c\u4ea6\u6216\u8005\u5176\u4ed6\u7684\u4eba\u53c2\u7682\u82f7\u6210\u5206\u3002\n\n&amp;nbsp;\n\n\u7b14\u8005\u4e5f\u4e86\u89e3\u4e86\u4e00\u4e9b\u5173\u4e8e\u836f\u54c1\u7684\u76f8\u5173\u77e5\u8bc6\uff0c\u5bf9\u4e8e\u5355\u65b9\u4ea7\u54c1\u548c\u590d\u65b9\u4ea7\u54c1\u6709\u4e86\u4e2a\u521d\u6b65\u7684\u8ba4\u77e5\u3002\u5728\u7b14\u8005\u7684\u8ba4\u77e5\u770b\u6765\uff0c\u4e24\u8005\u5404\u6709\u5343\u79cb\u3002\n\n&amp;nbsp;\n\n\u6bd4\u5982\u8bf4\uff1a\u5728\u4e0d\u8003\u8651\u4ea7\u54c1\u5242\u578b\u7684\u60c5\u51b5\u4e0b\uff08\u9488\u5242\uff0c\u80f6\u56ca\uff0c\u7c89\u5242\u7b49\u4e3a\u5242\u578b\uff09\uff0c\u4eba\u53c2\u7682\u82f7Rh2\u5355\u65b9\u4ea7\u54c1\u4eca\u5e78\u80f6\u56ca\uff0c\u6210\u5206\u5355\u4e00\u53ef\u6d4b\uff0c\u670d\u7528\u529f\u6548\u786e\u5b9a\uff0c\u5e76\u4e14\u80fd\u5c06\u5355\u4e00\u6210\u5206\uff0c\u4e5f\u5c31\u662f\u5c06\u4eba\u53c2\u7682\u82f7Rh2\u7684\u529f\u6548\u6700\u5168\u9762\uff0c\u6700\u5927\u9650\u5ea6\u7684\u53d1\u6325\uff0c\u4e0d\u5b58\u5728\u6210\u5206\u95f4\u5728\u5438\u6536\u65f6\u9020\u6210\u7684\u80a0\u90e8\u8d1f\u8377\uff0c\u8fdb\u800c\u5f71\u54cd\u5438\u6536\u6548\u679c\u3002\n\n&amp;nbsp;\n\n\u4eba\u53c2\u7682\u82f7Rh2\u590d\u65b9\u4ea7\u54c1\uff0c\u542b\u6709\u9664\u4eba\u53c2\u7682\u82f7Rh2\u4ee5\u5916\u7684\u6210\u5206\uff0c\u867d\u7136\u770b\u4f3c\u66f4\u52a0\u5168\u9762\uff0c\u5b9e\u9645\u4e0a\u5374\u6ca1\u6709\u7ecf\u8fc7\u4e25\u683c\u9a8c\u8bc1\uff0c\u5438\u6536\u5229\u7528\u7387\u4e5f\u4f1a\u504f\u4f4e\uff0c\u4f5c\u4e3a\u65e5\u5e38\u4fdd\u5065\u53ef\u4ee5\u5403\u4e00\u4e9b\uff0c\u8f85\u52a9\u6cbb\u7597\u7684\u6548\u679c\u8fd8\u6709\u5f85\u89c2\u5bdf\u3002\n\n&amp;nbsp;\n\n\u4eba\u53c2\u7682\u82f7Rh2\u6709\u4f55\u79cd\u529f\u6548 \n\n&amp;nbsp;\n\n\u4eca\u5e78\u80f6\u56ca\u7684\u795e\u79d8\u6210\u5206\u53ea\u662f\u7b80\u5355\u7684\u4eba\u53c2\u7682\u82f7Rh2\uff0c\u56e0\u6b64\uff0c\u5b83\u7684\u529f\u6548\u5c31\u662f\u9760\u4eba\u53c2\u7682\u82f7Rh2\u4f53\u73b0\u7684\uff0c\u90a3\u4e48\u4eba\u53c2\u7682\u82f7Rh2\u6709\u54ea\u4e9b\u795e\u5947\u7684\u529f\u6548\u5462\uff1f\n\n&amp;nbsp;\n\n1.\u63d0\u9ad8\u514d\u75ab\u529b \n\u4eba\u4f53\u514d\u75ab\u529b\u7684\u91cd\u8981\u6027\u5c31\u4e0d\u9700\u8981\u6211\u8fc7\u591a\u53d9\u8ff0\u4e86\uff0c\u514d\u75ab\u529b\u4f4e\u4e0b\uff0c\u4f1a\u9020\u6210\u4ec0\u4e48\u5f71\u54cd\uff0c\u8bb8\u591a\u4eba\u53ef\u80fd\u6bd4\u6211\u4e86\u89e3\u7684\u66f4\u5168\u9762\u3002\u4eba\u53c2\u7682\u82f7Rh2\u80fd\u63d0\u9ad8\u514d\u75ab\u529b\uff0c\u901a\u8fc7\u589e\u5f3a\u514d\u75ab\u7ec6\u80de\u6d3b\u6027\uff0c\u6bd4\u5982\u6dcb\u5df4\u7ec6\u80de\uff0cT\u7ec6\u80de\uff0c\u5de8\u566c\u7ec6\u80de\u7b49\u7684\u6740\u4f24\u6d3b\u6027\uff0c\u6765\u589e\u5f3a\u514d\u75ab\u7cfb\u7edf\u7684\u76d1\u542c\u529f\u80fd\uff0c\u9632\u6b62\u5916\u754c\u6709\u5bb3\u7269\u8d28\u3001\u7ec6\u83cc\u7684\u5165\u4fb5\u3002\n\n&amp;nbsp;\n\n2.\u6297\u75b2\u52b3   \n\u75b2\u52b3\u662f\u7531\u4e8e\u4eba\u4f53\u4e73\u9178\u53ca\u5176\u4ed6\u4ee3\u8c22\u4ea7\u7269\u7684\u5806\u79ef\uff0c\u5bfc\u81f4\u808c\u8089\u5f20\u529b\u4e0b\u964d\uff0c\u8fd0\u52a8\u8010\u4e45\u6027\u964d\u4f4e\u3002\u540c\u65f6\u7531\u4e8e\u4e8c\u6c27\u5316\u78b3\u7684\u5806\u79ef\uff0c\u523a\u6fc0\u5230\u795e\u7ecf\u4e2d\u67a2\uff0c\u5f15\u8d77\u778c\u7761\uff0c\u6253\u54c8\u6b20\uff0c\u7cbe\u795e\u4e0d\u632f\uff0c\u778c\u7761\u7b49\u8868\u73b0\u3002\u800c\u4eba\u53c2\u7682\u82f7Rh2\u80fd\u589e\u52a0\u4eba\u4f53\u7684\u7cd6\u539f\u50a8\u5907\uff0c\u51cf\u5c11\u7cd6\u539f\u7684\u6d88\u8017\uff0c\u964d\u4f4e\u5728\u8fd0\u52a8\u540e\u4ea7\u751f\u8840\u6e05\u5c3f\u7d20\u542b\u91cf\uff0c\u6291\u5236\u8fd0\u52a8\u540e\u8840\u4e73\u9178\u542b\u91cf\u7684\u4e0a\u5347\uff0c\u8fbe\u5230\u7f13\u89e3\u548c\u51cf\u8f7b\u75b2\u52b3\u4f5c\u7528\u3002\n\n&amp;nbsp;\n\n3.\u6297\u80bf\u7624  \n\u4eba\u53c2\u7682\u82f7Rh2\u76ee\u524d\u53d7\u5230\u56fd\u5185\u5916\u5b66\u8005\u7684\u91cd\u89c6\u7684\u4e00\u5927\u539f\u56e0\u5c31\u662f\u6297\u80bf\u7624\u529f\u6548\uff0c\u5df2\u7ecf\u6709\u5f88\u591a\u5173\u4e8e\u4eba\u53c2\u7682\u82f7Rh2\u6297\u80bf\u7624\u65b9\u9762\u7684\u6587\u732e\u548c\u5b9e\u9a8c\u8bc1\u5b9e\u4e86\u8fd9\u4e2a\u7ed3\u8bba\u3002\u53ea\u662f\u76ee\u524d\u8fd8\u6ca1\u6709\u4f5c\u4e3a\u836f\u54c1\u5e94\u7528\u7684\u4eba\u53c2\u7682\u82f7Rh2\u4ea7\u54c1\u3002\u56e0\u6b64\uff0c\u6b64\u529f\u6548\u6682\u4e14\u4e0d\u63d0\u3002\n\n&amp;nbsp;\n\n4.\u5176\u4ed6\u529f\u6548  \n\u4eba\u53c2\u7682\u82f7Rh2\u8fd8\u5177\u6709\u6297\u83cc\u3001\u6539\u5584\u5fc3\u8111\u8840\u7ba1\u4f9b\u8840\u4e0d\u8db3\u3001\u8c03\u8282\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u3001\u589e\u5f3a\u8bb0\u5fc6\u529b\u3001\u5ef6\u7f13\u8870\u8001\u7b49\u4fdd\u5065\u517b\u751f\u4f5c\u7528\u3002\n\n&amp;nbsp;\n\n\u4eca\u5e78\u80f6\u56ca\u7684\u795e\u79d8\u6210\u5206\u662f\u4eba\u53c2\u7682\u82f7Rh2\u3002\u53ea\u662f\u8fd9\u4e48\u770b\u7684\u8bdd\uff0c\u4eba\u53c2\u7682\u82f7Rh2\u786e\u5b9e\u662f\u4e00\u4e2a\u597d\u4e1c\u897f\uff0c\u4e0d\u6127\u662f\u73b0\u4ee3\u5316\u7684\u4e2d\u533b\u4e2d\u836f\u5206\u5b50\u836f\u7269\uff0c\u662f\u5c0f\u5206\u5b50\u7ed3\u6784\uff0c\u5e94\u8be5\u80fd\u53d1\u6325\u4e0a\u8ff0\u529f\u6548\u3002\u540c\u65f6\u5e0c\u671b\u670d\u7528\u4eca\u5e78\u80f6\u56ca\u7684\u670b\u53cb\u90fd\u80fd\u6709\u597d\u7684\u670d\u7528\u6548\u679c\uff0c\u5ef6\u5e74\u76ca\u5bff\u3002", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "subreddit_type": "public", "suggested_sort": "confidence", "thumbnail": "self", "title": "Break the mysterious ingredients of JINXING capsule", "url": "https://www.reddit.com/r/CLL_Leukemia/comments/7gta1b/break_the_mysterious_ingredients_of_jinxing/"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1510086250, "domain": "self.CLL_Leukemia", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/7bfyco/were_moving_to_rcll/", "id": "7bfyco", "is_crosspostable": true, "is_reddit_media_domain": false, "is_self": true, "is_video": false, "locked": false, "num_comments": 2, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/7bfyco/were_moving_to_rcll/", "pinned": false, "retrieved_on": 1510167209, "score": 3, "selftext": "Finally got hold of the mod that had r/cll and he was gracious enough to release it to us.  I'll be posting over there from now on.  It's just a much simpler title. ", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "self", "title": "We're moving to r/cll", "url": "https://www.reddit.com/r/CLL_Leukemia/comments/7bfyco/were_moving_to_rcll/"}, {"author": "Anticancer1975", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1509514070, "domain": "i.redd.it", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/7a1nt2/we_found_the_cure_of_cancer_\u03b1_taxol_organic_tea/", "id": "7a1nt2", "is_crosspostable": false, "is_reddit_media_domain": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/7a1nt2/we_found_the_cure_of_cancer_\u03b1_taxol_organic_tea/", "pinned": false, "retrieved_on": 1509595793, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "thumbnail_height": 78, "thumbnail_width": 140, "title": "WE FOUND THE CURE OF CANCER ! \u0391 TAXOL ORGANIC TEA ! IT CURES CANCER ONCE AND FOR ALL, F.D.A. approved Taxol in 1992 PCT/GR2016/000023 EXAMS!", "url": "https://i.redd.it/xb1n4838uavz.jpg"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1508703646, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/782okj/dr_awan_discusses_challenges_with_ibrutinib_in_cll/", "id": "782okj", "is_crosspostable": true, "is_reddit_media_domain": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/782okj/dr_awan_discusses_challenges_with_ibrutinib_in_cll/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "2il_OM1aC7KnTZLkGDTgehSOi8ITWNMTQBD1MqWpzcE", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/JwcnQfYB0boeXiep08adjZ5mDwRHDyBTnsSDbaAbY4I.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=240c3c235f17e0d03b4600a5704bb3d7", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/JwcnQfYB0boeXiep08adjZ5mDwRHDyBTnsSDbaAbY4I.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=635b7edc8f3880f33854fadc54d4fc4b", "width": 216}], "source": {"height": 240, "url": "https://i.redditmedia.com/JwcnQfYB0boeXiep08adjZ5mDwRHDyBTnsSDbaAbY4I.jpg?s=43376267098ace582faf7c3d7dc88c6e", "width": 240}, "variants": {}}]}, "retrieved_on": 1508786908, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/Gblyhu66DLPJcbQ9HZwxdPI-cjcB4JGkB6UJnhBE56k.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Dr. Awan Discusses Challenges With Ibrutinib in CLL", "url": "http://www.onclive.com/onclive-tv/dr-awan-discusses-challenges-with-ibrutinib-in-cll"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1508703622, "domain": "ajmc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/782ohb/study_car_tcell_therapy_highly_effective_in/", "id": "782ohb", "is_crosspostable": true, "is_reddit_media_domain": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/782ohb/study_car_tcell_therapy_highly_effective_in/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "X_SeRej_cExFu0OGRBhMPNVuOWL-fFj95Tm7Lq6Nl0w", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=29432581c1ea537453069c8c2faae36e", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=79bbc4cbb8a632ab71abfac7d9970d0a", "width": 216}], "source": {"height": 270, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?s=f6ead69e3a1a9ce00422387615828049", "width": 270}, "variants": {}}]}, "retrieved_on": 1508786892, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/djCK-tGo435UwQdRYxTGrF5DxCjCG0SQWRE9blQg0yo.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Study: CAR T-Cell Therapy Highly Effective in High-Risk Chronic Lymphocytic Leukemia", "url": "http://www.ajmc.com/newsroom/study-car-t-cell-therapy-highly-effective-in-high-risk-chronic-lymphocytic-leukemia"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1508703587, "domain": "businesswire.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/782obs/esanex_announces_first_patient_dosed_in_an/", "id": "782obs", "is_crosspostable": true, "is_reddit_media_domain": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 1, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/782obs/esanex_announces_first_patient_dosed_in_an/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "r-svz1-H5onIsxjdzaWFn-Qxrku1pEA8bmLh5uHFl_w", "resolutions": [{"height": 32, "url": "https://i.redditmedia.com/fkMVy7Ox0AOuidBZOhDRa2VTaMDPWHtuLVnY8zXmFlg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=3c547610ded64a3ba078de3e9c446fb5", "width": 108}], "source": {"height": 36, "url": "https://i.redditmedia.com/fkMVy7Ox0AOuidBZOhDRa2VTaMDPWHtuLVnY8zXmFlg.jpg?s=96c6fa058201c2536a99e40a432bce02", "width": 120}, "variants": {}}]}, "retrieved_on": 1508786853, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/Y_uLcc9eW4RbStIIZ9H5HvwiVZuIvWoa7nXc-gWy88E.jpg", "thumbnail_height": 21, "thumbnail_width": 70, "title": "Esanex Announces First Patient Dosed in an Open-Label Study of SNX-5422 in Chronic Lymphocytic Leukemia", "url": "http://www.businesswire.com/news/home/20171019005204/en/Esanex-Announces-Patient-Dosed-Open-Label-Study-SNX-5422"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1508703563, "domain": "cordis.europa.eu", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/782o8e/european_commission_cordis_news_and_events/", "id": "782o8e", "is_crosspostable": true, "is_reddit_media_domain": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/782o8e/european_commission_cordis_news_and_events/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "QoWow2N6njAchKneMmHO0u4Bon2wBCW-C4i7rXkcP_c", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/mfC-CRBXzikkaq7BLehvnPm5bO5-05YSxwVlMZUsdvM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=58eaede81e7be1d0dbd5578d4e83c567", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/mfC-CRBXzikkaq7BLehvnPm5bO5-05YSxwVlMZUsdvM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=af9a0e3fb903a9fc9e0399f852cca906", "width": 216}], "source": {"height": 167, "url": "https://i.redditmedia.com/mfC-CRBXzikkaq7BLehvnPm5bO5-05YSxwVlMZUsdvM.jpg?s=e0f83e9f5d34fd4a946f0d64cdaa579f", "width": 250}, "variants": {}}]}, "retrieved_on": 1508786834, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/FSqKgtOOTxykPGp4N8ZV99G5vQBgV5WjIZuaj1XG4Rc.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "European Commission : CORDIS : News and Events : Signification of Protein p-53 Isoforms in CLL", "url": "http://cordis.europa.eu/news/rcn/141764_en.html"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1508703532, "domain": "medicalnewsbulletin.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/782o4r/investigators_found_that_treatment_with/", "id": "782o4r", "is_crosspostable": true, "is_reddit_media_domain": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/782o4r/investigators_found_that_treatment_with/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "3YCAE11skLMoP1z1zIiTQS63oSH1lLYqENqmGkJio_4", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/7mmcMXCJj5L-4HTEFI4dA8diZ8V3oC8oTREOa8muvZ8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=b1bfd9052361f13c85ba271a5d462e54", "width": 108}, {"height": 143, "url": "https://i.redditmedia.com/7mmcMXCJj5L-4HTEFI4dA8diZ8V3oC8oTREOa8muvZ8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=a8170fdaf42be66383d6d8a95f57df74", "width": 216}, {"height": 211, "url": "https://i.redditmedia.com/7mmcMXCJj5L-4HTEFI4dA8diZ8V3oC8oTREOa8muvZ8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=f10169c4069005b1e366d2a2f3cd95d6", "width": 320}, {"height": 423, "url": "https://i.redditmedia.com/7mmcMXCJj5L-4HTEFI4dA8diZ8V3oC8oTREOa8muvZ8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=801298df8eca4253547ade243ce087c0", "width": 640}], "source": {"height": 461, "url": "https://i.redditmedia.com/7mmcMXCJj5L-4HTEFI4dA8diZ8V3oC8oTREOa8muvZ8.jpg?s=a68002d2697ddc2f751bd7be54d10e82", "width": 696}, "variants": {}}]}, "retrieved_on": 1508786815, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/Io4lG2z6hVbofHasIOnViWqj1TJyeZKza5c8OudJvdA.jpg", "thumbnail_height": 92, "thumbnail_width": 140, "title": "\"Investigators found that treatment with lenalidomide significantly improved progression-free survival\"", "url": "https://www.medicalnewsbulletin.com/maintenance-therapy-for-leukemia/"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1508703469, "domain": "medwirenews.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/782nvu/algorithm_may_help_identify_severe_neurotoxicity/", "id": "782nvu", "is_crosspostable": true, "is_reddit_media_domain": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/782nvu/algorithm_may_help_identify_severe_neurotoxicity/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "LiruQ3iALmwQFj-xOM8OGCkoMfg6mbva8DV3PhbIKaA", "resolutions": [{"height": 142, "url": "https://i.redditmedia.com/BcL5j2dahzJ1v9xCkz1OJZuCcoDO8NiVBtpuuyJki2Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=1ee7bdc66e674b098e006af5a0958126", "width": 108}, {"height": 285, "url": "https://i.redditmedia.com/BcL5j2dahzJ1v9xCkz1OJZuCcoDO8NiVBtpuuyJki2Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=7b3daccdb57ba02ea0657f68d8a14da0", "width": 216}], "source": {"height": 404, "url": "https://i.redditmedia.com/BcL5j2dahzJ1v9xCkz1OJZuCcoDO8NiVBtpuuyJki2Y.jpg?s=4e66b15cc90c16321f84d32f5685a423", "width": 306}, "variants": {}}]}, "retrieved_on": 1508786768, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/vDQsLD9_fXYBJq069ko2m5UU7xiKJqheTE9qVZi-ir8.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Algorithm may help identify severe neurotoxicity risk in CAR-T cell infusion patients", "url": "https://www.medwirenews.com/oncology/haematology/algorithm-may-help-identify-severe-neurotoxicity-risk-in-car-t-c/15144396"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1508703423, "domain": "financialstrend.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/782npu/tg_therapeutics_inc_nasdaqtgtx_reports_completes/", "id": "782npu", "is_crosspostable": true, "is_reddit_media_domain": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/782npu/tg_therapeutics_inc_nasdaqtgtx_reports_completes/", "pinned": false, "retrieved_on": 1508786737, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "TG Therapeutics Inc (NASDAQ:TGTX) Reports Completes Enrollment In The UNITY-CLL Phase III Trial", "url": "http://www.financialstrend.com/tg-therapeutics-inc-nasdaqtgtx-reports-completes-enrollment-in-the-unity-cll-phase-iii-trial-43893.html"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1508703349, "domain": "centerforbiosimilars.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/782ng0/study_injectable_anticancer_drugs_increase_in/", "id": "782ng0", "is_crosspostable": true, "is_reddit_media_domain": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/782ng0/study_injectable_anticancer_drugs_increase_in/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "0ZkQw-bi7tKTrP_MY0CIoi-lHCcl6Exwof6CqWO5KvE", "resolutions": [{"height": 113, "url": "https://i.redditmedia.com/Amyb4IBfkPZq-WNBzY20oadaJe_KtVldFOIr4a1ReUU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=b76c235009325f4c5a4fec758c916d7e", "width": 108}, {"height": 226, "url": "https://i.redditmedia.com/Amyb4IBfkPZq-WNBzY20oadaJe_KtVldFOIr4a1ReUU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=ee3c6a3c49af070bb5f02484ed395bb5", "width": 216}, {"height": 335, "url": "https://i.redditmedia.com/Amyb4IBfkPZq-WNBzY20oadaJe_KtVldFOIr4a1ReUU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=916691747d00266b4234eef9c6a469d3", "width": 320}], "source": {"height": 414, "url": "https://i.redditmedia.com/Amyb4IBfkPZq-WNBzY20oadaJe_KtVldFOIr4a1ReUU.jpg?s=753a45f980326c3c437b45ca9ee66eb2", "width": 395}, "variants": {}}]}, "retrieved_on": 1508786681, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/YfArIWv7Lsj4hL6kLrA15jCvaX0dhgq5FcTBwlQnb70.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Study: Injectable Anticancer Drugs Increase in Cost Regardless of Competition", "url": "http://www.centerforbiosimilars.com/news/study-injectable-anticancer-drugs-increase-in-cost-regardless-of-competition"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1508703332, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/782ndn/dr_wierda_discusses_sequencing_new_agents_in_cll/", "id": "782ndn", "is_crosspostable": true, "is_reddit_media_domain": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/782ndn/dr_wierda_discusses_sequencing_new_agents_in_cll/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "2il_OM1aC7KnTZLkGDTgehSOi8ITWNMTQBD1MqWpzcE", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/JwcnQfYB0boeXiep08adjZ5mDwRHDyBTnsSDbaAbY4I.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=240c3c235f17e0d03b4600a5704bb3d7", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/JwcnQfYB0boeXiep08adjZ5mDwRHDyBTnsSDbaAbY4I.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=635b7edc8f3880f33854fadc54d4fc4b", "width": 216}], "source": {"height": 240, "url": "https://i.redditmedia.com/JwcnQfYB0boeXiep08adjZ5mDwRHDyBTnsSDbaAbY4I.jpg?s=43376267098ace582faf7c3d7dc88c6e", "width": 240}, "variants": {}}]}, "retrieved_on": 1508786670, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/ngO1LavuUTFGnQGNLF9Am8Wkv6za3omUJ0lWg2wfMmw.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Dr. Wierda Discusses Sequencing New Agents in CLL", "url": "http://www.onclive.com/onclive-tv/dr-wierda-discusses-sequencing-new-agents-in-cll"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1508703313, "domain": "oncologynurseadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/782nbk/neurotoxicity_after_car_tcell_therapy_may_be/", "id": "782nbk", "is_crosspostable": true, "is_reddit_media_domain": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/782nbk/neurotoxicity_after_car_tcell_therapy_may_be/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "lhwMuQneDn5hs5KGGYIm3CFwmSw6PubjLlebHVMn8FA", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/dBbbnVVkgf_TB8ZTVkmVZNTDxUFuC8oYvATt6vSYV9Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=b420a5134eb763eb03fede4cfbab9788", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/dBbbnVVkgf_TB8ZTVkmVZNTDxUFuC8oYvATt6vSYV9Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=cab4ae951c7535d859126643d5c40e0c", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/dBbbnVVkgf_TB8ZTVkmVZNTDxUFuC8oYvATt6vSYV9Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=b13954bee2059759806c665248d7edee", "width": 320}, {"height": 427, "url": "https://i.redditmedia.com/dBbbnVVkgf_TB8ZTVkmVZNTDxUFuC8oYvATt6vSYV9Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=accd321868e9f114bd894302d4398636", "width": 640}], "source": {"height": 427, "url": "https://i.redditmedia.com/dBbbnVVkgf_TB8ZTVkmVZNTDxUFuC8oYvATt6vSYV9Y.jpg?s=8b413b58904c5c0de03dafd63a8e6dae", "width": 640}, "variants": {}}]}, "retrieved_on": 1508786659, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/E4tsUZeYQY_Og0io9Rep6GPGIc-XgGDVwoeGe0iKL_U.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "Neurotoxicity After CAR T-cell Therapy May Be Associated With Endothelial Activation", "url": "http://www.oncologynurseadvisor.com/leukemia/endothelial-activation-prior-lymphodepletion-chemotherapy-linked-neurotoxicity/article/700659/"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1508703241, "domain": "cancernetwork.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/782n2n/abnormal_liver_function_linked_to_survival_in_cll/", "id": "782n2n", "is_crosspostable": true, "is_reddit_media_domain": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/782n2n/abnormal_liver_function_linked_to_survival_in_cll/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "26TZ2BG8jBADKliE71F_B4a_WFHf4y2ksvpsOKVqw9k", "resolutions": [{"height": 154, "url": "https://i.redditmedia.com/04ltK7YzdZ5EszgOJuB2LHgFNhNQe6R8IllR3avUEjU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=ee1eac36cb447141e0287bc6b93cbd8f", "width": 108}, {"height": 309, "url": "https://i.redditmedia.com/04ltK7YzdZ5EszgOJuB2LHgFNhNQe6R8IllR3avUEjU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=18e16832ca64883e135f0ade1119f184", "width": 216}], "source": {"height": 358, "url": "https://i.redditmedia.com/04ltK7YzdZ5EszgOJuB2LHgFNhNQe6R8IllR3avUEjU.jpg?s=ebfe0967a8b491c96b1f9ed4562dde9e", "width": 250}, "variants": {}}]}, "retrieved_on": 1508786564, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/lO4wOndYq_e2jc58_NLNCRWx0uPdkHX-ecx_7KwWEwQ.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Abnormal Liver Function Linked to Survival in CLL", "url": "http://www.cancernetwork.com/chronic-lymphocytic-leukemia/abnormal-liver-function-linked-survival-cll"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1508703202, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/782mxi/dr_wierda_discusses_the_need_for_newer_therapies/", "id": "782mxi", "is_crosspostable": true, "is_reddit_media_domain": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/782mxi/dr_wierda_discusses_the_need_for_newer_therapies/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "2il_OM1aC7KnTZLkGDTgehSOi8ITWNMTQBD1MqWpzcE", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/JwcnQfYB0boeXiep08adjZ5mDwRHDyBTnsSDbaAbY4I.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=240c3c235f17e0d03b4600a5704bb3d7", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/JwcnQfYB0boeXiep08adjZ5mDwRHDyBTnsSDbaAbY4I.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=635b7edc8f3880f33854fadc54d4fc4b", "width": 216}], "source": {"height": 240, "url": "https://i.redditmedia.com/JwcnQfYB0boeXiep08adjZ5mDwRHDyBTnsSDbaAbY4I.jpg?s=43376267098ace582faf7c3d7dc88c6e", "width": 240}, "variants": {}}]}, "retrieved_on": 1508786538, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/rWgheRQf4w9YUQtf6az_dIf6anGGzO0Twb-H7B7Aw5U.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Dr. Wierda Discusses the Need for Newer Therapies in CLL", "url": "http://www.onclive.com/onclive-tv/dr-wierda-discusses-the-need-for-newer-therapies-in-cll"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1507579579, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/75bs6p/dr_wierda_discusses_trials_of_novel_combinations/", "id": "75bs6p", "is_crosspostable": true, "is_reddit_media_domain": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/75bs6p/dr_wierda_discusses_trials_of_novel_combinations/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "bJNNVLL5zYOwOM0cDntXauRy_tW-rzce2y7IgHR-XCQ", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/rgsVyKqa-4ulddtn_sA0YZrMzLexsSU_QioWMAZsULo.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=43ca73abf822fc30a4e3f51b61172494", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/rgsVyKqa-4ulddtn_sA0YZrMzLexsSU_QioWMAZsULo.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=a6e720db6cdf8e0a7b715fe4c49a0a6f", "width": 216}], "source": {"height": 209, "url": "https://i.redditmedia.com/rgsVyKqa-4ulddtn_sA0YZrMzLexsSU_QioWMAZsULo.jpg?s=923798a6fb143a53d3cd5cf6bb7d0da5", "width": 275}, "variants": {}}]}, "retrieved_on": 1507661965, "score": 2, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/qzNvPVVCAq6IIFmfzbqERpWUH0HdAjecfKrexG71MAc.jpg", "thumbnail_height": 106, "thumbnail_width": 140, "title": "Dr. Wierda Discusses Trials of Novel Combinations in CLL", "url": "http://www.onclive.com/conference-coverage/nccn-hem-2017/dr-wierda-discusses-trials-of-novel-combinations-in-cll"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1507266514, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/74lkat/cll_lenalidomide_maintenance_therapy_reduces/", "id": "74lkat", "is_crosspostable": true, "is_reddit_media_domain": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/74lkat/cll_lenalidomide_maintenance_therapy_reduces/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "NkwufhYfIPRVRyOIwAIu3ZuheYfsVXGnCpt-KF4d00k", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/JqcUpTGW7W036ednXQhj7FfWfX7DGHCTKvt6ZS216yw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=c7455fa793843670b0a239dc48333153", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/JqcUpTGW7W036ednXQhj7FfWfX7DGHCTKvt6ZS216yw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=3e1ca5db84925ae05fe5e78f0abd46ab", "width": 216}, {"height": 320, "url": "https://i.redditmedia.com/JqcUpTGW7W036ednXQhj7FfWfX7DGHCTKvt6ZS216yw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=52379ad550147b28a5da9cbba5da9265", "width": 320}], "source": {"height": 594, "url": "https://i.redditmedia.com/JqcUpTGW7W036ednXQhj7FfWfX7DGHCTKvt6ZS216yw.jpg?s=a264b40f03397698c7cf39ee07580826", "width": 594}, "variants": {}}]}, "retrieved_on": 1507353277, "score": 2, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/THppItSraH6Sddyu5Ck1cRsPQU80c8jc1Yv--6k35KA.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "CLL: Lenalidomide Maintenance Therapy Reduces Progression Risk", "url": "http://www.cancertherapyadvisor.com/chronic-lymphocytic-leukemia/chronic-leukemia-lenalidomide-maintenance-reduces-progression/article/698053/"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1506742502, "domain": "oncologynurseadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/73csbj/lenalidomide_maintenance_therapy_reduced_risk_of/", "id": "73csbj", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/73csbj/lenalidomide_maintenance_therapy_reduced_risk_of/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "N753fUL-fBLNd62w1lq5IuGPAVeCuqCMJuXRJwfH4sE", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/kUDwQ20NHRGFgoU3pHfb7MGrYru2Ynbs9BtrD1ZojOU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=41fedc945ec7aa9e06068c0e34f2de26", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/kUDwQ20NHRGFgoU3pHfb7MGrYru2Ynbs9BtrD1ZojOU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=f5d0fa7096f7321d9b090243189d43c4", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/kUDwQ20NHRGFgoU3pHfb7MGrYru2Ynbs9BtrD1ZojOU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=259c1d7f05aab6217233555d4cbc9709", "width": 320}, {"height": 427, "url": "https://i.redditmedia.com/kUDwQ20NHRGFgoU3pHfb7MGrYru2Ynbs9BtrD1ZojOU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=811757f764046acb8e99c3e9874eaf6f", "width": 640}], "source": {"height": 427, "url": "https://i.redditmedia.com/kUDwQ20NHRGFgoU3pHfb7MGrYru2Ynbs9BtrD1ZojOU.jpg?s=25e904f8e6a9adc578caff2fb699fe13", "width": 640}, "variants": {}}]}, "retrieved_on": 1506841218, "score": 2, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/zRKvUnEVeqK6v1qZTZho5B48t1H4CpX-BGZOQTSfgB4.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "Lenalidomide Maintenance Therapy Reduced Risk of Progression in CLL", "url": "http://www.oncologynurseadvisor.com/leukemia/lenalidomide-maintenance-therapy-in-cll/article/696619/"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1506401324, "domain": "targetedonc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/72i4zo/sustained_molecular_remissions_reported_in/", "id": "72i4zo", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/72i4zo/sustained_molecular_remissions_reported_in/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "XM_RjMlUF9pfEX0raaO0HDgrS9PwTWm5q9RS-r8Crq8", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=8b8bdfe16d31a7b36f7f6995991b63ca", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?s=c1fa7073f91a3a13437fb6762069e070", "width": 200}, "variants": {}}]}, "retrieved_on": 1506482266, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/pMrZx4RvOFRihh2-ah6p0m6a4hy_O04jXp1500WNEA0.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Sustained Molecular Remissions Reported in Patients With Relapsed/Refractory CLL After CD19 CAR-T Infusion", "url": "http://www.targetedonc.com/publications/targeted-therapies-cancer/2017/2017-August/sustained-molecular-remissions-reported-in-patients-with-relapsedrefractory-cll-after-cd19-cart-infusion"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1506401305, "domain": "pharmatimes.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/72i4xi/abbvieroches_venetoclax_hits_goals_in_cll_trial/", "id": "72i4xi", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/72i4xi/abbvieroches_venetoclax_hits_goals_in_cll_trial/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "A35noo3ua471tKW9xQql_SwY-OvdY-VtrPNhjSe5scE", "resolutions": [{"height": 80, "url": "https://i.redditmedia.com/XPnK-1GpLzDhCAbzfn0PZV39JbGbBK4i-6-9ykjdEAg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=3bfc67fdc9b13ba15b2d76eb825754ed", "width": 108}, {"height": 160, "url": "https://i.redditmedia.com/XPnK-1GpLzDhCAbzfn0PZV39JbGbBK4i-6-9ykjdEAg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=dd2c39ca3dc31a1d77621a890c20b5f7", "width": 216}, {"height": 237, "url": "https://i.redditmedia.com/XPnK-1GpLzDhCAbzfn0PZV39JbGbBK4i-6-9ykjdEAg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=4e1e59225847fa0a6a06f9e98c6a99c9", "width": 320}], "source": {"height": 460, "url": "https://i.redditmedia.com/XPnK-1GpLzDhCAbzfn0PZV39JbGbBK4i-6-9ykjdEAg.jpg?s=e35c4b94761141aa473e4f6bd0cd0ddb", "width": 620}, "variants": {}}]}, "retrieved_on": 1506482248, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/UDDJ2-THfMljQMmwzNgdcIk5D_rWVlUYIpwmZ8FCidg.jpg", "thumbnail_height": 103, "thumbnail_width": 140, "title": "AbbVie/Roche\u2019s venetoclax hits goals in CLL trial", "url": "http://www.pharmatimes.com/news/abbvieroches_venetoclax_hits_goals_in_cll_trial_1205773"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1506401241, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/72i4r2/high_response_rate_mrd_negativity_confirmed_for/", "id": "72i4r2", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/72i4r2/high_response_rate_mrd_negativity_confirmed_for/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "p0TIO_AkUHoL4_3EqmWXwmu68od2Eh9-ZtkOsXdkOHw", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/as2nEAdLLrZH-g-jXvzxZhccfjQWzRCXhjD7TUtbb3E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=ee01d36b17653c0dbf367fbb429107cb", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/as2nEAdLLrZH-g-jXvzxZhccfjQWzRCXhjD7TUtbb3E.jpg?s=96694d8caf4556f5c1ba205aeb565c65", "width": 200}, "variants": {}}]}, "retrieved_on": 1506482190, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/NGTLaDwSvc1NEbRNv57kWyJNn4BLRL7Na4MCQcj8hYg.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "High Response Rate, MRD Negativity Confirmed for Venetoclax in CLL", "url": "http://www.onclive.com/web-exclusives/high-response-rate-mrd-negativity-confirmed-for-venetoclax-in-cll"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1506117043, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/71u9fj/venetoclax_plus_rituximab_may_prolong/", "id": "71u9fj", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/71u9fj/venetoclax_plus_rituximab_may_prolong/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "mQYJJOvfPKlFN2MYQfAxR8BuRggdWbGVKiVfB8E81To", "resolutions": [{"height": 80, "url": "https://i.redditmedia.com/GgcIl0fZUL0jAo38MZG4z1qFa4sysdwdk3GcUBDKBOg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=2c82aa850650ece3b93ffc04787d41d6", "width": 108}, {"height": 161, "url": "https://i.redditmedia.com/GgcIl0fZUL0jAo38MZG4z1qFa4sysdwdk3GcUBDKBOg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=4d5810a9329a280ac175f8a5ed7c1691", "width": 216}, {"height": 239, "url": "https://i.redditmedia.com/GgcIl0fZUL0jAo38MZG4z1qFa4sysdwdk3GcUBDKBOg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=a13fabb053ec1d4013362bcda20a1cd9", "width": 320}, {"height": 479, "url": "https://i.redditmedia.com/GgcIl0fZUL0jAo38MZG4z1qFa4sysdwdk3GcUBDKBOg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=4de20d8bca30a83e7f605b63c019b459", "width": 640}], "source": {"height": 512, "url": "https://i.redditmedia.com/GgcIl0fZUL0jAo38MZG4z1qFa4sysdwdk3GcUBDKBOg.jpg?s=33331f9cfb6eb6ba9e919324fea97090", "width": 683}, "variants": {}}]}, "retrieved_on": 1506209963, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/KUtnZnkBaBPxsEnza2sjDgaMsdr5bBRWbIXhcpKNwEs.jpg", "thumbnail_height": 104, "thumbnail_width": 140, "title": "Venetoclax Plus Rituximab May Prolong Progression-free Survival in CLL", "url": "http://www.cancertherapyadvisor.com/chronic-lymphocytic-leukemia/chronic-leukemia-cll-venetoclax-rituximab-prolongs-survival/article/689840/"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1506117022, "domain": "clinicaltrials.pharmaceutical-business-review.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/71u9cf/roche_says_venetoclax_combination_improves_pfs_in/", "id": "71u9cf", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/71u9cf/roche_says_venetoclax_combination_improves_pfs_in/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "P-wDFOAd4G_1WTyCVrHj0zRymoyY5lILEp94ooJWuUU", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/sUQQxtjkxfDCW_Vet2Z2rneAuadz7G0bm2LiUtiUZd8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=7bcbbb5dc18f35e2863f55b2b4cef869", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/sUQQxtjkxfDCW_Vet2Z2rneAuadz7G0bm2LiUtiUZd8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=a9749024c249397999fe00621e8bff74", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/sUQQxtjkxfDCW_Vet2Z2rneAuadz7G0bm2LiUtiUZd8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=734e87a215457ca89ffbad792211db34", "width": 320}], "source": {"height": 299, "url": "https://i.redditmedia.com/sUQQxtjkxfDCW_Vet2Z2rneAuadz7G0bm2LiUtiUZd8.jpg?s=eeb99a380c69a06ccf5fbdd49b4f20a7", "width": 448}, "variants": {}}]}, "retrieved_on": 1506209931, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/uLFB0ePplHkxgf9jtxKmIzcU1gYT3WVg19ixkCJLgQc.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "Roche says Venetoclax combination improves PFS in phase III CLL trial", "url": "http://clinicaltrials.pharmaceutical-business-review.com/news/roches-venclextavenclyxto-succeeds-in-phase-3-chronic-lymphocytic-leukaemia-study-190917-5928555"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1505860824, "domain": "managedcaremag.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/716reh/venclextarituxan_combo_slows_cll_progression/", "id": "716reh", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/716reh/venclextarituxan_combo_slows_cll_progression/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "Iivh1nXR-3hZdUu0HhxpuyHnHWsU6PEx9uoZegTVSKQ", "resolutions": [{"height": 54, "url": "https://i.redditmedia.com/M1vOhveNwUnmNnUza4bni5sFffrdS8qqn_rYKPHv37o.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=119e31b5ed178eabcc0c4e3d3e0f0b05", "width": 108}], "source": {"height": 81, "url": "https://i.redditmedia.com/M1vOhveNwUnmNnUza4bni5sFffrdS8qqn_rYKPHv37o.jpg?s=3b589875962a0bef8a2188e1b4396a72", "width": 160}, "variants": {}}]}, "retrieved_on": 1505941918, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/5jpU5ULv36ruHcxBcXL3Ji9JPndAWQJ7oiEa0BY5ecQ.jpg", "thumbnail_height": 70, "thumbnail_width": 140, "title": "Venclexta/Rituxan Combo Slows CLL Progression", "url": "https://www.managedcaremag.com/news/venclextarituxan-combo-slows-cll-progression"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1505780301, "domain": "pnas.org", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/70z876/microrna_dysregulation_to_identify_therapeutic/", "id": "70z876", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/70z876/microrna_dysregulation_to_identify_therapeutic/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "9LWV5lw9_njZXoBHroJrD8kSPU55kL7I7ZhSofwrkX0", "resolutions": [{"height": 144, "url": "https://i.redditmedia.com/aoE33LNfJrP2o2kP-urcCGp1PNsP3UeQMhsj7vCW4o8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=59fed51c7f5865fc73e9f46741b4193b", "width": 108}], "source": {"height": 178, "url": "https://i.redditmedia.com/aoE33LNfJrP2o2kP-urcCGp1PNsP3UeQMhsj7vCW4o8.jpg?s=eedc04c3c703ed0122019aeb8a27816f", "width": 133}, "variants": {}}]}, "retrieved_on": 1505860524, "score": 2, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/Ucrt3axLPO4fzOgxmSF-F-u-GwGphDkqk0t9llT_qOc.jpg", "thumbnail_height": 70, "thumbnail_width": 70, "title": "MicroRNA dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemia", "url": "http://www.pnas.org/content/early/2017/09/14/1708264114.abstract"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1505780273, "domain": "endpts.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/70z83w/abbvie_and_roche_tout_a_positive_phiii_combo/", "id": "70z83w", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/70z83w/abbvie_and_roche_tout_a_positive_phiii_combo/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "5nmIzNmKSAWG99CyriXoDT3ev_qwPK0eFfckx8tKdRE", "resolutions": [{"height": 54, "url": "https://i.redditmedia.com/QoHd14-G0ryh4fuhx9blMi6s3dctw2ROiNo-MXDTAQE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=a801c68238932d240bd5f6d9a7b1b3d1", "width": 108}, {"height": 108, "url": "https://i.redditmedia.com/QoHd14-G0ryh4fuhx9blMi6s3dctw2ROiNo-MXDTAQE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=6cfd0bf77a4b6d2701e4a35b10c1288a", "width": 216}, {"height": 160, "url": "https://i.redditmedia.com/QoHd14-G0ryh4fuhx9blMi6s3dctw2ROiNo-MXDTAQE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=3d060e3875ceda82bea3580e8e7daec8", "width": 320}, {"height": 320, "url": "https://i.redditmedia.com/QoHd14-G0ryh4fuhx9blMi6s3dctw2ROiNo-MXDTAQE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=72d57c9a698485d646ae16305b9717bc", "width": 640}, {"height": 480, "url": "https://i.redditmedia.com/QoHd14-G0ryh4fuhx9blMi6s3dctw2ROiNo-MXDTAQE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=75497e2982adbe5e857f06f08cf2edf0", "width": 960}, {"height": 540, "url": "https://i.redditmedia.com/QoHd14-G0ryh4fuhx9blMi6s3dctw2ROiNo-MXDTAQE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=9c4b1c0efa2424dc2791d8ef98f3c0a9", "width": 1080}], "source": {"height": 1024, "url": "https://i.redditmedia.com/QoHd14-G0ryh4fuhx9blMi6s3dctw2ROiNo-MXDTAQE.jpg?s=fbe79e61ac8eb8a9f5ab3cf9a1ba833c", "width": 2048}, "variants": {}}]}, "retrieved_on": 1505860497, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/hhe9HPh14cBtzuu2E7HMgmIvS4b9lB1OIjps8bwkWaA.jpg", "thumbnail_height": 70, "thumbnail_width": 140, "title": "AbbVie and Roche tout a positive PhIII combo study of Venclexta, Rituxan in CLL ahead of FDA pitch", "url": "https://endpts.com/abbvie-and-roche-tout-a-positive-phiii-combo-study-of-venclexta-rituxan-in-cll-ahead-of-fda-pitch/"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1505780243, "domain": "curetoday.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/70z7zb/a_personalized_era_in_chronic_lymphocytic/", "id": "70z7zb", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/70z7zb/a_personalized_era_in_chronic_lymphocytic/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "88LNjfu6ck0iYMe6lkWIGguZt_q9YfZKqXGqus99y3Q", "resolutions": [{"height": 59, "url": "https://i.redditmedia.com/9_-sv4PN2RumW92a4V5sMtR26cZBvrghnJiaYW4ZSMM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=93b836236fea74f498d2945ddd7675d5", "width": 108}, {"height": 118, "url": "https://i.redditmedia.com/9_-sv4PN2RumW92a4V5sMtR26cZBvrghnJiaYW4ZSMM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=315f808610df341f379a9f9f06b6edf1", "width": 216}, {"height": 175, "url": "https://i.redditmedia.com/9_-sv4PN2RumW92a4V5sMtR26cZBvrghnJiaYW4ZSMM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=11c00976e80cab3c33009a313024babd", "width": 320}], "source": {"height": 282, "url": "https://i.redditmedia.com/9_-sv4PN2RumW92a4V5sMtR26cZBvrghnJiaYW4ZSMM.jpg?s=fa123b045ae71c661fcf26e9bcab2af7", "width": 514}, "variants": {}}]}, "retrieved_on": 1505860460, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/J264ewqjhEFt4Bs4GGWydx-0IBaq1Sf0I44eYZnuT_0.jpg", "thumbnail_height": 76, "thumbnail_width": 140, "title": "A Personalized Era in Chronic Lymphocytic Leukemia Treatment", "url": "http://www.curetoday.com/publications/cure/2017/hematology-2-2017/a-personalized-era-in-chronic-lymphocytic-leukemia-treatment"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1505779901, "domain": "seekingalpha.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/70z6qf/abbvie_announces_positive_topline_results_from/", "id": "70z6qf", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/70z6qf/abbvie_announces_positive_topline_results_from/", "pinned": false, "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "uJYM4x7IT38S26EaCfwYSbabI04PXznXxi9G-GkuWKU", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/VOn4dq_6hACOB-c78o7-f5TvRLaqigssB-ar0uydwkk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=13912cc92cfc56b2142b38ee12aa0961", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/VOn4dq_6hACOB-c78o7-f5TvRLaqigssB-ar0uydwkk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=f726abae02dd7a5b77d3dfa00d2a1d77", "width": 216}, {"height": 320, "url": "https://i.redditmedia.com/VOn4dq_6hACOB-c78o7-f5TvRLaqigssB-ar0uydwkk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=0ff4ee75373e92257cabe53a07646329", "width": 320}], "source": {"height": 410, "url": "https://i.redditmedia.com/VOn4dq_6hACOB-c78o7-f5TvRLaqigssB-ar0uydwkk.jpg?s=26fba4de00e806212a35ba24419d4bae", "width": 410}, "variants": {}}]}, "retrieved_on": 1505860136, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/AU4TDJU7YzpO0gI7-fy_Ct1S0uGBnsbaab3oA6iOjMQ.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "AbbVie Announces Positive Topline Results from Phase 3 Trial Evaluating VENCLEXTA/VENCLYXTO (Venetoclax) Tablets in Combination with Rituxan (rituximab) for the Treatment of R/R CLL", "url": "https://seekingalpha.com/pr/16943537-abbvie-announces-positive-topline-results-phase-3-trial-evaluating-venclexta-venclyxto"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1505537613, "domain": "thelancet.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/70f3bz/lenalidomide_maintenance_after_firstline_therapy/", "id": "70f3bz", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/70f3bz/lenalidomide_maintenance_after_firstline_therapy/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "rjNhLljEa5MKgCieRBVaVoqc4yOf5Wh4tl5QfIX9BCI", "resolutions": [{"height": 137, "url": "https://i.redditmedia.com/Q9nSnzANrTyBthjc9m7SuiKNMG1sHRy-2gcn4ydzOp0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=08996467abbe73e1bcbc32eba3da10b3", "width": 108}, {"height": 275, "url": "https://i.redditmedia.com/Q9nSnzANrTyBthjc9m7SuiKNMG1sHRy-2gcn4ydzOp0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=311b67e44c45308290e7c2ff9ddf9093", "width": 216}, {"height": 408, "url": "https://i.redditmedia.com/Q9nSnzANrTyBthjc9m7SuiKNMG1sHRy-2gcn4ydzOp0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=18b02a8f2c08599b81eb1566deb2061c", "width": 320}, {"height": 816, "url": "https://i.redditmedia.com/Q9nSnzANrTyBthjc9m7SuiKNMG1sHRy-2gcn4ydzOp0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=19b3e4144651ffa1caae5a23a1d40b1f", "width": 640}], "source": {"height": 825, "url": "https://i.redditmedia.com/Q9nSnzANrTyBthjc9m7SuiKNMG1sHRy-2gcn4ydzOp0.jpg?s=3a68b5fa02ea7012189fb31a4e7dfa1b", "width": 647}, "variants": {}}]}, "retrieved_on": 1505641007, "score": 2, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/e2d203gwjtK-ss_2gUQeAr9pBEMXOULdPoYOj_bpXWA.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study", "url": "http://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(17)30171-0/fulltext"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1505537573, "domain": "bmcgenomics.biomedcentral.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/70f37y/evolving_dna_methylation_and_gene_expression/", "id": "70f37y", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/70f37y/evolving_dna_methylation_and_gene_expression/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "8Izs0634eZEZwPq-hzA6GnLB4mZRE-dZoOkM6TZuOTk", "resolutions": [{"height": 143, "url": "https://i.redditmedia.com/J6rBbdkoAb6HPqysUxMzRkaj0q4VwrgU1oKfyVwYCNA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=751f42a8f4a253462d38807d31e5ccd4", "width": 108}], "source": {"height": 203, "url": "https://i.redditmedia.com/J6rBbdkoAb6HPqysUxMzRkaj0q4VwrgU1oKfyVwYCNA.jpg?s=2e6f8b1ff3d27da9cffd8ac69d474daa", "width": 153}, "variants": {}}]}, "retrieved_on": 1505640956, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/Qg5WgnsfPkrCS6Oko6nqE8i2J-acMeozsxvI2RkVtgY.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Evolving DNA methylation and gene expression markers of CLL are present in pre-diagnostic blood samples more than 10 years prior to diagnosis", "url": "https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-017-4117-4"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1505537374, "domain": "lymphomanewstoday.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/70f2r1/advanced_cll_and_sll_patients_aided_by_oral/", "id": "70f2r1", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/70f2r1/advanced_cll_and_sll_patients_aided_by_oral/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "oiX5vPdE65doqH4zj_S6gwogu4qq2YyqSsFTP-M_Id0", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/_E0ZKc6sRpKHHY0hB6VxlW6O7LgJXQIbhhiPBwkYSiE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=d47c638fac022bf4fff509c7f9c08684", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/_E0ZKc6sRpKHHY0hB6VxlW6O7LgJXQIbhhiPBwkYSiE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=e526a83185cb1a5c07a6169851ad02d1", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/_E0ZKc6sRpKHHY0hB6VxlW6O7LgJXQIbhhiPBwkYSiE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=36413498214ed4dce38b7bc068f043ce", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/_E0ZKc6sRpKHHY0hB6VxlW6O7LgJXQIbhhiPBwkYSiE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=f76307e148f335eb4bd5b94feed0902c", "width": 640}, {"height": 640, "url": "https://i.redditmedia.com/_E0ZKc6sRpKHHY0hB6VxlW6O7LgJXQIbhhiPBwkYSiE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=905a8a7ac9ce9f06f31c9050d150f913", "width": 960}], "source": {"height": 667, "url": "https://i.redditmedia.com/_E0ZKc6sRpKHHY0hB6VxlW6O7LgJXQIbhhiPBwkYSiE.jpg?s=8bb9e7d9e1d32dac6bb5a00b3ac1429a", "width": 1000}, "variants": {}}]}, "retrieved_on": 1505640715, "score": 3, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/pzxXRWp_BPrVX2DjZFcsTc3YLvGEAB9mn2CnlUcDrqI.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "Advanced CLL and SLL Patients Aided by Oral Duvelisib in Phase 3 Study, Verastem Reports", "url": "https://lymphomanewstoday.com/2017/09/07/verastem-to-ask-fda-to-approve-oral-duvelisib-to-treat-advanced-cll-sll-after-postive-trial-results/"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1505537271, "domain": "healio.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/70f2ie/duvelisib_extends_pfs_in_chronic_lymphocytic/", "id": "70f2ie", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/70f2ie/duvelisib_extends_pfs_in_chronic_lymphocytic/", "retrieved_on": 1505640595, "score": 2, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Duvelisib extends PFS in chronic lymphocytic leukemia, small lymphocytic lymphoma", "url": "https://www.healio.com/hematology-oncology/leukemia/news/online/%7B78d1bc0d-5ba3-463b-9c4f-2c57e1ca7908%7D/duvelisib-extends-pfs-in-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1505537202, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/70f2cr/dr_chavez_on_combination_of_ibrutinib_plus/", "id": "70f2cr", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/70f2cr/dr_chavez_on_combination_of_ibrutinib_plus/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "Iiw4nQqTd3MXEZJ868YWftZi9qTpHedC56SUzH9PQjE", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/r0BDL7TD8jMbE5_lcXIfdcC8ee4xUUbE1I2cRqrgwfk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=0fca5bfbc7bf3453cd7599afda75cb8e", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/r0BDL7TD8jMbE5_lcXIfdcC8ee4xUUbE1I2cRqrgwfk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=b814464c4813a96e6789ac8a7601062a", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/r0BDL7TD8jMbE5_lcXIfdcC8ee4xUUbE1I2cRqrgwfk.jpg?s=b73e0e28dc187d1c16ed4012dc5c4ad4", "width": 250}, "variants": {}}]}, "retrieved_on": 1505640511, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/N-yRxR8yIwYHKQLpTVq_gaClyK9yS64a7C60AQi5vtQ.jpg", "thumbnail_height": 106, "thumbnail_width": 140, "title": "Dr. Chavez on Combination of Ibrutinib Plus Ublituximab in CLL", "url": "http://www.onclive.com/onclive-tv/dr-chavez-on-combination-of-ibrutinib-plus-ublituximab-in-cll"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1505537134, "domain": "wallstreetpr.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/70f27k/verastem_inc_blood_cancer_program_succeeds_in/", "id": "70f27k", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/70f27k/verastem_inc_blood_cancer_program_succeeds_in/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "5Q7QQtuedZrjdYMpM3YAcQCISe9h2O-mz1NVoneKzRU", "resolutions": [{"height": 77, "url": "https://i.redditmedia.com/7xdJByyNFQ6DZJgx6DXrbl28bZKQlTrKUjRPs4oZMWY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=dd94ceb49d61a3d0f5c50e0fd69a01ff", "width": 108}, {"height": 154, "url": "https://i.redditmedia.com/7xdJByyNFQ6DZJgx6DXrbl28bZKQlTrKUjRPs4oZMWY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=e72e3369e3c44d3406b1f0cb876c1821", "width": 216}, {"height": 228, "url": "https://i.redditmedia.com/7xdJByyNFQ6DZJgx6DXrbl28bZKQlTrKUjRPs4oZMWY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=7878622b9f2bb222f66bab09d3dc5379", "width": 320}, {"height": 457, "url": "https://i.redditmedia.com/7xdJByyNFQ6DZJgx6DXrbl28bZKQlTrKUjRPs4oZMWY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=00ea15146bcda28c101561bcfbdf14ab", "width": 640}], "source": {"height": 500, "url": "https://i.redditmedia.com/7xdJByyNFQ6DZJgx6DXrbl28bZKQlTrKUjRPs4oZMWY.jpg?s=9533fc6d8a86cd66cace4712096a0ed3", "width": 700}, "variants": {}}]}, "retrieved_on": 1505640431, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/--fILj40rx8GXyajD9WDv_g5ivSgnFjOppDycFRWuyg.jpg", "thumbnail_height": 100, "thumbnail_width": 140, "title": "Verastem Inc Blood Cancer Program Succeeds In Final Phase Trial", "url": "https://www.wallstreetpr.com/verastem-inc-nasdaqvstm-blood-cancer-program-succeeds-in-final-phase-trial-40323"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1505324185, "domain": "globenewswire.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6zw56k/sandoz_proposed_biosimilar_rituximab_accepted_for/", "id": "6zw56k", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6zw56k/sandoz_proposed_biosimilar_rituximab_accepted_for/", "retrieved_on": 1505409072, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Sandoz proposed biosimilar rituximab accepted for review by the FDA", "url": "https://globenewswire.com/news-release/2017/09/12/1117744/0/en/Sandoz-proposed-biosimilar-rituximab-accepted-for-review-by-the-FDA.html"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1505324144, "domain": "marketrealist.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6zw510/the_latest_on_tevas_oncology_business/", "id": "6zw510", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6zw510/the_latest_on_tevas_oncology_business/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "2I1oDLWBiq0KM83U-OU6zssGlGYArN-cOwWvcqWApf4", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/yCwy6w03N02Cx6B7sHwoLT_zG815giKW555__4nQRPM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=82bac303dc7de80411ca38ac4f212346", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/yCwy6w03N02Cx6B7sHwoLT_zG815giKW555__4nQRPM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=8f8f86aeed2cd9e3980d5eb36bd78125", "width": 216}, {"height": 214, "url": "https://i.redditmedia.com/yCwy6w03N02Cx6B7sHwoLT_zG815giKW555__4nQRPM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=df8f8d31c5b8ef4ef2a74295cd2912aa", "width": 320}, {"height": 428, "url": "https://i.redditmedia.com/yCwy6w03N02Cx6B7sHwoLT_zG815giKW555__4nQRPM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=8204917969c633ab012c6500265bc81e", "width": 640}], "source": {"height": 442, "url": "https://i.redditmedia.com/yCwy6w03N02Cx6B7sHwoLT_zG815giKW555__4nQRPM.jpg?s=4f97faf8895a31a9cb82b493c5e2ad19", "width": 660}, "variants": {}}]}, "retrieved_on": 1505409029, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/Ho-t1GFpcD6B1AGanKME2Og8ZHLryHcgl6b-d-YC0XA.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "The Latest on TEVA's Oncology Business", "url": "http://marketrealist.com/2017/09/the-latest-on-tevas-oncology-business/"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1504757250, "domain": "lymphomahub.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ykwd5/patient_with_both_chronic_lymphocytic_leukemia/", "id": "6ykwd5", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ykwd5/patient_with_both_chronic_lymphocytic_leukemia/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "b7ZrVm1wwZTgPF0kljeSkJ978Z44rTHPEVGDrvbL9t0", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/aFQBwYUpVzhfpMzO_EnaAwq0KeGWxWUCEXD2JHwiKrQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=c075ef69c66f5479841c754677a52e00", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/aFQBwYUpVzhfpMzO_EnaAwq0KeGWxWUCEXD2JHwiKrQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=5e3daa5a719470365c7d1ca2a60efcf6", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/aFQBwYUpVzhfpMzO_EnaAwq0KeGWxWUCEXD2JHwiKrQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=c5977656a112e1e05b6d957750d8ef28", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/aFQBwYUpVzhfpMzO_EnaAwq0KeGWxWUCEXD2JHwiKrQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=9aa0df55871cd567be6425f80d245624", "width": 640}, {"height": 640, "url": "https://i.redditmedia.com/aFQBwYUpVzhfpMzO_EnaAwq0KeGWxWUCEXD2JHwiKrQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=2dcf7765a15f7ecffac51bd21b21d882", "width": 960}, {"height": 720, "url": "https://i.redditmedia.com/aFQBwYUpVzhfpMzO_EnaAwq0KeGWxWUCEXD2JHwiKrQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=4f1541b0c0e8d5bcba246e9754df0679", "width": 1080}], "source": {"height": 4000, "url": "https://i.redditmedia.com/aFQBwYUpVzhfpMzO_EnaAwq0KeGWxWUCEXD2JHwiKrQ.jpg?s=bf223de03eb10c273f163ce4d802f37d", "width": 6000}, "variants": {}}]}, "retrieved_on": 1504842877, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/42ruMEAflIAgXbCuhIEd727qKmjw0rR_yGOmnr0zZoM.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "Patient with both Chronic Lymphocytic Leukemia and Mestastatic Melanoma treated with pembrolizumab - a published case study", "url": "http://www.lymphomahub.com/medical-information/published-case-study-pembrolizumab-to-treat-a-patient-with-both-chronic-lymphocytic-leukemia-and-metastatic-melanoma"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1504757152, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ykw43/fda_puts_clinical_holds_on_offtheshelf_cart_trials/", "id": "6ykw43", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ykw43/fda_puts_clinical_holds_on_offtheshelf_cart_trials/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "-d8fKd-8LriRoJ73obz9rrHNmkR-FSuoa6zZv7tMQA0", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/AbrzdQ9ztLknCxB7NGWYUquxvWnTxtr8zvetTWTQoDA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=5de7979d9ef8fc03b1a571573bcd1ffe", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/AbrzdQ9ztLknCxB7NGWYUquxvWnTxtr8zvetTWTQoDA.jpg?s=85fe46d5ee339ca02a020879543ae63d", "width": 200}, "variants": {}}]}, "retrieved_on": 1504842788, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/bKPBAtvrmENMpGNvAlwkNSdQ82Gxukx58mJCgBPaI5o.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "FDA Puts Clinical Holds on \"Off-the-Shelf\" CAR-T Trials", "url": "http://www.onclive.com/web-exclusives/fda-puts-clinical-holds-on-offtheshelf-cart-trials"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1504756994, "domain": "xconomy.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ykvor/presage_bio_licenses_anticancer_drug_to_san/", "id": "6ykvor", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ykvor/presage_bio_licenses_anticancer_drug_to_san/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "aQsyIoe-PjRi-wfbPamXucO0MBEBQhyeh85BlDAP1Pc", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/237KP62UCTI5Lv288gA2WuK7msrZIs4p6HMoRyEbAFs.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=32ad07d69a3eef3a7b03cc00c5013514", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/237KP62UCTI5Lv288gA2WuK7msrZIs4p6HMoRyEbAFs.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=6c9c5dc28c2ac33209d6ac67047ef860", "width": 216}], "source": {"height": 200, "url": "https://i.redditmedia.com/237KP62UCTI5Lv288gA2WuK7msrZIs4p6HMoRyEbAFs.jpg?s=ddcd4a1203895a535838e8743279bf30", "width": 300}, "variants": {}}]}, "retrieved_on": 1504842621, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/_ul_jJZpUzveKrZJ5L27F1NT-IXFudLvBmE5cVOY2tE.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "Presage Bio Licenses Anti-Cancer Drug to San Diego\u2019s MEI Pharma", "url": "http://www.xconomy.com/san-diego/2017/09/05/presage-bio-licenses-anti-cancer-drug-to-san-diegos-mei-pharma/#"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1504565098, "domain": "sandiegouniontribune.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6y3sbh/ucsd_cancer_clinical_trial_gets_182_million/", "id": "6y3sbh", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6y3sbh/ucsd_cancer_clinical_trial_gets_182_million/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "CrDRMStvjtZI2iu7qbG-ffA7LxPlwRvojEta2DiMsGc", "resolutions": [{"height": 69, "url": "https://i.redditmedia.com/Pkn9oWzN6CLaCDxlA5mgqIN8GWksSZuaUERpnzJZGzQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=e0b2b79b18c1e470eb92a5d191560303", "width": 108}, {"height": 138, "url": "https://i.redditmedia.com/Pkn9oWzN6CLaCDxlA5mgqIN8GWksSZuaUERpnzJZGzQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=6cc4b0cbfe7288c4ce93f0f1d7c8e1f0", "width": 216}, {"height": 205, "url": "https://i.redditmedia.com/Pkn9oWzN6CLaCDxlA5mgqIN8GWksSZuaUERpnzJZGzQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=25b0c3012c26ff99d19b0b264baa9ca1", "width": 320}, {"height": 410, "url": "https://i.redditmedia.com/Pkn9oWzN6CLaCDxlA5mgqIN8GWksSZuaUERpnzJZGzQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=82879ed4365bd22b88091339676ab982", "width": 640}, {"height": 616, "url": "https://i.redditmedia.com/Pkn9oWzN6CLaCDxlA5mgqIN8GWksSZuaUERpnzJZGzQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=55276d90d1c0e7092e7a33aed685b106", "width": 960}, {"height": 693, "url": "https://i.redditmedia.com/Pkn9oWzN6CLaCDxlA5mgqIN8GWksSZuaUERpnzJZGzQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=45f8b72ff9381e779250a25c736e72fa", "width": 1080}], "source": {"height": 1315, "url": "https://i.redditmedia.com/Pkn9oWzN6CLaCDxlA5mgqIN8GWksSZuaUERpnzJZGzQ.jpg?s=337be9d359cdfa6dc037e5d1c8533ac0", "width": 2048}, "variants": {}}]}, "retrieved_on": 1504648516, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/Pq4QUh-wm_uriIH5yCKA8-iytPeN2a64gCA90tmYp6c.jpg", "thumbnail_height": 89, "thumbnail_width": 140, "title": "UCSD cancer clinical trial gets $18.2 million", "url": "http://www.sandiegouniontribune.com/business/biotech/sd-me-ucsd-cancer-20170904-story.html"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1504547016, "domain": "aurorahealthcare.org", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6y1v43/patients_needed_for_trial_ublituximab_tgr1202/", "id": "6y1v43", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6y1v43/patients_needed_for_trial_ublituximab_tgr1202/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "4DidIL2rt3NCX9MPmQ6NWshpgm5tnfreQ-plHewAH3E", "resolutions": [{"height": 15, "url": "https://i.redditmedia.com/NWtamXvxYLMs0lHFAE-q-ujQwUfYMW3MebYnVdf0WDo.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=0142bbd89b49393042afbd57a80022cf", "width": 108}], "source": {"height": 28, "url": "https://i.redditmedia.com/NWtamXvxYLMs0lHFAE-q-ujQwUfYMW3MebYnVdf0WDo.jpg?s=ab1aabbad9ebadf72c08926eaf26931b", "width": 200}, "variants": {}}]}, "retrieved_on": 1504631067, "score": 2, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/3jughmFUQHj9MC506BuRo131I9VAAS8uW-c-AjflMSs.jpg", "thumbnail_height": 19, "thumbnail_width": 140, "title": "PATIENTS NEEDED FOR TRIAL: Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Patients With Untreated and Previously Treated Chronic Lymphocytic Leukemia (UNITY-CLL) | Aurora Health Care", "url": "https://www.aurorahealthcare.org/aurora-research-institute/clinical-trials/nct02612311"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1504546510, "domain": "fanvive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6y1t28/kymriah_is_the_first_ever_fda_approved_gene/", "id": "6y1t28", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6y1t28/kymriah_is_the_first_ever_fda_approved_gene/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "GJOScSDIFmNMp_Qm3-8xIwaw41yTfupzKYlwo7TZzC8", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/2XvQx30oq5_BI_8x_aeV43cIR9L7F49K-LRdWxKEFJg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=1cceee51f35ee35e283155378d37ac2b", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/2XvQx30oq5_BI_8x_aeV43cIR9L7F49K-LRdWxKEFJg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=4d00e8fe14fdb09dbdd10d170e9b302e", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/2XvQx30oq5_BI_8x_aeV43cIR9L7F49K-LRdWxKEFJg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=f6f9df24f0623c25412bbc78a6d64cdd", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/2XvQx30oq5_BI_8x_aeV43cIR9L7F49K-LRdWxKEFJg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=8eb11b8de48733637d7d83a1b017ac3e", "width": 640}, {"height": 640, "url": "https://i.redditmedia.com/2XvQx30oq5_BI_8x_aeV43cIR9L7F49K-LRdWxKEFJg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=4a0478e9de676b83a5b7e65558624b35", "width": 960}, {"height": 720, "url": "https://i.redditmedia.com/2XvQx30oq5_BI_8x_aeV43cIR9L7F49K-LRdWxKEFJg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=077fc739b2a3549b9c458fd7112ed8b4", "width": 1080}], "source": {"height": 1280, "url": "https://i.redditmedia.com/2XvQx30oq5_BI_8x_aeV43cIR9L7F49K-LRdWxKEFJg.jpg?s=832a41f7d63093da47b352e362f525c8", "width": 1920}, "variants": {}}]}, "retrieved_on": 1504630568, "score": 2, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/K1JCbnXwTK8VcIT3dMObFo1Ii-9XnG4MXPVs2G5cDS0.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "Kymriah is the first ever FDA approved gene therapy", "url": "http://fanvive.com/2017/09/01/kymriah-first-fda-approved-gene-therapy/"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1504545921, "domain": "bloodjournal.org", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6y1qo5/rituximabbased_first_line_treatment_for_chronic/", "id": "6y1qo5", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6y1qo5/rituximabbased_first_line_treatment_for_chronic/", "retrieved_on": 1504630017, "score": 2, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Rituximab-based first line treatment for chronic GVHD after allogeneic SCT: results of a phase 2 study", "url": "http://www.bloodjournal.org/content/early/2017/09/01/blood-2017-05-786137?sso-checked=true"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1504159198, "domain": "cnn.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6x53jj/fda_announces_first_us_gene_therapy_approval/", "id": "6x53jj", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6x53jj/fda_announces_first_us_gene_therapy_approval/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "sTMPTg1Nai8a8ou0lhiRljDlxTuzG0PjmQ_mxJRMpME", "resolutions": [{"height": 60, "url": "https://i.redditmedia.com/Wdgg2gnMVvyEYD4vhBXvk93ij3hsEt-91ajv03dAH5c.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=bb5834575bc40df53d0821c662e42639", "width": 108}, {"height": 121, "url": "https://i.redditmedia.com/Wdgg2gnMVvyEYD4vhBXvk93ij3hsEt-91ajv03dAH5c.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=0f08432cd5737e51340a35537433a3d7", "width": 216}, {"height": 180, "url": "https://i.redditmedia.com/Wdgg2gnMVvyEYD4vhBXvk93ij3hsEt-91ajv03dAH5c.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=dcfd2bfa6cd152e3660ec50f1a293884", "width": 320}, {"height": 360, "url": "https://i.redditmedia.com/Wdgg2gnMVvyEYD4vhBXvk93ij3hsEt-91ajv03dAH5c.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=5a4d73659e00e9d2130174a055d173b7", "width": 640}, {"height": 540, "url": "https://i.redditmedia.com/Wdgg2gnMVvyEYD4vhBXvk93ij3hsEt-91ajv03dAH5c.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=12931a67aa65911e7e4c628d5d6f3b87", "width": 960}, {"height": 607, "url": "https://i.redditmedia.com/Wdgg2gnMVvyEYD4vhBXvk93ij3hsEt-91ajv03dAH5c.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=0b56a729e435e7293d26bebf39e95591", "width": 1080}], "source": {"height": 619, "url": "https://i.redditmedia.com/Wdgg2gnMVvyEYD4vhBXvk93ij3hsEt-91ajv03dAH5c.jpg?s=25957b53c0843898f1ddb654ed9e976c", "width": 1100}, "variants": {}}]}, "retrieved_on": 1504244295, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/X003kZm7uPbMLIRUtD0Xgy2pVJNQksx1gNgyqzRxwaQ.jpg", "thumbnail_height": 78, "thumbnail_width": 140, "title": "FDA announces first US gene therapy approval", "url": "http://www.cnn.com/2017/08/30/health/fda-first-gene-therapy-leukemia/index.html"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1504158185, "domain": "fiercebiotech.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6x517b/hitandrun_gene_therapy_nanoparticles_could/", "id": "6x517b", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6x517b/hitandrun_gene_therapy_nanoparticles_could/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "bawTdRbt4yY0RWs6t-f2wHGYmcSwJUYpvpKmuGFhhtA", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/LS5vLYQSkRnL-4nlJT3pvyxWCN-LvHd1CB9LgVNdkqY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=116b3c54deb1d7c17fca0725562e8223", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/LS5vLYQSkRnL-4nlJT3pvyxWCN-LvHd1CB9LgVNdkqY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=0f67fd48d082b3cf221b67d8d7ff8ec1", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/LS5vLYQSkRnL-4nlJT3pvyxWCN-LvHd1CB9LgVNdkqY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=4bf1b713bc145bcd166e825f3f53fd98", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/LS5vLYQSkRnL-4nlJT3pvyxWCN-LvHd1CB9LgVNdkqY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=9489e6d7807bbcdfaab077cc9a3ffde6", "width": 640}, {"height": 640, "url": "https://i.redditmedia.com/LS5vLYQSkRnL-4nlJT3pvyxWCN-LvHd1CB9LgVNdkqY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=cedf7e92cefdd436d022f922321dbd50", "width": 960}, {"height": 720, "url": "https://i.redditmedia.com/LS5vLYQSkRnL-4nlJT3pvyxWCN-LvHd1CB9LgVNdkqY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=97266635b0548c6845ae30829d6bbb4b", "width": 1080}], "source": {"height": 800, "url": "https://i.redditmedia.com/LS5vLYQSkRnL-4nlJT3pvyxWCN-LvHd1CB9LgVNdkqY.jpg?s=c65028b45979028ba291bfa4cb31823e", "width": 1200}, "variants": {}}]}, "retrieved_on": 1504243396, "score": 2, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/eitBysJt-5CYDTBYVh1HM3dnAzbfwQRVljdIGo-oRRo.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "\u2018Hit-and-run\u2019 gene therapy nanoparticles could enhance CAR-T treatments", "url": "http://www.fiercebiotech.com/research/hit-and-run-gene-therapy-nanoparticles-could-enhance-car-t-treatments"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1504158150, "domain": "philly.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6x514k/fda_approves_firstever_tcell_cancer_treatment/", "id": "6x514k", "is_crosspostable": true, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6x514k/fda_approves_firstever_tcell_cancer_treatment/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "o4mbg7kMbfVqVLo-co7KYCycWxtWx0o8DmhGcGSnBTM", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/aw1hVwn5dNQQ_fO9fH7l7w5FR4vuOENQ5N2GWMpkvpA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=48e0fb80479a60203f7eb7296596f270", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/aw1hVwn5dNQQ_fO9fH7l7w5FR4vuOENQ5N2GWMpkvpA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=d4670f7581a6b76bb9d73d283b938514", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/aw1hVwn5dNQQ_fO9fH7l7w5FR4vuOENQ5N2GWMpkvpA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=edd1b1f6b3ee9aadbbf63b244cfd6bd8", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/aw1hVwn5dNQQ_fO9fH7l7w5FR4vuOENQ5N2GWMpkvpA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=bc98225a10c468705fc3a3751e97c335", "width": 640}, {"height": 640, "url": "https://i.redditmedia.com/aw1hVwn5dNQQ_fO9fH7l7w5FR4vuOENQ5N2GWMpkvpA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=41e0364164b23555ca163be2c2a8c8b3", "width": 960}, {"height": 720, "url": "https://i.redditmedia.com/aw1hVwn5dNQQ_fO9fH7l7w5FR4vuOENQ5N2GWMpkvpA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=379f2c116a3d9b0b69641e9d31014b69", "width": 1080}], "source": {"height": 800, "url": "https://i.redditmedia.com/aw1hVwn5dNQQ_fO9fH7l7w5FR4vuOENQ5N2GWMpkvpA.jpg?s=3906e69a08d663e7dc3a72b630863f9b", "width": 1200}, "variants": {}}]}, "retrieved_on": 1504243363, "score": 2, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/EOQftu77PtnxYY6cckRQwM3BxbnsluqIX8nS_xa_u9w.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "FDA approves first-ever T-cell cancer treatment, pioneered at Penn, CHOP", "url": "http://www.philly.com/philly/health/health-news/fda-approves-novartis-t-cell-therapy-pioneered-at-penn-chop-20170830.html"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1503770218, "domain": "eurekalert.org", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6w700m/states_stem_cell_agency_awards_182_million_grant/", "id": "6w700m", "is_crosspostable": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6w700m/states_stem_cell_agency_awards_182_million_grant/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "t1d_Z49YT_niS88RE7TlHSq2sL8tW3dv-og70bgeqWQ", "resolutions": [{"height": 99, "url": "https://i.redditmedia.com/8C5sLpjm6BOSFfg89OpxhXB8vhVjIP4u1D1hwRmVkKc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=965c741095d51f029805c41a54993af5", "width": 108}, {"height": 198, "url": "https://i.redditmedia.com/8C5sLpjm6BOSFfg89OpxhXB8vhVjIP4u1D1hwRmVkKc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=b164e970112ea45ac2eb276acd21db63", "width": 216}, {"height": 293, "url": "https://i.redditmedia.com/8C5sLpjm6BOSFfg89OpxhXB8vhVjIP4u1D1hwRmVkKc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=9fb7dd2a6d2eb21cc51a75161d717736", "width": 320}], "source": {"height": 413, "url": "https://i.redditmedia.com/8C5sLpjm6BOSFfg89OpxhXB8vhVjIP4u1D1hwRmVkKc.jpg?s=14c22d8e9bf9e858006d987ef0d152d7", "width": 450}, "variants": {}}]}, "retrieved_on": 1503865168, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/x3oUrhCqCC5txlRD3FrxJldbxkL74BdYsRK_VZtpSJk.jpg", "thumbnail_height": 128, "thumbnail_width": 140, "title": "State's stem cell agency awards $18.2 million grant for B cell cancer clinical trial", "url": "https://www.eurekalert.org/pub_releases/2017-08/uoc--ssc082417.php"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1503732294, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6w4bbl/cll_the_biologics_of_ibrutinib_therapy/", "id": "6w4bbl", "is_crosspostable": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6w4bbl/cll_the_biologics_of_ibrutinib_therapy/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "MfNtLyJcltU6uqRgfkax1-4e9hoBOKUEqLhABBi2hNo", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/uCnPAjm7Bdw4X2DP9Sp4QkvATmgvzQUmbHfg1CezhOc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=588df65658b1bb015cae205f5cf587c4", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/uCnPAjm7Bdw4X2DP9Sp4QkvATmgvzQUmbHfg1CezhOc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=5019cecbbd39df8cca64a9111c76da6f", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/uCnPAjm7Bdw4X2DP9Sp4QkvATmgvzQUmbHfg1CezhOc.jpg?s=41c2370f51c109eb6478688b39a8068a", "width": 250}, "variants": {}}]}, "retrieved_on": 1503835354, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/18d7lRLFSX5v6gw4urn_IAE23HS8W5yFPc32YemPzOw.jpg", "thumbnail_height": 106, "thumbnail_width": 140, "title": "CLL: The Biologics of Ibrutinib Therapy", "url": "http://www.onclive.com/inside-oncology/cll-therapeutic-management/cll-the-biologics-of-ibrutinib-therapy"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1503732257, "domain": "lymphomahub.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6w4b99/postallogeneic_stem_cell_transplant_lenalidomide/", "id": "6w4b99", "is_crosspostable": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6w4b99/postallogeneic_stem_cell_transplant_lenalidomide/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "MkXzSCBRo6ltMXuWC9TzVWhprpYciT3_lDHRiPu4tBw", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/z9ApbzeAG_gTksU5YN3UeR5mpbCw6zdn9q3RBkpowtg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=c239335b8750355cb3a65262776a8821", "width": 108}, {"height": 143, "url": "https://i.redditmedia.com/z9ApbzeAG_gTksU5YN3UeR5mpbCw6zdn9q3RBkpowtg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=5995e04485d0854bd5782b97e67aa2f6", "width": 216}, {"height": 212, "url": "https://i.redditmedia.com/z9ApbzeAG_gTksU5YN3UeR5mpbCw6zdn9q3RBkpowtg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=1a2198544fc57cf55d92893403078ed6", "width": 320}, {"height": 424, "url": "https://i.redditmedia.com/z9ApbzeAG_gTksU5YN3UeR5mpbCw6zdn9q3RBkpowtg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=e1da61751f29535c162dc1538f286def", "width": 640}, {"height": 637, "url": "https://i.redditmedia.com/z9ApbzeAG_gTksU5YN3UeR5mpbCw6zdn9q3RBkpowtg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=b13bad856d16e1c7ab9bc4e5940fd07c", "width": 960}, {"height": 716, "url": "https://i.redditmedia.com/z9ApbzeAG_gTksU5YN3UeR5mpbCw6zdn9q3RBkpowtg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=c2fdf4c858a6fbff5509e3fe5b7583f0", "width": 1080}], "source": {"height": 770, "url": "https://i.redditmedia.com/z9ApbzeAG_gTksU5YN3UeR5mpbCw6zdn9q3RBkpowtg.jpg?s=15f2a8eb2d2ade903b830dfce84011ec", "width": 1160}, "variants": {}}]}, "retrieved_on": 1503835321, "score": 3, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/8h7Pr3MJEp5km8WXtfUpDenzKx8EBrIBU6P4TbqHaeo.jpg", "thumbnail_height": 92, "thumbnail_width": 140, "title": "Post-allogeneic stem cell transplant, lenalidomide is not a viable option for persistent Chronic Lymphocytic Leukemia - results of a randomized phase II trial", "url": "http://www.lymphomahub.com/medical-information/randomized-phase-ii-results-lenalidomide-is-not-a-viable-option-post-allogeneic-stem-cell-transplant-for-persistent-chronic-lymphocytic-leukemia"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1503732204, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6w4b57/patient_selection_for_cll_treatment/", "id": "6w4b57", "is_crosspostable": false, "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6w4b57/patient_selection_for_cll_treatment/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "4WplX9KrcjEFCC8HPY1avPeTxYVJzdmrx4yZHA1tZRI", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/isxow6kJOYFFqJRA3vb0QMg1PaP6Yw8lq0aO5o_P9AY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=2a16f47036c9a9c8d5016cc239829b2b", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/isxow6kJOYFFqJRA3vb0QMg1PaP6Yw8lq0aO5o_P9AY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=cb2ca7f8347208feb34556ed2f553331", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/isxow6kJOYFFqJRA3vb0QMg1PaP6Yw8lq0aO5o_P9AY.jpg?s=5fbf7cfc05f05f7eec9fab003892093c", "width": 250}, "variants": {}}]}, "retrieved_on": 1503835282, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/oay8oy88vPgw3W_Yg9bccxI2bZm-v2CUbfVHKQxadSQ.jpg", "thumbnail_height": 106, "thumbnail_width": 140, "title": "Patient Selection for CLL Treatment", "url": "http://www.onclive.com/inside-oncology/cll-therapeutic-management/patient-selection-for-cll-treatment"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1503065582, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ui2xo/dr_chavez_shares_his_advice_for_treating_patients/", "id": "6ui2xo", "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ui2xo/dr_chavez_shares_his_advice_for_treating_patients/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "L3TyjfjHAHsQoe9InGqFMWH-SsY-Id3OHRvuGXyMlSM", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/HuMaEE71zCUdLPoAEOQzsd9UoJ1QSycu_ze4qwWfi7I.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=d6c1b46317af16e993da2af5a0a010f7", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/HuMaEE71zCUdLPoAEOQzsd9UoJ1QSycu_ze4qwWfi7I.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=714589160c7bbc3c0d4575b01fd077da", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/HuMaEE71zCUdLPoAEOQzsd9UoJ1QSycu_ze4qwWfi7I.jpg?s=37902be5b90a00bc77788ea74bf4190e", "width": 250}, "variants": {}}]}, "retrieved_on": 1503155645, "score": 3, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/0NHpBWLEKQzDQ7ztO2kJojMcSmTE3zXf0CtgsSStXbw.jpg", "thumbnail_height": 106, "thumbnail_width": 140, "title": "Dr. Chavez Shares His Advice for Treating Patients With CLL", "url": "http://www.onclive.com/onclive-tv/dr-chavez-shares-his-advice-for-treating-patients-with-cll"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1503065512, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ui2mv/dr_byrd_on_longterm_safety_data_with_ibrutinib_in/", "id": "6ui2mv", "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ui2mv/dr_byrd_on_longterm_safety_data_with_ibrutinib_in/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "IH-PVFKjb9K4QDaJEpOIPx-Mth6M6-000223OSYuGlM", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/Rd0UrcMAOZLuQ87JlKEGuC5snRpnQRoEkF0IB2tMg5E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=abfa08f15e8c7c5200f3a4d36b988046", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/Rd0UrcMAOZLuQ87JlKEGuC5snRpnQRoEkF0IB2tMg5E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=7d814a3e73bc907603ecef88f9032ba1", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/Rd0UrcMAOZLuQ87JlKEGuC5snRpnQRoEkF0IB2tMg5E.jpg?s=8b90c8890e4ba981b9fd604f9c176130", "width": 250}, "variants": {}}]}, "retrieved_on": 1503155550, "score": 2, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/jVNNzyY4ZxVwoJEd2FFePIsTt3mWq9Yc-aEMiHy7Yq4.jpg", "thumbnail_height": 106, "thumbnail_width": 140, "title": "Dr. Byrd on Long-term Safety Data With Ibrutinib in CLL", "url": "http://www.onclive.com/onclive-tv/dr-byrd-on-longterm-safety-data-with-ibrutinib-in-cll"}, {"author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1502918995, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6u5abe/dr_furman_on_considering_factors_for_upfront/", "id": "6u5abe", "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6u5abe/dr_furman_on_considering_factors_for_upfront/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "7druxHUeT4PZK9Bl08JXyyI4EDLItVFkRKUOiOm9FY4", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/gtIZoLK4xlf7W9mB1y6qEhx_xeENgE1-MLwhorQTmug.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=133ea88875f2af5d66e4c8f02bbd5ad7", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/gtIZoLK4xlf7W9mB1y6qEhx_xeENgE1-MLwhorQTmug.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=1ccb5b6822beff5ebe7867e1d56a74a6", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/gtIZoLK4xlf7W9mB1y6qEhx_xeENgE1-MLwhorQTmug.jpg?s=b4128b447e84f3d89371180852160d69", "width": 250}, "variants": {}}]}, "retrieved_on": 1503001720, "score": 1, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/Ex5PXnM6vSlJSrOCDafeFy516hg6urQqc_daPX-CG6Y.jpg", "thumbnail_height": 106, "thumbnail_width": 140, "title": "Dr. Furman on Considering Factors for Upfront Therapy in CLL", "url": "http://www.onclive.com/onclive-tv/dr-furman-on-considering-factors-for-upfront-therapy-in-cll"}, {"approved_at_utc": null, "author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1502864266, "domain": "healio.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6u06v1/car_tcell_therapy_effective_for_chronic/", "id": "6u06v1", "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "over_18": false, "parent_whitelist_status": null, "permalink": "/r/CLL_Leukemia/comments/6u06v1/car_tcell_therapy_effective_for_chronic/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "7bnLBzoCLpKoIycONW07gEmSL22_gh9KIPhfnEP9dTk", "resolutions": [], "source": {"height": 106, "url": "https://i.redditmedia.com/n95lRcyJwxjkkslDXQvsObkJ5-BNYF0qw63H2jFwUSQ.jpg?s=a9dfe9b4fbfe1bde5f70565cca50ddd0", "width": 80}, "variants": {}}]}, "retrieved_on": 1502944716, "score": 2, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/MWDEnNEcxIsnuXIOOVAAbjlZP4WOnZ5RYmUUa5lR3Lo.jpg", "thumbnail_height": 70, "thumbnail_width": 70, "title": "CAR T-cell therapy effective for chronic lymphocytic leukemia", "url": "https://www.healio.com/hematology-oncology/leukemia/news/in-the-journals/%7Bef4c6189-129e-4b9c-a2b2-17449b8d56f9%7D/car-t-cell-therapy-effective-for-chronic-lymphocytic-leukemia", "view_count": null, "whitelist_status": null}, {"approved_at_utc": null, "author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1502864234, "domain": "lymphomanewstoday.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6u06si/some_cll_patients_see_tumors_reduced_by/", "id": "6u06si", "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "over_18": false, "parent_whitelist_status": null, "permalink": "/r/CLL_Leukemia/comments/6u06si/some_cll_patients_see_tumors_reduced_by/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "HLqjZ0axpE_AlbLc5oi6a95k1mJZ0MqNfPHTkmqdWo8", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/rnf8wnfrikeFqKCoyEmkD0Nyw5eeFdIDVpmqEMRI55E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=39ba9afcc09ba7e888c7c854024ec8a9", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/rnf8wnfrikeFqKCoyEmkD0Nyw5eeFdIDVpmqEMRI55E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=4c85fee0a8bb4321675813a95a84dfb5", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/rnf8wnfrikeFqKCoyEmkD0Nyw5eeFdIDVpmqEMRI55E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=871c6ec53bca6e8e388fef08c7480bd3", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/rnf8wnfrikeFqKCoyEmkD0Nyw5eeFdIDVpmqEMRI55E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=b311072890ed2948ca17843b5d505c1b", "width": 640}, {"height": 640, "url": "https://i.redditmedia.com/rnf8wnfrikeFqKCoyEmkD0Nyw5eeFdIDVpmqEMRI55E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=767bdab6a453dffa4a73655d3013b75f", "width": 960}], "source": {"height": 667, "url": "https://i.redditmedia.com/rnf8wnfrikeFqKCoyEmkD0Nyw5eeFdIDVpmqEMRI55E.jpg?s=b5e4d16caed80aeb5c2ffdc4f98a98ed", "width": 1000}, "variants": {}}]}, "retrieved_on": 1502944694, "score": 2, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/n1v7IpYSIHdkuAF79Bvfam1kzRsMrp689xLU-ljdLEM.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "Some CLL Patients See Tumors Reduced By Investigational CAR T-Cell Therapy, Studies Find", "url": "https://lymphomanewstoday.com/2017/08/14/resistant-chronic-lymphocytic-leukemia-investigational-car-t-cell-therapy-seen-as-effective-in-studies/", "view_count": null, "whitelist_status": null}, {"approved_at_utc": null, "author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1502042292, "domain": "lymphomanewstoday.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6rztjl/chronic_graftversushostdisease_therapy_imbruvica/", "id": "6rztjl", "is_self": false, "is_video": false, "locked": false, "num_comments": 1, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6rztjl/chronic_graftversushostdisease_therapy_imbruvica/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "W3j-zUF8Svv2Lq2dymSZnTF2t59HmpL5zPWtphEYgZ4", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/PGAYRiXgPPxrAcs7BkNletEgXcn2WO-fx2WiNJ-TKXA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=ed9dbfb97339d651fa0a89ec534468bf", "width": 108}, {"height": 143, "url": "https://i.redditmedia.com/PGAYRiXgPPxrAcs7BkNletEgXcn2WO-fx2WiNJ-TKXA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=73718b1e0570c082294b2aa821a4044a", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/PGAYRiXgPPxrAcs7BkNletEgXcn2WO-fx2WiNJ-TKXA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=e292102fe5135775785ae6e026f571c8", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/PGAYRiXgPPxrAcs7BkNletEgXcn2WO-fx2WiNJ-TKXA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=4dcfa5f5bff006689fb5b25b82c95531", "width": 640}, {"height": 639, "url": "https://i.redditmedia.com/PGAYRiXgPPxrAcs7BkNletEgXcn2WO-fx2WiNJ-TKXA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=678d234a51689043eab3aee27171d2a7", "width": 960}], "source": {"height": 666, "url": "https://i.redditmedia.com/PGAYRiXgPPxrAcs7BkNletEgXcn2WO-fx2WiNJ-TKXA.jpg?s=68c9b552cdfbc3a7a7de1dbe2cc45499", "width": 1000}, "variants": {}}]}, "retrieved_on": 1502315103, "score": 1, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/hnXfzM5hc1ueph4Y6S3kOUtORcczQbFG-ewywA4j-0E.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "Chronic Graft-Versus-Host-Disease Therapy Imbruvica Gets FDA Approval", "url": "https://lymphomanewstoday.com/2017/08/04/chronic-graft-versus-host-disease-cgvhd-therapy-imbruvica-ibrutinib-gets-fda-approval-for-adults/", "view_count": null}, {"approved_at_utc": null, "author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1501800292, "domain": "targetedonc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6rg6sb/ibrutinib_approved_by_fda_for_gvhd/", "id": "6rg6sb", "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6rg6sb/ibrutinib_approved_by_fda_for_gvhd/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "3NW1V7Lb9ad-2wLPuwzWSR-4Vvh2xv6EXtK7bqXRboc", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/cPvNKbOvz3PSOSIOt5MixkPksJ1vX_70s9v_JFlPWBU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=9a1f6e814e4d6cad8407f1439694b1c2", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/cPvNKbOvz3PSOSIOt5MixkPksJ1vX_70s9v_JFlPWBU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=30bc5fa52d9bac7be0447f5bf0c77fde", "width": 216}, {"height": 320, "url": "https://i.redditmedia.com/cPvNKbOvz3PSOSIOt5MixkPksJ1vX_70s9v_JFlPWBU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=3b7f38c382461c8fbf65710aa692e48d", "width": 320}], "source": {"height": 400, "url": "https://i.redditmedia.com/cPvNKbOvz3PSOSIOt5MixkPksJ1vX_70s9v_JFlPWBU.jpg?s=e8a540ea6248c246ace125964fc7f637", "width": 400}, "variants": {}}]}, "retrieved_on": 1502305261, "score": 2, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/s5Brm3qP3RVHPqAmeqCrOHyG0DauECs61TEDD5lJ-HU.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Ibrutinib Approved by FDA for GVHD", "url": "http://www.targetedonc.com/news/ibrutinib-approved-by-fda-for-gvhd", "view_count": null}, {"approved_at_utc": null, "author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1501631215, "domain": "genengnews.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6r0awl/immunotherapy_approaches_against_chronic_form_of/", "id": "6r0awl", "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6r0awl/immunotherapy_approaches_against_chronic_form_of/", "retrieved_on": 1502297087, "score": 1, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "thumbnail_height": null, "thumbnail_width": null, "title": "Immunotherapy Approaches against Chronic Form of Leukemia Emerge", "url": "http://www.genengnews.com/gen-news-highlights/immunotherapy-approaches-against-chronic-form-of-leukemia-emerge/81254741", "view_count": null}, {"approved_at_utc": null, "author": "HighYield", "author_flair_css_class": null, "author_flair_text": null, "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1501631168, "domain": "lymphomahub.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6r0aqg/car_tcell_therapy_shown_to_result_in_durable/", "id": "6r0aqg", "is_self": false, "is_video": false, "locked": false, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6r0aqg/car_tcell_therapy_shown_to_result_in_durable/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "9XKpQo7-IXYpCFYG7Yzt1VYhtbp0orVSUz5vHmiPOck", "resolutions": [{"height": 56, "url": "https://i.redditmedia.com/HV0LGOQxdhKw4KvQi2H59tumlfHZuDjHTVfA4Gx00Ts.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=746435ec6df57b64909ac3bd3fd6fec8", "width": 108}, {"height": 113, "url": "https://i.redditmedia.com/HV0LGOQxdhKw4KvQi2H59tumlfHZuDjHTVfA4Gx00Ts.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=dbfbeb46f4a9acc3e42704814293ccbc", "width": 216}, {"height": 168, "url": "https://i.redditmedia.com/HV0LGOQxdhKw4KvQi2H59tumlfHZuDjHTVfA4Gx00Ts.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=1de0d5e15fd68a6b5713b762d3b7c921", "width": 320}, {"height": 336, "url": "https://i.redditmedia.com/HV0LGOQxdhKw4KvQi2H59tumlfHZuDjHTVfA4Gx00Ts.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=df1ac875eb0a4f019228a16e6182066f", "width": 640}], "source": {"height": 371, "url": "https://i.redditmedia.com/HV0LGOQxdhKw4KvQi2H59tumlfHZuDjHTVfA4Gx00Ts.jpg?s=6923a472b687f25815febe8be85f7b20", "width": 706}, "variants": {}}]}, "retrieved_on": 1502297084, "score": 1, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/t3sKbqmjtXBZN-VrNyxKuFxAhv4IcFRb1NZGWgahTgs.jpg", "thumbnail_height": 73, "thumbnail_width": 140, "title": "CAR T-cell therapy shown to result in durable molecular remissions in CLL post-ibrutinib", "url": "http://www.lymphomahub.com/medical-information/cll-post-ibrutinib-car-t-cell-therapy-shown-to-result-in-durable-molecular-remissions", "view_count": null}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1501005988, "domain": "lymphomahub.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6phz37/pembrolizumab_is_beneficial_for_cll_patients_with/", "gilded": 0, "id": "6phz37", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6phz37/pembrolizumab_is_beneficial_for_cll_patients_with/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "R4VLeMIhKkmhwmmgIs4OD4RcBMQhPQTlyVIkHwAezSg", "resolutions": [{"height": 94, "url": "https://i.redditmedia.com/-hPMWRHQb4p6gRW-FCik2DQ09v_sBrrHTIsBBDM7jQ8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=2637619b9042623b1513677a8d14ee7a", "width": 108}, {"height": 189, "url": "https://i.redditmedia.com/-hPMWRHQb4p6gRW-FCik2DQ09v_sBrrHTIsBBDM7jQ8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=60265558d7eb7f909559dd5792f65ee4", "width": 216}, {"height": 280, "url": "https://i.redditmedia.com/-hPMWRHQb4p6gRW-FCik2DQ09v_sBrrHTIsBBDM7jQ8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=806349b7fa17edbb9d3d6378872ef3d9", "width": 320}], "source": {"height": 439, "url": "https://i.redditmedia.com/-hPMWRHQb4p6gRW-FCik2DQ09v_sBrrHTIsBBDM7jQ8.jpg?s=942160a5bb30cd37608e374154b8e783", "width": 500}, "variants": {}}]}, "retrieved_on": 1502143660, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/6a1jeAKB7nK_LX-oiCOpAiXXH4Qm4h9G3O1TtIfXLnM.jpg", "thumbnail_height": 122, "thumbnail_width": 140, "title": "Pembrolizumab is beneficial for CLL patients with Richter transformation", "url": "http://www.lymphomahub.com/medical-information/pembrolizumab-is-beneficial-for-cll-patients-with-richter-transformation"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1501005966, "domain": "genomeweb.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6phyzs/more_cart_therapies_sought/", "gilded": 0, "id": "6phyzs", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6phyzs/more_cart_therapies_sought/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "lXuqEf6s-gRqw0_ZbemGahgX8U8O-u59x-ELE3y5GUo", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/UWvy3ITUEBpY_qXBfc793Xeu53fTNWnq2rQelkHGbZY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=d7344a063e1ee4eda2574541423b8574", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/UWvy3ITUEBpY_qXBfc793Xeu53fTNWnq2rQelkHGbZY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=bbdec75c05cf5eac24c2cbb277774e57", "width": 216}, {"height": 320, "url": "https://i.redditmedia.com/UWvy3ITUEBpY_qXBfc793Xeu53fTNWnq2rQelkHGbZY.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=db2313b79738bd9d87baa897e908f7d3", "width": 320}], "source": {"height": 540, "url": "https://i.redditmedia.com/UWvy3ITUEBpY_qXBfc793Xeu53fTNWnq2rQelkHGbZY.jpg?s=478f11ae12117bec74325bf7f82f1de2", "width": 540}, "variants": {}}]}, "retrieved_on": 1502143659, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/ORP9YWI_oTYJFFFYGD827HE5z-elww_I7LzI9ixnTbg.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "More CAR-T Therapies Sought", "url": "https://www.genomeweb.com/scan/more-car-t-therapies-sought"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1501005944, "domain": "newswise.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6phyw8/cirm_approves_58_million_grant_for_cart_therapy/", "gilded": 0, "id": "6phyw8", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6phyw8/cirm_approves_58_million_grant_for_cart_therapy/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "FaTecqGAZFlUVb8HP1Tr2JSTdLd3ty8lcpjrc0fh6aE", "resolutions": [], "source": {"height": 100, "url": "https://i.redditmedia.com/Qlcx61YjuVmnZ90KJR2q9iXYj8V93BdhY-DYJyjHeqc.jpg?s=fe13bfd7994f316a7858631153c17886", "width": 100}, "variants": {}}]}, "retrieved_on": 1502143658, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/lLUNx8hVkBtVH1-IVdzzCk_HAqlqqrAS1vr-rgpcdVw.jpg", "thumbnail_height": 70, "thumbnail_width": 70, "title": "CIRM Approves $5.8 Million Grant for CAR-T Therapy That Targets Cancer Stem Cells", "url": "https://www.newswise.com/articles/cirm-approves-5-8-million-grant-for-car-t-therapy-that-targets-cancer-stem-cells"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1501005928, "domain": "dukechronicle.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6phytx/duke_researchers_advance_potential_treatment_for/", "gilded": 0, "id": "6phytx", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 1, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6phytx/duke_researchers_advance_potential_treatment_for/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "mpGhFziBVXnpg4BQBZSElUSe4KnNaVVbMsgrbW4ZUds", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/YjGyyYsHOqEj-cKWHH2Q-TtLOLa7os_KemDSN23C6BA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=44075ab9965dd1e9d274fc9edb598576", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/YjGyyYsHOqEj-cKWHH2Q-TtLOLa7os_KemDSN23C6BA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=c55b649ab37d4961f31105cdf83f7549", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/YjGyyYsHOqEj-cKWHH2Q-TtLOLa7os_KemDSN23C6BA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=e6c0e9c084655950345b196f5279f24e", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/YjGyyYsHOqEj-cKWHH2Q-TtLOLa7os_KemDSN23C6BA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=b1e3588f2ae7ba3c03e174a77a27850a", "width": 640}, {"height": 640, "url": "https://i.redditmedia.com/YjGyyYsHOqEj-cKWHH2Q-TtLOLa7os_KemDSN23C6BA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=7b384cf3d31bb5f254af453736032106", "width": 960}], "source": {"height": 667, "url": "https://i.redditmedia.com/YjGyyYsHOqEj-cKWHH2Q-TtLOLa7os_KemDSN23C6BA.jpg?s=6d0c1fa193ed77f496480e0d80715264", "width": 1000}, "variants": {}}]}, "retrieved_on": 1502143657, "score": 3, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/fH_pA8sP-gvjQX1YjwOz_fMheuDujJm484pac-jFYtE.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "Duke researchers advance potential treatment for leukemia", "url": "http://www.dukechronicle.com/article/2017/07/duke-researchers-advance-potential-new-treatment-for-leukemia"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1501005907, "domain": "clinicaloncology.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6phyqi/anticd20_therapy_boosts_efficacy_of_ibrutinib_in/", "gilded": 0, "id": "6phyqi", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6phyqi/anticd20_therapy_boosts_efficacy_of_ibrutinib_in/", "retrieved_on": 1502143656, "score": 3, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Anti-CD20 Therapy Boosts Efficacy of Ibrutinib in CLL", "url": "http://www.clinicaloncology.com/Hematologic-Malignancies/Article/07-17/Anti-CD20-Therapy-Boosts-Efficacy-of-Ibrutinib-in-CLL/41786"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1501005883, "domain": "dovepress.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6phymy/ofatumumab_a_valid_treatment_option_for_chronic/", "gilded": 0, "id": "6phymy", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6phymy/ofatumumab_a_valid_treatment_option_for_chronic/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "hq73X5EeZXU-WtHb7zuSeNvlCcrW5zRA5BI-eJ2M_ws", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/d7w_BjQwsuvNHR0snNCJImgYByetlzhJgVPXWu7BXYQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=a7b34cc0f7a982de0513dcbc60da7612", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/d7w_BjQwsuvNHR0snNCJImgYByetlzhJgVPXWu7BXYQ.jpg?s=54fdd9e7fef2fda23afcc8d655a4a5e0", "width": 200}, "variants": {}}]}, "retrieved_on": 1502143654, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/f08loT6eH-juZiYyDhTN57SnpNYyZQ8hP7ZKJGOQNp4.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Ofatumumab - a valid treatment option for chronic lymphocytic leukemia", "url": "https://www.dovepress.com/ofatumumab-a-valid-treatment-option-for-chronic-lymphocytic-leukemia-p-peer-reviewed-fulltext-article-TCRM"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1501005853, "domain": "genengnews.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6phyhn/incyte_doses_first_patient_in_phase_iii_study_of/", "gilded": 0, "id": "6phyhn", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6phyhn/incyte_doses_first_patient_in_phase_iii_study_of/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "3n5jBNHZv74a4TsqGQIXgQj7q_5sHSLeufh-X4u9vjA", "resolutions": [{"height": 58, "url": "https://i.redditmedia.com/0OamrNEmU3zc-RtW4OmlOiKLUQp6lr3XwP7TMlyTDDI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=3cdfd505f0e889b6c5e826d7a1aa3c69", "width": 108}, {"height": 116, "url": "https://i.redditmedia.com/0OamrNEmU3zc-RtW4OmlOiKLUQp6lr3XwP7TMlyTDDI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=81dfbcf66e6673e16f13d2e3f7254fa4", "width": 216}, {"height": 173, "url": "https://i.redditmedia.com/0OamrNEmU3zc-RtW4OmlOiKLUQp6lr3XwP7TMlyTDDI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=3641c066fe69c75f138e234325968be0", "width": 320}, {"height": 346, "url": "https://i.redditmedia.com/0OamrNEmU3zc-RtW4OmlOiKLUQp6lr3XwP7TMlyTDDI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=6ed5c430f0070ea889b172102abc46e4", "width": 640}, {"height": 520, "url": "https://i.redditmedia.com/0OamrNEmU3zc-RtW4OmlOiKLUQp6lr3XwP7TMlyTDDI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=1364f6ab1b53bb00c39fcd5bb45989cb", "width": 960}, {"height": 585, "url": "https://i.redditmedia.com/0OamrNEmU3zc-RtW4OmlOiKLUQp6lr3XwP7TMlyTDDI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=000d6d323fa8ffa6f1b1f400cb2ff4c1", "width": 1080}], "source": {"height": 650, "url": "https://i.redditmedia.com/0OamrNEmU3zc-RtW4OmlOiKLUQp6lr3XwP7TMlyTDDI.jpg?s=66686d3f77bcc1f656ad0582df774fe7", "width": 1200}, "variants": {}}]}, "retrieved_on": 1502143653, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/TM6ZUH_S0GZJJ6u8Ixnd1b5H8qHlQNg8JpVfCP6RnJU.jpg", "thumbnail_height": 75, "thumbnail_width": 140, "title": "Incyte Doses First Patient in Phase III Study of GVHD Candidate Itacitinib", "url": "http://www.genengnews.com/gen-news-highlights/incyte-doses-first-patient-in-phase-iii-study-of-gvhd-candidate-itacitinib/81254687"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1501005827, "domain": "iflscience.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6phye3/promising_treatment_for_leukemia_leads_to/", "gilded": 0, "id": "6phye3", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6phye3/promising_treatment_for_leukemia_leads_to/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "5iPqu0v0slRg8v9AgTgxKbRaHffk3FB51ir03VbrbF4", "resolutions": [{"height": 60, "url": "https://i.redditmedia.com/IJlrhAIheKvyRFpKZSYkH9c0ZBEFkjl5K3pqPpLlblQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=cf5b0110ea0f297b2deddbeebe161cf4", "width": 108}, {"height": 121, "url": "https://i.redditmedia.com/IJlrhAIheKvyRFpKZSYkH9c0ZBEFkjl5K3pqPpLlblQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=76e0758519954d694f37f216ce77a01b", "width": 216}, {"height": 180, "url": "https://i.redditmedia.com/IJlrhAIheKvyRFpKZSYkH9c0ZBEFkjl5K3pqPpLlblQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=3d372d996f093840b8e3b87ac6bd35d4", "width": 320}, {"height": 360, "url": "https://i.redditmedia.com/IJlrhAIheKvyRFpKZSYkH9c0ZBEFkjl5K3pqPpLlblQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=0a714272f899c80a83daccafaf69ed1c", "width": 640}], "source": {"height": 405, "url": "https://i.redditmedia.com/IJlrhAIheKvyRFpKZSYkH9c0ZBEFkjl5K3pqPpLlblQ.jpg?s=5b56078ed7436cbdc905058ab28fbd4e", "width": 720}, "variants": {}}]}, "retrieved_on": 1502143651, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/o6IZWbdH3ifeS7XzrZbVebDnVervb4uLU2ElidmyjXA.jpg", "thumbnail_height": 78, "thumbnail_width": 140, "title": "Promising Treatment For Leukemia Leads To Remission In Clinical Trials", "url": "http://www.iflscience.com/health-and-medicine/promising-treatment-for-leukemia-leads-to-remission-in-clinical-trials/all/"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1500493210, "domain": "eurekalert.org", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6oaxrf/car_tcell_therapy_for_leukemia_leads_to/", "gilded": 0, "id": "6oaxrf", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6oaxrf/car_tcell_therapy_for_leukemia_leads_to/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "7cCr7Brsu0sbVlGwp1wIfS3QRUmw3ZQDvYKz1N1hefU", "resolutions": [{"height": 36, "url": "https://i.redditmedia.com/WtnxpqbBLW67vuu2mj_4bj9HFBW9m9DlFauFpIIxbhM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=28af4ea1144fa650421f4a8840ae671f", "width": 108}, {"height": 72, "url": "https://i.redditmedia.com/WtnxpqbBLW67vuu2mj_4bj9HFBW9m9DlFauFpIIxbhM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=6ea79e44a6403d16908074040b59ad9d", "width": 216}, {"height": 106, "url": "https://i.redditmedia.com/WtnxpqbBLW67vuu2mj_4bj9HFBW9m9DlFauFpIIxbhM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=aae849b84282e374f72d77ae9d9d8550", "width": 320}, {"height": 213, "url": "https://i.redditmedia.com/WtnxpqbBLW67vuu2mj_4bj9HFBW9m9DlFauFpIIxbhM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=62245c915a116b40d8ed9dad8fa70f44", "width": 640}], "source": {"height": 300, "url": "https://i.redditmedia.com/WtnxpqbBLW67vuu2mj_4bj9HFBW9m9DlFauFpIIxbhM.jpg?s=e6c50f37ff07f248953093b21930f4cb", "width": 900}, "variants": {}}]}, "retrieved_on": 1502121851, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/0IkkecrwzWg8lYjnr499Bl2opWLVpQ7wQ5c6b51L_SA.jpg", "thumbnail_height": 46, "thumbnail_width": 140, "title": "CAR T-cell therapy for leukemia leads to remissions in clinical trial", "url": "https://eurekalert.org/pub_releases/2017-07/fhcr-ctt071417.php"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1500493178, "domain": "medicalxpress.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6oaxmo/car_tcell_therapy_for_leukemia_leads_to/", "gilded": 0, "id": "6oaxmo", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6oaxmo/car_tcell_therapy_for_leukemia_leads_to/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "ekHIoJ8yMZMP60reb8ySZ6625xBgfMeATOuZYQhNpik", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/xGPTPDfB_HrOKBb0S8o18wO7haWQQ5Pe9k00HXQ1i5A.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=1d0cea6771231d16e3cf9b076403a13c", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/xGPTPDfB_HrOKBb0S8o18wO7haWQQ5Pe9k00HXQ1i5A.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=1a7f40295ba27022c1f702d8d8bd999e", "width": 216}], "source": {"height": 308, "url": "https://i.redditmedia.com/xGPTPDfB_HrOKBb0S8o18wO7haWQQ5Pe9k00HXQ1i5A.jpg?s=34180c8def811e2cdfd3cc082545e9de", "width": 308}, "variants": {}}]}, "retrieved_on": 1502121848, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/0PY4kqZniyjqllHFJCtyteh-ocAl1DYGLCe339gu62c.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "CAR T-cell therapy for leukemia leads to remissions in clinical trial", "url": "https://medicalxpress.com/news/2017-07-car-t-cell-therapy-leukemia-remissions.html"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1500395992, "domain": "telegraph.co.uk", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6o1ycq/new_hope_for_leukaemia_patients_as_therapy_shown/", "gilded": 0, "id": "6o1ycq", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6o1ycq/new_hope_for_leukaemia_patients_as_therapy_shown/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "Jom4UKCV_Fom9220TP4pk6h1YSl9APccGPHzJTq5-rk", "resolutions": [{"height": 67, "url": "https://i.redditmedia.com/FB5yVbzUXQZj3Yv5UOXGi1PLkGPf6t2CcJACG0HPdoE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=58221ed00cdcd0356cc8e252d87863e3", "width": 108}, {"height": 134, "url": "https://i.redditmedia.com/FB5yVbzUXQZj3Yv5UOXGi1PLkGPf6t2CcJACG0HPdoE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=a1f012b5cbf17be8dfdeea882124c5ea", "width": 216}, {"height": 199, "url": "https://i.redditmedia.com/FB5yVbzUXQZj3Yv5UOXGi1PLkGPf6t2CcJACG0HPdoE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=b12e461f280fdc6272c55b9f9f4082a2", "width": 320}, {"height": 399, "url": "https://i.redditmedia.com/FB5yVbzUXQZj3Yv5UOXGi1PLkGPf6t2CcJACG0HPdoE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=0812a9826bbf9cda461b20cd4357f756", "width": 640}], "source": {"height": 536, "url": "https://i.redditmedia.com/FB5yVbzUXQZj3Yv5UOXGi1PLkGPf6t2CcJACG0HPdoE.jpg?s=7692beeb7724f109967bea936bef3648", "width": 858}, "variants": {}}]}, "retrieved_on": 1502117294, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/hFs5GwpW3vvU5-LHIW53OnnQj_mHXGTGzeZrRUhblBw.jpg", "thumbnail_height": 87, "thumbnail_width": 140, "title": "New hope for leukaemia patients as therapy shown to shrink tumours or make them disappear", "url": "http://www.telegraph.co.uk/news/2017/07/17/new-hope-forleukaemia-patients-therapy-shown-toshrink-tumours/"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1500223651, "domain": "hitechbeacon.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6nn637/fda_close_to_approving_revolutionary_cancer/", "gilded": 0, "id": "6nn637", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6nn637/fda_close_to_approving_revolutionary_cancer/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "-dMiHiOCanRwSGx6ivLiyjqpBNCkR9gE32XlufHW64o", "resolutions": [{"height": 60, "url": "https://i.redditmedia.com/ebXRoCgUJgGSWBIJldNVxCQ-baIAyhPH8tld6eISTpU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=f32651d7e2d4f43c935b7cb32d636ea1", "width": 108}, {"height": 121, "url": "https://i.redditmedia.com/ebXRoCgUJgGSWBIJldNVxCQ-baIAyhPH8tld6eISTpU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=f352135ccd03c1b3e91701588734afb9", "width": 216}, {"height": 180, "url": "https://i.redditmedia.com/ebXRoCgUJgGSWBIJldNVxCQ-baIAyhPH8tld6eISTpU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=97b7a2e4b9ebd8d52d787736b4d73770", "width": 320}, {"height": 360, "url": "https://i.redditmedia.com/ebXRoCgUJgGSWBIJldNVxCQ-baIAyhPH8tld6eISTpU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=5ce37a1f5e537a7b0167f8b23046f30c", "width": 640}, {"height": 540, "url": "https://i.redditmedia.com/ebXRoCgUJgGSWBIJldNVxCQ-baIAyhPH8tld6eISTpU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=8d4c8721c0eb533d1e2c4801e8f7a9f1", "width": 960}, {"height": 607, "url": "https://i.redditmedia.com/ebXRoCgUJgGSWBIJldNVxCQ-baIAyhPH8tld6eISTpU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=09a863e9274e384600b02b8496d82366", "width": 1080}], "source": {"height": 2916, "url": "https://i.redditmedia.com/ebXRoCgUJgGSWBIJldNVxCQ-baIAyhPH8tld6eISTpU.jpg?s=8b550d726cc66aeecfddef154a99d02e", "width": 5184}, "variants": {}}]}, "retrieved_on": 1502109846, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/mOX6NPRwKk51nE9ooehbLtvWjQ4vyzpAIHZRcmJMvpY.jpg", "thumbnail_height": 78, "thumbnail_width": 140, "title": "FDA close to approving revolutionary cancer treatment", "url": "http://hitechbeacon.com/2017/07/14/fda-close-to-approving-revolutionary-cancer-treatment.html"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1500223629, "domain": "sportnewscity.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6nn60j/gene_therapy_for_cancer_nears_fda_approval/", "gilded": 0, "id": "6nn60j", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6nn60j/gene_therapy_for_cancer_nears_fda_approval/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "0jiRUZg1_lDcXf-uk-Kx3GugL_gSuR-JJSDwQUGZ-xM", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/mTPoFy4uAu3qKfrvNemElCWZlylcsP1SLOnX8qnACuU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=fc7bb88d7cd7c5297d6a3de201e5e9c9", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/mTPoFy4uAu3qKfrvNemElCWZlylcsP1SLOnX8qnACuU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=44df6d01aca6876fa105cca7b470c70d", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/mTPoFy4uAu3qKfrvNemElCWZlylcsP1SLOnX8qnACuU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=1124ca7f1bbb33abde8d5d2a75c30a7a", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/mTPoFy4uAu3qKfrvNemElCWZlylcsP1SLOnX8qnACuU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=ea00a8715f0f3f6c7963fc157852bcc7", "width": 640}, {"height": 640, "url": "https://i.redditmedia.com/mTPoFy4uAu3qKfrvNemElCWZlylcsP1SLOnX8qnACuU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=2e5c37d594f031205353540c1aea02f8", "width": 960}], "source": {"height": 640, "url": "https://i.redditmedia.com/mTPoFy4uAu3qKfrvNemElCWZlylcsP1SLOnX8qnACuU.jpg?s=54ac218e3656d5d61df2d616f618d695", "width": 960}, "variants": {}}]}, "retrieved_on": 1502109845, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/DmPFD2d5bW7Jn-3gay2B2R1ZZVZ8He7RLp1naTXaE2A.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "Gene therapy for cancer nears FDA approval", "url": "http://sportnewscity.com/2017/07/14/gene-therapy-for-cancer-nears-fda-approval.html"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1499996818, "domain": "fiercebiotech.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6n64il/cord_blood_inspires_an_alternative_to_cart_for/", "gilded": 0, "id": "6n64il", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6n64il/cord_blood_inspires_an_alternative_to_cart_for/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "i_l6p9TTaLgAkxJYSG3EauLi3XnYtA_tO1VVmM6e6gs", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/_ySldmDQqplQl1PjiEUVnzMr9KrYcT3sluofYXX8Lxk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=a93f589a682add47ca2d093269327673", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/_ySldmDQqplQl1PjiEUVnzMr9KrYcT3sluofYXX8Lxk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=ae1af2fbc1f3ed7566257d4ffc9d10d4", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/_ySldmDQqplQl1PjiEUVnzMr9KrYcT3sluofYXX8Lxk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=78c22a27553708a9bb0aab74df035119", "width": 320}, {"height": 427, "url": "https://i.redditmedia.com/_ySldmDQqplQl1PjiEUVnzMr9KrYcT3sluofYXX8Lxk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=4b77e5ab7e2a932360391ff293ab6c4e", "width": 640}, {"height": 640, "url": "https://i.redditmedia.com/_ySldmDQqplQl1PjiEUVnzMr9KrYcT3sluofYXX8Lxk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=a096c050b5f8557108081cf63dd0d5f3", "width": 960}, {"height": 720, "url": "https://i.redditmedia.com/_ySldmDQqplQl1PjiEUVnzMr9KrYcT3sluofYXX8Lxk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=1acfd11fcd4724d8e592274f25067c2c", "width": 1080}], "source": {"height": 1335, "url": "https://i.redditmedia.com/_ySldmDQqplQl1PjiEUVnzMr9KrYcT3sluofYXX8Lxk.jpg?s=94f507d734d3c031c2eeba3a13db1d4c", "width": 2000}, "variants": {}}]}, "retrieved_on": 1502101229, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/jqxSHNfC97CC5uW08U54AoalbnO4yPldJ7iVQEt_6T8.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "Cord blood inspires an alternative to CAR-T for treating blood cancers", "url": "http://www.fiercebiotech.com/research/cord-blood-inspires-alternative-to-car-t-for-treating-blood-cancers"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1499996794, "domain": "medicalxpress.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6n64gi/genetically_enhanced_cordblood_derived_immune/", "gilded": 0, "id": "6n64gi", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6n64gi/genetically_enhanced_cordblood_derived_immune/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "ekHIoJ8yMZMP60reb8ySZ6625xBgfMeATOuZYQhNpik", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/xGPTPDfB_HrOKBb0S8o18wO7haWQQ5Pe9k00HXQ1i5A.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=1d0cea6771231d16e3cf9b076403a13c", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/xGPTPDfB_HrOKBb0S8o18wO7haWQQ5Pe9k00HXQ1i5A.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=1a7f40295ba27022c1f702d8d8bd999e", "width": 216}], "source": {"height": 308, "url": "https://i.redditmedia.com/xGPTPDfB_HrOKBb0S8o18wO7haWQQ5Pe9k00HXQ1i5A.jpg?s=34180c8def811e2cdfd3cc082545e9de", "width": 308}, "variants": {}}]}, "retrieved_on": 1502101228, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/2IHPtcGeuM10EJ1qgNvaC51Jmeod3CBmG4xKRic63KU.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Genetically enhanced, cord-blood derived immune cells strike B-cell cancers", "url": "https://medicalxpress.com/news/2017-07-genetically-cord-blood-derived-immune-cells.html"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1499918451, "domain": "raps.org", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6mz89t/fda_panel_votes_unanimously_in_favor_of_first/", "gilded": 0, "id": "6mz89t", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6mz89t/fda_panel_votes_unanimously_in_favor_of_first/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "5_EchK5evbYeI3yfb7DY6SnNWfDUNI62Hp2MgGYjbxQ", "resolutions": [{"height": 80, "url": "https://i.redditmedia.com/2T5Jc_WBubyqjvs2mqONQTKcNGoPQqO57HW_kn70ZPU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=9bccf98bc70580deded574633c39f14f", "width": 108}, {"height": 160, "url": "https://i.redditmedia.com/2T5Jc_WBubyqjvs2mqONQTKcNGoPQqO57HW_kn70ZPU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=bff8516fbb257e4b397aea08e443441f", "width": 216}, {"height": 237, "url": "https://i.redditmedia.com/2T5Jc_WBubyqjvs2mqONQTKcNGoPQqO57HW_kn70ZPU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=c684f303f2f66451f76ac5ddb5606e1d", "width": 320}, {"height": 475, "url": "https://i.redditmedia.com/2T5Jc_WBubyqjvs2mqONQTKcNGoPQqO57HW_kn70ZPU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=b38a145d8c0caac6b59c436c0a696fbc", "width": 640}], "source": {"height": 705, "url": "https://i.redditmedia.com/2T5Jc_WBubyqjvs2mqONQTKcNGoPQqO57HW_kn70ZPU.jpg?s=49a96aaf520d8cf33089060029747a14", "width": 948}, "variants": {}}]}, "retrieved_on": 1502097795, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/KJnzAlsCPzy7mdHUVQTMhDfMQi2B4ErzeqSMLDTQTkw.jpg", "thumbnail_height": 104, "thumbnail_width": 140, "title": "FDA Panel Votes Unanimously in Favor of First CAR-T Cancer Therapy", "url": "http://www.raps.org/Regulatory-Focus/News/2017/07/12/28073/FDA-Panel-Votes-Unanimously-in-Favor-of-First-CAR-T-Cancer-Therapy/"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1499819925, "domain": "lymphomanewstoday.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6mqho0/fda_will_review_biologics_license_application_for/", "gilded": 0, "id": "6mqho0", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6mqho0/fda_will_review_biologics_license_application_for/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "WnMDhA3fxJ7npXQrRYWGmw0ndibZEpZ0XI7C2fzx19g", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/I7q1QWeou7AhPq5e2b4ZNs2qMOKQyf48Sxd6I-R4jGA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=ef6a6a5bc8df4a7f08f5f03905062031", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/I7q1QWeou7AhPq5e2b4ZNs2qMOKQyf48Sxd6I-R4jGA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=7f6b9b9c817c7fa29d48bdc0764d0f44", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/I7q1QWeou7AhPq5e2b4ZNs2qMOKQyf48Sxd6I-R4jGA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=046d6084718b72bd917e66e2cee648f0", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/I7q1QWeou7AhPq5e2b4ZNs2qMOKQyf48Sxd6I-R4jGA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=bff8654fabbdd22d8b2e4257566833e7", "width": 640}, {"height": 640, "url": "https://i.redditmedia.com/I7q1QWeou7AhPq5e2b4ZNs2qMOKQyf48Sxd6I-R4jGA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=22451df8674391bb416ebc98484dc8e3", "width": 960}], "source": {"height": 667, "url": "https://i.redditmedia.com/I7q1QWeou7AhPq5e2b4ZNs2qMOKQyf48Sxd6I-R4jGA.jpg?s=15a6fb393c887fef458b0c6a828ce60b", "width": 1000}, "variants": {}}]}, "retrieved_on": 1502093453, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/TRghfEQD3S_rrtZ1NNcma62mDvwjxP4nWfLCaSvcMto.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "FDA Will Review Biologics License Application for Biosimilar Truxima", "url": "https://lymphomanewstoday.com/2017/07/11/fda-review-biologics-license-application-truxima-biosimilar-rituxan/"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1499819812, "domain": "washingtonpost.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6mqhbi/first_gene_therapy_a_true_living_drug_on_the_cusp/", "gilded": 0, "id": "6mqhbi", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6mqhbi/first_gene_therapy_a_true_living_drug_on_the_cusp/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "ocMr6BCrxfKAmFn1Klp4uiCmt-99vWvaJ00gPA49QVY", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/dv7J5jM-fL1IkSxAAQCpLsyi3DLx_8WPxE5hA5UWXlw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=a50d6be2c3c96190b7cd7227fc890cfb", "width": 108}, {"height": 142, "url": "https://i.redditmedia.com/dv7J5jM-fL1IkSxAAQCpLsyi3DLx_8WPxE5hA5UWXlw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=7a607ebc2e15206811352eba29ffd8ca", "width": 216}, {"height": 211, "url": "https://i.redditmedia.com/dv7J5jM-fL1IkSxAAQCpLsyi3DLx_8WPxE5hA5UWXlw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=797a43c338222a2c63fae536a11134d5", "width": 320}, {"height": 423, "url": "https://i.redditmedia.com/dv7J5jM-fL1IkSxAAQCpLsyi3DLx_8WPxE5hA5UWXlw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=1c27653344004c6d41825944caa276f2", "width": 640}, {"height": 635, "url": "https://i.redditmedia.com/dv7J5jM-fL1IkSxAAQCpLsyi3DLx_8WPxE5hA5UWXlw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=049fc01e6f9d3cba32b1b7d048a95857", "width": 960}, {"height": 714, "url": "https://i.redditmedia.com/dv7J5jM-fL1IkSxAAQCpLsyi3DLx_8WPxE5hA5UWXlw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=99159423920db2a46d83b121fe45bdce", "width": 1080}], "source": {"height": 982, "url": "https://i.redditmedia.com/dv7J5jM-fL1IkSxAAQCpLsyi3DLx_8WPxE5hA5UWXlw.jpg?s=73626b55a8d2010e38e268927a90d16e", "width": 1484}, "variants": {}}]}, "retrieved_on": 1502093449, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/2gxN9NxpSJhooUboPVPiCUocmTx30lX9dcd3yQM73lk.jpg", "thumbnail_height": 92, "thumbnail_width": 140, "title": "First gene therapy \u2014 \u2018a true living drug\u2019 \u2014 on the cusp of FDA approval", "url": "https://www.washingtonpost.com/national/health-science/first-gene-therapy--a-true-living-drug--on-the-cusp-of-fda-approval/2017/07/11/bd7872a0-618a-11e7-a4f7-af34fc1d9d39_story.html?utm_term=.ee28f770de60"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1499816693, "domain": "streetinsider.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6mq6xl/phase_1_trial_of_btk_inhibitor_arq_531_begins/", "gilded": 0, "id": "6mq6xl", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6mq6xl/phase_1_trial_of_btk_inhibitor_arq_531_begins/", "retrieved_on": 1502093306, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Phase 1 Trial of BTK Inhibitor, ARQ 531 Begins", "url": "https://www.streetinsider.com/Corporate+News/ArQule+%28ARQL%29+Says+First+Patient+Dosed+in+Phase+1+Trial+of+BTK+Inhibitor%2C+ARQ+531/13086864.html"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1499283290, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6lgd7p/inhibiting_cfh_may_improve_responses_to_rituximab/", "gilded": 0, "id": "6lgd7p", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6lgd7p/inhibiting_cfh_may_improve_responses_to_rituximab/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "9U3WMCVAxMq6tqYydGRhZmoWYbLceT_X8ihzE4F9RcE", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/ZYdfuIe7v8xt2He5fQVUdr7N1mgbRngs6sTwhPMbTzM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=c4d9e82fdaa83faacce8e10a6d0969dd", "width": 108}, {"height": 142, "url": "https://i.redditmedia.com/ZYdfuIe7v8xt2He5fQVUdr7N1mgbRngs6sTwhPMbTzM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=a97ed658646dd03085521721247ad3e4", "width": 216}, {"height": 211, "url": "https://i.redditmedia.com/ZYdfuIe7v8xt2He5fQVUdr7N1mgbRngs6sTwhPMbTzM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=a06ddfc421ce5b81c4a2cf42df0176c0", "width": 320}, {"height": 422, "url": "https://i.redditmedia.com/ZYdfuIe7v8xt2He5fQVUdr7N1mgbRngs6sTwhPMbTzM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=bf6534fb0d16dc1f4d741fcaad88fe0d", "width": 640}], "source": {"height": 481, "url": "https://i.redditmedia.com/ZYdfuIe7v8xt2He5fQVUdr7N1mgbRngs6sTwhPMbTzM.jpg?s=f120ce269ea0d0256b31eeaf58033741", "width": 728}, "variants": {}}]}, "retrieved_on": 1502070675, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/bIPdiJ0mFgdeVOo_z1RdmLuLgnQ3VPAVXh7YbgNHKdU.jpg", "thumbnail_height": 92, "thumbnail_width": 140, "title": "Inhibiting CFH May Improve Responses to Rituximab in CLL", "url": "http://www.cancertherapyadvisor.com/chronic-lymphocytic-leukemia/chronic-leukemia-cll-cfh-inhibition-rituximab-treatment/article/672386/"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1499279912, "domain": "ajmc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6lfzeu/novel_antibody_may_restore_immune_response_to/", "gilded": 0, "id": "6lfzeu", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6lfzeu/novel_antibody_may_restore_immune_response_to/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "X_SeRej_cExFu0OGRBhMPNVuOWL-fFj95Tm7Lq6Nl0w", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=29432581c1ea537453069c8c2faae36e", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=79bbc4cbb8a632ab71abfac7d9970d0a", "width": 216}], "source": {"height": 270, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?s=f6ead69e3a1a9ce00422387615828049", "width": 270}, "variants": {}}]}, "retrieved_on": 1502070485, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/wuSmTw9Z1R6UePgoli5jjbMqHAuGPfrHO9RzybSIyYA.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Novel Antibody May Restore Immune Response to Rituximab for CLL", "url": "http://www.ajmc.com/newsroom/novel-antibody-may-restore-immune-response-to-rituximab-for-cll"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1498711885, "domain": "ajmc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6k65o8/venclextavenclyxto_effective_in_treating_chronic/", "gilded": 0, "id": "6k65o8", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6k65o8/venclextavenclyxto_effective_in_treating_chronic/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "X_SeRej_cExFu0OGRBhMPNVuOWL-fFj95Tm7Lq6Nl0w", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=29432581c1ea537453069c8c2faae36e", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=79bbc4cbb8a632ab71abfac7d9970d0a", "width": 216}], "source": {"height": 270, "url": "https://i.redditmedia.com/C5KfE6KzfIB_yCeJgx2Ca1OEwV6RKlk9-iEehFEixn8.jpg?s=f6ead69e3a1a9ce00422387615828049", "width": 270}, "variants": {}}]}, "retrieved_on": 1500193422, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/iT88lFAYmrJOL5Fad189PmP6dtBLQ9KcjVX95HZrr4Q.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Venclexta/Venclyxto Effective in Treating Chronic Lymphocytic Leukemia", "url": "http://www.ajmc.com/newsroom/venclextavenclyxto-effective-in-treating-chronic-lymphocytic-leukemia"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1498711863, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6k65lh/absolute_lymphocyte_counts_predictive_of_survival/", "gilded": 0, "id": "6k65lh", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6k65lh/absolute_lymphocyte_counts_predictive_of_survival/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "UzXwKNl9WahixYmmeHZNSwkeYI6-R2lKe3PXrKNwWx0", "resolutions": [{"height": 65, "url": "https://i.redditmedia.com/TX5AwKH0sPd7L7GNuXrqrCzShkNsKEqcDlFniuPB_bM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=22dd2456014cc2b9f52f4c3e541845f7", "width": 108}, {"height": 130, "url": "https://i.redditmedia.com/TX5AwKH0sPd7L7GNuXrqrCzShkNsKEqcDlFniuPB_bM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=c9ccb58ff4eee9e34837ac5a1a703942", "width": 216}, {"height": 194, "url": "https://i.redditmedia.com/TX5AwKH0sPd7L7GNuXrqrCzShkNsKEqcDlFniuPB_bM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=17604d64ad450a573a64cc5be100991b", "width": 320}], "source": {"height": 194, "url": "https://i.redditmedia.com/TX5AwKH0sPd7L7GNuXrqrCzShkNsKEqcDlFniuPB_bM.jpg?s=c2747726c601bb87470f8969b23d79ad", "width": 320}, "variants": {}}]}, "retrieved_on": 1500193421, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/ODNaXYIiWrCPYQg10PI1jC55b45I6IxICVUCBIvdLcc.jpg", "thumbnail_height": 84, "thumbnail_width": 140, "title": "Absolute Lymphocyte Counts Predictive of Survival With CLL Post-FCR", "url": "http://www.cancertherapyadvisor.com/chronic-lymphocytic-leukemia/lymphocyte-counts-predict-survival-cll/article/671558/"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1498711840, "domain": "researchitaly.it", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6k65jn/health_from_san_raffaele_hospital_a_new_key_to/", "gilded": 0, "id": "6k65jn", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6k65jn/health_from_san_raffaele_hospital_a_new_key_to/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "jYbXw7x8NyhZre5vVz77JwIkL3g8qn5eZM8fon3DuUM", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/RakOvNlGuP0ewvVk4mnBGcKTXeQnidk3iB2uzjza41s.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=33315beb1c3cefd80163c576ad2a7442", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/RakOvNlGuP0ewvVk4mnBGcKTXeQnidk3iB2uzjza41s.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=c86ca0e30f3fdec506a0e37a17e97e8c", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/RakOvNlGuP0ewvVk4mnBGcKTXeQnidk3iB2uzjza41s.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=74e2dc9762b5a02fd0957cebb78325a3", "width": 320}], "source": {"height": 280, "url": "https://i.redditmedia.com/RakOvNlGuP0ewvVk4mnBGcKTXeQnidk3iB2uzjza41s.jpg?s=bdbee0128e1dcbfd58cf3e36d0cf495f", "width": 420}, "variants": {}}]}, "retrieved_on": 1500193421, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/rzi3l8mpqwJjb2VJnbBVDv2zmIUJJ08Lcz0vgDHysbk.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "Health, from San Raffaele hospital a new key to fight chronic lymphocytic leukemia", "url": "https://www.researchitaly.it/en/news/health-from-san-raffaele-hospital-a-new-key-to-fight-chronic-lymphocytic-leukemia/"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1498457420, "domain": "cancernetwork.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6jjdqv/adding_ublituximab_to_ibrutinib_improves_relapsed/", "gilded": 0, "id": "6jjdqv", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6jjdqv/adding_ublituximab_to_ibrutinib_improves_relapsed/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "1q11Dx1E1wPnOoqxqF8Y694jmeOyQQ11-AaU7zCrDcM", "resolutions": [{"height": 142, "url": "https://i.redditmedia.com/95DQzm2SkZI_WlFFtmW61KtxcICS0a2gvRzCMa0qOMw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=151c736fdd9d347660a865a7841409f8", "width": 108}], "source": {"height": 198, "url": "https://i.redditmedia.com/95DQzm2SkZI_WlFFtmW61KtxcICS0a2gvRzCMa0qOMw.jpg?s=8264cc8423d85e55d2efdd1564e176fc", "width": 150}, "variants": {}}]}, "retrieved_on": 1500182172, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/ODRkCFxNe_2GuILGSdUFXNmRytXZkh29L_GK9b908cc.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Adding Ublituximab to Ibrutinib Improves Relapsed CLL Response Rates", "url": "http://www.cancernetwork.com/leukemia-lymphoma/adding-ublituximab-ibrutinib-improves-relapsed-cll-response-rates"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1498457380, "domain": "pipelinereview.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6jjdnh/abbvie_announces_phase_2_trial_evaluating/", "gilded": 0, "id": "6jjdnh", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6jjdnh/abbvie_announces_phase_2_trial_evaluating/", "retrieved_on": 1500182170, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "AbbVie Announces Phase 2 Trial Evaluating VENCLYXTO (venetoclax) in Patients with R/R CLL w/ 17p Del", "url": "http://pipelinereview.com/index.php/2017062365047/Small-Molecules/AbbVie-Announces-Pivotal-Phase-2-Trial-Evaluating-VENCLYXTO-venetoclax-in-Patients-with-Relapsed/Refractory-Chronic-Lymphocytic-Leukemia-CLL-with-17p-Deletion-to-be-Prese.html"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1498457293, "domain": "targetedonc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6jjdfj/ifcg_regimen_induces_high_rate_of_bone_marrow_mrd/", "gilded": 0, "id": "6jjdfj", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6jjdfj/ifcg_regimen_induces_high_rate_of_bone_marrow_mrd/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "yjAwKBv5YBME0q2JhYkdhORH8--3L2kSKtzvPBz-HDw", "resolutions": [{"height": 45, "url": "https://i.redditmedia.com/Hemzvt1iJ7WUtx5WrVYpmQR39cu9YCWybc700-Sr4Lk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=6191eaf8159ba5ddd94e2e60f1e231f9", "width": 108}], "source": {"height": 57, "url": "https://i.redditmedia.com/Hemzvt1iJ7WUtx5WrVYpmQR39cu9YCWybc700-Sr4Lk.jpg?s=697ca02046000b2e436e35cda3c45ecb", "width": 136}, "variants": {}}]}, "retrieved_on": 1500182168, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/5TEugKLFKbTR8YH0Mma-Q4OMm4OimdCx7aA9bYfNgNU.jpg", "thumbnail_height": 29, "thumbnail_width": 70, "title": "iFCG Regimen Induces High Rate of Bone Marrow MRD Negativity in IGHV-Mutated CLL", "url": "http://www.targetedonc.com/conference/asco-cll-2017/ifcg-regimen-induces-high-rate-of-bone-marrow-mrd-negativity-in-ighvmutated-cll"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1498457277, "domain": "patientdaily.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6jjder/abbvie_says_imbruvica_more_effective_than/", "gilded": 0, "id": "6jjder", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6jjder/abbvie_says_imbruvica_more_effective_than/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "njD_PBeEeXhGbqDfHZvJUEU4cuqKUmU1VpEUS8Ml95o", "resolutions": [{"height": 67, "url": "https://i.redditmedia.com/L5LrNziunZyzM73Jmbdy_7KG5Ba7zahqdnJVFitnIPA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=ed35c80d632cdc304d3c5c31d47b9628", "width": 108}, {"height": 135, "url": "https://i.redditmedia.com/L5LrNziunZyzM73Jmbdy_7KG5Ba7zahqdnJVFitnIPA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=3f3d5e399f8723e5bab69c80d66eadb6", "width": 216}, {"height": 200, "url": "https://i.redditmedia.com/L5LrNziunZyzM73Jmbdy_7KG5Ba7zahqdnJVFitnIPA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=6512e08052b70258388b9d82e8e2b5ed", "width": 320}], "source": {"height": 375, "url": "https://i.redditmedia.com/L5LrNziunZyzM73Jmbdy_7KG5Ba7zahqdnJVFitnIPA.jpg?s=2cc6ffc2d2ce7072e2a4e88f19df38d4", "width": 600}, "variants": {}}]}, "retrieved_on": 1500182167, "score": 3, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/KnInbrLBJb0awdCU68Y3JSHGSe5wIE8VHHU-J7Wb9I0.jpg", "thumbnail_height": 87, "thumbnail_width": 140, "title": "AbbVie says Imbruvica more effective than chlorambucil in fighting chronic lymphocytic leukemia", "url": "http://patientdaily.com/stories/511130760-abbvie-says-imbruvica-more-effective-than-chlorambucil-in-fighting-chronic-lymphocytic-leukemia"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1498457258, "domain": "curetoday.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6jjddn/fda_approves_rituxan_hycela_for_blood_cancers/", "gilded": 0, "id": "6jjddn", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6jjddn/fda_approves_rituxan_hycela_for_blood_cancers/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "3BYbi0wvrcRf0EhZWUFkqifjO4EzyAMqtFTjDz0xyEE", "resolutions": [{"height": 59, "url": "https://i.redditmedia.com/qaNxwVe50MNWNqFyCYqc-A5ADKnghyzleiiRfrjST80.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=3f4eb24b1598cab882a10496eee483c5", "width": 108}, {"height": 118, "url": "https://i.redditmedia.com/qaNxwVe50MNWNqFyCYqc-A5ADKnghyzleiiRfrjST80.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=31025d2b7f3306ade65d7e1b86fbeb2e", "width": 216}, {"height": 175, "url": "https://i.redditmedia.com/qaNxwVe50MNWNqFyCYqc-A5ADKnghyzleiiRfrjST80.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=cd00ba4472614af0afb7ebf312ebf276", "width": 320}], "source": {"height": 282, "url": "https://i.redditmedia.com/qaNxwVe50MNWNqFyCYqc-A5ADKnghyzleiiRfrjST80.jpg?s=8df0612b9de981be97f9e74d900d1867", "width": 514}, "variants": {}}]}, "retrieved_on": 1500182167, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/-J5bufdVATcqI6UH-GdNhnw0uDb9x_BCJy40C-9HTMY.jpg", "thumbnail_height": 76, "thumbnail_width": 140, "title": "FDA Approves Rituxan Hycela for Blood Cancers", "url": "http://www.curetoday.com/articles/fda-approves-rituxan-hycela-for-blood-cancers"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1498457200, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6jjd8y/fda_approves_subcutaneous_rituximab_and/", "gilded": 0, "id": "6jjd8y", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 1, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6jjd8y/fda_approves_subcutaneous_rituximab_and/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "MV-WEbEuGW6BV4YI3qvGzKtlP3-xd5JHcU9xuT7zk8k", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/uUp0eFBJ85jzAuinnx0uvti_qBKGhchuxGLoOhwVicA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=06d1d4b38bb894d5a60a2fd58dddbb13", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/uUp0eFBJ85jzAuinnx0uvti_qBKGhchuxGLoOhwVicA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=844d346c2565b388f93a48c83655f883", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/uUp0eFBJ85jzAuinnx0uvti_qBKGhchuxGLoOhwVicA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=af3b0d1e2b5cf5ae80fa47f1fd8285f3", "width": 320}], "source": {"height": 338, "url": "https://i.redditmedia.com/uUp0eFBJ85jzAuinnx0uvti_qBKGhchuxGLoOhwVicA.jpg?s=96c7e9e4f913abf0693cc4cfc3d43f4f", "width": 507}, "variants": {}}]}, "retrieved_on": 1500182165, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/fJZzjXWz33w5zTsCIPkPUEkl_FHreASeJN_-Pjh-aSM.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "FDA Approves Subcutaneous Rituximab and Hyaluronidase Human for Blood Cancers", "url": "http://www.cancertherapyadvisor.com/chronic-lymphocytic-leukemia/chronic-leukemia-lymphoma-fda-approval-rituximab-blood-cancer/article/670870/"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1498090321, "domain": "targetedonc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ipw6l/ibrutinib_shows_strong_pfs_and_os_benefits_in/", "gilded": 0, "id": "6ipw6l", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ipw6l/ibrutinib_shows_strong_pfs_and_os_benefits_in/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "XM_RjMlUF9pfEX0raaO0HDgrS9PwTWm5q9RS-r8Crq8", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=8b8bdfe16d31a7b36f7f6995991b63ca", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?s=c1fa7073f91a3a13437fb6762069e070", "width": 200}, "variants": {}}]}, "retrieved_on": 1500167539, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/XrttmZlugKIMSORuvahOzhn_yth8cnH-BfT3QYccSwI.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Ibrutinib Shows Strong PFS and OS Benefits in RESONATE Study Follow-Up", "url": "http://www.targetedonc.com/conference/asco-cll-2017/ibrutinib-shows-strong-pfs-and-os-benefits-in-resonate-study-followup"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1498090301, "domain": "targetedonc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ipw4g/obinutuzumabbendamustine_combo_shows_promising/", "gilded": 0, "id": "6ipw4g", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ipw4g/obinutuzumabbendamustine_combo_shows_promising/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "XM_RjMlUF9pfEX0raaO0HDgrS9PwTWm5q9RS-r8Crq8", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=8b8bdfe16d31a7b36f7f6995991b63ca", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?s=c1fa7073f91a3a13437fb6762069e070", "width": 200}, "variants": {}}]}, "retrieved_on": 1500167538, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/UzbZ_ZX9fmjHUmKzFs4qfsB_aJiaLbRTbwqw-V62V6Q.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Obinutuzumab/Bendamustine Combo Shows Promising Response Rates in Upfront CLL", "url": "http://www.targetedonc.com/conference/asco-cll-2017/obinutuzumabbendamustine-combo-shows-promising-response-rates-in-upfront-cll"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1497723317, "domain": "specialtypharmacytimes.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6huwl4/longterm_data_offers_positive_findings_for/", "gilded": 0, "id": "6huwl4", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6huwl4/longterm_data_offers_positive_findings_for/", "retrieved_on": 1500152180, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Long-Term Data Offers Positive Findings for Imbruvica (ibrutinib)", "url": "https://www.specialtypharmacytimes.com/news/long-term-data-offers-positive-findings-for-imbruvica"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1497656346, "domain": "proactiveinvestors.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6hq7o0/ibrutinib_ublituximab_tg_therapeutics_inc_boosted/", "gilded": 0, "id": "6hq7o0", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 1, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6hq7o0/ibrutinib_ublituximab_tg_therapeutics_inc_boosted/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "46mUEhkn8UEtx0huivwMj-AY_aymOWWit6IZKGvMNew", "resolutions": [{"height": 66, "url": "https://i.redditmedia.com/46aKGt-FbHrPRbogBSHtNGl3DtG52fCBMPfLceYvZ0Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=749d852833b6a8814a1258a9dcbc5d20", "width": 108}, {"height": 133, "url": "https://i.redditmedia.com/46aKGt-FbHrPRbogBSHtNGl3DtG52fCBMPfLceYvZ0Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=119d37851f16465b1a705e4dcc66fd75", "width": 216}, {"height": 197, "url": "https://i.redditmedia.com/46aKGt-FbHrPRbogBSHtNGl3DtG52fCBMPfLceYvZ0Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=b1e8cc8063f026b127e23b5abfdd71ab", "width": 320}, {"height": 395, "url": "https://i.redditmedia.com/46aKGt-FbHrPRbogBSHtNGl3DtG52fCBMPfLceYvZ0Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=797c94022d93bb331175eb5dbc90a4bc", "width": 640}], "source": {"height": 468, "url": "https://i.redditmedia.com/46aKGt-FbHrPRbogBSHtNGl3DtG52fCBMPfLceYvZ0Y.jpg?s=d7fcceece9d7f40cf26f658d6dba8c5b", "width": 757}, "variants": {}}]}, "retrieved_on": 1500149868, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/bftK82tO-9wc-TmAY2zQr4PqhaM3iMKQtnenATimIlI.jpg", "thumbnail_height": 86, "thumbnail_width": 140, "title": "Ibrutinib + Ublituximab: TG Therapeutics Inc boosted by leukemia drug trial", "url": "http://www.proactiveinvestors.com/companies/news/179393/tg-therapeutics-boosted-by-leukemia-179393.html"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1497656178, "domain": "healio.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6hq74k/video_addition_of_ublituximab_tg1101_to_ibrutinib/", "gilded": 0, "id": "6hq74k", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6hq74k/video_addition_of_ublituximab_tg1101_to_ibrutinib/", "retrieved_on": 1500149860, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "VIDEO: Addition of ublituximab (TG-1101) to ibrutinib effective for high-risk chronic lymphocytic leukemia", "url": "https://www.healio.com/hematology-oncology/leukemia/news/online/%7Be1dfeb34-73e5-4eb0-bb78-91ffde58d3bb%7D/video-addition-of-ublituximab-to-ibrutinib-effective-for-high-risk-chronic-lymphocytic-leukemia"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1497572686, "domain": "prnewswire.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6hj3n2/feinstein_institute_scientist_recognized_for/", "gilded": 0, "id": "6hj3n2", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6hj3n2/feinstein_institute_scientist_recognized_for/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "5o95WzBKGFjwbVq6SKQpI4DYCpDW5Gapm4NkHL2ilMg", "resolutions": [{"height": 56, "url": "https://i.redditmedia.com/YJ-CcisOTMi4w1JYSUwXMGDBy5KqCy0JU_YixDRfz_Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=4420a74cac51b491add62111c3fb7da8", "width": 108}, {"height": 113, "url": "https://i.redditmedia.com/YJ-CcisOTMi4w1JYSUwXMGDBy5KqCy0JU_YixDRfz_Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=91305ed15ec336386fedc3bec2624767", "width": 216}, {"height": 167, "url": "https://i.redditmedia.com/YJ-CcisOTMi4w1JYSUwXMGDBy5KqCy0JU_YixDRfz_Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=a36a81b402c83673bf6433356693eb3e", "width": 320}, {"height": 335, "url": "https://i.redditmedia.com/YJ-CcisOTMi4w1JYSUwXMGDBy5KqCy0JU_YixDRfz_Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=8715038ce3f1aa13ecd87e18c525949a", "width": 640}, {"height": 502, "url": "https://i.redditmedia.com/YJ-CcisOTMi4w1JYSUwXMGDBy5KqCy0JU_YixDRfz_Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=c305571133aa064132f767817196a45f", "width": 960}, {"height": 565, "url": "https://i.redditmedia.com/YJ-CcisOTMi4w1JYSUwXMGDBy5KqCy0JU_YixDRfz_Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=af05a53da50b26408228f9e3a8781853", "width": 1080}], "source": {"height": 1414, "url": "https://i.redditmedia.com/YJ-CcisOTMi4w1JYSUwXMGDBy5KqCy0JU_YixDRfz_Y.jpg?s=955b39f923d0d837e40089d32038c662", "width": 2700}, "variants": {}}]}, "retrieved_on": 1500146267, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/8AtQp5s2Jf76gs6WX0Td3OXj_Pb8wRaqZGby04nTeyI.jpg", "thumbnail_height": 73, "thumbnail_width": 140, "title": "Feinstein Institute Scientist Recognized for Innovative Chronic Lymphocytic Leukemia Research", "url": "http://www.prnewswire.com/news-releases/feinstein-institute-scientist-recognized-for-innovative-chronic-lymphocytic-leukemia-research-300474720.html"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1497549532, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6hgprr/dr_pinillaibarz_on_ibrutinibs_efficacy_in/", "gilded": 0, "id": "6hgprr", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6hgprr/dr_pinillaibarz_on_ibrutinibs_efficacy_in/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "VLGbXBd4Vw5L1YJcoFOCvl17SlO-AHmgKmZtYhs1-L0", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/QxcfCgrJlOmNke0uGqntRbvy2eq5y3T0A9-mkFuZ9L0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=ba29cdeba0c739fb27f426e938d5eb12", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/QxcfCgrJlOmNke0uGqntRbvy2eq5y3T0A9-mkFuZ9L0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=9058520864a1ad167abbfcbfd45efcf6", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/QxcfCgrJlOmNke0uGqntRbvy2eq5y3T0A9-mkFuZ9L0.jpg?s=73f320ac2bb7a05f2dd0b3eb03731b19", "width": 250}, "variants": {}}]}, "retrieved_on": 1500145067, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/9dltO2u6L-LKivFP1TmDQAn6Ga6_RPeaqpvSOQlwGvI.jpg", "thumbnail_height": 106, "thumbnail_width": 140, "title": "Dr. Pinilla-Ibarz on Ibrutinib's Efficacy in Treating High-Risk Patients With CLL", "url": "http://www.onclive.com/onclive-tv/dr-pinillaibarz-on-ibrutinibs-efficacy-in-treating-highrisk-patients-with-cll"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1497549493, "domain": "globenewswire.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6hgpm4/tg_therapeutics_inc_announces_followup_data_for/", "gilded": 0, "id": "6hgpm4", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6hgpm4/tg_therapeutics_inc_announces_followup_data_for/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "jHRjX6VCjQcOpJgBDSINddQLt4EcWKs0Hr3lSsgE2AA", "resolutions": [{"height": 31, "url": "https://i.redditmedia.com/Cb2ONJHgXhsoT2k5JOvQA5kq4x3qRhs7xtHnWIj5J80.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=394d0f6814424d7a0ebabc571764b656", "width": 108}], "source": {"height": 44, "url": "https://i.redditmedia.com/Cb2ONJHgXhsoT2k5JOvQA5kq4x3qRhs7xtHnWIj5J80.jpg?s=71b181174a6ef6c878e5dd0d636737ae", "width": 150}, "variants": {}}]}, "retrieved_on": 1500145065, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/2rB8wyfERXjdd3G8hKf-YpDKUYszfZ88RFZlvKaA-08.jpg", "thumbnail_height": 41, "thumbnail_width": 140, "title": "TG Therapeutics, Inc. Announces Follow-Up Data for Combination of TGR-1202 (umbralisib) plus Ibrutinib in Patients with Relapsed or Refractory CLL", "url": "https://globenewswire.com/news-release/2017/06/14/1018856/0/en/TG-Therapeutics-Inc-Announces-Follow-Up-Data-for-Combination-of-TGR-1202-umbralisib-plus-Ibrutinib-in-Patients-with-Relapsed-or-Refractory-CLL-and-MCL-at-the-14th-International-Con.html"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1497406005, "domain": "targetedonc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6h4kim/experts_share_insight_on_ibrutinibs_bright_future/", "gilded": 0, "id": "6h4kim", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6h4kim/experts_share_insight_on_ibrutinibs_bright_future/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "XM_RjMlUF9pfEX0raaO0HDgrS9PwTWm5q9RS-r8Crq8", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=8b8bdfe16d31a7b36f7f6995991b63ca", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?s=c1fa7073f91a3a13437fb6762069e070", "width": 200}, "variants": {}}]}, "retrieved_on": 1500139054, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/l6KAkQP2umjfq7ttyZtapZkvyG_-Q55iUrqTa3i4CsE.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Experts Share Insight on Ibrutinib's Bright Future in CLL Landscape", "url": "http://www.targetedonc.com/publications/evolving-paradigms/2017/CLL/experts-share-insight-on-ibrutinibs-bright-future-in-cll-landscape"}, {"author": "DefendUrRights", "author_flair_css_class": null, "author_flair_richtext": [], "author_flair_text": null, "author_flair_type": "text", "author_fullname": "t2_12ac4p", "author_patreon_flair": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1540279044, "domain": "self.CLL_Leukemia", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/9qmlhs/wanting_to_take_part_in_a_clinical_trial_for/", "gildings": {"gid_1": 0, "gid_2": 0, "gid_3": 0}, "id": "9qmlhs", "is_crosspostable": true, "is_meta": false, "is_original_content": false, "is_reddit_media_domain": false, "is_robot_indexable": true, "is_self": true, "is_video": false, "link_flair_background_color": "", "link_flair_richtext": [], "link_flair_text_color": "dark", "link_flair_type": "text", "locked": false, "media_only": false, "no_follow": true, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/9qmlhs/wanting_to_take_part_in_a_clinical_trial_for/", "pinned": false, "retrieved_on": 1540279044, "score": 1, "selftext": "CLL/sll/lymphoma using Rick Simpson Oil, smokeables, as adjuvant treatment. \n\nI went to MD Anderson for tests, blood typing, FISH (tells you how screwed your chromosomes are) and CAT scan to view organs. Nodules  around everywhere. But blood counts are low, I.e., white blood count was 25,000 last test in January.  WBC is puke need to be in the 100,000+ range for me to be considered for any treatment. My chosen treatment is Rick Simpson Oil @ 1 gm/day for 60 days. I\u2019ll drop in with my blood tests to share as they come in. I\u2019m traveling to Colorado to get what I need. ", "send_replies": true, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "subreddit_subscribers": 59, "subreddit_type": "public", "suggested_sort": "confidence", "thumbnail": "self", "title": "Wanting to take part in a clinical trial for CLL/sll/lymphoma", "url": "https://www.reddit.com/r/CLL_Leukemia/comments/9qmlhs/wanting_to_take_part_in_a_clinical_trial_for/"}, {"author": "Svjsjsuq8100", "author_flair_css_class": null, "author_flair_richtext": [], "author_flair_text": null, "author_flair_type": "text", "can_mod_post": false, "contest_mode": false, "created_utc": 1532123324, "domain": "self.CLL_Leukemia", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/90k4oe/ok/", "gilded": 0, "id": "90k4oe", "is_crosspostable": true, "is_original_content": false, "is_reddit_media_domain": false, "is_self": true, "is_video": false, "link_flair_richtext": [], "link_flair_text_color": "dark", "link_flair_type": "text", "locked": false, "media_only": false, "no_follow": true, "num_comments": 0, "num_crossposts": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/90k4oe/ok/", "pinned": false, "retrieved_on": 1532123326, "rte_mode": "markdown", "score": 1, "selftext": "https://fortnite-gifts.com/?id=5b5258031a374", "send_replies": true, "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "subreddit_subscribers": 45, "subreddit_type": "public", "suggested_sort": "confidence", "thumbnail": "self", "title": "Ok", "url": "https://www.reddit.com/r/CLL_Leukemia/comments/90k4oe/ok/"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1497399643, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6h404k/less_than_a_quarter_of_patients_with_cll_tested/", "gilded": 0, "id": "6h404k", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6h404k/less_than_a_quarter_of_patients_with_cll_tested/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "1Aerl9NY1BLE3ptMNbIQgsnuDN2avmqHlhVZomj_n0k", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/dR4eWGWgTuLq1aZM9dxNbjqavxK0nm-xl0A8d8iXG5c.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=73a1b47e5acea844dbf21b50a6cb5d4f", "width": 108}, {"height": 143, "url": "https://i.redditmedia.com/dR4eWGWgTuLq1aZM9dxNbjqavxK0nm-xl0A8d8iXG5c.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=63eae97977db252c9a3b1ca40ec4d136", "width": 216}, {"height": 212, "url": "https://i.redditmedia.com/dR4eWGWgTuLq1aZM9dxNbjqavxK0nm-xl0A8d8iXG5c.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=58158c765e5fe0c889776fa3fdef8de2", "width": 320}, {"height": 425, "url": "https://i.redditmedia.com/dR4eWGWgTuLq1aZM9dxNbjqavxK0nm-xl0A8d8iXG5c.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=975e8cc36e264ef6033668d901da4d0b", "width": 640}], "source": {"height": 483, "url": "https://i.redditmedia.com/dR4eWGWgTuLq1aZM9dxNbjqavxK0nm-xl0A8d8iXG5c.jpg?s=5308d02cb739e50ae763092fca57a1d1", "width": 726}, "variants": {}}]}, "retrieved_on": 1500138769, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/ztintEdSIEBEo_iCjxOk9uzyi8iLIfS4RqgEln3BnkY.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "Less Than A Quarter of Patients With CLL Tested for IGHV Mutation Prior to Initial Therapy", "url": "http://www.cancertherapyadvisor.com/chronic-lymphocytic-leukemia/chronic-leukemia-cll-quarter-patients-tested-ighv-mutation-before-therapy/article/667807/"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1497391386, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6h386x/byrd_highlights_ibrutinibs_continued_progress_in/", "gilded": 0, "id": "6h386x", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6h386x/byrd_highlights_ibrutinibs_continued_progress_in/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "X7aby1MKp06jw4tTezZ1PO1bDCFKxsTsumQ0nfhtrd8", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/fVlMEAz3ARtsgmPdcdklnvNd6E7_5XqHIVIzBVRtKXo.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=e2b596fa6b113ed944ec100c1b76113a", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/fVlMEAz3ARtsgmPdcdklnvNd6E7_5XqHIVIzBVRtKXo.jpg?s=23289ce78f80226377886f24ef7a9d6e", "width": 200}, "variants": {}}]}, "retrieved_on": 1500138383, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/3dyFGb4Cie_MhJx1UDSqXt9FFeM4Gj4tmmvxt3AjOt0.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Byrd Highlights Ibrutinib's Continued Progress in CLL", "url": "http://www.onclive.com/web-exclusives/byrd-highlights-ibrutinibs-continued-progress-in-cll"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1497390617, "domain": "cancernetwork.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6h35fs/car_t_cellibrutinib_combination_may_improve_cll/", "gilded": 0, "id": "6h35fs", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6h35fs/car_t_cellibrutinib_combination_may_improve_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "N5euoXkvImhO4oh16YY1bi5PNHz7alQUJ7vJRCfuLEQ", "resolutions": [{"height": 142, "url": "https://i.redditmedia.com/PXW8xmzUzATHo592Roxwta6Vf5KA7gqFRdes6NTAOpw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=dbda12039a9924db924943946c151045", "width": 108}], "source": {"height": 198, "url": "https://i.redditmedia.com/PXW8xmzUzATHo592Roxwta6Vf5KA7gqFRdes6NTAOpw.jpg?s=8cbb562ce88a5da1857891a4bd70ae36", "width": 150}, "variants": {}}]}, "retrieved_on": 1500138344, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/pxG5UaaK6SLF6_foQjYWuSaKcUIvwcX3eA8SABz7MZg.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "CAR T Cell/Ibrutinib Combination May Improve CLL Response Rates", "url": "http://www.cancernetwork.com/asco-hematology/car-t-cell-ibrutinib-combination-may-improve-cll-response-rates"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1497389707, "domain": "targetedonc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6h323a/current_approaches_to_diagnosis_and_risk/", "gilded": 0, "id": "6h323a", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6h323a/current_approaches_to_diagnosis_and_risk/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "XM_RjMlUF9pfEX0raaO0HDgrS9PwTWm5q9RS-r8Crq8", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=8b8bdfe16d31a7b36f7f6995991b63ca", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?s=c1fa7073f91a3a13437fb6762069e070", "width": 200}, "variants": {}}]}, "retrieved_on": 1500138298, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/iF2u1rkmaH-_tTQnx-2c0fOwp-xCJx98h6Q4qZ6Bz3M.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Current Approaches to Diagnosis and Risk Stratification in Chronic Lymphocytic Leukemia", "url": "http://www.targetedonc.com/publications/evolving-paradigms/2017/cll/current-approaches-to-diagnosis-and-risk-stratification-in-chronic-lymphocytic-leukemia"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1497032515, "domain": "sgul.ac.uk", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ga8fi/cannabinoids_used_in_sequence_with_chemotherapy/", "gilded": 0, "id": "6ga8fi", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ga8fi/cannabinoids_used_in_sequence_with_chemotherapy/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "UzEVkJjj1dK4RA4ZgPM2QKq0hjeBiFjXxcrq7OdYm08", "resolutions": [{"height": 60, "url": "https://i.redditmedia.com/_H6MELggVtNMqcEBrBDemvF9u02jtI2N2qXh_2ejrHM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=10eeca7ca2bba15f7c6c72c53a43da27", "width": 108}, {"height": 121, "url": "https://i.redditmedia.com/_H6MELggVtNMqcEBrBDemvF9u02jtI2N2qXh_2ejrHM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=22fcf78c293838275ab18213a35e656f", "width": 216}, {"height": 179, "url": "https://i.redditmedia.com/_H6MELggVtNMqcEBrBDemvF9u02jtI2N2qXh_2ejrHM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=f5e6331e01a6bca5543f86e5f585e9bb", "width": 320}, {"height": 359, "url": "https://i.redditmedia.com/_H6MELggVtNMqcEBrBDemvF9u02jtI2N2qXh_2ejrHM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=505e5779914744de55fa2481997ee7ef", "width": 640}], "source": {"height": 449, "url": "https://i.redditmedia.com/_H6MELggVtNMqcEBrBDemvF9u02jtI2N2qXh_2ejrHM.jpg?s=5c20711c4c223f130e7c8995ac817bd6", "width": 800}, "variants": {}}]}, "retrieved_on": 1500123153, "score": 3, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/X42hqZhFH8UabwEDRTKnfqNTk0XlKKYWlZ2CchWlabg.jpg", "thumbnail_height": 78, "thumbnail_width": 140, "title": "Cannabinoids used in sequence with chemotherapy are a more effective treatment for cancer", "url": "https://www.sgul.ac.uk/news/news-archive/cannabinoids-used-in-sequence-with-chemotherapy-are-a-more-effective-treatment-for-cancer"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1496967468, "domain": "streetinsider.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6g4yhc/abbvie_announces_longterm_imbruvica_efficacy_and/", "gilded": 0, "id": "6g4yhc", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 1, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6g4yhc/abbvie_announces_longterm_imbruvica_efficacy_and/", "retrieved_on": 1500120395, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "AbbVie Announces Long-Term IMBRUVICA Efficacy and Safety Data in CLL at ASCO", "url": "https://www.streetinsider.com/Corporate+News/AbbVie+%28ABBV%29+Announces+Long-Term+IMBRUVICA+Efficacy+and+Safety+Data+in+CLLSLL+at+ASCO/12977374.html"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1496967419, "domain": "pipelinereview.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6g4ya9/new_data_presented_at_asco_2017_finds_imbruvica/", "gilded": 0, "id": "6g4ya9", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6g4ya9/new_data_presented_at_asco_2017_finds_imbruvica/", "retrieved_on": 1500120393, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "New Data Presented at ASCO 2017 Finds IMBRUVICA (ibrutinib) May Offer a More Targeted Approach to CLL Treatment than Chemotherapy Agent Chlorambucil in Treatment-Na\u00efve Patients", "url": "http://pipelinereview.com/index.php/2017060564830/Small-Molecules/New-Data-Presented-at-ASCO-2017-Finds-IMBRUVICA-ibrutinib-May-Offer-a-More-Targeted-Approach-to-Chronic-Lymphocytic-Leukemia-CLL-Treatment-than-Chemotherapy-Agent-Chloram.html"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1496967092, "domain": "newswise.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6g4x4y/clt119_personalized_cell_therapy_combined_with/", "gilded": 0, "id": "6g4x4y", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 7, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6g4x4y/clt119_personalized_cell_therapy_combined_with/", "retrieved_on": 1500120377, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "CLT119: Personalized Cell Therapy Combined with Ibrutinib Achieves Complete Remission in High Percentage of Chronic Lymphocytic Leukemia Patients", "url": "http://www.newswise.com/articles/personalized-cell-therapy-combined-with-ibrutinib-achieves-complete-remission-in-high-percentage-of-chronic-lymphocytic-leukemia-patients"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1496966972, "domain": "globenewswire.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6g4wnk/tg1101_tg_therapeutics_reports_positive_data_from/", "gilded": 0, "id": "6g4wnk", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 3, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6g4wnk/tg1101_tg_therapeutics_reports_positive_data_from/", "retrieved_on": 1500120371, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "TG-1101: TG Therapeutics Reports Positive Data from Phase 3 GENUINE Trial of TG-1101 in Combination with Ibrutinib on ASCO Meetings", "url": "https://globenewswire.com/news-release/2017/06/03/1007925/0/en/TG-Therapeutics-Announces-Positive-Data-from-Phase-3-GENUINE-Trial-of-TG-1101-in-Combination-with-Ibrutinib-in-Patients-with-High-Risk-Chronic-Lymphocytic-Leukemia-at-the-53rd-Annu.html"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1496947626, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6g2xn5/young_patients_with_cll_at_risk_for_secondary/", "gilded": 0, "id": "6g2xn5", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6g2xn5/young_patients_with_cll_at_risk_for_secondary/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "I3vNg39OARycVnpW_lfVuSk_P2jn4Q1lVQ9MoIWD0OI", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/P99UvJ81UdVJOfWLlpffJjEaaGAdU-j2LJJD9B76gbc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=4dfe72090d171e5c2ae9287db30a5707", "width": 108}, {"height": 143, "url": "https://i.redditmedia.com/P99UvJ81UdVJOfWLlpffJjEaaGAdU-j2LJJD9B76gbc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=94724e9ca7cff3b33f2d77d5dd3a7081", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/P99UvJ81UdVJOfWLlpffJjEaaGAdU-j2LJJD9B76gbc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=1d89c6b3e6fa09ace76ec668fc230c0b", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/P99UvJ81UdVJOfWLlpffJjEaaGAdU-j2LJJD9B76gbc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=95c31698621507eadf2fffab03889891", "width": 640}], "source": {"height": 483, "url": "https://i.redditmedia.com/P99UvJ81UdVJOfWLlpffJjEaaGAdU-j2LJJD9B76gbc.jpg?s=39b04f90fb640f6dd69725aa71e137dc", "width": 725}, "variants": {}}]}, "retrieved_on": 1500119341, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/5vPjvcLZlnyAR0VTERpmk1JzV8fbri8BFfpPOAtVFBg.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "Young Patients With CLL At Risk for Secondary Cancers", "url": "http://www.cancertherapyadvisor.com/asco-2017/chronic-leukemia-cll-young-patients-secondary-cancer/article/663920/"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1496504400, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6f1t19/venetoclax_plus_rituximab_induces_durable/", "gilded": 0, "id": "6f1t19", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6f1t19/venetoclax_plus_rituximab_induces_durable/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "z80b6eNvbf4OxqlIIE7fxYRQ0OEngrWEDLTzq_Rb45I", "resolutions": [{"height": 75, "url": "https://i.redditmedia.com/hFgVLBFlJ5MS-vsSPHo1hygN_ItPP6Ri3zMuwl0UB7s.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=4ae4d00ce714cf74a8acf97e6ddeb58f", "width": 108}, {"height": 151, "url": "https://i.redditmedia.com/hFgVLBFlJ5MS-vsSPHo1hygN_ItPP6Ri3zMuwl0UB7s.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=68eb7b4491fc45a27174d618fe98573d", "width": 216}, {"height": 224, "url": "https://i.redditmedia.com/hFgVLBFlJ5MS-vsSPHo1hygN_ItPP6Ri3zMuwl0UB7s.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=1893b33dc46b4e5e7732fa30d9092b67", "width": 320}], "source": {"height": 348, "url": "https://i.redditmedia.com/hFgVLBFlJ5MS-vsSPHo1hygN_ItPP6Ri3zMuwl0UB7s.jpg?s=11d8ab07dc7eae1ff98d31482faa0db0", "width": 495}, "variants": {}}]}, "retrieved_on": 1500100545, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/7Y1QgVV8PruDiqkpk6WKMjYAdR0QGG3_6-wsnYS5GkQ.jpg", "thumbnail_height": 98, "thumbnail_width": 140, "title": "Venetoclax Plus Rituximab Induces Durable Responses in CLL", "url": "http://www.cancertherapyadvisor.com/chronic-lymphocytic-leukemia/chronic-leukemia-cll-venetoclax-rituximab-induces-response/article/662078/"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1496415717, "domain": "mdedge.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6euwn1/evaluation_of_treatment_patterns_and_outcomes_for/", "gilded": 0, "id": "6euwn1", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 1, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6euwn1/evaluation_of_treatment_patterns_and_outcomes_for/", "retrieved_on": 1500097072, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Evaluation of treatment patterns and outcomes for elderly patients with CLL", "url": "http://www.mdedge.com/fedprac/article/136935/hematologic-malignancies/chronic-lymphocytic-leukemia-real-world"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1496415292, "domain": "ncbi.nlm.nih.gov", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6euv3u/engagement_of_the_bcell_receptor_of_cll_cells/", "gilded": 0, "id": "6euv3u", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 1, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6euv3u/engagement_of_the_bcell_receptor_of_cll_cells/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "fqYo9dqgZisH-fGmf0KgaHeTaszw55vS9HO6U_Fq0L4", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/CcRXH-AOnQ7XZQAmQIAE51bRPCkl2wYSfTLBWJYWNi8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=99f0f47de216e404f1b76eed0ecb0d21", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/CcRXH-AOnQ7XZQAmQIAE51bRPCkl2wYSfTLBWJYWNi8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=a7a484b893698da08ee595667d150cc2", "width": 216}], "source": {"height": 256, "url": "https://i.redditmedia.com/CcRXH-AOnQ7XZQAmQIAE51bRPCkl2wYSfTLBWJYWNi8.jpg?s=a4fc7600cbc46c99dead7deebb01a055", "width": 256}, "variants": {}}]}, "retrieved_on": 1500097050, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/e7L9hl7v-kmTtLLPkROEoDwOmSmxgDoXIyVVs_OwsKU.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Engagement of the B-cell receptor of CLL cells drives global and MYC-specific mRNA translation", "url": "https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=26491071"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1496415092, "domain": "ncbi.nlm.nih.gov", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6euueg/targeting_bcl2_with_venetoclax_in_relapsed/", "gilded": 0, "id": "6euueg", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6euueg/targeting_bcl2_with_venetoclax_in_relapsed/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "fqYo9dqgZisH-fGmf0KgaHeTaszw55vS9HO6U_Fq0L4", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/CcRXH-AOnQ7XZQAmQIAE51bRPCkl2wYSfTLBWJYWNi8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=99f0f47de216e404f1b76eed0ecb0d21", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/CcRXH-AOnQ7XZQAmQIAE51bRPCkl2wYSfTLBWJYWNi8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=a7a484b893698da08ee595667d150cc2", "width": 216}], "source": {"height": 256, "url": "https://i.redditmedia.com/CcRXH-AOnQ7XZQAmQIAE51bRPCkl2wYSfTLBWJYWNi8.jpg?s=a4fc7600cbc46c99dead7deebb01a055", "width": 256}, "variants": {}}]}, "retrieved_on": 1500097041, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/e7L9hl7v-kmTtLLPkROEoDwOmSmxgDoXIyVVs_OwsKU.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia", "url": "https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=26639348"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1496414912, "domain": "seekingalpha.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6eutrc/investment_article_duvelisib_a_molecule_with_a/", "gilded": 0, "id": "6eutrc", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6eutrc/investment_article_duvelisib_a_molecule_with_a/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "M8UN9RUNtS-Cgwlu3O6jhRXfvFSW0NS4yi6p2wr5Tzk", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/Kp_7YzzjcE3gncSCMnHRK734CZdVW0LPWKt29tNe7iQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=f63d0bd3e5c90d54a60d46a633417513", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/Kp_7YzzjcE3gncSCMnHRK734CZdVW0LPWKt29tNe7iQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=d7092cfbfdc7792358a9631acd3bd43b", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/Kp_7YzzjcE3gncSCMnHRK734CZdVW0LPWKt29tNe7iQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=f16fae8faa143a145de6b131f5cda23b", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/Kp_7YzzjcE3gncSCMnHRK734CZdVW0LPWKt29tNe7iQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=58b6bbfd41e8c806e2184ff34f72d93d", "width": 640}, {"height": 640, "url": "https://i.redditmedia.com/Kp_7YzzjcE3gncSCMnHRK734CZdVW0LPWKt29tNe7iQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=4f3dd9fad38b7e153de58d15485946ad", "width": 960}, {"height": 720, "url": "https://i.redditmedia.com/Kp_7YzzjcE3gncSCMnHRK734CZdVW0LPWKt29tNe7iQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=dbfafd92da823c0f595855b833b13b51", "width": 1080}], "source": {"height": 3000, "url": "https://i.redditmedia.com/Kp_7YzzjcE3gncSCMnHRK734CZdVW0LPWKt29tNe7iQ.jpg?s=82059a0f7c34046f4c356cd53c6fca36", "width": 4500}, "variants": {}}]}, "retrieved_on": 1500097032, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/J14Cd06SbTZntIJAjv6-J6OpJV2nPJCZWS-grNakMhQ.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "{Investment Article} - Duvelisib, A Molecule with a Lot of Potential But All of it Highly Speculative", "url": "https://seekingalpha.com/article/4070332-verastem-boosts-oncologic-drug-portfolio-fuels-stock-price"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1496355995, "domain": "thepharmaletter.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6eqbo2/abbvie_disappointed_as_nice_issues_negative_draft/", "gilded": 0, "id": "6eqbo2", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6eqbo2/abbvie_disappointed_as_nice_issues_negative_draft/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "dM8ivh0a3YA5VBkwiISiLfrLesYM_KIJa9MnLGgFpcA", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/KrrYajyFb1MdSFfxXBSc7wZNMjpjLptWOpn6G8sjcAk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=15564292ae0ced16866c31cf73bfa0dd", "width": 108}, {"height": 143, "url": "https://i.redditmedia.com/KrrYajyFb1MdSFfxXBSc7wZNMjpjLptWOpn6G8sjcAk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=cec929875c28db17d55450c81259d93c", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/KrrYajyFb1MdSFfxXBSc7wZNMjpjLptWOpn6G8sjcAk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=3500c7daf2e0c27bf0bd4e220584e64a", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/KrrYajyFb1MdSFfxXBSc7wZNMjpjLptWOpn6G8sjcAk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=3b8ee4fd31623d60708971c3d8b545ad", "width": 640}], "source": {"height": 466, "url": "https://i.redditmedia.com/KrrYajyFb1MdSFfxXBSc7wZNMjpjLptWOpn6G8sjcAk.jpg?s=d3af7aad49a4baf904ce78280a2c61a8", "width": 700}, "variants": {}}]}, "retrieved_on": 1500094735, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/I4kN8YXMQxh463MO9quTls4dGdXs6Y0CbpiZaNAMVnQ.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "AbbVie disappointed as NICE issues negative draft appraisal on Venetoclax", "url": "https://www.thepharmaletter.com/article/abbvie-disappointed-as-nice-issues-negative-draft-appraisal-on-venetoclax"}, {"approved_at_utc": null, "author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "banned_at_utc": null, "brand_safe": false, "can_mod_post": false, "contest_mode": false, "created_utc": 1496337653, "domain": "telegraph.co.uk", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6eo8dn/scientists_create_designer_virus_to_kickstart/", "gilded": 0, "id": "6eo8dn", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6eo8dn/scientists_create_designer_virus_to_kickstart/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "p0GugSI50PZJO6ruGoL2kgN65hdAexGVc-aH1y9gfbM", "resolutions": [{"height": 67, "url": "https://i.redditmedia.com/Y_KENMxdnDB2qleRwdxo70on_vuNSyDAUz-deHZO5j8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=1d301abded7d0773606a0b59a2161e67", "width": 108}, {"height": 134, "url": "https://i.redditmedia.com/Y_KENMxdnDB2qleRwdxo70on_vuNSyDAUz-deHZO5j8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=3f671c4efe5131a92516e552c6c91da2", "width": 216}, {"height": 199, "url": "https://i.redditmedia.com/Y_KENMxdnDB2qleRwdxo70on_vuNSyDAUz-deHZO5j8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=56be07488cacabab6556f072b81548c7", "width": 320}, {"height": 399, "url": "https://i.redditmedia.com/Y_KENMxdnDB2qleRwdxo70on_vuNSyDAUz-deHZO5j8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=07a720c78d5fb1c9eedc5904b94224ab", "width": 640}], "source": {"height": 523, "url": "https://i.redditmedia.com/Y_KENMxdnDB2qleRwdxo70on_vuNSyDAUz-deHZO5j8.jpg?s=95bc3b4aa2d1373d9953a4c4838a0e1f", "width": 837}, "variants": {}}]}, "retrieved_on": 1500093694, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/b43UW2F6TjlnKVDbqyq2Ohi7V_UaHLiK1z-tZZrlVC8.jpg", "thumbnail_height": 87, "thumbnail_width": 140, "title": "Scientists create designer virus to kickstart immune system and kill cancer", "url": "http://www.telegraph.co.uk/science/2017/05/26/scientists-create-designer-virus-kickstart-immune-system-kill/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1496273160, "domain": "theguardian.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6eiu8c/high_blood_platelet_count_as_good_a_cancer/", "gilded": 0, "id": "6eiu8c", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6eiu8c/high_blood_platelet_count_as_good_a_cancer/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "UmTGzj119bZ-_f4Ki31W9E5175ZlVMf8vzqLvQxmA3I", "resolutions": [{"height": 56, "url": "https://i.redditmedia.com/UsvpVsj0l6rA3RRMZ6DVQujITydXT68qyJCx6VvZLD4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=004234f1cb0aa3b3fb60f330ee5ade45", "width": 108}, {"height": 113, "url": "https://i.redditmedia.com/UsvpVsj0l6rA3RRMZ6DVQujITydXT68qyJCx6VvZLD4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=4d17a14839db6b06420a4778d552f703", "width": 216}, {"height": 168, "url": "https://i.redditmedia.com/UsvpVsj0l6rA3RRMZ6DVQujITydXT68qyJCx6VvZLD4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=e4bdc8753962ca3a7f606fb1885fbd81", "width": 320}, {"height": 336, "url": "https://i.redditmedia.com/UsvpVsj0l6rA3RRMZ6DVQujITydXT68qyJCx6VvZLD4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=ba971e27c37797cd0a6480051ee41d64", "width": 640}, {"height": 504, "url": "https://i.redditmedia.com/UsvpVsj0l6rA3RRMZ6DVQujITydXT68qyJCx6VvZLD4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=dbe36afd30738de5eda108d12f4e00b4", "width": 960}, {"height": 567, "url": "https://i.redditmedia.com/UsvpVsj0l6rA3RRMZ6DVQujITydXT68qyJCx6VvZLD4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=3c3afcc3e40620b97dac707e6828bf69", "width": 1080}], "source": {"height": 630, "url": "https://i.redditmedia.com/UsvpVsj0l6rA3RRMZ6DVQujITydXT68qyJCx6VvZLD4.jpg?s=9ab12bf3325a5c8ea5b592e7cbe24cfd", "width": 1200}, "variants": {}}]}, "retrieved_on": 1497200894, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/3Gxo8XjNAVzGqGmRbnFyIsP_fOGckN8QDv0NO9ka0Pg.jpg", "thumbnail_height": 73, "thumbnail_width": 140, "title": "High blood platelet count 'as good a cancer predictor as a lump in the breast'", "url": "https://www.theguardian.com/science/2017/may/23/high-blood-platelet-count-as-good-a-cancer-predictor-as-a-lump-in-the-breast"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1496190962, "domain": "medicaldaily.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ebggp/a_cancer_drug_unexpectedly_reduced_allergic/", "gilded": 0, "id": "6ebggp", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 2, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ebggp/a_cancer_drug_unexpectedly_reduced_allergic/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "uo-0Pp0XQ8Nk20lM8QbosjBCpyq7_rfbsCxTNcprxyA", "resolutions": [{"height": 68, "url": "https://i.redditmedia.com/lAlFWCwsbsO-nrYyUR1ZFxWAynbdk2rsCAZuLGGpcLE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=885ea06017479eff844c737686172174", "width": 108}, {"height": 137, "url": "https://i.redditmedia.com/lAlFWCwsbsO-nrYyUR1ZFxWAynbdk2rsCAZuLGGpcLE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=a12f7f7263089bafe1169200a977cfa2", "width": 216}, {"height": 203, "url": "https://i.redditmedia.com/lAlFWCwsbsO-nrYyUR1ZFxWAynbdk2rsCAZuLGGpcLE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=8f1318696f7c30b7f710a7bb128d86df", "width": 320}, {"height": 406, "url": "https://i.redditmedia.com/lAlFWCwsbsO-nrYyUR1ZFxWAynbdk2rsCAZuLGGpcLE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=529bae5037115627163e4ba88fc96c7a", "width": 640}], "source": {"height": 406, "url": "https://i.redditmedia.com/lAlFWCwsbsO-nrYyUR1ZFxWAynbdk2rsCAZuLGGpcLE.jpg?s=977959a56a01404da2e171e39833d1bc", "width": 640}, "variants": {}}]}, "retrieved_on": 1497197253, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/hr3plaYMAEAQSoNVtx3aX3lLzdQclesIEwFGT7UbC-I.jpg", "thumbnail_height": 88, "thumbnail_width": 140, "title": "A Cancer Drug Unexpectedly Reduced Allergic Reactions By 90 Percent", "url": "http://www.medicaldaily.com/cancer-drug-reduced-ragweed-pet-allergies-90-percent-ibrutinib-shows-promise-417859"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1496190896, "domain": "bloodjournal.org", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ebg9r/impact_of_ibrutinib_dose_adherence_on_therapeutic/", "gilded": 0, "id": "6ebg9r", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 1, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ebg9r/impact_of_ibrutinib_dose_adherence_on_therapeutic/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "leaCPLQ5mmnvM4bjfCVanLoaC_IxpXzzk3ic-JxaU8Y", "resolutions": [{"height": 139, "url": "https://i.redditmedia.com/DBK2NBWdckLaosGNHnf1sm_HF6pd_MO_wzTM9_Ffoy4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=361c7a1959822de857bbaaa5354e6648", "width": 108}, {"height": 279, "url": "https://i.redditmedia.com/DBK2NBWdckLaosGNHnf1sm_HF6pd_MO_wzTM9_Ffoy4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=c6495dd7f01dffd27f867a6164ce31ec", "width": 216}, {"height": 414, "url": "https://i.redditmedia.com/DBK2NBWdckLaosGNHnf1sm_HF6pd_MO_wzTM9_Ffoy4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=3ad524a55566144cb51f41d4878a2b6e", "width": 320}, {"height": 828, "url": "https://i.redditmedia.com/DBK2NBWdckLaosGNHnf1sm_HF6pd_MO_wzTM9_Ffoy4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=a687965e9df12a6d96172f1cd05a0b0f", "width": 640}, {"height": 1242, "url": "https://i.redditmedia.com/DBK2NBWdckLaosGNHnf1sm_HF6pd_MO_wzTM9_Ffoy4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=9b15d99e1cd4c96f70a8899d1da09cae", "width": 960}, {"height": 1397, "url": "https://i.redditmedia.com/DBK2NBWdckLaosGNHnf1sm_HF6pd_MO_wzTM9_Ffoy4.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=17b08f35897f3b006c99bba9f9cc30a5", "width": 1080}], "source": {"height": 2376, "url": "https://i.redditmedia.com/DBK2NBWdckLaosGNHnf1sm_HF6pd_MO_wzTM9_Ffoy4.jpg?s=5aea96cd821ac9c366d89405342c4e2f", "width": 1836}, "variants": {}}]}, "retrieved_on": 1497197250, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/iju_xMVU_UDTw1oLrTvkxGJ9DADaJ3UyxU3KZ7kCNxE.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL", "url": "http://www.bloodjournal.org/content/129/19/2612?sso-checked=true"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1496190850, "domain": "lymphomahub.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ebg4s/iwcll_2017_ibrutinib_inhibits_cxcr4/", "gilded": 0, "id": "6ebg4s", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ebg4s/iwcll_2017_ibrutinib_inhibits_cxcr4/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "tBRA8zdPhk-qPvwV8O8vZEVtuP4_BxU-1zXIwms50Ac", "resolutions": [{"height": 68, "url": "https://i.redditmedia.com/I4iaxCD8elF8W4JOWiqlyPWrqbaJ0YfarxRMGu4B7Jw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=02914537406ed590f25489f06e5ceb79", "width": 108}, {"height": 136, "url": "https://i.redditmedia.com/I4iaxCD8elF8W4JOWiqlyPWrqbaJ0YfarxRMGu4B7Jw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=1362c95213ec839a0f9d5556e5de0fde", "width": 216}, {"height": 202, "url": "https://i.redditmedia.com/I4iaxCD8elF8W4JOWiqlyPWrqbaJ0YfarxRMGu4B7Jw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=5cee7eda01b49176a6a4e681ebb73ee0", "width": 320}, {"height": 405, "url": "https://i.redditmedia.com/I4iaxCD8elF8W4JOWiqlyPWrqbaJ0YfarxRMGu4B7Jw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=8976fd7ac7763788c848f75322a2513e", "width": 640}, {"height": 608, "url": "https://i.redditmedia.com/I4iaxCD8elF8W4JOWiqlyPWrqbaJ0YfarxRMGu4B7Jw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=a58978eb4bb4b646da8da40d117ccd12", "width": 960}, {"height": 684, "url": "https://i.redditmedia.com/I4iaxCD8elF8W4JOWiqlyPWrqbaJ0YfarxRMGu4B7Jw.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=a699665c79e87b80f0a16b9e5e6f684a", "width": 1080}], "source": {"height": 936, "url": "https://i.redditmedia.com/I4iaxCD8elF8W4JOWiqlyPWrqbaJ0YfarxRMGu4B7Jw.jpg?s=1da8e3bf844290c1119a467503085ca5", "width": 1477}, "variants": {}}]}, "retrieved_on": 1497197249, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/Ci8pZkkDvd0IIFQIvVwxoCUEdaY60BTh-bYiEHrJQG4.jpg", "thumbnail_height": 88, "thumbnail_width": 140, "title": "iwCLL 2017 - Ibrutinib inhibits CXCR4 expression/function and causes CLL cell death by neglect", "url": "http://www.lymphomahub.com/medical-information/ibrutinib-inhibits-cxcr4-expressionfunction-and-causes-cll-cell-death-by-neglect-presentation-at-iwcll-2017"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1496190826, "domain": "lymphomahub.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ebg1n/iwcll_2017_ibrutinib_inhibits_il4_production_by/", "gilded": 0, "id": "6ebg1n", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ebg1n/iwcll_2017_ibrutinib_inhibits_il4_production_by/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "0AgNIrmoCfU5BHUZaDbqxubgvpMns7dj_x-f3vntNwg", "resolutions": [{"height": 55, "url": "https://i.redditmedia.com/YA6-zTmvRqL8XRJh7wMsQ7qPVX3vl1Wzc01J-RcaUSE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=71a198c4c066b139fc52b6fb4d813e60", "width": 108}, {"height": 111, "url": "https://i.redditmedia.com/YA6-zTmvRqL8XRJh7wMsQ7qPVX3vl1Wzc01J-RcaUSE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=23f44919fe66d14b54a5be71f06b3e59", "width": 216}, {"height": 165, "url": "https://i.redditmedia.com/YA6-zTmvRqL8XRJh7wMsQ7qPVX3vl1Wzc01J-RcaUSE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=e903576cd77be0af47431acfd52c674c", "width": 320}, {"height": 330, "url": "https://i.redditmedia.com/YA6-zTmvRqL8XRJh7wMsQ7qPVX3vl1Wzc01J-RcaUSE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=504584d1fe34a8647a3fd98ca6aa9e50", "width": 640}, {"height": 495, "url": "https://i.redditmedia.com/YA6-zTmvRqL8XRJh7wMsQ7qPVX3vl1Wzc01J-RcaUSE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=f66682fe97ab2fa05c75264ae9d56d71", "width": 960}, {"height": 557, "url": "https://i.redditmedia.com/YA6-zTmvRqL8XRJh7wMsQ7qPVX3vl1Wzc01J-RcaUSE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=58b8c9229e4094ec4a78a4eb96379922", "width": 1080}], "source": {"height": 762, "url": "https://i.redditmedia.com/YA6-zTmvRqL8XRJh7wMsQ7qPVX3vl1Wzc01J-RcaUSE.jpg?s=2b8968ea3c516c431cb9b5a8a7a0240d", "width": 1477}, "variants": {}}]}, "retrieved_on": 1497197247, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/ox6RMzQxIdj8Z9umKRbeNJIyCVIvIl9MnECskgXNMzE.jpg", "thumbnail_height": 72, "thumbnail_width": 140, "title": "iwCLL 2017 - Ibrutinib inhibits IL-4 production by T-cells and expression of smIL-4R on CLL B-cells", "url": "http://www.lymphomahub.com/medical-information/ibrutinib-inhibits-il-4-production-by-t-cells-and-expression-of-smil-4r-on-cll-b-cells-presentation-at-iwcll-2017"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1496190740, "domain": "proactiveinvestors.co.uk", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ebfro/redx_pharma_plc_reveals_more_potent_efficacy_data/", "gilded": 0, "id": "6ebfro", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ebfro/redx_pharma_plc_reveals_more_potent_efficacy_data/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "yvlWWufNJP2JtD77grF1UWcUqX-4lhY_UEqc9wschkU", "resolutions": [{"height": 66, "url": "https://i.redditmedia.com/trDhp6wV7dQGAMr119FMZFZ5MLhRnX7VLLNlg-x_ya8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=cd3537dcb917f26aae1a8f0efef0394f", "width": 108}, {"height": 133, "url": "https://i.redditmedia.com/trDhp6wV7dQGAMr119FMZFZ5MLhRnX7VLLNlg-x_ya8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=e8e277017a3af5721b46b080a50628fe", "width": 216}, {"height": 198, "url": "https://i.redditmedia.com/trDhp6wV7dQGAMr119FMZFZ5MLhRnX7VLLNlg-x_ya8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=5fec602a3a97bc8a74a29129390de0ac", "width": 320}, {"height": 396, "url": "https://i.redditmedia.com/trDhp6wV7dQGAMr119FMZFZ5MLhRnX7VLLNlg-x_ya8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=541632c086198911fd8dbe06926283c2", "width": 640}], "source": {"height": 468, "url": "https://i.redditmedia.com/trDhp6wV7dQGAMr119FMZFZ5MLhRnX7VLLNlg-x_ya8.jpg?s=e2595a5191ede6f71ed252c4aa579f25", "width": 755}, "variants": {}}]}, "retrieved_on": 1497197244, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/Sl851V3SJObdGtfMKE2YYpISlxh-bFlEo2wdTKsDSDs.jpg", "thumbnail_height": 86, "thumbnail_width": 140, "title": "Redx Pharma PLC reveals more \u201cpotent efficacy data\u201d for leukaemia drug", "url": "http://www.proactiveinvestors.co.uk/companies/news/177774/redx-pharma-reveals-more-potent-efficacy-data-for-leukaemia-drug-177774.html"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1496190685, "domain": "military-technologies.net", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ebfkt/imbruvica_ibrutinib_pooled_outcomes_data_from/", "gilded": 0, "id": "6ebfkt", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 1, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ebfkt/imbruvica_ibrutinib_pooled_outcomes_data_from/", "retrieved_on": 1497197240, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "IMBRUVICA (ibrutinib) Pooled Outcomes Data from Three Phase 3 Studies Suggest Potential Clinical Efficacy in Patients with High-Risk CLL", "url": "http://www.military-technologies.net/2017/05/14/imbruvica-ibrutinib-pooled-outcomes-data-from-three-phase-3-studies-suggest-potential-clinical-efficacy-in-patients-with-high-risk-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma-cll/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1496171763, "domain": "nasdaq.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6e9i4y/abbvie_and_jj_present_positive_imbruvica_leukemia/", "gilded": 0, "id": "6e9i4y", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6e9i4y/abbvie_and_jj_present_positive_imbruvica_leukemia/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "dPgRp3fR1h_Kc_Ant1B2IiqIsd5973FZT1fw6TmXqhw", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/1-laLbtdpMtCGlBGedBwhb2NDGeLgdrw0VaZMwvd6no.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=d4d6c594f710134d660904bd81501866", "width": 108}, {"height": 216, "url": "https://i.redditmedia.com/1-laLbtdpMtCGlBGedBwhb2NDGeLgdrw0VaZMwvd6no.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=25496ff7dadef0f0069babe605ca9964", "width": 216}], "source": {"height": 300, "url": "https://i.redditmedia.com/1-laLbtdpMtCGlBGedBwhb2NDGeLgdrw0VaZMwvd6no.jpg?s=b801406435161bdbd0cb8847e23eeeaa", "width": 300}, "variants": {}}]}, "retrieved_on": 1497196281, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/Qq9bP118KLzMUk_yw0viKvxJGm-fU_OrbNm6xBoNaq0.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "AbbVie and J&amp;J Present Positive Imbruvica Leukemia Data", "url": "http://www.nasdaq.com/article/abbvie-and-jj-present-positive-imbruvica-leukemia-data-cm789249"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1496171642, "domain": "lymphomahub.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6e9hnm/risk_factors_linked_to_poor_outcomes_with_other/", "gilded": 0, "id": "6e9hnm", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 1, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6e9hnm/risk_factors_linked_to_poor_outcomes_with_other/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "j7OJGvKpRKEJ1d6anuVuwIg2kq9IfeghHUKrJk5f128", "resolutions": [{"height": 60, "url": "https://i.redditmedia.com/8SQGjMnWbTKmyf337O4pQqbI26XvohuvVlI273Mqrso.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=c5328990e3b921c0656ff533b0b9c3eb", "width": 108}, {"height": 121, "url": "https://i.redditmedia.com/8SQGjMnWbTKmyf337O4pQqbI26XvohuvVlI273Mqrso.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=d6d7d6b8b5bf7c03085e3c7c94419e27", "width": 216}, {"height": 179, "url": "https://i.redditmedia.com/8SQGjMnWbTKmyf337O4pQqbI26XvohuvVlI273Mqrso.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=d5438227758381880544682fa563eaea", "width": 320}, {"height": 358, "url": "https://i.redditmedia.com/8SQGjMnWbTKmyf337O4pQqbI26XvohuvVlI273Mqrso.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=1ee485c5ac321c409bee9fada2fce8d3", "width": 640}, {"height": 538, "url": "https://i.redditmedia.com/8SQGjMnWbTKmyf337O4pQqbI26XvohuvVlI273Mqrso.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=9e8c302cd5e835ab6f57c928d526f8be", "width": 960}, {"height": 605, "url": "https://i.redditmedia.com/8SQGjMnWbTKmyf337O4pQqbI26XvohuvVlI273Mqrso.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=30997d6caa5639f14b75242eb1636666", "width": 1080}], "source": {"height": 927, "url": "https://i.redditmedia.com/8SQGjMnWbTKmyf337O4pQqbI26XvohuvVlI273Mqrso.jpg?s=67ce4f33ea49885958502db4148be69a", "width": 1654}, "variants": {}}]}, "retrieved_on": 1497196274, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/Wd9eTew-bCw-8Ji4VUTzgFZ1cGm4lQr4B-9ARsSj2pk.jpg", "thumbnail_height": 78, "thumbnail_width": 140, "title": "risk factors linked to poor outcomes with other therapies may be irrelevant when predicting outcomes with ibrutinib \u2013 abstract presentation at iwCLL", "url": "http://www.lymphomahub.com/medical-information/resonate-resonate-2-and-helios-risk-factors-linked-to-poor-outcomes-with-other-therapies-may-be-irrelevant-when-predicting-outcomes-with-ibrutinib-abstract-presentation-at-iwcll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1496171555, "domain": "lymphomahub.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6e9hbz/iwcll_2017_baseline_left_atrial_abnormality/", "gilded": 0, "id": "6e9hbz", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6e9hbz/iwcll_2017_baseline_left_atrial_abnormality/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "Egpw0qnYWEVhJaDCB4jSPh_YZKVMvR7jP0AKE82qHhA", "resolutions": [{"height": 60, "url": "https://i.redditmedia.com/63xxRWwyW3XdDelKEXZoUuM28_JzPkssOyPhN6pgq4k.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=88eba4b381de1d20b437768c1bfb469b", "width": 108}, {"height": 121, "url": "https://i.redditmedia.com/63xxRWwyW3XdDelKEXZoUuM28_JzPkssOyPhN6pgq4k.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=93b9ce6506ca7a885d498991f8fc34d7", "width": 216}, {"height": 180, "url": "https://i.redditmedia.com/63xxRWwyW3XdDelKEXZoUuM28_JzPkssOyPhN6pgq4k.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=9f88449f3f355339965832966f44a2a5", "width": 320}, {"height": 361, "url": "https://i.redditmedia.com/63xxRWwyW3XdDelKEXZoUuM28_JzPkssOyPhN6pgq4k.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=2aecdac4f3803db1fecd7a9af05982c3", "width": 640}, {"height": 541, "url": "https://i.redditmedia.com/63xxRWwyW3XdDelKEXZoUuM28_JzPkssOyPhN6pgq4k.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=a2f5506cee6f09b2533c167b5b1081a0", "width": 960}, {"height": 609, "url": "https://i.redditmedia.com/63xxRWwyW3XdDelKEXZoUuM28_JzPkssOyPhN6pgq4k.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=fa2f2c28a09303c4a510031b38a107dd", "width": 1080}], "source": {"height": 933, "url": "https://i.redditmedia.com/63xxRWwyW3XdDelKEXZoUuM28_JzPkssOyPhN6pgq4k.jpg?s=d2545c742a662183cfd8afe62fd262f6", "width": 1654}, "variants": {}}]}, "retrieved_on": 1497196270, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/e_o_fPVgPj6LjoetMKYoSoqabfE7Zd3KKtS4lckiFC4.jpg", "thumbnail_height": 78, "thumbnail_width": 140, "title": "iwCLL 2017 - Baseline left atrial abnormality independently predicts atrial fibrillation in CLL patients treated with ibrutinib", "url": "http://www.lymphomahub.com/medical-information/baseline-left-atrial-abnormality-independently-predicts-atrial-fibrillation-in-cll-patients-treated-with-ibrutinib-presentation-at-iwcll-2017"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1496171506, "domain": "lymphomahub.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6e9h48/iwcll_2017_anticd19_cart_cell_therapy_with/", "gilded": 0, "id": "6e9h48", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6e9h48/iwcll_2017_anticd19_cart_cell_therapy_with/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "n5TXTMIUaPXhPyqtHo1nvADupV-v3Oh3R_ihZUbBjcI", "resolutions": [{"height": 66, "url": "https://i.redditmedia.com/uxLsYm2mveMvARxXq2F-JB0uULdV8Gc_3jWGu8U2l2Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=f01b4c691e4d4b2dacbac6d3ede16314", "width": 108}, {"height": 132, "url": "https://i.redditmedia.com/uxLsYm2mveMvARxXq2F-JB0uULdV8Gc_3jWGu8U2l2Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=cd2b6a7c1905a99de387bfe2f8daaea4", "width": 216}, {"height": 195, "url": "https://i.redditmedia.com/uxLsYm2mveMvARxXq2F-JB0uULdV8Gc_3jWGu8U2l2Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=cdce508673d0f3e8a4e4126e5ba17ef4", "width": 320}, {"height": 391, "url": "https://i.redditmedia.com/uxLsYm2mveMvARxXq2F-JB0uULdV8Gc_3jWGu8U2l2Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=caef6abfb448c8944c9ed8d919893ba5", "width": 640}, {"height": 586, "url": "https://i.redditmedia.com/uxLsYm2mveMvARxXq2F-JB0uULdV8Gc_3jWGu8U2l2Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=c2938b6d010550d2fa21c0d41f70193e", "width": 960}, {"height": 660, "url": "https://i.redditmedia.com/uxLsYm2mveMvARxXq2F-JB0uULdV8Gc_3jWGu8U2l2Y.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=d37c4a599a83ac89706e75869f60709a", "width": 1080}], "source": {"height": 1011, "url": "https://i.redditmedia.com/uxLsYm2mveMvARxXq2F-JB0uULdV8Gc_3jWGu8U2l2Y.jpg?s=3f035db606b9fd91d61b2bf187e5bea1", "width": 1654}, "variants": {}}]}, "retrieved_on": 1497196267, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/Jt5-_REm5fvQrH0A-xC-npCgUpsocRCsNUcdNlk6FQQ.jpg", "thumbnail_height": 85, "thumbnail_width": 140, "title": "iwCLL 2017 - anti-CD19 CAR-T cell therapy with defined T-cell subsets for ibrutinib-refractory CLL", "url": "http://www.lymphomahub.com/medical-information/anti-cd19-car-t-cell-therapy-with-defined-t-cell-subsets-for-ibrutinib-refractory-cll-presentation-at-iwcll-2017"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1496171472, "domain": "baystreet.ca", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6e9gzb/arqule_stock_up_28_on_lab_data_for_bcell_lymphoma/", "gilded": 0, "id": "6e9gzb", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6e9gzb/arqule_stock_up_28_on_lab_data_for_bcell_lymphoma/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "AoJLkW5t2wSAzVQzCkqSvQxrqyW7GRYfEt4zJ0WF8lM", "resolutions": [{"height": 42, "url": "https://i.redditmedia.com/Db_CZvbXWrqotQIbCEETbpKOAIxjF-Y0Tu_C4Y3Ejng.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=0345edab00062dde7f08b52ca0553469", "width": 108}, {"height": 84, "url": "https://i.redditmedia.com/Db_CZvbXWrqotQIbCEETbpKOAIxjF-Y0Tu_C4Y3Ejng.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=1c055d1820ebcb38c4cd5c8f25710f4c", "width": 216}, {"height": 125, "url": "https://i.redditmedia.com/Db_CZvbXWrqotQIbCEETbpKOAIxjF-Y0Tu_C4Y3Ejng.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=e910760d49d719b61c4b409bc7be2f10", "width": 320}, {"height": 250, "url": "https://i.redditmedia.com/Db_CZvbXWrqotQIbCEETbpKOAIxjF-Y0Tu_C4Y3Ejng.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=5e186f14ba2201858a9719184af7dc10", "width": 640}, {"height": 375, "url": "https://i.redditmedia.com/Db_CZvbXWrqotQIbCEETbpKOAIxjF-Y0Tu_C4Y3Ejng.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=cf5e6e5d2b10a9487e936aa9125837aa", "width": 960}], "source": {"height": 400, "url": "https://i.redditmedia.com/Db_CZvbXWrqotQIbCEETbpKOAIxjF-Y0Tu_C4Y3Ejng.jpg?s=4fa1f315f6b8a1bca910ad61086e13af", "width": 1024}, "variants": {}}]}, "retrieved_on": 1497196265, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/Es3_SOa9CCvTziCVCiqzis5Hrnkjng9rBSiGHudq8jU.jpg", "thumbnail_height": 54, "thumbnail_width": 140, "title": "ArQule Stock Up 28% on Lab Data for B-Cell Lymphoma Drug", "url": "http://www.baystreet.ca/articles/stockstowatch.aspx?id=1827"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1496171356, "domain": "lymphomahub.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6e9gjh/iwcll_2017_life_after_ibrutinib_for_cll_patients/", "gilded": 0, "id": "6e9gjh", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6e9gjh/iwcll_2017_life_after_ibrutinib_for_cll_patients/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "UhgRdoyRZshabM2HipRERMTcKMCEbTBQ5QL7DE0vfGU", "resolutions": [{"height": 59, "url": "https://i.redditmedia.com/wlxRuv0qEAQrHMQmvLqARB6PYn94BN3w0oSr33-Ii_E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=242b50bd197428210b8120a432c52cdc", "width": 108}, {"height": 118, "url": "https://i.redditmedia.com/wlxRuv0qEAQrHMQmvLqARB6PYn94BN3w0oSr33-Ii_E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=f01a33e9e0d6e492c3fe7848cc85f84c", "width": 216}, {"height": 175, "url": "https://i.redditmedia.com/wlxRuv0qEAQrHMQmvLqARB6PYn94BN3w0oSr33-Ii_E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=99b1f768ad10c32fa0850bcd228f940b", "width": 320}, {"height": 351, "url": "https://i.redditmedia.com/wlxRuv0qEAQrHMQmvLqARB6PYn94BN3w0oSr33-Ii_E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=fbb86ebdf7decdbd0455dfddffa1e80d", "width": 640}, {"height": 527, "url": "https://i.redditmedia.com/wlxRuv0qEAQrHMQmvLqARB6PYn94BN3w0oSr33-Ii_E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=3d944c9f938f3d82dd223f254a82d27d", "width": 960}, {"height": 593, "url": "https://i.redditmedia.com/wlxRuv0qEAQrHMQmvLqARB6PYn94BN3w0oSr33-Ii_E.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=b5d96bb9eb29259df0bf3968f113da74", "width": 1080}], "source": {"height": 909, "url": "https://i.redditmedia.com/wlxRuv0qEAQrHMQmvLqARB6PYn94BN3w0oSr33-Ii_E.jpg?s=8a24bde5f5c7b69066c45690b57d36bb", "width": 1653}, "variants": {}}]}, "retrieved_on": 1497196259, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/2RM-KkJXKptasPeWI1D19NHTrK1IdkodnbFjKlpoBfM.jpg", "thumbnail_height": 76, "thumbnail_width": 140, "title": "iwCLL 2017 - life after ibrutinib for CLL patients: Pre-clinical and clinical studies", "url": "http://www.lymphomahub.com/medical-information/life-after-ibrutinib-pre-clinical-and-clinical-studies-presentation-at-iwcll-2017"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1496171296, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6e9gbj/ibrutinib_provides_longterm_benefits_for_patients/", "gilded": 0, "id": "6e9gbj", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6e9gbj/ibrutinib_provides_longterm_benefits_for_patients/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "GJCBcqO2ek1HEEiRpuF_h822DdZxMin6Pe5uK_byWMg", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/7gWye--MUBnJbPQodBVr_C0VwhEUILF_owcT6rGF8qc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=c3801ae008d7c92f91c15d7d67e1245f", "width": 108}, {"height": 143, "url": "https://i.redditmedia.com/7gWye--MUBnJbPQodBVr_C0VwhEUILF_owcT6rGF8qc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=e7ec5072cbc28d2e99a8ae1bcd3e25e3", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/7gWye--MUBnJbPQodBVr_C0VwhEUILF_owcT6rGF8qc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=bf4079774d28847fe9d3a13aea9e87d6", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/7gWye--MUBnJbPQodBVr_C0VwhEUILF_owcT6rGF8qc.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=f6075b168429e1f3da0df63a30973e22", "width": 640}], "source": {"height": 483, "url": "https://i.redditmedia.com/7gWye--MUBnJbPQodBVr_C0VwhEUILF_owcT6rGF8qc.jpg?s=30cc8ee6f6222939bbe1f4fe34753f50", "width": 725}, "variants": {}}]}, "retrieved_on": 1497196256, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/CCbE6BT3ibHUMh5N-g_cbDDqjgcFZN1Ue0t-_daRTjg.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "Ibrutinib Provides Long-term Benefits for Patients With CLL", "url": "http://www.cancertherapyadvisor.com/asco-2017/chronic-leukemia-cll-ibrutinib-long-term-benefits/article/663921/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1496171201, "domain": "healio.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6e9fy7/selective_brutons_tyrosine_kinase_inhibitor_shows/", "gilded": 0, "id": "6e9fy7", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6e9fy7/selective_brutons_tyrosine_kinase_inhibitor_shows/", "retrieved_on": 1497196251, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Selective Bruton's tyrosine kinase inhibitor shows long-term safety, efficacy in CLL", "url": "http://www.healio.com/hematology-oncology/leukemia/news/in-the-journals/%7Bac0c2a23-9f84-45c4-870b-0cdbb7caf3ce%7D/selective-brutons-tyrosine-kinase-inhibitor-shows-long-term-safety-efficacy-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1496171113, "domain": "mdedge.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6e9flo/ecg_finding_predicts_afib_in_ibrutinibtreated_cll/", "gilded": 0, "id": "6e9flo", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6e9flo/ecg_finding_predicts_afib_in_ibrutinibtreated_cll/", "retrieved_on": 1497196247, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "ECG finding predicts AFib in ibrutinib-treated CLL", "url": "http://www.mdedge.com/hematologynews/article/138894/cll/ecg-finding-predicts-afib-ibrutinib-treated-cll"}, {"author": "KongFuPanda", "author_created_utc": 1344977704, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_8o4e3", "brand_safe": false, "contest_mode": false, "created_utc": 1495358349, "domain": "lymphomahub.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6cfoly/on_the_origin_of_cll_evolution_presentation_at/", "gilded": 0, "id": "6cfoly", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6cfoly/on_the_origin_of_cll_evolution_presentation_at/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "hPLNLsS51piJc-WRPj3RR8CFojCNaco9LDycQGKqefk", "resolutions": [{"height": 61, "url": "https://i.redditmedia.com/T5gN26TcQea_KSvInaFtOdT5YZBSO9d_biP-GZfa9Dg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=6cdc5a21356c90c6a8489f2f65f03228", "width": 108}, {"height": 123, "url": "https://i.redditmedia.com/T5gN26TcQea_KSvInaFtOdT5YZBSO9d_biP-GZfa9Dg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=4985dcbc1c4debed35c1b325fbc4cb9f", "width": 216}, {"height": 182, "url": "https://i.redditmedia.com/T5gN26TcQea_KSvInaFtOdT5YZBSO9d_biP-GZfa9Dg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=513fcf5c287fd269909d3a08828461ed", "width": 320}, {"height": 365, "url": "https://i.redditmedia.com/T5gN26TcQea_KSvInaFtOdT5YZBSO9d_biP-GZfa9Dg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=ad4e84cd790c9919c8a95a3b1e2a4ef3", "width": 640}, {"height": 548, "url": "https://i.redditmedia.com/T5gN26TcQea_KSvInaFtOdT5YZBSO9d_biP-GZfa9Dg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=363759b31c28c024bb21c12c2849c657", "width": 960}, {"height": 616, "url": "https://i.redditmedia.com/T5gN26TcQea_KSvInaFtOdT5YZBSO9d_biP-GZfa9Dg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=cd5ecd12841f609c015325aa7a9fdf6c", "width": 1080}], "source": {"height": 944, "url": "https://i.redditmedia.com/T5gN26TcQea_KSvInaFtOdT5YZBSO9d_biP-GZfa9Dg.jpg?s=5dfdbac0da03185c92c9d4353a46eee4", "width": 1653}, "variants": {}}]}, "retrieved_on": 1497163411, "score": 3, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/dGNCNGjlD7PkHQzLsyyWALZfpNkBK7JpH6kJFkiJeUY.jpg", "thumbnail_height": 79, "thumbnail_width": 140, "title": "On the Origin of CLL Evolution \u2013 presentation at iwCLL 2017", "url": "http://www.lymphomahub.com/medical-information/on-the-origin-of-cll-evolution-presentation-at-iwcll-2017"}, {"author": "KongFuPanda", "author_created_utc": 1344977704, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_8o4e3", "brand_safe": false, "contest_mode": false, "created_utc": 1495357566, "domain": "lymphomahub.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6cfna5/revised_iwcll_guidelines_for_the_approach_to_a/", "gilded": 0, "id": "6cfna5", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6cfna5/revised_iwcll_guidelines_for_the_approach_to_a/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "nt_-5O3-LsmP_1a_hlHRGXTcg2Pus5K4sm3cYmERllE", "resolutions": [{"height": 64, "url": "https://i.redditmedia.com/Q45JjvIgQlOBz1AlmrsQEVPONW7Cui-9uEtwD7pq71M.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=c543ddc1c7889fb2a816e32d53628fa1", "width": 108}, {"height": 129, "url": "https://i.redditmedia.com/Q45JjvIgQlOBz1AlmrsQEVPONW7Cui-9uEtwD7pq71M.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=c47d3267a4c70a1ad1386ccebe61078d", "width": 216}, {"height": 192, "url": "https://i.redditmedia.com/Q45JjvIgQlOBz1AlmrsQEVPONW7Cui-9uEtwD7pq71M.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=da25889a972fecb8165a14e32fc1cb33", "width": 320}, {"height": 384, "url": "https://i.redditmedia.com/Q45JjvIgQlOBz1AlmrsQEVPONW7Cui-9uEtwD7pq71M.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=2db212a47a4c93a740483a2b892519da", "width": 640}, {"height": 576, "url": "https://i.redditmedia.com/Q45JjvIgQlOBz1AlmrsQEVPONW7Cui-9uEtwD7pq71M.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=0697e534fc4d94162cb3f0499810641c", "width": 960}, {"height": 648, "url": "https://i.redditmedia.com/Q45JjvIgQlOBz1AlmrsQEVPONW7Cui-9uEtwD7pq71M.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=2c1504c59cd3cd0d0251e25cfc04eade", "width": 1080}], "source": {"height": 993, "url": "https://i.redditmedia.com/Q45JjvIgQlOBz1AlmrsQEVPONW7Cui-9uEtwD7pq71M.jpg?s=8bfb9ebafe4adf06090baa8f9903cb75", "width": 1654}, "variants": {}}]}, "retrieved_on": 1497163393, "score": 3, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/DpLatnCFH3ORqUOTlJtPyvJGy4Kdx1tEWUm9X9cjI7I.jpg", "thumbnail_height": 84, "thumbnail_width": 140, "title": "Revised iwCLL guidelines for the approach to a CLL patient \u2013 presentation at iwCLL 2017", "url": "http://www.lymphomahub.com/medical-information/revised-iwcll-guidelines-for-the-approach-to-a-cll-patient-presentation-at-iwcll-2017"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1494534613, "domain": "nps.org.au", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ams8j/venetoclax_for_chronic_lymphocytic_leukaemia/", "gilded": 0, "id": "6ams8j", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ams8j/venetoclax_for_chronic_lymphocytic_leukaemia/", "retrieved_on": 1497131384, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Venetoclax for chronic lymphocytic leukaemia", "url": "https://www.nps.org.au/australian-prescriber/articles/venetoclax-for-chronic-lymphocytic-leukaemia"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1494479128, "domain": "cordis.europa.eu", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ai462/european_commission_cordis_news_and_events/", "gilded": 0, "id": "6ai462", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ai462/european_commission_cordis_news_and_events/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "8AcB88i935NRc_2OEKFafH9IBEEufeJOAatvlPPxP5E", "resolutions": [{"height": 81, "url": "https://i.redditmedia.com/BNV7HL4ujDpOBLk8enepeasL4b2y3PT1snJ1Jlal4Ac.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=16493650fe56036c4ff39278622da522", "width": 108}, {"height": 162, "url": "https://i.redditmedia.com/BNV7HL4ujDpOBLk8enepeasL4b2y3PT1snJ1Jlal4Ac.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=55cf45e807df8528cd6a2bb455484074", "width": 216}], "source": {"height": 188, "url": "https://i.redditmedia.com/BNV7HL4ujDpOBLk8enepeasL4b2y3PT1snJ1Jlal4Ac.jpg?s=124d251a45dc67c17a4beeadcc6e45eb", "width": 250}, "variants": {}}]}, "retrieved_on": 1497073277, "score": 3, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/mdzkHao6auFqm26jcOHsAFV1zZh1-OxG0e5NXNJGUN4.jpg", "thumbnail_height": 105, "thumbnail_width": 140, "title": "European Commission : CORDIS : News and Events : Genetic Events in Chronic Lymphocytic Leukemia", "url": "http://cordis.europa.eu/news/rcn/140615_en.html"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1494479075, "domain": "lymphomahub.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ai40z/positive_opinion_given_by_the_ema_chmp_to_the/", "gilded": 0, "id": "6ai40z", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 1, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ai40z/positive_opinion_given_by_the_ema_chmp_to_the/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "99B7m-9LtiLgHyZwF__X_O7NH_LTehvLjnM_wP2f2RQ", "resolutions": [{"height": 56, "url": "https://i.redditmedia.com/v0ry8W9vcMNZeOIiORnosnBUharqMft32OM6tzHiWbk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=cdda11d4c5201f90f5adfca9b8cd92fc", "width": 108}, {"height": 113, "url": "https://i.redditmedia.com/v0ry8W9vcMNZeOIiORnosnBUharqMft32OM6tzHiWbk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=c058e3424ff40bd4205fd10fdd93cf01", "width": 216}, {"height": 168, "url": "https://i.redditmedia.com/v0ry8W9vcMNZeOIiORnosnBUharqMft32OM6tzHiWbk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=49e58d11137d60e2bbf544cfb61e9cb9", "width": 320}, {"height": 336, "url": "https://i.redditmedia.com/v0ry8W9vcMNZeOIiORnosnBUharqMft32OM6tzHiWbk.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=51ec2a0cd7332f367939a85677200c6c", "width": 640}], "source": {"height": 371, "url": "https://i.redditmedia.com/v0ry8W9vcMNZeOIiORnosnBUharqMft32OM6tzHiWbk.jpg?s=7ad54d11cbed31c40e4f8d91ad390a96", "width": 706}, "variants": {}}]}, "retrieved_on": 1497073274, "score": 3, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/OU2Eb2LCOBVGgr36mEmqQFbWuki_T8YY-Si9fo7szio.jpg", "thumbnail_height": 73, "thumbnail_width": 140, "title": "Positive opinion\u2019 given by the EMA CHMP to the rituximab biosimilar rixathon for the treatment of Chronic Lymphocytic Leukemia", "url": "http://www.lymphomahub.com/medical-information/rituximab-biosimilar-rixathon-given-positive-opinion-by-the-ema-chmp-for-use-in-follicular-and-diffuse-large-b-cell-lymphoma-and-chronic-lymphocytic-leukemia"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1494478954, "domain": "lymphomahub.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ai3ov/updated_results_of_a_phase_iii_trial_idelalisib/", "gilded": 0, "id": "6ai3ov", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 1, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ai3ov/updated_results_of_a_phase_iii_trial_idelalisib/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "w3udqu2111-bdmoXEvY3cslcUtDr7gLwrjFqQbdgDhg", "resolutions": [{"height": 56, "url": "https://i.redditmedia.com/5BUDVVE85s638BnbK6XOaJ0tOL_ggPrriu0zE0cRgVs.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=61b97e83fc759a050b0bfb326a26777d", "width": 108}, {"height": 113, "url": "https://i.redditmedia.com/5BUDVVE85s638BnbK6XOaJ0tOL_ggPrriu0zE0cRgVs.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=aa69fd55b053f43dbbd02efbdf1cfcc4", "width": 216}, {"height": 168, "url": "https://i.redditmedia.com/5BUDVVE85s638BnbK6XOaJ0tOL_ggPrriu0zE0cRgVs.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=9b8f61036d6da92c2714411c113fb8e5", "width": 320}, {"height": 336, "url": "https://i.redditmedia.com/5BUDVVE85s638BnbK6XOaJ0tOL_ggPrriu0zE0cRgVs.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=f658b874bdd079c9c8e1cd9198397baf", "width": 640}], "source": {"height": 371, "url": "https://i.redditmedia.com/5BUDVVE85s638BnbK6XOaJ0tOL_ggPrriu0zE0cRgVs.jpg?s=98fecd96d0a8765f7ab6c6b35b213f61", "width": 706}, "variants": {}}]}, "retrieved_on": 1497073270, "score": 3, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/aFutv1qKbtNUBpFd4m22yb6xqAJMvVAyalcqlQ65fdI.jpg", "thumbnail_height": 73, "thumbnail_width": 140, "title": "Updated results of a phase III trial: idelalisib combined with ofatumumab is safe and effective in relapsed Chronic Lymphocytic Leukemia patients", "url": "http://www.lymphomahub.com/medical-information/idelalisib-combined-with-ofatumumab-is-safe-and-effective-in-relapsed-chronic-lymphocytic-leukemia-patients-updated-results-of-a-phase-iii-trial"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1494478861, "domain": "bloodjournal.org", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6ai3hi/ventricular_arrhythmias_and_sudden_death_in/", "gilded": 0, "id": "6ai3hi", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6ai3hi/ventricular_arrhythmias_and_sudden_death_in/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "XqUtWXAjlNCc0yBsQscBA2XZGUDj8iMRPEqY_ASaaiw", "resolutions": [{"height": 139, "url": "https://i.redditmedia.com/-6lU7IQv3hTIm3vPn-YIMy1ux17PTvMv43hW6fzBR3s.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=951a57c81ba04edc4da220087fa1db12", "width": 108}, {"height": 279, "url": "https://i.redditmedia.com/-6lU7IQv3hTIm3vPn-YIMy1ux17PTvMv43hW6fzBR3s.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=065a30e437994f02e2de90443102dcad", "width": 216}, {"height": 414, "url": "https://i.redditmedia.com/-6lU7IQv3hTIm3vPn-YIMy1ux17PTvMv43hW6fzBR3s.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=15cc3c92c81dcfffa0916ad6cee79b05", "width": 320}, {"height": 828, "url": "https://i.redditmedia.com/-6lU7IQv3hTIm3vPn-YIMy1ux17PTvMv43hW6fzBR3s.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=1ab43c4d07e58dc02f3483fa1f3a98c9", "width": 640}, {"height": 1242, "url": "https://i.redditmedia.com/-6lU7IQv3hTIm3vPn-YIMy1ux17PTvMv43hW6fzBR3s.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=6e52943264813945fb0bd0b233310d79", "width": 960}, {"height": 1397, "url": "https://i.redditmedia.com/-6lU7IQv3hTIm3vPn-YIMy1ux17PTvMv43hW6fzBR3s.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=1080&amp;s=1ac18b6279516ce8ab1b175827699745", "width": 1080}], "source": {"height": 2376, "url": "https://i.redditmedia.com/-6lU7IQv3hTIm3vPn-YIMy1ux17PTvMv43hW6fzBR3s.jpg?s=28e97dee8b22f9b7244a2624739af33b", "width": 1836}, "variants": {}}]}, "retrieved_on": 1497073267, "score": 3, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/OnA08-ucHG-E8lTmLEfC2tbozPTHOrIuIFho3u2Ba30.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Ventricular arrhythmias and sudden death in patients taking ibrutinib", "url": "http://www.bloodjournal.org/content/129/18/2581?sso-checked=true"}, {"author": "KongFuPanda", "author_created_utc": 1344977704, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_8o4e3", "brand_safe": false, "contest_mode": false, "created_utc": 1494358533, "domain": "targetedonc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6a7p80/investigators_set_sights_on_combinations_for/", "gilded": 0, "id": "6a7p80", "is_self": false, "is_video": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6a7p80/investigators_set_sights_on_combinations_for/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "XM_RjMlUF9pfEX0raaO0HDgrS9PwTWm5q9RS-r8Crq8", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=8b8bdfe16d31a7b36f7f6995991b63ca", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?s=c1fa7073f91a3a13437fb6762069e070", "width": 200}, "variants": {}}]}, "retrieved_on": 1497068127, "score": 3, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/eKJX3g3nW4sMKa-L9-GojnP5eT-IslpE-9O05fvKICo.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Investigators Set Sights on Combinations for Frontline CLL Treatment", "url": "http://www.targetedonc.com/news/investigators-set-sights-on-combinations-for-frontline-cll-treatment"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1493564936, "domain": "clinicaloncology.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/68fwac/ibrutinib_controls_chronic_gvhd_after_steroids/", "gilded": 0, "id": "68fwac", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/68fwac/ibrutinib_controls_chronic_gvhd_after_steroids/", "retrieved_on": 1494650722, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Ibrutinib Controls Chronic GVHD After Steroids Fail", "url": "http://www.clinicaloncology.com/Hematologic-Malignancies/Article/04-17/Ibrutinib-Controls-Chronic-GVHD-After-Steroids-Fail/40941"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1493564888, "domain": "news-medical.net", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/68fw5v/scientists_announce_outstanding_results_of_new/", "gilded": 0, "id": "68fw5v", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/68fw5v/scientists_announce_outstanding_results_of_new/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "tXB99omiB6DbEaroOCGyiem-_j5XxtKfmaN0U-tfyUA", "resolutions": [{"height": 83, "url": "https://i.redditmedia.com/amzOHefIwabOlr0zXChsqk9wW5UGmMBi4hrOne8NLBQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=bb621784846e06a82a2351e5e8a595cb", "width": 108}, {"height": 167, "url": "https://i.redditmedia.com/amzOHefIwabOlr0zXChsqk9wW5UGmMBi4hrOne8NLBQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=b7c58cb0ed8e73679201d92ab88f4425", "width": 216}, {"height": 247, "url": "https://i.redditmedia.com/amzOHefIwabOlr0zXChsqk9wW5UGmMBi4hrOne8NLBQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=b48f951b4152ec472fe32998a9c9d1e2", "width": 320}], "source": {"height": 480, "url": "https://i.redditmedia.com/amzOHefIwabOlr0zXChsqk9wW5UGmMBi4hrOne8NLBQ.jpg?s=6545c61fcd4117f9001847d20c56f2a7", "width": 620}, "variants": {}}]}, "retrieved_on": 1494650720, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/ePyILETsdLlCczavDhindKsVJO1hd8GGVgMLdo03L0Y.jpg", "thumbnail_height": 108, "thumbnail_width": 140, "title": "Scientists announce \u2018outstanding\u2019 results of new blood cancer study", "url": "http://www.news-medical.net/news/20170427/Scientists-announce-e28098outstandinge28099-results-of-new-blood-cancer-study.aspx"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1493174853, "domain": "figshare.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/67lezo/duvelisib_a_phosphoinositide3_kinase_\u03b4\u03b3_inhibitor/", "gilded": 0, "id": "67lezo", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 1, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/67lezo/duvelisib_a_phosphoinositide3_kinase_\u03b4\u03b3_inhibitor/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "N8uTIWG7dMg0Wa3v43gA5yS2ajKGIzMipfpE5tnjrvo", "resolutions": [{"height": 139, "url": "https://i.redditmedia.com/yX5LWb2wPR1_dApjSUsQYyu-rdMwZ4pEetEfzpoGusE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=4806df9180918e0a64d709fd0351a692", "width": 108}, {"height": 279, "url": "https://i.redditmedia.com/yX5LWb2wPR1_dApjSUsQYyu-rdMwZ4pEetEfzpoGusE.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=4b94fad5b45255f454a8ee493392da13", "width": 216}], "source": {"height": 324, "url": "https://i.redditmedia.com/yX5LWb2wPR1_dApjSUsQYyu-rdMwZ4pEetEfzpoGusE.jpg?s=0b230edb5343737c38d3fa2879c0b352", "width": 250}, "variants": {}}]}, "retrieved_on": 1494635363, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/7_F96CEXEuRlcLZEV0xkFHenCPXXQ2d5ITXr38Wn_YQ.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Duvelisib: a phosphoinositide-3 kinase \u03b4/\u03b3 inhibitor for chronic lymphocytic leukemia", "url": "https://figshare.com/articles/Duvelisib_a_phosphoinositide-3_kinase_inhibitor_for_chronic_lymphocytic_leukemia/4903166"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1493174308, "domain": "economiccalendar.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/67ldbn/jefferies_begins_coverage_on_tg_therapeutics_tgtx/", "gilded": 0, "id": "67ldbn", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/67ldbn/jefferies_begins_coverage_on_tg_therapeutics_tgtx/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "GheTIvct9KPmWjZoB1xmtssPUwUITAbCpKTFMgoypyY", "resolutions": [{"height": 67, "url": "https://i.redditmedia.com/rEIhQetP9MyRbFA04ITSrmeabFK_sjDIHKTZvRgKhuA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=b8a193f90481ecaf955d0d9c2d5014bc", "width": 108}, {"height": 134, "url": "https://i.redditmedia.com/rEIhQetP9MyRbFA04ITSrmeabFK_sjDIHKTZvRgKhuA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=5422912f5e1cb4485fb50af323e74848", "width": 216}, {"height": 199, "url": "https://i.redditmedia.com/rEIhQetP9MyRbFA04ITSrmeabFK_sjDIHKTZvRgKhuA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=0fd19b7846c7bb6c37fdf0d53a9a87c6", "width": 320}, {"height": 398, "url": "https://i.redditmedia.com/rEIhQetP9MyRbFA04ITSrmeabFK_sjDIHKTZvRgKhuA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=e09515c1b4300a93593847337e1d3794", "width": 640}], "source": {"height": 560, "url": "https://i.redditmedia.com/rEIhQetP9MyRbFA04ITSrmeabFK_sjDIHKTZvRgKhuA.jpg?s=9b90930cdb67de02086551f7250f0b50", "width": 900}, "variants": {}}]}, "retrieved_on": 1494635341, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/Npb6zglg2FqesAzM8qjVrMhJX1e1B-YuaHN5D64B0SY.jpg", "thumbnail_height": 87, "thumbnail_width": 140, "title": "Jefferies Begins Coverage On TG Therapeutics (TGTX) With Buy Rating", "url": "http://www.economiccalendar.com/2017/04/25/jefferies-begins-coverage-on-tg-therapeutics-tgtx-with-buy-rating/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1493164481, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/67khss/complete_response_to_chemo_critical_in_cll/", "gilded": 0, "id": "67khss", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/67khss/complete_response_to_chemo_critical_in_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "-d8fKd-8LriRoJ73obz9rrHNmkR-FSuoa6zZv7tMQA0", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/AbrzdQ9ztLknCxB7NGWYUquxvWnTxtr8zvetTWTQoDA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=5de7979d9ef8fc03b1a571573bcd1ffe", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/AbrzdQ9ztLknCxB7NGWYUquxvWnTxtr8zvetTWTQoDA.jpg?s=85fe46d5ee339ca02a020879543ae63d", "width": 200}, "variants": {}}]}, "retrieved_on": 1494634904, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/wrKljUghuwf1VidAfR9cJE4gNv1A-Vyg_keriH8jQV8.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Complete Response to Chemo Critical in CLL Patients Who Develop Hodgkin Lymphoma", "url": "http://www.onclive.com/web-exclusives/complete-response-to-chemo-critical-in-cll-patients-who-develop-hodgkin-lymphoma"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1492964603, "domain": "benzinga.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6733ky/physician_views_offlabel_use_a_doubleedged_sword/", "gilded": 0, "id": "6733ky", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6733ky/physician_views_offlabel_use_a_doubleedged_sword/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "eCyp1UIHbWfwbDBPLCOHkSwlgUXRzD9X2O0NQO1aJSk", "resolutions": [{"height": 81, "url": "https://i.redditmedia.com/jUyED9ITkHcFEI0NW4YwBVgWHouxrEdH9aPMA-4ZKEg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=9f8e29d33eb95945ccc3835b13f07a5a", "width": 108}, {"height": 162, "url": "https://i.redditmedia.com/jUyED9ITkHcFEI0NW4YwBVgWHouxrEdH9aPMA-4ZKEg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=278cdffaa12e331a443680680e228dc7", "width": 216}, {"height": 240, "url": "https://i.redditmedia.com/jUyED9ITkHcFEI0NW4YwBVgWHouxrEdH9aPMA-4ZKEg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=0c2288d74e1ecc59db83438dc78d74c9", "width": 320}], "source": {"height": 300, "url": "https://i.redditmedia.com/jUyED9ITkHcFEI0NW4YwBVgWHouxrEdH9aPMA-4ZKEg.jpg?s=1ba4565fb08c44a3676c6aa2a3b547d1", "width": 400}, "variants": {}}]}, "retrieved_on": 1494626301, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/GtVJH0QSTg1utwQjFYpV5XKHlAXZaQVp82afxzMpk9Y.jpg", "thumbnail_height": 105, "thumbnail_width": 140, "title": "Physician Views Off-Label Use A 'Double-Edged Sword' For TG Therapeutics", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/17/04/9329393/physician-views-off-label-use-a-double-edged-sword-for-t"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1492964314, "domain": "bloodjournal.org", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6732lv/pembrolizumab_in_cll_patients_with_richters/", "gilded": 0, "id": "6732lv", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6732lv/pembrolizumab_in_cll_patients_with_richters/", "retrieved_on": 1494626288, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Pembrolizumab in CLL patients with Richter's transformation and relapsed CLL", "url": "http://www.bloodjournal.org/content/early/2017/04/19/blood-2017-02-765685?sso-checked=true"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1492964243, "domain": "targetedonc.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6732dy/study_finds_longer_survival_seen_with_ibrutinib/", "gilded": 0, "id": "6732dy", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6732dy/study_finds_longer_survival_seen_with_ibrutinib/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "XM_RjMlUF9pfEX0raaO0HDgrS9PwTWm5q9RS-r8Crq8", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=8b8bdfe16d31a7b36f7f6995991b63ca", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/RmMNnhI3cTt_WpH42zmSROAcaPyhzsy7mE3DsTdiyGI.jpg?s=c1fa7073f91a3a13437fb6762069e070", "width": 200}, "variants": {}}]}, "retrieved_on": 1494626285, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/x_QQZWKh9_tGPdvR0iJROxtNYyddB2Ijwe0xMBWHrSc.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Study Finds Longer Survival Seen With Ibrutinib Discontinuation Due to Toxicities", "url": "http://www.targetedonc.com/news/study-finds-longer-survival-seen-with-ibrutinib-discontinuation-due-to-toxicities"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1492964194, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/67328f/ibrutinib_better_than_bendamustine_for_os_in_cll/", "gilded": 0, "id": "67328f", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/67328f/ibrutinib_better_than_bendamustine_for_os_in_cll/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "-d8fKd-8LriRoJ73obz9rrHNmkR-FSuoa6zZv7tMQA0", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/AbrzdQ9ztLknCxB7NGWYUquxvWnTxtr8zvetTWTQoDA.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=5de7979d9ef8fc03b1a571573bcd1ffe", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/AbrzdQ9ztLknCxB7NGWYUquxvWnTxtr8zvetTWTQoDA.jpg?s=85fe46d5ee339ca02a020879543ae63d", "width": 200}, "variants": {}}]}, "retrieved_on": 1494626283, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/vKqSaLBagEVb1dX8Dj5PVX3zXOvvslzmuTcU6kUIN5c.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Ibrutinib Better Than Bendamustine for OS in CLL, Indirect Comparison Suggests", "url": "http://www.onclive.com/web-exclusives/ibrutinib-better-than-bendamustine-for-os-in-cll-indirection-comparison-suggests"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1492964121, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6731zw/dr_parikh_on_the_optimal_frontline_therapy_for/", "gilded": 0, "id": "6731zw", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6731zw/dr_parikh_on_the_optimal_frontline_therapy_for/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "2zlUW9NBGF3sfzzISA-Wa4j3CrMQ-_gs4HrwFTFnX64", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/8lrLB_-wgOIsjO_B39ysSClNT3FHIlOGWOmkQafdSP8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=39a37d6c91fec3651238c29348eea71a", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/8lrLB_-wgOIsjO_B39ysSClNT3FHIlOGWOmkQafdSP8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=31403d5c7e0abc65f978b90b8681202a", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/8lrLB_-wgOIsjO_B39ysSClNT3FHIlOGWOmkQafdSP8.jpg?s=a42ac7a6c6814750c58531b2fa304c98", "width": 250}, "variants": {}}]}, "retrieved_on": 1494626280, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/PLVwJoym33ndwoiSTmT1xLV9lye-xaOWNYUFHzy0jXY.jpg", "thumbnail_height": 106, "thumbnail_width": 140, "title": "Dr. Parikh on the Optimal Frontline Therapy for Patients With CLL", "url": "http://www.onclive.com/onclive-tv/dr-parikh-on-the-optimal-frontline-therapy-for-patients-with-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1492663030, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/66fjnp/dr_zelenetz_on_potential_of_acalabrutinib_and/", "gilded": 0, "id": "66fjnp", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/66fjnp/dr_zelenetz_on_potential_of_acalabrutinib_and/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "f8R6bV1fKkdHFcn3v_6cQPPoYevBvD9XuEh7bCaHx0M", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/3KcJoBlBk8AMieZSxw3kU-eGPARC0DSJxEoBg6J_xAs.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=70b7b85f09ba9183b0a786c03c4a5220", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/3KcJoBlBk8AMieZSxw3kU-eGPARC0DSJxEoBg6J_xAs.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=afcdff1b37a57595ee123c97ec4186ba", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/3KcJoBlBk8AMieZSxw3kU-eGPARC0DSJxEoBg6J_xAs.jpg?s=c2a5464da0bc19934af210d16a96d374", "width": 250}, "variants": {}}]}, "retrieved_on": 1494614671, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/t2ZPzw7FX-1G44r8nEiVrM2BlviCErYvws92RRHtwws.jpg", "thumbnail_height": 106, "thumbnail_width": 140, "title": "Dr. Zelenetz on Potential of Acalabrutinib and BGB-3111 in CLL", "url": "http://www.onclive.com/onclive-tv/dr-zelenetz-on-potential-of-acalabrutinib-and-bgb3111-in-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1492662608, "domain": "patientdaily.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/66fij1/fda_to_review_abbvie_drug_to_assist_marrow/", "gilded": 0, "id": "66fij1", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/66fij1/fda_to_review_abbvie_drug_to_assist_marrow/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "eigVP2-DjoH3cotsE4HxQhaLdEE8F9do83ERvTTv_Us", "resolutions": [{"height": 67, "url": "https://i.redditmedia.com/NBLMpDLucg9Jh0uo-F83sdwIqcr7nHYanITcTIB8S-M.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=1f743f4b2e3684d6f7e47372dd6f268a", "width": 108}, {"height": 135, "url": "https://i.redditmedia.com/NBLMpDLucg9Jh0uo-F83sdwIqcr7nHYanITcTIB8S-M.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=377e7d55855617bfb3b9e68df5116bab", "width": 216}, {"height": 200, "url": "https://i.redditmedia.com/NBLMpDLucg9Jh0uo-F83sdwIqcr7nHYanITcTIB8S-M.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=55081e5f5f7e9540a5ed7ef8a0f910fd", "width": 320}], "source": {"height": 375, "url": "https://i.redditmedia.com/NBLMpDLucg9Jh0uo-F83sdwIqcr7nHYanITcTIB8S-M.jpg?s=dd0e44d9f2804f1046e4d0a74e1882a1", "width": 600}, "variants": {}}]}, "retrieved_on": 1494614655, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/dCu1jFkFGXetCkQklm0FIY0E_bcpudc7Hj6dUHP5r60.jpg", "thumbnail_height": 87, "thumbnail_width": 140, "title": "FDA to review AbbVie drug to assist marrow transplants", "url": "http://patientdaily.com/stories/511104706-fda-to-review-abbvie-drug-to-assist-marrow-transplants"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1492578758, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/6688y9/ibrutinib_discontinuation_in_cll_examined_to_help/", "gilded": 0, "id": "6688y9", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/6688y9/ibrutinib_discontinuation_in_cll_examined_to_help/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "RmcTw3I1y4Nq30D50TzDw-E8wHtuGoUtqNpVzih8pWM", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/1gQfh9eyOIvjIcFo3H5yQorRp08K7aAtxt4DEXLdzLI.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=08710367be31a48764431391a32a988c", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/1gQfh9eyOIvjIcFo3H5yQorRp08K7aAtxt4DEXLdzLI.jpg?s=638df5d4a96983793db5bb4f6c1867f3", "width": 200}, "variants": {}}]}, "retrieved_on": 1494611069, "score": 3, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/uu52hY91C8b7RfK0KuBJPMpw0keXTbAHSuf3s2vlAag.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Ibrutinib Discontinuation in CLL Examined to Help Develop Salvage Approaches", "url": "http://www.onclive.com/web-exclusives/ibrutinib-discontinuation-in-cll-examined-to-help-develop-salvage-approaches"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1492189252, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/65dq3s/akt_inhibition_with_mk2206_in_relapsedrefractory/", "gilded": 0, "id": "65dq3s", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/65dq3s/akt_inhibition_with_mk2206_in_relapsedrefractory/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "9U3WMCVAxMq6tqYydGRhZmoWYbLceT_X8ihzE4F9RcE", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/ZYdfuIe7v8xt2He5fQVUdr7N1mgbRngs6sTwhPMbTzM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=c4d9e82fdaa83faacce8e10a6d0969dd", "width": 108}, {"height": 142, "url": "https://i.redditmedia.com/ZYdfuIe7v8xt2He5fQVUdr7N1mgbRngs6sTwhPMbTzM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=a97ed658646dd03085521721247ad3e4", "width": 216}, {"height": 211, "url": "https://i.redditmedia.com/ZYdfuIe7v8xt2He5fQVUdr7N1mgbRngs6sTwhPMbTzM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=a06ddfc421ce5b81c4a2cf42df0176c0", "width": 320}, {"height": 422, "url": "https://i.redditmedia.com/ZYdfuIe7v8xt2He5fQVUdr7N1mgbRngs6sTwhPMbTzM.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=bf6534fb0d16dc1f4d741fcaad88fe0d", "width": 640}], "source": {"height": 481, "url": "https://i.redditmedia.com/ZYdfuIe7v8xt2He5fQVUdr7N1mgbRngs6sTwhPMbTzM.jpg?s=f120ce269ea0d0256b31eeaf58033741", "width": 728}, "variants": {}}]}, "retrieved_on": 1494595852, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/w7eYktvtcl8I1Kl2zip0DlqBneOkbcQcsoeT-HIdcHE.jpg", "thumbnail_height": 92, "thumbnail_width": 140, "title": "Akt Inhibition With MK-2206 in Relapsed/Refractory Chronic Lymphocytic Leukemia", "url": "http://www.cancertherapyadvisor.com/chronic-lymphocytic-leukemia/chronic-leukemia-cll-akt-inhibition-mk2206-treatment/article/650433/"}, {"author": "[deleted]", "author_flair_css_class": null, "author_flair_text": null, "brand_safe": false, "contest_mode": false, "created_utc": 1492123663, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/658w6h/bcl2_bcr_inhibitors_show_promise_in/", "gilded": 0, "id": "658w6h", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/658w6h/bcl2_bcr_inhibitors_show_promise_in/", "retrieved_on": 1494593463, "score": 1, "secure_media_embed": {}, "selftext": "[deleted]", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "thumbnail_height": 93, "thumbnail_width": 140, "title": "BCL-2, BCR Inhibitors Show Promise in Relapsed/Refractory CLL", "url": "http://www.cancertherapyadvisor.com/chronic-lymphocytic-leukemia/chronic-leukemia-cll-bcl2-bcr-inhibitor-shows-promise/article/650432/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1492123614, "domain": "lymphomanewstoday.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/658w01/arqule_wins_fda_approval_to_begin_clinical/", "gilded": 0, "id": "658w01", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/658w01/arqule_wins_fda_approval_to_begin_clinical/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "ODhF8l1TF5ZqLvRnXbTBKl2DNU4C64OV-OHG85g7nMI", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/kxowe6Px7xNU748YduB6QjxIDPTsEH7InGt1ofsfwSg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=0b9f6297663dc8b71cd36c42fa912e7f", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/kxowe6Px7xNU748YduB6QjxIDPTsEH7InGt1ofsfwSg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=b659c3625de824c37c0a23a235f8e0d4", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/kxowe6Px7xNU748YduB6QjxIDPTsEH7InGt1ofsfwSg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=1fa711a010492c49e0960ed970cd4565", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/kxowe6Px7xNU748YduB6QjxIDPTsEH7InGt1ofsfwSg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=bbe9a2ae4252e5e1f50b6680b6825b4a", "width": 640}, {"height": 640, "url": "https://i.redditmedia.com/kxowe6Px7xNU748YduB6QjxIDPTsEH7InGt1ofsfwSg.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=960&amp;s=862c1c5bfb5486a456c5ea2ae29f8c7c", "width": 960}], "source": {"height": 667, "url": "https://i.redditmedia.com/kxowe6Px7xNU748YduB6QjxIDPTsEH7InGt1ofsfwSg.jpg?s=3e5b19e29c84ed699c4eb57fb433e556", "width": 1000}, "variants": {}}]}, "retrieved_on": 1494593461, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/U_72f3V-75fA_X9Yk8O-3wLOPmh6bBHQt8hIxRM5N2I.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "ArQule Wins FDA Approval to Begin Clinical Testing of ARQ 531 in B-cell Leukemias", "url": "https://lymphomanewstoday.com/2017/04/13/patients-b-cell-malignancies-arq-531-therapy-fda-approval/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1492051765, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/652wi8/dr_goy_discusses_recent_updates_in_the_treatment/", "gilded": 0, "id": "652wi8", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/652wi8/dr_goy_discusses_recent_updates_in_the_treatment/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "idV2HTcD_PSZcNNy56uaUn3V3inrv5av37uYulV5S5E", "resolutions": [{"height": 82, "url": "https://i.redditmedia.com/LUhQHreIXt4Bd1zwKdMmC5uPwYyASlJs5tBRVPypSz8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=2ffc4ff4edb67514e25441c675f1f610", "width": 108}, {"height": 164, "url": "https://i.redditmedia.com/LUhQHreIXt4Bd1zwKdMmC5uPwYyASlJs5tBRVPypSz8.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=9ab387f7a96808b2c7d4f188b5e83d13", "width": 216}], "source": {"height": 190, "url": "https://i.redditmedia.com/LUhQHreIXt4Bd1zwKdMmC5uPwYyASlJs5tBRVPypSz8.jpg?s=2a8aef5f46a265211233ae0693bd6c5b", "width": 250}, "variants": {}}]}, "retrieved_on": 1494590492, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/RBrqQDJMGAekwRaLa21EBUv2GSMEYwQ9Db8a74enQf8.jpg", "thumbnail_height": 106, "thumbnail_width": 140, "title": "Dr. Goy Discusses Recent Updates in the Treatment of CLL", "url": "http://www.onclive.com/onclive-tv/dr-goy-discusses-recent-updates-in-the-treatment-of-cll"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1492051739, "domain": "pharmiweb.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/652wfk/scottish_medicines_consortium_smc_recommends/", "gilded": 0, "id": "652wfk", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/652wfk/scottish_medicines_consortium_smc_recommends/", "retrieved_on": 1494590491, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Scottish Medicines Consortium (SMC) recommends Imbruvica (ibrutinib) for restricted use in patients with Chronic Lymphocytic Leukaemia (CLL) in Scotland", "url": "http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=214815#.WO7ivNLyuUk"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1492051682, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/652w90/beyond_myeloma_new_roles_for_imids/", "gilded": 0, "id": "652w90", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/652w90/beyond_myeloma_new_roles_for_imids/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "by3lfEobUeyH9SI60jSk2sUncoLpgaDrds9bOAexfeY", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/emWEVT0LgjOhyRC3PLRVMbFVrSPdFhttMjCWLNqstXQ.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=f719af00ed17d735d989868ab7f04457", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/emWEVT0LgjOhyRC3PLRVMbFVrSPdFhttMjCWLNqstXQ.jpg?s=b521909842174fdab11f027b2c4fdd04", "width": 200}, "variants": {}}]}, "retrieved_on": 1494590489, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/xMRaIAtfbzRmFQqfrossMb9xF_Z5KksrNsqdKqYDgS4.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Beyond Myeloma: New Roles for IMiDs", "url": "http://www.onclive.com/publications/oncology-live/2017/vol-18-no-07/beyond-myeloma-new-roles-for-imids"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1491973637, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/64w7ux/cd49d_expression_associated_with_lymphadenopathy/", "gilded": 0, "id": "64w7ux", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/64w7ux/cd49d_expression_associated_with_lymphadenopathy/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "5q6PpmynrCZnXcos5tnp_SL8x_aYIJAJGgZMSk16gB0", "resolutions": [{"height": 72, "url": "https://i.redditmedia.com/Lzj4OUIvqoT_HpnUzTRFSRLlyWL8FySp302PPrvhYH0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=9c1dcbc84dca93b70cc5659b8d1c389e", "width": 108}, {"height": 144, "url": "https://i.redditmedia.com/Lzj4OUIvqoT_HpnUzTRFSRLlyWL8FySp302PPrvhYH0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=72e4e282ba4eb927c1b58ba70c7ed95e", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/Lzj4OUIvqoT_HpnUzTRFSRLlyWL8FySp302PPrvhYH0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=c4835155663515bd6668666f2b49415f", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/Lzj4OUIvqoT_HpnUzTRFSRLlyWL8FySp302PPrvhYH0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=275a82e3e819255fcb818dd662d0b122", "width": 640}], "source": {"height": 485, "url": "https://i.redditmedia.com/Lzj4OUIvqoT_HpnUzTRFSRLlyWL8FySp302PPrvhYH0.jpg?s=4ec63dc5539cf93c79dbccc56651fd51", "width": 727}, "variants": {}}]}, "retrieved_on": 1494587157, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/NZuqWUo4BCy8og17VUuKRBg-fVoKGYaz_jkuy6xWuak.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "CD49d Expression Associated With Lymphadenopathy in CLL", "url": "http://www.cancertherapyadvisor.com/chronic-lymphocytic-leukemia/chronic-leukemia-cll-cd49d-expression-lymphadenopathy/article/649647/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1491883598, "domain": "healio.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/64omsm/outcomes_worse_for_cll_patients_who_discontinue/", "gilded": 0, "id": "64omsm", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/64omsm/outcomes_worse_for_cll_patients_who_discontinue/", "retrieved_on": 1494583326, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Outcomes worse for CLL patients who discontinue ibrutinib after disease transformation", "url": "http://www.healio.com/hematology-oncology/leukemia/news/in-the-journals/%7Bbd693ff4-a2ce-4fb5-ae42-2f7011ea88a3%7D/outcomes-worse-for-cll-patients-who-discontinue-ibrutinib-after-disease-transformation"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1491680774, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/648z7z/expert_summarizes_state_of_car_tcell_therapy_in/", "gilded": 0, "id": "648z7z", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/648z7z/expert_summarizes_state_of_car_tcell_therapy_in/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "J0qAmdC9piPkocYZRArngvtVzvNpTW9xX4crSEufQp0", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/iC1bTwinaP7_Kkb8gYojFkvW8smOY1fkEqA7Xt_oLvo.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=f44f7f382c6ad3d7aea607f39cae513c", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/iC1bTwinaP7_Kkb8gYojFkvW8smOY1fkEqA7Xt_oLvo.jpg?s=f865639823f7437be4f17054603b1394", "width": 200}, "variants": {}}]}, "retrieved_on": 1494575588, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/LKnBQja60hluWNHtrvRMSOdoVMAQOIjbAnYeuwq9K7s.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "Expert Summarizes State of CAR T-Cell Therapy in Hematologic Malignancies", "url": "http://www.onclive.com/web-exclusives/expert-summarizes-state-of-car-tcell-therapy-in-hematologic-malignancies"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1491490887, "domain": "onclive.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/63tgas/fda_accepts_ibrutinib_application_for_gvhd/", "gilded": 0, "id": "63tgas", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 1, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/63tgas/fda_accepts_ibrutinib_application_for_gvhd/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "LDBOz-0psdN_dizDyxcY9CegH7vWmTgTlAWnQoAUbKs", "resolutions": [{"height": 108, "url": "https://i.redditmedia.com/w8FxBJkR7N8JGw2Ajt70mTjm0oMr02T7foGyFP8GkSU.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=4d6aa530f309409738136c5ad3e911c1", "width": 108}], "source": {"height": 200, "url": "https://i.redditmedia.com/w8FxBJkR7N8JGw2Ajt70mTjm0oMr02T7foGyFP8GkSU.jpg?s=cb1d27f9924ce02d62b3b94e1b9df05b", "width": 200}, "variants": {}}]}, "retrieved_on": 1494567864, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://a.thumbs.redditmedia.com/YVnmYIJKtJW_cG3du4Q4pNyRkHnGdlj8zaQb5yVf878.jpg", "thumbnail_height": 140, "thumbnail_width": 140, "title": "FDA Accepts Ibrutinib Application for GVHD", "url": "http://www.onclive.com/web-exclusives/fda-accepts-ibrutinib-application-for-gvhd"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1491355426, "domain": "cancertherapyadvisor.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/63ii1c/fda_accepts_for_review_ibrutinibs_snda_for_cgvhd/", "gilded": 0, "id": "63ii1c", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/63ii1c/fda_accepts_for_review_ibrutinibs_snda_for_cgvhd/", "post_hint": "link", "preview": {"enabled": false, "images": [{"id": "RtRtE4rFVwiF52cfyxk9nSuTkFC1Q6Yj4vnWPiWXnnE", "resolutions": [{"height": 71, "url": "https://i.redditmedia.com/XDN7cIh5ZBcGLvMSwOtvZFyJ52nCJuuT-M0jinfx0p0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=108&amp;s=0c38008c494e2c18ecfa60af09d4edfd", "width": 108}, {"height": 143, "url": "https://i.redditmedia.com/XDN7cIh5ZBcGLvMSwOtvZFyJ52nCJuuT-M0jinfx0p0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=216&amp;s=967b425fa7a38a9c39f33a9cecfa99b0", "width": 216}, {"height": 213, "url": "https://i.redditmedia.com/XDN7cIh5ZBcGLvMSwOtvZFyJ52nCJuuT-M0jinfx0p0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=320&amp;s=9871c4f72bbd9dea9e676a5c4b3b240d", "width": 320}, {"height": 426, "url": "https://i.redditmedia.com/XDN7cIh5ZBcGLvMSwOtvZFyJ52nCJuuT-M0jinfx0p0.jpg?fit=crop&amp;crop=faces%2Centropy&amp;arh=2&amp;w=640&amp;s=0ce19812e13670c5ae04b2b9e6c9bc68", "width": 640}], "source": {"height": 483, "url": "https://i.redditmedia.com/XDN7cIh5ZBcGLvMSwOtvZFyJ52nCJuuT-M0jinfx0p0.jpg?s=b8408724d4741814d37a5c7dff75766e", "width": 725}, "variants": {}}]}, "retrieved_on": 1494562350, "score": 2, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "https://b.thumbs.redditmedia.com/fY7Fd7VfFw0kxWESL9YFqEFkgZOXoDJpage2XgW0sDc.jpg", "thumbnail_height": 93, "thumbnail_width": 140, "title": "FDA Accepts for Review Ibrutinib's sNDA for cGVHD", "url": "http://www.cancertherapyadvisor.com/side-effect-management/fda-accepts-ibrutinib-snda-gvhd-graft-host-disease/article/648422/"}, {"author": "HighYield", "author_created_utc": 1395854191, "author_flair_css_class": null, "author_flair_text": null, "author_fullname": "t2_fv3pu", "brand_safe": false, "contest_mode": false, "created_utc": 1491008716, "domain": "engine.scichina.com", "full_link": "https://www.reddit.com/r/CLL_Leukemia/comments/62pl4s/gold_nanoclusters_suppress_cll_cells_by/", "gilded": 0, "id": "62pl4s", "is_self": false, "locked": false, "media_embed": {}, "num_comments": 0, "over_18": false, "permalink": "/r/CLL_Leukemia/comments/62pl4s/gold_nanoclusters_suppress_cll_cells_by/", "retrieved_on": 1492477458, "score": 1, "secure_media_embed": {}, "selftext": "", "spoiler": false, "stickied": false, "subreddit": "CLL_Leukemia", "subreddit_id": "t5_3i04y", "suggested_sort": "confidence", "thumbnail": "default", "title": "Gold Nanoclusters Suppress CLL Cells by Inhibiting Thioredoxin Reductase 1, Induce Apoptosis (PDF Download for Full Text)", "url": "http://engine.scichina.com/publisher/scp/journal/SB/doi/10.1016/j.scib.2017.03.024?slug=abstract"}]